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Summary
ChIP-chip is a technology originally developed to determine the binding sites
of proteins in chromatin on a genome wide scale. Its uses have since been
expanded to analyse other genome features, such as epigenetic modifications
and, in our laboratory, DNA damage. Datasets comprise many thousands of
data points and therefore require bioinformatic tools for their analysis. Cur-
rently available tools are limited in their applications and lack the ability to
normalise data so as to allow relative comparisons between different datasets.
This has limited the analyses of multiple ChIP-chip datasets from different
experimental conditions.
The first part of the study presented here is bioinformatic, presenting a
selection of tools written in R for ChIP-chip data analysis, including a novel
normalisation procedure which allows datasets from different conditions to be
analysed together, permitting comparisons of values between different exper-
iments and opening up a new dimension of analysis of these datasets. A novel
enrichment detection procedure is presented, suited to many formats of data,
including protein binding (which forms peaks) and epigenetic modifications
(which can form extended regions of enrichment). Graphical tools are also
presented, to facilitate the analysis of these large datasets. A method of pre-
dicting the output of a ChIP-chip dataset is presented, which has been used
to show that ChIP-chip is capable of detecting sequence dependent damage
events. All functions work together, using a common data format, and are
efficient and easy to use.
The second part of this study applies these bioinformatic tools in a bi-
ological context. An analysis of Abf1 protein binding datasets has been
undertaken, revealing many more binding sites than had previously been
identified. Analysis of the sequences at these binding sites identified the pre-
viously determined consensus binding motif in only a subset, with no novel
motif identifiable in the remainder, suggesting binding may be influenced by
factors other than sequence.

Contents
List of Figures xii
List of Tables xv
List of R Scripts xvi
List of Abbreviations xviii
1 Introduction 1
1.1 Microarrays . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Hypothesis generation . . . . . . . . . . . . . . . . . . 2
1.1.2 Types of microarray . . . . . . . . . . . . . . . . . . . 4
1.1.2.1 RNA detection . . . . . . . . . . . . . . . . . 5
1.1.2.2 DNA detection . . . . . . . . . . . . . . . . . 7
1.1.2.3 Protein detection . . . . . . . . . . . . . . . . 11
1.1.2.4 Other applications . . . . . . . . . . . . . . . 11
1.1.3 Normalisation . . . . . . . . . . . . . . . . . . . . . . . 11
1.1.3.1 Gene expression . . . . . . . . . . . . . . . . 14
1.1.3.2 ChIP-chip . . . . . . . . . . . . . . . . . . . . 20
1.1.4 ChIP-chip data processing . . . . . . . . . . . . . . . . 25
1.1.4.1 Peak detection . . . . . . . . . . . . . . . . . 26
1.1.4.2 Making comparisons between datasets . . . . 27
1.2 DNA damage . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
1.2.1 DNA . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
1.2.1.1 Structure . . . . . . . . . . . . . . . . . . . . 31
1.2.1.2 Chromatin . . . . . . . . . . . . . . . . . . . 32
1.2.1.3 Replication . . . . . . . . . . . . . . . . . . . 32
1.2.2 DNA damage and repair . . . . . . . . . . . . . . . . . 33
1.2.2.1 Base modifications . . . . . . . . . . . . . . . 34
1.2.2.2 Structural alterations . . . . . . . . . . . . . . 36
1.2.2.3 Strand breakages . . . . . . . . . . . . . . . . 39
vii
1.2.3 Consequences of defective DNA repair . . . . . . . . . 41
1.2.3.1 Congenital diseases . . . . . . . . . . . . . . . 41
1.2.3.2 Acquired diseases . . . . . . . . . . . . . . . . 43
1.3 Measuring DNA damage . . . . . . . . . . . . . . . . . . . . . 46
1.3.1 Low resolution techniques . . . . . . . . . . . . . . . . 47
1.3.2 High resolution techniques . . . . . . . . . . . . . . . . 51
1.4 CPDs and NER: a paradigm . . . . . . . . . . . . . . . . . . . 52
1.4.1 Ultra violet radiation . . . . . . . . . . . . . . . . . . . 52
1.4.1.1 Cyclobutane pyrimidine dimers . . . . . . . . 53
1.4.2 Saccharomyces cerevisiae as a model organism . . . . . 53
1.4.3 Nucleotide excision repair . . . . . . . . . . . . . . . . 55
1.4.3.1 Lesion recognition . . . . . . . . . . . . . . . 56
1.4.3.2 Lesion repair . . . . . . . . . . . . . . . . . . 58
1.4.4 The Abf1 protein . . . . . . . . . . . . . . . . . . . . . 59
1.4.4.1 Role in NER . . . . . . . . . . . . . . . . . . 62
1.5 This study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
2 Technical Overview 67
2.1 Microarrays . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
2.2 Chromatin immunoprecipitation . . . . . . . . . . . . . . . . . 69
2.3 Amplification . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
2.4 Fluorescent labelling and hybridisation . . . . . . . . . . . . . 71
2.5 Microarray processing . . . . . . . . . . . . . . . . . . . . . . 72
2.6 Feature extraction . . . . . . . . . . . . . . . . . . . . . . . . 72
2.7 Data analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
3 Creation of a collection of R scripts to process and interrogate
ChIP-chip data 75
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3.2 The scripts . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
3.2.1 Loading data . . . . . . . . . . . . . . . . . . . . . . . 79
3.2.1.1 Utilising limma . . . . . . . . . . . . . . . . . 79
3.2.1.2 The arrayData class . . . . . . . . . . . . . . 80
3.2.1.3 Creating new arrayData objects . . . . . . . 81
3.2.1.4 Writing arrayData to external files . . . . . . 92
3.2.1.5 The genomeAnnotation class . . . . . . . . . 94
3.2.2 Quality assessment . . . . . . . . . . . . . . . . . . . . 97
3.2.3 Accessing data . . . . . . . . . . . . . . . . . . . . . . 102
3.2.4 Manipulation of arrayData objects . . . . . . . . . . . 104
3.2.5 Displaying data . . . . . . . . . . . . . . . . . . . . . . 109
3.2.6 Plotting data . . . . . . . . . . . . . . . . . . . . . . . 112
viii
3.2.6.1 Genome plots . . . . . . . . . . . . . . . . . . 112
3.2.6.2 Histograms, density and Q-Q plots . . . . . . 124
3.2.6.3 Profile plots . . . . . . . . . . . . . . . . . . . 130
3.2.6.4 Rainbow plots . . . . . . . . . . . . . . . . . 139
3.2.7 Annotating data . . . . . . . . . . . . . . . . . . . . . 142
3.2.7.1 Positions plot . . . . . . . . . . . . . . . . . . 146
3.2.7.2 Venn diagrams . . . . . . . . . . . . . . . . . 149
3.2.7.3 Extracting sequence information . . . . . . . 153
3.3 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 154
4 Development of a novel normalisation method 158
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
4.2 Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
4.2.1 Expectations of the data . . . . . . . . . . . . . . . . . 160
4.2.2 Overview . . . . . . . . . . . . . . . . . . . . . . . . . 162
4.2.3 Preprocessing . . . . . . . . . . . . . . . . . . . . . . . 164
4.2.3.1 Removing irrelevant probe values . . . . . . . 164
4.2.3.2 Removing absent values . . . . . . . . . . . . 169
4.2.4 Full processing . . . . . . . . . . . . . . . . . . . . . . 170
4.2.4.1 Quantile normalisation . . . . . . . . . . . . . 170
4.2.4.2 Pseudo-modal shift and background scaling . 175
4.3 Application . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182
4.3.1 Validation . . . . . . . . . . . . . . . . . . . . . . . . . 194
4.4 Alternative process . . . . . . . . . . . . . . . . . . . . . . . . 195
4.4.1 DNA spikes . . . . . . . . . . . . . . . . . . . . . . . . 195
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
5 Development of a novel enrichment detection method 207
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
5.1.1 Existing methods . . . . . . . . . . . . . . . . . . . . . 208
5.1.2 Motivation for creating a new method . . . . . . . . . 214
5.2 Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
5.2.1 Window determination . . . . . . . . . . . . . . . . . . 224
5.2.1.1 Cutoff calculation . . . . . . . . . . . . . . . . 233
5.2.2 Enrichment detection . . . . . . . . . . . . . . . . . . . 235
5.2.3 Peak detection . . . . . . . . . . . . . . . . . . . . . . 236
5.3 Testing the performance of the algorithm . . . . . . . . . . . . 241
5.3.1 Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244
5.3.1.1 Creating simulated ChIP-chip data . . . . . . 244
5.3.1.2 Using spike datasets . . . . . . . . . . . . . . 245
5.3.2 Optimisation of the algorithm . . . . . . . . . . . . . . 246
ix
5.3.2.1 Optimising the window size selection . . . . . 253
5.3.2.2 Optimising the FDRE value selection . . . . . 258
5.3.2.3 Optimising the scale value selection . . . . . . 260
5.3.2.4 Summary . . . . . . . . . . . . . . . . . . . . 267
5.3.3 Comparison with other methods . . . . . . . . . . . . . 269
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271
6 Development of a method to predict sequence specific dam-
age events 275
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 275
6.2 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 276
6.3 Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . 276
6.4 Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 280
6.5 Alternative algorithm . . . . . . . . . . . . . . . . . . . . . . . 280
6.6 Application . . . . . . . . . . . . . . . . . . . . . . . . . . . . 284
6.6.1 Comparisons . . . . . . . . . . . . . . . . . . . . . . . 287
6.6.2 Uses . . . . . . . . . . . . . . . . . . . . . . . . . . . . 290
6.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 294
7 Genome wide analysis of the binding site locations of the
Abf1 protein 295
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . 295
7.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
7.2.1 Generation of data . . . . . . . . . . . . . . . . . . . . 296
7.2.2 Data validation . . . . . . . . . . . . . . . . . . . . . . 296
7.2.3 Data normalisation . . . . . . . . . . . . . . . . . . . . 297
7.2.4 Peak detection . . . . . . . . . . . . . . . . . . . . . . 297
7.2.5 Hypergeometric distribution . . . . . . . . . . . . . . . 297
7.2.6 Sequence extraction . . . . . . . . . . . . . . . . . . . . 298
7.2.7 Sequence analysis . . . . . . . . . . . . . . . . . . . . . 298
7.2.8 Motif logo creation . . . . . . . . . . . . . . . . . . . . 298
7.2.9 Ganapathi data . . . . . . . . . . . . . . . . . . . . . . 299
7.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 300
7.3.1 Data validation . . . . . . . . . . . . . . . . . . . . . . 300
7.3.2 Consequences of normalisation . . . . . . . . . . . . . . 302
7.3.3 Peak detection . . . . . . . . . . . . . . . . . . . . . . 308
7.3.4 Genomic binding site locations . . . . . . . . . . . . . . 315
7.3.5 Comparison with other datasets . . . . . . . . . . . . . 316
7.3.6 Sequences at binding sites . . . . . . . . . . . . . . . . 323
7.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 334
x
8 Conclusions and future work 337
Bibliography 343
A Electronic Appendix Structure 367
xi
List of Figures
1.1 Gene expression microarray data representation . . . . . . . . 15
1.2 Total intensity normalisation representation . . . . . . . . . . 18
1.3 Lowess normalisation representation . . . . . . . . . . . . . . . 19
1.4 ChIP-chip microarray data representation . . . . . . . . . . . 23
1.5 The cyclobutane pyrimidine dimer . . . . . . . . . . . . . . . . 54
1.6 Kinked DNA molecule . . . . . . . . . . . . . . . . . . . . . . 54
1.7 Abf1 and GG-NER . . . . . . . . . . . . . . . . . . . . . . . . 64
2.1 Agilent 4 x 44k microarray format . . . . . . . . . . . . . . . . 68
2.2 The importance of IP and input samples . . . . . . . . . . . . 74
2.3 Feature extraction file format . . . . . . . . . . . . . . . . . . 74
3.1 Overview of the functions presented . . . . . . . . . . . . . . . 78
3.2 Tab-delimited file format . . . . . . . . . . . . . . . . . . . . . 83
3.3 Output of the checkData function . . . . . . . . . . . . . . . . 103
3.4 Output of arrayData show method . . . . . . . . . . . . . . . 111
3.5 Output of arrayData summary method . . . . . . . . . . . . . 113
3.6 Output of arrayData plot method . . . . . . . . . . . . . . . 125
3.7 Output of arrayData statistical graphics . . . . . . . . . . . . 131
3.8 Output of profilePlot function . . . . . . . . . . . . . . . . 140
3.9 ORF position examples . . . . . . . . . . . . . . . . . . . . . . 145
3.10 Output of positionsPlot function . . . . . . . . . . . . . . . 148
4.1 Examples of data distributions . . . . . . . . . . . . . . . . . . 161
4.2 Mitochondrial probe binding values . . . . . . . . . . . . . . . 167
4.3 Probe GC contents . . . . . . . . . . . . . . . . . . . . . . . . 167
4.4 The effect of quantile normalisation on data . . . . . . . . . . 173
4.5 Example data Q-Q plots . . . . . . . . . . . . . . . . . . . . . 174
4.6 Representation of the pseudo-modal shift . . . . . . . . . . . . 177
4.7 Representation of the background scaling . . . . . . . . . . . . 181
4.8 Density plots of H3Ac data undergoing normalisation . . . . . 183
4.9 Density plots of Gcn5p data undergoing normalisation . . . . 184
xii
4.10 Profiles of replicate H3Ac data undergoing normalisation . . . 186
4.11 Profiles of averaged H3Ac data undergoing normalisation . . . 187
4.12 Profiles of replicate Gcn5 binding data undergoing normalisation188
4.13 Profiles of averaged Gcn5 data undergoing normalisation . . . 189
4.14 Q-Q plots of H3Ac data undergoing normalisation . . . . . . . 192
4.15 Q-Q plots of Gcn5p data pre- and post-normalisation . . . . . 193
4.16 Probes chosen for Q-PCR analysis . . . . . . . . . . . . . . . . 196
4.17 Bar charts of data from probes chosen for Q-PCR . . . . . . . 197
4.18 Bar charts of microarray and Q-PCR data . . . . . . . . . . . 198
4.19 Microarray and Q-PCR values correlation . . . . . . . . . . . 200
5.1 Representation of the formation of a peak shape . . . . . . . . 226
5.2 How different window sizes affect enrichment detection . . . . 227
5.3 Examples of sliding windows . . . . . . . . . . . . . . . . . . . 229
5.4 Representation of window determination . . . . . . . . . . . . 229
5.5 Window determination and enrichment detection process flow
chart . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231
5.6 Representation of window determination and enrichment de-
tection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232
5.7 Enrichment detection representation . . . . . . . . . . . . . . 237
5.8 Peak detection process flow chart . . . . . . . . . . . . . . . . 239
5.9 Representation of peak determination . . . . . . . . . . . . . . 240
5.10 Calculating the PBR with consistent peaks . . . . . . . . . . . 242
5.11 Calculating the PBR with inconsistent peaks . . . . . . . . . . 243
5.12 Johnson et. al.’s data correlations . . . . . . . . . . . . . . . . 248
5.13 ROC plot properties . . . . . . . . . . . . . . . . . . . . . . . 252
5.14 Labelling of consecutive enriched regions . . . . . . . . . . . . 254
5.15 ROC curves from window size variations . . . . . . . . . . . . 257
5.16 ROC curves from FDRE variations . . . . . . . . . . . . . . . 261
5.17 ROC curves from simulated data . . . . . . . . . . . . . . . . 263
5.18 ROC curves from averaged spiked data . . . . . . . . . . . . . 265
5.19 ROC curves from combined spiked data . . . . . . . . . . . . . 266
5.20 Example analysis of peak detection results . . . . . . . . . . . 270
5.21 ROC-like curves created by Johnson et al. (2008) . . . . . . . 272
6.1 CPD dataset density plots . . . . . . . . . . . . . . . . . . . . 277
6.2 CPD damage profile . . . . . . . . . . . . . . . . . . . . . . . 285
6.3 CPD damage scatter plot . . . . . . . . . . . . . . . . . . . . . 286
6.4 Histogram of predicted and actual differences . . . . . . . . . 291
6.5 Q-Q plot of predicted and actual differences . . . . . . . . . . 292
6.6 Q-Q plot of predicted and actual non-outlier differences . . . . 293
xiii
7.1 Abf1 checkData output . . . . . . . . . . . . . . . . . . . . . 301
7.2 Raw Abf1 data density plots . . . . . . . . . . . . . . . . . . . 304
7.3 Normalised Abf1 data density plots . . . . . . . . . . . . . . . 305
7.4 Raw Abf1 data profile . . . . . . . . . . . . . . . . . . . . . . 306
7.5 Normalised Abf1 data profile . . . . . . . . . . . . . . . . . . . 306
7.6 Effect of normalisation on averaged Abf1 data . . . . . . . . . 307
7.7 Abf1 data correlations . . . . . . . . . . . . . . . . . . . . . . 309
7.8 Venn diagram of Abf1 peaks . . . . . . . . . . . . . . . . . . . 310
7.9 Venn diagram of overlapping Abf1 peaks . . . . . . . . . . . . 310
7.10 Rainbow plot of Abf1 peak changes . . . . . . . . . . . . . . . 312
7.11 Scatter plots of Abf1 peak changes . . . . . . . . . . . . . . . 313
7.12 Abf1 peaks profile plot . . . . . . . . . . . . . . . . . . . . . . 314
7.13 Abf1 binding site locations . . . . . . . . . . . . . . . . . . . . 317
7.14 Filtered Abf1 binding site locations . . . . . . . . . . . . . . . 318
7.15 Previously published Abf1 comparisons . . . . . . . . . . . . . 320
7.16 Ganapathi et. al.’s data . . . . . . . . . . . . . . . . . . . . . 322
7.17 Sequence logos from PBRs containing the consensus . . . . . . 326
7.18 Sequence logos from all PBRs . . . . . . . . . . . . . . . . . . 326
7.19 Sequence logos from filtered PBRs . . . . . . . . . . . . . . . . 328
7.20 Sequence logos from PBRs without the consensus . . . . . . . 329
7.21 Sequence logos with variable gap regions from PBRs without
the consensus . . . . . . . . . . . . . . . . . . . . . . . . . . . 329
7.22 Sequence logos from filtered PBRs without the consensus . . . 330
7.23 Sequence logos with variable gap regions from filtered PBRs
without the consensus . . . . . . . . . . . . . . . . . . . . . . 330
7.24 Abf1 peak heights and numbers of motifs . . . . . . . . . . . . 332
7.25 Gaps between Abf1 peaks and motifs . . . . . . . . . . . . . . 333
xiv
List of Tables
4.1 Quantile normalisation example data . . . . . . . . . . . . . . 171
4.2 Quantile normalisation example processing . . . . . . . . . . . 171
4.3 Quantile normalisation example result . . . . . . . . . . . . . 174
4.4 Normalisaed microarray and Q-PCR comparison P-values . . . 199
4.5 Raw microarray and Q-PCR comparison P-values . . . . . . . 199
4.6 Spike probes summary . . . . . . . . . . . . . . . . . . . . . . 202
5.1 Peak detection methods . . . . . . . . . . . . . . . . . . . . . 209
5.2 Johnson et al. (2008) spike datasets . . . . . . . . . . . . . . . 247
5.3 Window sizes for testing simulated data . . . . . . . . . . . . 254
5.4 Window sizes for testing spike data . . . . . . . . . . . . . . . 255
5.5 FDRE values for testing simulated data . . . . . . . . . . . . . 259
7.1 Abf1 ChIP-chip datasets . . . . . . . . . . . . . . . . . . . . . 296
7.2 Numbers of Abf1 binding peaks detected . . . . . . . . . . . . 309
7.3 Abf1 binding sites found in previous studies . . . . . . . . . . 320
7.4 Abf1 PBR lengths . . . . . . . . . . . . . . . . . . . . . . . . . 324
7.5 Abf1 PBR motif counts . . . . . . . . . . . . . . . . . . . . . . 324
7.6 Filtered Abf1 PBR motif counts . . . . . . . . . . . . . . . . . 328
xv
List of R Scripts
3.1 loadArray . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
3.2 splitCoords . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
3.3 arrayDataValidity . . . . . . . . . . . . . . . . . . . . . . . . . 91
3.4 writeArrayData . . . . . . . . . . . . . . . . . . . . . . . . . . 93
3.5 loadAnnotation . . . . . . . . . . . . . . . . . . . . . . . . . . 95
3.6 genomeAnnotation . . . . . . . . . . . . . . . . . . . . . . . . 96
3.7 checkData . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
3.8 arrayData extraction . . . . . . . . . . . . . . . . . . . . . . . 104
3.9 Mathematical operators . . . . . . . . . . . . . . . . . . . . . 105
3.10 arrayData rowMeans . . . . . . . . . . . . . . . . . . . . . . . 107
3.11 arrayData cbind . . . . . . . . . . . . . . . . . . . . . . . . . . 108
3.12 arrayData display . . . . . . . . . . . . . . . . . . . . . . . . . 109
3.13 plot arrayData . . . . . . . . . . . . . . . . . . . . . . . . . . 115
3.14 plot genomeAnnotation . . . . . . . . . . . . . . . . . . . . . . 121
3.15 arrayData histogram . . . . . . . . . . . . . . . . . . . . . . . 124
3.16 arrayData density plot . . . . . . . . . . . . . . . . . . . . . . 127
3.17 arrayData Q-Q plot . . . . . . . . . . . . . . . . . . . . . . . . 129
3.18 profilePlot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
3.19 rainbowPlot . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
3.20 getProbeInfo . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
3.21 positionsPlot . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
3.22 venn . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
3.23 overlap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
3.24 getSequences . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
4.1 normalise . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
4.2 rmRegions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
4.3 rmNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
4.4 quantileNormalise . . . . . . . . . . . . . . . . . . . . . . . . . 175
4.5 shiftByMode . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
4.6 stNormScale . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
xvi
5.1 peakDetection . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
5.2 consecutive . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
5.3 peakList . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
6.1 predictProfile . . . . . . . . . . . . . . . . . . . . . . . . . . . 282
xvii
List of Abbreviations
A Adenine
Abf1 ARS binding factor 1
ARS Autonomously replicating sequence
BER Base excision repair
bp Base pair(s)
C Cytosine
cDNA Complementary DNA
ChIP Chromatin immunoprecipitation
ChIP-chip ChIP on a microarray chip
CNV Copy number variation
CPD Cyclobutane pyrimidine dimer
DE Differentially expressed
DNA Deoxyribonucleic acid
DSB Double strand break
dsDNA Double stranded DNA
FDRE False discovery rate equivalent
FN False negative
FP False positive
G Guanine
GG-NER Global genome nucleotide excision repair
GRF General regulatory factor
H3Ac Histone H3 acetylation
HAT Histone acetyl transferase
HEJ Homologous end joining
HMM Hidden Markov model
IP Immunoprecipitated
LOH Loss of heterozygosity
Mb Megabase(s)
min Minute(s)
miRNA MicroRNA
mRNA Messenger RNA
xviii
MS Mass spectrometry
NDE Non-differentially expressed
NER Nucleotide excision repair
NHEJ Non-homologous end joining
nm Nanometre(s)
ORF Open reading frame
PARP Poly(ADP-ribose) polymerase
PBR Potential binding region
PCR Polymerase chain reaction
PIC Pre-incision complex
Q-PCR Quantitative polymerase chain reaction
Q-Q Quantile-quantile
RNA Ribonucleic acid
RNAPII RNA polymerase II
RPA Replication protein A
sec Second(s)
SNP Single nucleotide polymorphism
SSB Single strand break
ssDNA Single stranded DNA
SWI/SNF Switch/ sucrose non-fermentable
T Thymine
TC-NER Transcription coupled nucleotide excision repair
TLS Translesion synthesis
TN True negative
TP True positive
U Uracil
UV Ultra violet
xix

Chapter 1
Introduction
Investigations into the induction of, cellular responses to, and the repair of
DNA damage have been crucial to understanding the mechanisms that have
developed within cells to deal with this damage and the implications this
can have on many diseases. Multiple assays have been developed to analyse
different aspects of these in the laboratory. Here, DNA microarrays have
been used to measure some of these end points. Ultra violet (UV) light has
been used to induce DNA damage in cells, which is itself measured with a
novel microarray technology, along with the measurements of various cellular
responses. This study focuses on bioinformatic analyses of data produced
from these investigations and the development of new bioinformatic tools
to facilitate these analyses. It is therefore split into two broad sections:
microarray technology and its associated bioinformatic processing, and the
(nucleotide excision) repair of damaged DNA.
1.1 Microarrays
A microarray, in the molecular biological context, is an array of spots each
containing a sample of DNA for use in genetic testing (OED, 2011). Simply
put, it is a small, rectangular, solid surface containing a regular pattern
of spots of multiple copies of single stranded DNA molecules bound to the
surface at one end. A pool of DNA applied to this surface and allowed to
hybridise to any complementary probes can be detected by means of the
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attachment of fluorescent molecules to the pooled DNA. The sequences of
DNA probes at the features on the microarray are known, and so the presence
of fluorescence at any given location can be associated with that sequence.
The microarrays available today contain tens of thousands to millions of
features each, which can result in the production of vast quantities of data.
There is some variation in terminology in the microarray field. For pur-
poses of clarity, the following definitions will be used throughout this thesis:
Probe An individual strand of DNA of known sequence, bound to the sur-
face of a microarray.
Feature A collection of a number of probes, all of the same sequence, in
an area of defined size and shape and at a known location on the
microarray.
Microarray A collection of a quantity of different features arranged in a
regular pattern of known, defined properties.
Slide The physical object upon which one or more microarrays reside.
This section outlines the different microarray applications currently avail-
able and the in silico procedures used to transform the signals these produce
into biologically meaningful results.
1.1.1 Hypothesis generation
The basic principle of a scientific experiment is to measure a factor of interest
under different conditions so as to prove or disprove a hypothesis relating to
the response of the factor to the different conditions. For example, one may,
based on prior knowledge and observations, formulate the hypothesis that
a protein binds to DNA following a particular treatment. To test this one
could measure the amount of the protein bound to DNA before and after the
treatment. The hypothesis would be proved if the protein was seen bound
to the DNA only after the treatment. This result would then become prior
knowledge and used to formulate and test further hypotheses. This ‘classical’
approach to science, using the accumulation of knowledge to generate and
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test new ideas, has been used for centuries and continues to be a valuable
tool in scientific progression. A famous example is Edward Jenner’s testing
of the hypothesis that cowpox infection conferred smallpox immunity, by
inoculating James Phipps with cowpox and subsequently attempting to infect
him with smallpox, which failed. In addition, many scientific discoveries have
occurred by serendipity, that is, a result was not obtained via the testing of
a hypothesis but by the product of coincidental events. A famous example
is the discovery of penicillin by Alexander Flemming: he did not set out to
test whether or not penicillin was an antibiotic, rather he found the product
of a mould growing on some discarded culture plates of Staphylococci caused
the surrounding cells to undergo lysis.
The advent of the ‘genomics era’ has allowed the development of technolo-
gies that allow new results to be found ‘by chance’, rather than by conduct-
ing specific hypothesis testing investigations. These experiments are termed
‘hypothesis generating’ and facilitate the discovery of results that may not
otherwise have been specifically looked for. This is achieved by the testing
of a large number of individual biological conditions at once, such as the
expression levels of thousands of genes, or the properties of thousands of ge-
nomic regions with respect to some condition, such as protein binding. This
is equivalent to performing thousands of individual assays by conventional
methods, which is not practical, which is why only those designed to test
specific hypotheses are ever carried out. Removing this limitation means
that data can be generated that otherwise would not be and so new and
unexpected phenomena may be found, leading to the generation of new hy-
potheses. Microarray investigations are often carried out with the intention
of being hypothesis generating. The results of an investigation or investi-
gations can be used to construct a hypothesis that may or may not have
otherwise been conceived. That is to say, new or unusual phenomena may be
seen that would never have been specifically looked for and so would remain
unknown unless found by chance.
Genome wide technologies, such as microarrays, generally have too low a
signal-to-noise ratio to prove a hypothesis outright, meaning results need to
be corroborated by alternative, more sensitive technologies. The microarray
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results may lead to the generation of a hypothesis relating to a small number
of factors, all of which can be investigated with more sensitive tests, such as
differential expression in a small number of genes. This can completely prove
or disprove the hypothesis. It may also produce a hypothesis relating to a
large number of factors, such as a protein binding at multiple sites throughout
a genome. In this situation more sensitive tests can be carried out with a
subset of representative data. If these microarray results are shown to be
correct it is reasonable to assume that the data are consistent across the
rest of the microarray. The hypothesis therefore remains valid, but is not
completely proven. A set of results, once generated, has the potential to
be used to generate many more hypotheses, possibly far removed from the
reason the original assay was carried out. This can greatly accelerate the
rate of scientific discovery.
Much of the bioinformatic work presented in this thesis aims to facilitate
the discovery of new results and the generation of new hypotheses. The
graphical display tools (Chapter 3) allow potential patterns in the data to
be discerned; the normalisation procedure (Chapter 4) allows datasets to
be compared, revealing potential novel responses to changes in conditions;
and the enrichment detection procedure (Chapter 5) allows potential novel
binding regions to be identified.
1.1.2 Types of microarray
The first microarray paper was published in 1995 (Schena et al., 1995), where
cellular DNA amounts were measured to gain information on gene expression
levels in the plant Arabidopsis thaliana. This microarray contained only a
fraction of the number of features available on today’s arrays, at 48. The
advances in microarray technology over the 17 years since this publication
have meant microarray use has expanded into several applications. Hoheisel
(2006) provides a summary of these which, although outdated in some cases,
provides a good indication of the range of potential applications. The main
applications available today are summarised in the following sections, along
with their non-microarray alternatives.
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1.1.2.1 RNA detection
Measurement of messenger RNA (mRNA) levels allows the gathering of in-
formation relating to gene expression and the regulation thereof. RNA is
purified from the cell and amplified as complementary DNA (cDNA) which
is applied to the microarray.
Gene expression profiling
Gene expression profiling is the measurement of the level of expression of
genes, indicative of the level of protein production. This can provide im-
portant information about how, when and where genes are expressed or re-
pressed and how this changes in response to particular conditions or between
different cell types, genetic mutants, individuals or disease states. Several
methods have been developed to achieve this, such as creating reporter gene
constructs, where a level of fluorescence or enzymatic activity represents the
level of gene expression, or Northern blots, where the mRNA amount pro-
duced from a gene is visualised by autoradiography using electrophoretic gels
and nitrocellulose paper (Alberts et al., 2002). These technologies are time
consuming and allow the analysis of only small numbers of genes at a time.
Microarrays can overcome this limitation by allowing measurements of the
expression levels of thousands of genes in a single assay.
Profiling of 45 A. thaliana cDNAs was the use of the first microarray
(Schena et al., 1995). This remains the most popular microarray use today
(NIH Entrez search results; data not shown), with microarrays available con-
taining gene sequences from many organisms. Expression profiling allows
the expression levels of genes to be determined by measuring the amounts
of mRNA produced from gene expression. These microarrays contain probes
corresponding to mRNA sequences, or parts thereof. There are two sources
of these sequences, the most common of which is cDNA molecules (Schena,
2003), originally used by Schena et al. (1995). These cDNAs are produced
from mRNAs by the reverse transcriptase enzyme, which uses RNA tem-
plates to produce DNA sequences, and applied to the slide surface. As the
sequences are produced directly from the mRNAs they are intended to mea-
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sure they can be long in length (typically 500-2500 bases) and produce good
hybridisation signals (Schena, 2003). The alternative method is to produce
oligonucleotides by chemical synthesis, first used on microarrays by Lock-
hart et al. (1996). These may be synthesised directly on the slide surface,
base-by-base, or elsewhere and applied as a single strand in the same way
as a cDNA (Schulze and Downward, 2001). These technologies have been
reviewed and compared extensively over the course of their development (for
example, Schulze and Downward, 2001; Li et al., 2002; Tan et al., 2003).
Alternative splicing analysis
Alternative splicing is another method by which protein production can be
regulated by the (eukaryotic) cell (Alberts et al., 2002). Genes are divided
into expressed sequences (exons) and intervening sequences (introns). Ini-
tially all exon and intron sequences are transcribed into a pre-RNA, and
then the intron sequences are removed by RNA splicing on the way to pro-
ducing the final mRNA. Alternative splicing is a process by which different
exons are incorporated into the final mRNA, which go on to produce dif-
ferent proteins, meaning single genes can produce multiple products. Gene
transcription microarrays can be extended to examine alternative splicing
by incorporating probes representing all exons (for example, Johnson et al.,
2003). This allows not only the expression of genes to be measured, but the
identification of which exons are present in the final mRNAs.
MicroRNAs
MicroRNAs (miRNAs) are short (typically 21–22 nt) RNA molecules de-
rived from non-protein coding genes (Watson et al., 2003). These molecules
play important regulatory roles in animals and plants by targeting mRNAs
with sequence homology for cleavage or translational repression, thereby reg-
ulating protein production levels (reviewed in Bartel, 2004). A microarray
containing probes corresponding to known miRNA sequences allows the de-
tection and identification of those present in a given sample (Liu et al., 2004).
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1.1.2.2 DNA detection
Measurement of DNA levels allows the gathering of information relating to
events which occur directly on or in DNA. DNA is purified from the cell,
amplified and applied to the microarray.
Comparative genome hybridisations
Copy number variation (CNV) is a change in the numbers of copies of regions
of DNA arising from deletions, insertions and duplications of DNA segments.
These can range in size from kilobases to megabases and the frequencies of
these variations themselves vary between populations (Redon et al., 2006).
CNVs can alter gene expression and phenotypic variation, cause diseases and
confer risk to complex disease traits. They are common in cancers and their
investigation can provide markers of prediction of disease outcome, treat-
ment responses and identification of genes to target for therapy (reviewed in
Albertson et al., 2003).
Comparative genome hybridisation (CGH) is a method of analysing whole
genomes for CNVs. The original technology used metaphase chromosomes
as a representation of a genome, to which differentially labelled total ge-
nomic test and reference DNA was allowed to hybridise. Visualisation of the
chromosome allowed the physical locations of CNVs to be mapped (Pinkel
and Albertson, 2005). This method limits the detection of events involv-
ing regions of less than 20 Mb, a problem which can be overcome by using
microarrays in place of the reference metaphase chromosome (Solinas-Toldo
et al., 1997; Pinkel et al., 1998), termed array-CGH.
Array-CGH microarrays contain probes corresponding to regions of a
genome. Fragmented, labelled genomic DNA is allowed to hybridise to these
probes, providing an indication of the amount present at each location. Vari-
ations in copy number show up as increased or decreased signal intensities.
Depending on the probe density and length of the CNV region, this may
occur at a single probe or over multiple, consecutive probes. This type of
microarray therefore allows regions of CNV between samples to be found at
a resolution theoretically limited only by the probes used.
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Chromatin immunoprecipitation on microarray chips
DNA-protein interactions play important roles in genome regulation. Tran-
scription factors, for example, regulate the expression of genes, nucleosomes
play structural roles and repair enzymes process sites of DNA damage. Deter-
mining where proteins bind in a genome is therefore crucial to investigating
both their function(s) and their site(s) of action. Methods to achieve this
at particular sites include DNAse footprinting (Galas and Schmitz, 1978),
which uses radioactive end-labelling of a DNA fragment of interest and the
protective effect of the protein against enzymatic degradation of the DNA
to identify binding sites as ‘footprints’ with gel electrophoresis, and the elec-
trophoretic mobility shift assay (EMSA) (Garner and Revzin, 1981), which
uses gel electrophoresis to identify protein-bound DNA by the associated
shift in band position on the gel, which can be combined with an antibody
against the protein to create a ‘super-shift’.
Chromatin immunoprecipitation (ChIP) is another method that can be
used to identify protein binding sites. It uses an antibody to the protein
of interest to extract, or immunoprecipitate, it and any DNA it is bound
to, from the pool of total genomic DNA. PCR primers designed at a region
of interest are then used to determine if that region is present in the im-
munoprecipitated pool. All of these assays allow the identification of protein
binding at individual, pre-determined sites of interest only.
ChIP combined with microarray chips (ChIP-chip) is a technology de-
veloped to determine the genome wide binding sites of proteins (Ren et al.,
2000), hence its alternative name of genome wide location analysis. It works
on a similar principle to array-CGH, in that a whole genome (or a genome
section of interest) is represented by the features on a microarray. ChIP is
carried out, using an antibody to the protein of interest to separate chro-
matin fragments bound to the protein from the rest of the genome (history
and protocol information available in Carey et al., 2009). These separated
fragments are then purified, amplified, fluorescently labelled and applied to
the microarray. The amount of bound material at any given location allows
an estimate of the binding site of the protein to be made, at a resolution
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limited by the probes and DNA fragment lengths applied.
Since its first use the technology has been developed to allow the analysis
of other features of chromatin, such as histone modifications (Kurdistani et al.
(2004), for example), DNA methylation (Weber et al. (2005), for example)
and DNA damage (Teng et al., 2011). The technology has also advanced to
allow binding site locations to be determined at high resolution, to within
several base pairs (Lee et al. (2007), for example).
DNA immunoprecipitation on microarray chips
The DNA sequences at which proteins bind can be used to determine bind-
ing sequence specificity and predict sites in the genome at which proteins
may bind. These can be derived from in vivo protein-DNA interaction as-
says, such as those described in the previous section, or by specific in vitro
techniques. For example, SELEX (Systematic Evolution of Ligands by Ex-
ponential Enrichment; Tuerk and Gold, 1990) uses randomly generated DNA
sequences to iteratively determine protein binding sites. Such in vitro tech-
niques are free of the cooperative and/or competitive effects of other proteins
in the cell, meaning the protein can bind to any and all potential sites.
DNA immunoprecipitation (DIP) on microarray chips (DIP-chip) is an
alternative in vitro method to ChIP-chip to determine the genome wide iden-
tification of protein binding sites (Liu et al., 2005; Gossett and Lieb, 2010).
A sample of purified protein of interest is incubated with naked, sheared
genomic DNA and allowed to hybridise. These bound fragments are sepa-
rated by immunoprecipitation or affinity purification and purified, amplified,
fluorescently labelled and applied to a genome wide microarray as used in
ChIP-chip. The advantage of this method is any amount of protein can be
added to the mix, so it can be performed with proteins whose cellular ex-
pression levels may be too low for effective ChIP-chip. The disadvantage is
that, as it is an in vitro technique, the result is not necessarily representa-
tive of what happens in a cell. There may be potential binding sites of a
protein that are never actually bound by the protein in vivo, and so are not
biologically relevant, but this technique will still show them. Similarly, there
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may be sites that are only bound in vivo under certain conditions, but this
technique will not be able to distinguish between them.
Genotyping
Single nucleotide polymorphisms (SNPs) are single base pair differences de-
tected in the genomes of individuals at a frequency more than 1% in a popu-
lation. These represent approximately 90% of the genetic variation between
humans (reviewed by Brookes, 1999). They have important implications
in many diseases, including cancers, as certain SNPs are associated with a
greater risk of developing the disease. They can be detected with a variety
of methods, such as PCR, where primers are designed over the SNP site such
that a fragment will only be amplified with one version of the polymorphism,
or the use of restriction enzymes, which are able to cut at one version of the
polymorphism and not the other. Gel assays are then used to resolve both
of these. Microarrays can be used to determine the presence of known SNPs
by using probes covering the regions of sequence variation (Gunderson et al.,
1998). Presence of DNA on a feature containing probes representing a SNP
shows that that SNP is present in the genome being examined.
Mutations introducing alterations in the form of SNPs can lead to loss
of heterozygosity (LOH). This is the loss of two functional copies of a gene,
which with respect to cancer usually refers to a tumour suppressor gene
or similar. A mutation in one copy of the gene on one chromosome leaves a
second functional copy on the second chromosome and so often no phenotypic
effect is seen, that is, the individual remains healthy. LOH follows a mutation
in the remaining functional copy of the gene leading to a loss of functionality.
Microarrays can be used to specifically analyse these LOH-associated SNPs.
DNA resequencing is the sequencing of known DNA regions to detect
unknown mutations (Sram et al., 2008). This can be achieved using microar-
rays with probes containing sequences that vary from the known sequence
being investigated, by incorporating a single base change in the sequence.
Presence of DNA bound to such a fragment, over the unmodified sequence,
indicates the presence of the mutation. This was first applied to the human
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mitochondrial genome (Chee et al., 1996).
1.1.2.3 Protein detection
Microarrays have also been used to investigate protein-DNA binding in vitro
by applying epitope-tagged proteins directly to a microarray containing dou-
ble stranded DNA probes (Mukherjee et al., 2004). The probes these pro-
teins bind to can be detected with a labelled antibody against the epitope
tag. Binding sequence motifs can then be determined based on all of the
bound probes.
1.1.2.4 Other applications
As well as these general, whole genome approaches, microarrays can be used
for more specific, targeted investigations. For example, in the field of geno-
toxicity testing both gene expression and SNP arrays can be used to in-
vestigate the effects of compounds on cells. Gene expression arrays can be
used to screen for changes in expression levels linked to particular genotoxic
responses and may enable the distinction of different classes of genotoxic
compounds that operate via different modes of action (Newton et al. (2004),
for example).
1.1.3 Normalisation
Microarrays can produce large amounts of data: one or two intensity values
per feature (from one or two colour format microarrays respectively) mean
each microarray can produce upwards of two million separate values. These
data are produced by a scanner, which records the intensity of light emitted
from each feature on the slide. The more labelled DNA that has hybridised to
a feature, the brighter the fluorescence. The dyes used to label the DNA have
specific excitation and emission frequencies. A laser of the correct frequency
is used to excite the dye and the resulting fluorescence at the excitation
frequency is recorded. The features on two colour microarrays are excited
and recorded at the two relevant frequencies. An image of the microarray
is created from all the excitation values, recording the regions surrounding
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features as well as the features themselves. Software is then used to convert
the features in the image into numerical values, which may also take account
of the fluorescence in the background regions. These values are stored along
with probe specific information. Full details of this procedure are given in
Chapter 2.
Microarray investigations are not generally carried out individually but,
as with many other experimental procedures, are performed in replicate. Cer-
tain types of investigation, such as gene expression profiling, examine mul-
tiple conditions, with replicate assays carried out for each condition. The
intention with these investigation is to compare the results relative to each
different experimental condition, to determine changes between them. This
differs to other uses, such as genotyping, which produce binary results, where
the presence or absence of DNA on each feature is the final result, showing,
for example, the presence or absence of a given SNP. ChIP-chip is gener-
ally currently used as in the latter example, but the data have the potential
to generate results as in the former, as demonstrated later in this thesis,
greatly expanding the use of the technology. Microarray analysis is reliant
on a robust normalisation procedure, as outlined in the following section.
Multiple assays are performed because of random ‘noise’ in datasets, caused
by inherent variations in the microarray technology. Readings representing
genuine biological phenomena, or ‘signal’, can only be reliably differentiated
from this noise by their consistency across different datasets, whereas anoma-
lous, high, chance readings caused by the noise occur randomly across the
datasets. Therefore the more variation between datasets, the more difficult
it is to distinguish biologically relevant signals from this background noise.
Some of the noise can be minimised by good working practices when prepar-
ing the microarrays, but much of it is always present due to factors beyond
the control of the operator (Johnson et al., 2008). This needs to be removed
by the application of a normalisation procedure to the data. Gentleman
(2005) summarises this problem:
“In an ideal experiment, no normalisation would be necessary,
as the technical variations would have been avoided in the first
place. In a real experiment, a certain amount of technical varia-
12
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tion cannot be avoided, and can be accounted for and corrected
in the subsequent analysis through a normalisation procedure.
However, if the technical variations become too large, they turn
into a quality problem.”
Normalisation in this context refers to the processing of multiple datasets
so as to make them comparable with each other by removing any variation
not caused by the biological factor under investigation. It is therefore essen-
tial and as such has been extensively discussed and different methods com-
pared, initially with reference to gene expression microarray investigations
(see Butte, 2002; Quackenbush et al., 2002; Bolstad et al., 2003; Shedden
et al., 2005; Do et al., 2006; Fujita et al., 2006, for examples) and more re-
cently ChIP-chip investigations (see Buck and Lieb, 2004; Peng et al., 2007;
Johnson et al., 2008; Adriaens et al., 2012, for examples). Gentleman (2005)
summarises the concept:
“The purpose of normalisation is to identify and remove sys-
tematic technical variation while retaining the biological signal.
Among the sources of technical variation are different labelling ef-
ficiencies and scanning properties of the Cy3 and Cy5 dyes [and]
different scanning parameters. . . Normalisation procedures aim
to ensure that the observed differences in intensity indeed reflect
the differential gene expression and not artificial biases due to
such technical factors.”
Although written with reference to gene expression microarrays, the principle
of this quote is equally applicable to other types of microarray experiments
and the words “gene expression” can be substituted for “DNA amounts” to
reflect the same problem faced with ChIP-chip data.
Normalisation can be broadly divided into two categories, intra- and inter-
dataset, which, depending on the method of normalisation chosen, are carried
out separately or as one process. For replicate (biological or technical) assays
measuring a single condition, such as biological repeats of gene expression
assays to determine mRNA levels, this means removing any variations arising
in the carrying out of separate assays, termed intra-dataset normalisation.
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Theoretically these datasets should be exactly the same, as the same variable
is being measured. This is not actually the case, because of the noise in the
data. Intra-dataset normalisation aims to remove as much of this variation
as possible. For experiments with two or more conditions, such as those per-
formed over a period of time or subject to different treatments, in addition to
performing intra-dataset normalisation on the replicate assays, inter-dataset
normalisation also needs to be performed. This aims to remove the same
variation as intra-dataset normalisation, but leave any of the biologically rel-
evant variation caused by the deliberate changing of experimental conditions,
thus allowing a comparison of the effect of the experiment to be made. Some
normalisation methods combine both of these principles.
1.1.3.1 Gene expression
Several normalisation methods have been developed for gene expression mi-
croarray data, which aim to allow comparisons of gene expression levels be-
tween different conditions. These methods work on the assumption that the
majority of gene expression levels do not change under any given change in
conditions, and of those that do change there will be approximately equal
numbers of up- and down-regulated genes, resulting in an approximately
symmetrical distribution of probe values (Figure 1.1). These unchanging
‘background’ levels act as internal controls against which the changed levels
can be measured. The unchanged values can be easily identified as they rep-
resent the bulk of the data. The normalisation methods aim to make these
background probes consistent across all datasets, altering the changed probes
as they do so, with the result that the changed probes can be compared across
all datasets relative to the background values. In gene expression investiga-
tions these comparisons show increases or decreases in gene expression levels
in response to the change in experimental conditions.
A simple normalisation was applied to the first microarray datasets (Schena
et al., 1995) to correct for differences in the two fluorescent dyes being used.
A DNA sample of known concentration (1:1,000 dilution) was added to both
pools of DNA and labelled with the respective dye. The values from the two
14
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Figure 1.1: Gene expression microarray data representation: One set of gene
expression microarray values are represented plotted against another (top
panel). The oval represents the region containing the majority of the data,
with darker greys representing more data, where the values are the same
in both datasets. A small number of genes are up- or down-regulated in
one dataset relative to the other, indicated with grey crosses. The ratios of
the two datasets creates an approximately symmetrical distribution (bottom
panel). Red arrows show the regions of data in the top panel which form the
parts of the distribution in the bottom panel.
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pools were adjusted by ‘matching’ the signals from the added DNA. As the
sensitivity and numbers of features on gene expression microarrays has in-
creased, so normalisation methods have been adapted to provide robust and
reliable results. More recently, normalisation methods have been adapted
and developed for use with other types of microarray, such as ChIP-chip and
array-CGH (reviewed by Lai et al. (2005)).
The following sections give brief descriptions of some of the more com-
monly applied gene expression microarray normalisation methods.
Total intensity normalisation
Total intensity normalisation normalises the signals from two channels based
on their total intensities (summarised from Quackenbush et al. (2002)). It
relies on several assumptions about the assay, the first of which is that equal
amounts of material for the two samples are applied to the microarray. As
there are millions of individual molecules in each sample, it follows that the
average mass of each molecule is the same and consequently the same num-
ber of molecules are present in each sample. The probes on the microarray
are assumed to randomly interrogate the two samples, meaning the probes
must represent a random sample of genes. Approximately the same numbers
of molecules from each sample should hybridise to each microarray, because
it is assumed that equal numbers of genes will be up- and down-regulated in
the two samples. Therefore it is assumed that the total signal intensities of
the two channels should be the same. A normalisation factor is calculated
based on the actual total signal intensities, which is used to calculate the
normalised intensities. There are several ways in which this can be applied,
such as adjusting both channels to a defined mean or median ratio. These
methods are generally considered to be too simplistic as they do not take
into account systematic biases which may occur in the data. In theory, plot-
ting one set of signal intensities against the other should show data centred
around a straight line. This is based on the same assumptions as above, that
a random sample of genes is represented with equal numbers of up- and down-
regulated genes (implicit in this is the assumption that most genes are not
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disregulated between the two samples). However, intensity dependent effects
may mean that values are higher or lower than expected at different points
across the spread of data, creating a non-linear relationship. If not corrected
for this may produce spurious results in the analysis as the higher (lower) val-
ues may be incorrectly interpreted as up-regulated (down-regulated) genes.
Figure 1.2 represents this procedure with two datasets that have a non-linear
relationship, showing the adjustment cannot take account of this. The fol-
lowing methods attempt to take account of non-linear relationships between
data.
Lowess
Locally weighted linear regression (lowess) (Cleveland, 1979) is a method of
smoothing a scatter plot via a polynomial fit to the data, using weighted
least squares. This allows a non-linear fit to be calculated between the two
sets of signal intensities. Lowess applies a locally weighted linear regression
through the data, which emphasises the contributions of data close to other
points, thus minimising the effects of disregulated genes. Each data point
is adjusted based on the fit, creating data centred around an approximately
straight line. Figure 1.3 represents this procedure with two datasets that
have a non-linear relationship, showing the adjustment takes account of this
to bring the whole bulk of the data to lie on the line y = x. This may be
applied globally, to all the data at once, or locally, to subsets at a time.
In the event that there is a linear intensity dependent relationship between
datasets, linear regression can be applied to perform a correction.
VSN
A variance stabilisation normalisation (VSN) was created to take account of
the fact that the variance of intensity values can increase with their means
(Huber et al., 2002). This means values that differ by the same factor can
produce varying significance levels depending on their intensity values, which
has important implications in gene expression monitoring. A lowly expressed
gene whose transcription level doubles is as biologically significant as a highly
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Figure 1.2: Total intensity normalisation representation: The grey shape rep-
resents the bulk of the data when two datasets are plotted together, showing
a non-linear relationship. The mean for each dataset is shown with a dashed
black line. The procedure adjusts the data to make these means lie on the
same value, bringing them to lie on the line y = x, represented with dashed
grey lines. This shows that the procedure cannot bring all of the data to lie
on this line.
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Figure 1.3: Lowess normalisation representation: The grey shape represents
the bulk of the data when two datasets are plotted together, showing a
non-linear relationship. The Lowess polynomial fit through these data is
represented with a dashed black line. The procedure adjusts the data to
make this line lie on the line y = x, represented with dashed grey lines. This
shows that the procedure brings all of the data to centre on this line.
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expressed gene with the same increase, but intensity-dependent variance vari-
ations may mean this is not borne out statistically. This is corrected for by
applying a variance stabilising transformation to the data. This replaces the
log-ratios with a difference statistic which displays approximately constant
variance independent of the spot intensity (Huber et al., 2002).
Quantile
Quantile normalisation aims to make the distributions of probe intensities
across a set of microarrays the same (Bolstad et al., 2003). This is achieved
by sorting the values in each set of data, replacing all the values of each
row with the mean of the sorted data in the row, and rearranging the values
back to their original order. This comes from the fact that quantile-quantile
(Q-Q) plots display identical distributions as data points aligned along the
line y = x, which also applies in n-dimensional space with n datasets. The
quantile normalisation procedure adjusts the data such that all datasets lie
on this line in n dimensional space, or any two lie on the line y = x in a
standard Q-Q plot. This has the effect of adjusting all distributions to the
same ‘average’ distribution. The procedure is described in more detail in
Section 4.2.4.1.
1.1.3.2 ChIP-chip
ChIP-chip was originally developed to determine the in vivo binding posi-
tions of chromatin associated proteins (Ren et al., 2000). Here 6,361 DNA
fragments, each representing one intergenic region of the yeast genome, on
a microarray were used to analyse the binding sites of the Gal4 and Ste12
transcription factors. Since this first use the technology has been developed
to allow the analysis of other features of chromatin, such as histone mod-
ifications (Kurdistani et al., 2004, for example), and DNA damage (Teng
et al., 2011). The technology has also advanced to allow locations to be de-
termined to within several base pairs (Lee et al. (2007), for example). All
of these methods required normalisation of some sort to remove the varia-
tions inherent in the technologies. Because the technology has generally been
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used to determine the binding positions of factors of interest, normalisation
has been focussed on removing variation between replicate datasets so as to
enhance downstream analysis. This allows locations to be assigned binary
values representing whether or not they are deemed binding sites. Within
these replicate datasets the values can be analysed to determine relative dif-
ferences in their levels at the different sites identified. These indicate relative
differences in the levels of occupancy of the factor under investigation. This is
akin to the analyses that are performed with array-CGH data, which identify
changes in binding levels with the same datasets to find regions of genome
duplications. This has been used to show, for example, relative differences
in the levels of histone occupancy across the yeast genome (Lee et al., 2007).
The current limitation with ChIP-chip normalisation lies in the lack of a nor-
malisation method that allows comparisons of this type to be made between
different datasets from different experimental conditions. This is exemplified
by analyses such as those carried out by Schlecht et al. (2008), where three
datasets of Abf1 binding were created from three different experimental con-
ditions, but comparisons between them were limited to identifying sites of
shared or different occupancy.
The format of data generated by ChIP-chip microarrays is different to
that described for gene expression microarrays in the previous section. All
of these methods rely on the assumptions that the bulk of the data points do
not vary between experiments and that the data form roughly symmetrical
distributions. The next stages of processing go on to identify the relatively
small number of values that change significantly between datasets, repre-
senting differentially expressed genes. These same assumptions do not hold
for ChIP-chip data. The distribution of ChIP-chip data is asymmetrical be-
cause as immunoprecipitated material binds to the probes of the microarray
the resulting intensity values can only be larger than the background, never
smaller, which gives the distribution a positive skew (this has been pointed
out several times, for example, by Buck and Lieb, 2004, . Figure 1.4 shows a
representation of this type of data) Additionally, a large proportion of probe
values may change between different conditions because a large proportion of
the genome may be immunoprecipitated. These features of the data violate
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the assumptions of the normalisation procedures. Therefore their applica-
tion to ChIP-chip data can have the effect of removing biological variations
from datasets of different experimental conditions. For example, where large
sections of a genome show an increase in the factor of interest between two ex-
perimental conditions, the distributions of the two datasets will be markedly
different. Specifically, the modal points of the distributions will be different,
from the low end in the first dataset (where the bulk of the data represent un-
enriched regions of the genome) to the high end in the second dataset (where
the bulk of the data now represent enriched regions of the genome), which is
an important biological variation which should be maintained between the
two datasets. However, normalisation methods for gene expression data will
seek to remove this difference, under the assumption that the bulk of the data
should not change between conditions. Quantile normalisation, for example,
would take the two different data distributions and produce a third, ‘aver-
aged’ distribution, thereby removing all biologically relevant information in
the two datasets and producing a third, unrepresentative dataset.
These differences in the properties of the data, meaning that methods
developed for gene expression data are not necessarily suitable for application
to ChIP-chip data, is an important fact which has been pointed out previously
by Ponzielli et al. (2008):
“Experimental design parameters for mRNA expression arrays
have been extensively evaluated by a number of groups over the
last decade. As a result, the key factors are well understood and
the assays have been optimised. It is possible, for example, to
estimate the number of biological repeats required to sufficiently
power a specific hypothesis-testing question. Despite this clear
evidence that parameter optimisation can greatly improve the
quantity and quality of information retrieved from an array anal-
ysis, ChIP-chip design parameters have not yet been thoroughly
and systematically investigated, and it cannot be assumed that
parameters and processes would be the same for both mRNA and
ChIP-chip arrays”.
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Figure 1.4: ChIP-chip microarray data representation: One set of ChIP-chip
microarray values are represented plotted against another (top panel). The
grey shape represents the region containing the majority of the data, where
a large proportion of values are higher in one dataset. The darker greys
represent more data. The ratios of the two datasets creates a positively
skewed distribution (bottom panel). Red arrows show the regions of data in
the top panel which form the parts of the distribution in the bottom panel.
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ChIP-chip data normalisation has generally focused on the task of peak
detection, that is, on methods of data manipulation that aid the finding
of sites of enrichment across multiple datasets in order to identify protein
binding sites. Buck and Lieb (2004) discuss the following two methods.
Median percentile ranks
Median percentile ranks converts all data to ranks, thus removing any biases
in the data and removing the need for further processing. This is therefore
not strictly a normalisation procedure, but in allowing multiple datasets to
be analysed together it performs a similar function and therefore warrants
discussion. The ranks are used to identify regions of enrichment across mul-
tiple datasets. The median percentile rank for data point x is calculated as
the proportion of the data less than x. In this way the ranks run from 0 to 1.
If several replicate datasets consist only of random noise, the rankings of the
datasets will be random. Therefore the medians of the ranks of each data
point will form a normal distribution. If a subset of data points are enriched
they will lie at the upper end of their respective rankings and will therefore
produce high median values. With enough replicates and high enough lev-
els of enrichment these high median values can be distinguished from the
rest of data as a second distribution, alongside the normal distribution of
background values. A cutoff value can be determined and used to identify
enriched regions. Proteins with small amounts of enrichment may not be
detectable via this method. In converting to ranks all binding data is lost
which may limit further analyses.
Single array error model
The single array error model was used in early microarray investigations (Ren
et al., 2000; Roberts et al., 2000) which tended to contain few probes, with
single probes representing sites of enrichment. It allows replicate experiments
to be averaged with suitable weightings to take account of differences in
variance between different datasets (Buck and Lieb, 2004), thus improving
the ability to detect sites of genuine enrichment.
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Peng’s method
Peng et al. (2007) present a novel normalisation method specifically designed
for ChIP-chip data, without the potential problems associated with gene
transcription microarray normalisation methods. This is focused on removing
the need to carry out mock controls in experiments. These are assays carried
out with no antibody, or an antibody against a target not present in the
sample, with the aim of gauging any biases which may occur. This data can
then be subtracted from the data created with the antibody, to leave only
enrichment resulting from the antibody. It uses the first order differences
of probe values to create a symmetrical distribution of values. A straight
line fitted through this data provides a means of rotating it to lie on the
line y = 0. The same rotation factor can be applied to the original data to
cause the background portion to lie on the line y = 0. Lowess normalisation
can then be used to correct for any non-linear artifacts in this data. A
horizontal line can then be used to represent the cutoff between background
and enriched data points. This method doesn’t allow for multiple datasets
to be normalised together.
A recent evaluation by Adriaens et al. (2012) compared six of the above
mentioned normalisation methods commonly used with ChIP-chip and DNA
methylation investigations: VSN; lowess; quantile; T-quantile; Tukey’s bi-
weight scaling; and the method of Peng et al. (2007). They determined
T-quantile normalisation to be the best, which is quantile normalisation ap-
plied separately to different datasets in batches, as it conserved enriched and
un-enriched signals, allowed identification of regions known to be enriched
and improved comparability between datasets.
1.1.4 ChIP-chip data processing
Johnson et al. (2008) carried out an investigation to evaluate variability in
ChIP-chip experiments using predefined DNA targets. These targets con-
sisted of 100 samples of cloned genomic DNA sequences added at levels
ranging from 1.25- to 196-fold above the background level (a commercial
human genomic DNA preparation). Known quantities of DNA sequences
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such as these are termed ‘spike ins’, or simply ‘spikes’, and adding them
in this manner is termed ‘spiking in’. The overall aim of this investigation
was to test the performance of the various microarray platforms and analysis
methods. They found that the microarray platform used was not the primary
determinant of overall performance and attribute the variations in results to
variations in performance between labs, protocols and algorithms.
Ponzielli et al. (2008) carried out an assessment of a range of ChIP-chip
experimental design parameters including antibody selection, array batches,
dye effects, scanner calibrations, environmental conditions, handling, ampli-
fication methods and hybridisation controls. They found that all the aspects
tested had an influence on the final results, which is not unexpected given
that each of the aspects is known to have some inherent variation of its own.
One surprising result from the study was that the day on which hybridisa-
tion was performed had a greater influence than the array batch used or dye
swaps. There is no explanation for this and it goes to demonstrate that, even
if it were possible to eliminate all variations of known origin, there would still
be some variation between experiments caused by as yet unidentified factors.
It is this range of influences on the final results that necessitates the need for
robust normalisation methods.
1.1.4.1 Peak detection
ChIP-chip analyses often require the application of an algorithm to detect
regions of enrichment or peaks. These algorithms attempt to separate sec-
tions of genuine enrichment from background noise or non-specific binding.
Several algorithms have been developed for this purpose, which are discussed
in Chapter 5. They allow the large amounts of data generated by ChIP-chip
experiments to be reduced to a list of sites of enrichment. These sites can be
used in further investigations, such as confirmation of the presence of the fac-
tor of interest by other methods, and sequence analysis, to identify common
sequences in the binding regions.
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1.1.4.2 Making comparisons between datasets
Conspicuous by its near absence in all of the ChIP-chip data normalisation
literature is discussion of making robust comparisons between datasets gen-
erated under different biological conditions. This is standard practice with
other types of microarray investigations. Gene expression microarrays, for
example, are used to determine which genes are disregulated by certain ex-
perimental conditions. Array-CGH, as stated in the name, compares the
hybridisations of different genomes. For the most part ChIP-chip has been
used to investigate only one factor of interest at a time, such as determining
where in the genome a protein binds. Little work has been done to normalise
datasets from different conditions to allow comparisons of binding levels to
be made between them, which is one aspect of the work presented in this
thesis.
Some early ChIP-chip investigations do make limited comparisons be-
tween different datasets, such as Pokholok et al. (2005), who compare hi-
stone H3 and H4 profiles over an average gene. This is done graphically,
and no mention is made of any normalisation carried out to specifically
allow the comparison of data between different datasets. No conclusions
are drawn from this comparison. Penterman et al. (2007) compare ChIP-
chip DNA methylation profiles by a simple subtraction of mutant from wild
type datasets. This allowed regions of different methylation levels to be
determined between the two. These were analysed statistically to identify
difference values greater than those expected by chance. Farthing et al.
(2008) compare DNA methylation profiles in mouse promoters with, “al-
gorithms. . . developed to assess differences in promoter methylation between
the different cell types.” This uses “a 500 bp sliding window to identify areas
where the methylation state consistently and significantly changed between
the two tissues being compared.” No mention of a normalisation procedure
prior to the application of these procedures is made in either investigation.
With datasets such as these, where the factor being investigated occurs over
large stretches of the genome, it is relatively easy to determine whether or
not those regions correspond in different datasets. It is not possible, without
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proper normalisation, to infer any numerical information from the compar-
isons, which these investigations do not attempt.
A package for the analysis of ChIP-chip data, CARPET (Cesaroni et al.,
2008), includes a method to compare different datasets. It is stated that
“. . . cross-comparison of [ChIP-chip] experiments is a significant problem that
needs to be addressed.” However, the method presented provides only a lim-
ited solution to this problem, by extracting common or unique regions from
two datasets analysed with their peak detection algorithm. No normalisation
method is provided to ensure that the results of peak detection on the two
datasets are comparable. As mentioned above, if the peak detection method
is robust, simply defining regions sharing enrichment is valid, provided no
numerical information is inferred, that is, no comparisons of peak heights are
made.
Several methods of analysing datasets of the same type but created by
different methods or on different platforms have emerged. These allow more
than one dataset to be combined to enhance the detection of the factor of
interest. Choi et al. (2009) propose a hierarchical hidden Markov model
(HMM) to allow the joint analysis of ChIP-chip and ChIP-seq data of the
same condition to enhance the detection of binding sites. It is limited to one
ChIP-chip and one ChIP-seq dataset only. Another package for the analysis
of ChIP-chip data, JAMIE (joint analysis of multiple ChIP-chip experiments;
Wu and Ji, 2010) allows multiple experiments to be analysed together. This
is achieved through a hierarchical mixture model which analyses multiple
datasets from different experiments and platforms to “capture correlations”
between them. This allows improved peak detection over analysing each of
the datasets individually, which may allow more potential binding sites to be
identified and therefore increases the amount of potential information that
can be extracted from datasets. Chen et al. (2011) present MM-ChIP, a
model-based meta-analysis software to integrate results from different inves-
tigations to improve the sensitivity and specificity of detection of enriched
regions. This uses a two-step process which first fits the data to a platform-
specific model to increase the signal-to-noise ratio and calculates a score to
quantify signal enrichment via a sliding window, then calculates Z-scores for
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each region, which are combined for all datasets. The statistical properties of
these scores are used to determine enriched regions across all datasets. None
of these methods contain any normalisation procedures and so comparisons
cannot be made between the binding levels in different datasets.
Johannes et al. (2010) acknowledge the problem with respect to the com-
parison of chromatin profiles with ChIP-chip and ChIP-seq data. They say,
“with ChIP samples collected from different tissue types and/or individuals,
we can now begin to characterize stochastic or systematic changes in epige-
netic patterns. . . this requires statistical methods that permit a simultane-
ous comparison of multiple ChIP samples on a global as well as locus-specific
scale.” However, it is computationally limited to a small number of datasets
and is recommended as a “first-pass algorithm” to identify candidate regions,
which should be followed with another, unspecified, algorithm to fine tune
the results. As it is intended for use with ChIP-chip and ChIP-seq data
together it will not necessarily work with ChIP-chip alone.
To date, the only publication which addresses the problem with a specific
normalisation method is by Landfors et al. (2011), which is aimed at nor-
malising any skewed data sets, not specifically ChIP-chip data. Here data is
first normalised by a “standard normalisation technique of the user’s choos-
ing,” then a method of determining whether or not the distribution of the
dataset is skewed (detection of skewed experiments, DSE) is combined with
a hidden Markov model-assisted normalisation method. Non-skewed data
is deemed to not require further normalisation. The HMM-assisted normal-
isation procedure aims to identify regions that are unaltered between the
different datasets. These regions are used to estimate a normalisation func-
tion which is used to normalise the whole dataset. The HMM algorithm
identifies the unaltered regions on which to perform the next normalisation
procedure by analysing the ratios of the averaged two datasets. Those closest
to zero are classified as unaltered.
None of these methods specifically address the problem of the lack of a
robust normalisation procedure to allow comparisons to be made between
ChIP-chip datasets produced from more than one different biological condi-
tions. A novel normalisation method which aims to achieve this is presented
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in Chapter 4 and applied to real ChIP-chip data in Chapters 5 and 7.
1.2 DNA damage
The work presented in this thesis is all linked to DNA damage, either directly,
in the case of its measurement, or indirectly, in the case of measuring other
cellular responses to damage induction. All of the datasets used in this thesis
were produced for analyses related to the repair of DNA damage. This section
gives an overview of the DNA molecule, the damage it can acquire and the
processes that exist to repair it.
1.2.1 DNA
Deoxyribonucleic acid — DNA — is the fundamental building block of life.
It encodes everything crucial for the correct functioning of cells and is the
molecule of genetic inheritance. Its stability is therefore critical to it being
able to correctly perform its functions. It has posed life on Earth a problem
that this molecule is not chemically inert, but faces constant challenges to its
stability. Water, for example, can hydrolyse bonds in DNA, free radicals can
oxidise bonds, ultra violet (UV) radiation can fuse adjacent bases together
and ionising radiation can break the double stranded backbone. Organisms
of all known types have developed a range of mechanisms to deal with these
various genetic insults. Incorrect repair of DNA damage can result in various
outcomes, from no phenotypic change if, for example, a silent mutation is
created, to cell death if, for example, the damage is so great the cell cannot
deal with it or functional mutations are created in critical regions of the
genome. Somewhere between these two extremes lies a region where cells
survive the damage event but do so in a way that they become rogue; beyond
the normal cellular controls in such a way that they will eventually, without
intervention, lead to the death of the organism, as is the case in cancer.
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1.2.1.1 Structure
The structure of DNA was famously elucidated in 1953 by Watson and Crick,
using x-ray crystallography images generated by Rosalind Franklin (Crick
and Watson, 1953). It was immediately obvious to these researchers that the
structure of DNA lends itself to copying, stating, “if the sequence of bases
on one chain is given, then the sequence on the other chain is automatically
determined.” This has indeed shown itself to be true, and it is the duplication
of this sequence that is required for the continued proliferation of life.
DNA comprises two polynucleotide chains twisted around each other to
form a double helix. Nucleotides, the building blocks of DNA, consist of
a phosphate molecule joined to a sugar molecule joined to a base. The
orientation of a nucleotide strand is described by the free carbon molecules
of the sugar at either end of the chain: 3′ and 5′. This polarity enables the
differentiation of the two strand ends.
The ‘backbone’ of DNA is formed by repeating sugar–phosphate groups,
and so these are constant in all nucleotides. The variation comes about
by different base structures. There are two classes of base: purines and
pyrimidines. The purines are named adenine (A) and guanine (G) which are
derived from double ring structures. The pyrimidines are named thymine
(T) and cytosine (C) which are derived from single ring structures. The two
strands of the double helix are held together by hydrogen bonds between
these nucleotides and the variations in the four structures are such that
pairings can only form between specific pairs: A always pairs with T and G
always pairs with C. Two hydrogen bonds form between A and T, while three
form between G and C, making this second pairing slightly stronger. This
bonding means that the nucleotides are positioned inside the helix, with the
sugar-phosphate backbone on the outside. The two strands run antiparallel
to each other, that is, one runs 5′ to 3′ and its complement runs 3′ to 5′.
There are multiple forms DNA can take: in cells it is usually a right-
handed helix in the ‘B’ form. This has each base pair (bp) displaced by
approximately 36°, resulting in there being approximately 10 bp per complete
revolution of the helix. DNA is a reasonably flexible molecule and even allows
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bases to ‘flip out’ or protrude from the helix. This flexibility has important
implications in DNA repair.
The order of DNA’s nucleotides encodes its information, in a way that
can be thought of as a four-letter alphabet. Genes, or open reading frames
(ORFs), encode proteins. These sequences are transcribed to mRNA strands
which are then processed by ribosomes to produce proteins. Sequences of
triplicate nucleotides, named codons, represent amino acids. The sequence
is read by the ribosome which adds the correct amino acid to an extending
polypeptide chain. Much information is also contained in the sequences sur-
rounding ORFs, which do not encode proteins but carry important regulatory
information to control how cellular processes act upon the DNA.
1.2.1.2 Chromatin
In eukaryotic cells DNA does not exist in the naked state of the double helix
described above. Instead it is packaged into a supercoiled, complex, highly
condensed DNA-protein structure named chromatin. This is a hierarchical
structure, summarised as follows (adapted from Watson et al., 2003). The
first level is the nucleosome, which consists of a 160–165 bp segment of DNA
wrapped around a core of 8 histone proteins, comprising 2 copies each of
histones H2A, H2B, H3 and H4. The N-termini of these proteins protrude
from the nucleosome. A segment of 13–18 bp of linker DNA between each
nucleosome gives the structure a ‘beads-on-a-string’ appearance under the
electron microscope. Histone H1 binds this linker region, stabilising the
structure, creating a more defined angle between the nucleosomes. The next
level of structure is the 30 nm fibre: an assembly of nucleosomes 30 nm in
diameter. This is further condensed by looping the fibre around a protein
core. This creates a structure around 10,000 times more condensed than
naked DNA.
1.2.1.3 Replication
The two complementary strands of DNA make it possible to copy information
into new cells, enabling the inheritance of the genetic code. When a cell
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reproduces, each of the strands serves as a template for the creation of a new,
complementary, strand. This results in two identical copies of the original
molecule which are distributed to the two daughter cells.
DNA replication requires a DNA polymerase: an enzyme which reads the
existing DNA sequence and inserts the appropriate complementary base into
the synthesising sequence. There are various types of DNA polymerase, each
with different functions and characteristics, but all perform this same basic
task. The enzymes have a single active site, which catalyses the addition of
any of the four bases, arranged as a pocket around the DNA molecule. When
the correct complementary base enters this pocket the molecular arrangement
is such that the reaction to join it to the new DNA molecule is catalysed.
DNA polymerases are capable of adding up to 1,000 nucleotides a second to
a synthesising DNA strand as they move along the template strand (Watson
et al., 2003).
Specific exonucleases proof read newly synthesised DNA to correct erro-
neously added nucleotides. Approximately 1 in 105 nucleotides are incorrectly
incorporated by the DNA polymerase during replication. Exonucleases de-
grade DNA from its ends and so the proof reading exonuclease can remove
an incorrect nucleotide at the end of the newly synthesised DNA strand,
allowing the polymerase another opportunity to add the correct nucleotide.
This increases the accuracy of DNA replication to approximately 1 incorrect
insertion per 107 nucleotides.
1.2.2 DNA damage and repair
The DNA molecule is susceptible to many types of damaging agents. These
damages can occur spontaneously, as a result of normal cellular conditions,
or from extra-cellular sources. Endogenous DNA damage events arise as a
result of reactions with substances present in cells for normal functionality.
These spontaneous lesions can occur at high rates because of the constant
contact with the damaging chemicals. Exogenous DNA damages arise outside
of the cell and as such generally occur at lower frequencies than endogenous
damages. They may be caused by chemical or physical insults. Several repair
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pathways have evolved in cells to process the various types of damage that
they are constantly subject to. This section briefly outlines the main types of
damage and the repair pathways that deal with them, split into three sections:
events which modify single bases, events which alter the DNA structure and
events which cause the breakage of DNA strands. Information is taken from
Alberts et al. (2002), Watson et al. (2003) and Friedberg et al. (2006).
1.2.2.1 Base modifications
Base modification events occur at single bases, causing deviation from the
intended DNA sequence. They can cause bases to become unrecognisable by
the replication and transcription machinery, inhibiting or disrupting these
processes, or substitute incorrect bases into the sequence, causing the po-
tential proliferation of mutations. Transitions are interchanges of the same
class of base, that is, a purine for a purine or a pyrimidine for a pyrimidine.
Transversions are interchanges of different classes of base, that is, a purine
for a pyrimidine or vice versa.
Deamination
Deamination is the removal of an amine group from a nucleotide, which
occurs via a hydrolysis reaction. Cytosine is the most frequently deaminated
base, at a rate of ∼100–500 per diploid human cell per day. This produces
uracil (U), a base not naturally present in DNA. Uracil is a pyrimidine which
pairs with adenine, so leads to the incorporation of an adenine, rather than
guanine, into the opposite strand during replication, inducing a C:G to T:A
mutation.
Adenine and guanine can also be deaminated to hypoxanthine and xan-
thine respectively, both of which pair with cytosine, but at a much lower rate
than cytosine. Adenine deamination therefore induces an A:T to G:C muta-
tion, while xanthine forms only two of the usual three hydrogen bonds with
cytosine and so may result in the arrest of DNA synthesis. The abnormal
bases created by these deamination reactions can be recognised by the cell
and repaired. However, 5-methyl cytosine (a cytosine modified by a methyl
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transferase enzyme for regulatory purposes) can be deaminated to thymine,
inducing a C:G to T:A mutation. As this will not be recognised by the cell as
an abnormal base the mutation can become fixed, and methylated cytosines
are known mutation hot spots (Denissenko et al., 1997, for example).
Depurination
Depurination is the removal of a purine base from the deoxyribose sugar.
Like deamination, it is a spontaneous hydrolysis reaction. Depurination of
adenine and guanine can produce an abasic site, that is, a deoxyribose lacking
a base. This occurs at a rate of ∼18,000 per diploid human cell per day. The
genetic information can be recovered from the complementary strand if this
occurs in double stranded DNA, but may be mutagenic in single stranded
DNA.
Depyrimidination
Depyrimidination occurs by the same mechanism as depurination. Pyrimi-
dine nucleosides are more stable than purine nucleosides, and so the rate of
depyrimidination is less, at ∼600 per diploid human cell per day.
Oxidation
Oxidation can occur at all four DNA bases, but is most common at guanine
due to it having the highest oxidation potential. Reactive oxygen species are
generated as by-products of oxygen metabolism and as such oxidative stress
is an unavoidable consequence of life in an oxygen-rich atmosphere. It can
produce over 80 types of base damage. 7,8-dihydro-8-oxoguanine (commonly
shortened to 8-oxoG) is among the most common, occurring at a rate of
∼1,000-2,000 per diploid human cell per day. This can pair with adenine as
well as cytosine and thereby induce G:C to T:A mutations. Ring saturated
pyrimidines, such as thymine glycol, and lipid peroxidation products arise at
a rate of ∼2,000 and ∼1,000 per diploid human cell per day respectively.
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Alkylation
Alkylation is the transfer of an alkyl group to bases or the phosphates of the
DNA backbone. One of the most vulnerable sites is the oxygen of carbon
atom 6 of guanine. This produces O6-methylguanine which often mispairs
with thymine, inducing a G:C to A:T mutation. There is a variety of a en-
dogenous and exogenous alkylating agents.
All of the above types of damage are repaired via the base excision repair
(BER) pathway. DNA glycosylase enzymes recognise and remove specific
damage types, leaving an apurinic or apyrimidinic (AP) site. In the case of
spontaneous depurination and depyrimidination this glycosylase step is not
required. The sites are cleaved by an AP endonuclease enzyme, of which there
are four classes. All cleave at the phosphate groups 3′ and 5′ to the baseless
site, but leave either 3′-OH and 5′-phosphate or 3′-phosphate and 5′-OH
termini. Some glycosylases are bi-functional, that is, they also perform the
cleavage step and therefore do not require the action of an AP endonuclease.
The resulting single strand break is repaired by either short- or long-patch
BER. Short-patch repair replaces the single removed nucleotide while long-
patch repair replaces a stretch of 2-10 nucleotides.
Incorrect base incorporation
Incorrect bases can be incorporated through the simple insertion of the wrong
base by a DNA polymerase during DNA synthesis, resulting in mismatches.
Additionally, free bases may be damaged before being incorporated into
DNA.
1.2.2.2 Structural alterations
Structural alterations may occur at single or multiple bases, or within the
backbone of the double helix. They may arise from reactions within the
DNA structure or with outside molecules. They alter the structure of the
helix such that it becomes distorted, that is, it deviates from the normal
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structure previously discussed. These distortions can block replication and
transcription.
Base substitution
Molecules of sufficiently similar structure — base analogues — can be incor-
porated into DNA in the place of true bases. Although similar enough to be
processed by the cell as a real base, they do not behave as such once incorpo-
rated into the DNA and so can lead to mistakes during replication. One of
the most mutagenic base analogues is 5-bromouracil. This is an analogue of
thymine but can mispair with guanine in double stranded DNA. Tautomers
of the bases also exist, where the protons occupy different positions in the
molecule. These can theoretically cause mispairings between bases, but no
evidence has been found that they do so in cells (Pray, 2008).
Intercalation
Flat, polycyclic ring-containing molecules can slip between bases within the
DNA double helix. This can cause the deletion or addition of bases during
replication, creating frame shift mutations. This can have severe effects on
proteins if arising within coding genes.
Inter- and intra-strand cross links
Chemical bonds can be created between nucleotides on the two strands of the
double helix (inter), or between nucleotides on the same strand of the helix
(intra). These can block the DNA polymerase, thereby causing cell death.
Bulky adducts
Large, bulky molecules can be chemically bonded to DNA, distorting its
shape. An example that can cause multiple types of damage is the platinat-
ing class of chemotherapeutic drugs (cisplatin, oxaliplatin and carboplatin).
These can create crosslinks between guanine bases on the same strand, ad-
jacent to each other or separated by one base, and on opposite strands,
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separated by one base. They can also form adducts on individual guanine
bases. The absorption of UV radiation can cause the covalent bonding of ad-
jacent pyrimidine bases (see Section 1.4.1.1), creating a DNA adduct without
it interacting with another chemical.
These types of damage are repaired in part via the nucleotide excision
repair (NER) pathway. The first stage of this pathway, the recognition of a
lesion, is split into two sub-pathways. Lesions arising in genes that are being
actively transcribed cause the arrest of the RNA polymerase, recruiting the
rest of the NER machinery to the site. This is transcription coupled NER
(TC-NER). All lesions, including those in genes being actively transcribed,
but primarily those in non-coding regions, genes not being transcribed and
the non-coding strand of genes being transcribed, can be recognised by spe-
cific proteins, including the human DDB and XPC-Rad23B complexes, which
recruit the NER machinery to the site. This is global genome NER (GG-
NER). Thus there is faster repair of adducts in genes being actively tran-
scribed than the rest of the genome because they are able to be detected by
both sub-pathways. After the initial recognition of damage sites the path-
ways converge. The DNA is unwound at the site of damage by two helicase
enzymes, XPB and XPD, and two incisions are made in the strand contain-
ing the damage, one either side, by two endonuclease enzymes, XPG and
XPF. This creates a strand 25-30 nucleotides long which is removed from
the helix. A DNA polymerase then fills this gap, reading from the remaining
strand, and DNA ligase seals the nicks. GG-NER is discussed in more detail
in Section 1.4.3.
Some types of DNA damage can be directly reversed by enzymes. One
such example is photoreactivation, where the energy from light is harnessed
by the photolyase enzyme to break apart the covalent bonds between two
bases in a cyclobutane pyrimidine dimer (CPD), restoring the original con-
figuration. This enzyme is not present in humans. This type of reaction acts
directly on the damaged bases, converting them back to their original forms,
and as such does not require a DNA template or the incorporation of new
nucleotides.
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In some cases DNA synthesis will continue across a damage site, which
may be preferable to the cell rather than aborting the synthesis to repair the
lesion. This is achieved via the translesion synthesis (TLS) pathway. This
requires the use of specialised polymerases to synthesise across the damage.
In general, these polymerases have low fidelity, that is, they often incorporate
the wrong base with an undamaged DNA template. However, they are much
more efficient at incorporating the correct base at damage sites than normal
polymerases. They often have larger active sites to allow the adduct to fit.
At sites of damage the PCNA protein is ubiquitinated, which signals the
polymerase switching.
1.2.2.3 Strand breakages
Strand breakages are the introduction of nicks into the phosphodiester back-
bone of DNA. They may arise in one or both strands.
Single strand breaks
Single strand breaks (SSBs) are the breakage of the backbone of one strand of
the double helix which can be induced by certain wavelengths of radiation and
as a result of other cellular repair processes. They leave the DNA molecule
intact by virtue of the remaining second strand. Two single strand breaks
close together on opposite strands however can lead to a more severe dou-
ble strand break (DSB), as can an approaching replication fork. Cells have
therefore developed efficient systems to detect and repair these breaks to pre-
vent them becoming more severe. Poly(ADP-ribose) polymerase (PARP) is
one such sensor, which binds to SSBs with high affinity and acts as a signal
for repair. One important protein in the repair process, which interacts with
PARP, is XRCC1. This has multiple roles in SSB repair and is thought to
act as an important scaffold protein in interacting with several other pro-
teins with roles in the repair pathway, including end processing, gap filling
and ligation.
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Double strand breaks
DSBs form when the backbones of both strands of the double helix are severed
in close proximity, creating two separate DNA molecules, which can lead to
chromosomal rearrangements. There are two main mechanisms for the repair
of these breaks: directly rejoining the free ends of the two molecules (non-
homologous end joining; NHEJ), which does not necessarily join the correct
two free ends, or utilising regions of similar or identical sequence to the free
ends elsewhere in the genome to aid the joining of the free ends to what is
likely to be the correct sequence (homologous end joining; HEJ).
HEJ uses a short section of a sister chromosome with sequence homology
to the free DNA ends to rejoin the ends together without loss of information.
The MRN-complex recognises DSBs and locates to their sites, and medi-
ates the processes required for HEJ to take place. The 5′ ends of the DNA
strands are resected, leaving 3′ overhangs. An overhang can then invade
the region of the sister chromosome with sequence homology, base pairing
with the homologous sequence and displacing the complementary strand. A
DNA polymerase can then extend the 3′ ends based on the complementary
sequences of the invaded chromosome. This forms two Holliday junctions,
the resolution of which produces either cross-over or non-crossover products.
This utilisation of identical sequences means that repair by this method is
error free.
NHEJ occurs when a sister chromosome is not present, that is, before
DNA replication has taken place and therefore represents the major DSB re-
pair pathway in humans. Two free ends are simply ligated together, mediated
by Ku proteins. Small regions of homology present on single stranded DNA
(ssDNA) at the ends of the strands, which can be as little as one nucleotide in
length (serendipitous microhomologies) are utilised for this process. This is
therefore an error prone repair process but as so little of the human genome
is coding it seems that this small loss of information is generally tolerated.
However, there is no way of knowing that the two free ends being joined
by this process are correct, that is, were originally joined together before
the break, so this type of repair can induce chromosomal rearrangements, a
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hallmark of cancer.
1.2.3 Consequences of defective DNA repair
Repair of DNA damage is vital for cellular proliferation and organism sur-
vival. Organisms with serious DNA repair defects often do not survive be-
yond the very early stages of life. There are many congenital diseases of repair
pathways in humans which confer increased risk of cancers or/and reduced
lifespans. Additionally, acquired diseases can arise following the incorrect
repair of a damage event in an otherwise healthy individual.
1.2.3.1 Congenital diseases
Over 20 diseases are associated with mutations in around 50 genes involved
in DNA repair (reviewed by Lehmann and O’Driscoll, 2010). The following
information is taken from this review.
Three main diseases are associated with defects in the NER pathway:
xeroderma pigmentosum (XP), Cockayne syndrome (CS) and trichothiodys-
trophy (TTD). XP arises from mutations in any one of the seven XP genes,
designated A to G (see Section 1.4.3), and is characterised by sensitivity
to sunlight, skin pigmentation changes and multiple skin cancers on areas
exposed to sunlight. It is also associated with neurological abnormalities
in some cases. CS is associated with mutations in the CSA and CSB genes.
The proteins encoded by these genes are required to displace the stalled poly-
merase at damage sites in genes being actively transcribed and as such this
disease is specifically related to TC-NER. The symptoms include dwarfism,
severe physical and mental retardation, neurological and retinal degenera-
tion, ataxic gait, deafness and sun sensitivity. Notably, there is no skin
pigmentation or increased risk of skin cancer. It is thought the symptoms of
the disease are related to the accumulation of oxidative damage, the removal
of which CSA and CSB are also involved with. TTD arises from mutations
in the XPB and XPD genes and is characterised by sulphur-deficient, brittle
hair, ichthyotic skin, beta thalassaemia trait, physical and mental retardation
and sun sensitivity, but again no skin pigmentation or increased skin cancer
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risk. It is thought these symptoms are related to defects in transcription, in
which XPB and XPD also play a role in initiation, whereas in XP they are
related to defects in repair.
Defects in the TLS pathway can also cause an XP variant, XP-V, with
20% of patients having normal NER but mutations in polymerase η. This
polymerase is able to carry out TLS past UV-induced and other DNA adducts.
Without its activity cells cannot effectively repicate across damage when nec-
essary.
Patients with clinical symptoms related to defects in HEJ and NHEJ
are rare. The BRCA1 and BRCA2 genes, mutations in which are linked
to familial breast cancer, play roles in HEJ. Several diseases are linked to
defects in the signal transduction cascade activated by DNA breaks. The
ATM and ATR kinases coordinate these downstream events, activated by
DSBs and ssDNA respectively. Ataxia-telangiectasia, ataxia telangiectasia-
like disorder and Nijmegen breakage syndrome are linked to defects in ATM,
with symptoms including increased cancer predisposition. Seckel syndrome
is associated with ATR mutations.
Mutations in three of the five RECQ genes, involved in homologous re-
combination and suppression of illegitimate recombination, result in several
disorders. Bloom syndrome (BLM) is characterised by a reduced stature, re-
duced fertility, chromosome abnormalities and high cancer incidence. These
cells have a very high incidence of sister chromosome exchanges. Werner
syndrome (WRN) is characterised by features of premature aging and an in-
creased incidence of soft tissue carcinomas. These cells show a high frequency
of illegitimate recombination. Rothmund-Thompson syndrome is linked with
abnormalities of the skin and skeleton and an increase in cancer incidence.
Fanconi anaemia patients suffer from defects in interstrand cross link re-
pair. It results from mutations in any one of 13 FANC genes. Cells are hyper-
sensitive to cross linking agents and slightly sensitive to ionising radiation.
Clinical symptoms are progressive aplastic anaemia, skeletal abnormalities
and lymphoid malignancy.
Defects in mismatch repair cause the autosomal dominant condition hered-
itary nonpolyposis colon carcinoma (HNPCC). The majority of cases arise
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from mutations in the genes MSH2 — involved in mismatch recognition —
and MLH1 — recruited to mismatches once recognised. The reason for tu-
mours arising only in the colon when mismatch repair is vital in all cells is
currently unclear, but is thought to be related to the high replicative turnover
in the gut layer.
Various diseases are associated with defects in the various parts of BER.
Spinocerebellar ataxia with axonal neuropathy (SCAN1), a disease associ-
ated with neurodegeneration, results from mutations in the TDP1 gene.
This is involved in removing topoisomerase I enzymes from DNA, the in-
hibition of which results in a reduced ability to repair single strand breaks.
Ataxia-oculomotor apraxia type 1 (AOA1), a disease associated with cere-
bellar atrophy and sensorimotor neuropathy, results from mutations in the
APTX gene. This is involved in the removal of intermediates in the repair of
DNA breaks, inhibition of which it is thought causes the build up of breaks
in cerebellar DNA.
Other diseases include cerebro-oculo-facio-skeletal (COFS) syndrome, re-
sulting from mutations in the CSB gene and PIBIDS — named after the
features of Photosensitivity, Ichthyosis, Brittle hair, Intellectual impairment,
Decreased fertility and Short stature — which is considered to by synony-
mous with the photosensitive form of TTD (Friedberg et al., 2006). Because
these diseases are so rare it can be difficult to categorise and compartmen-
talise them, and there is likely a spectrum of diseases with overlapping clinical
features (Friedberg et al., 2006).
1.2.3.2 Acquired diseases
Cancers can arise in any person. Certain DNA repair defects can cause
increased incidence or risk of cancers, as outlined in the previous section, but
DNA repair errors in otherwise healthy individuals can also lead to cancer
formation. There are a number of unusual properties a cell must gain in
order to make the transition from normal to cancerous. These changes take
the cells beyond the normal controls and allow them to proliferate in the
uncontrollable manner associated with cancers. Multiple functions exists in
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cells to prevent them acquiring these properties, but occasionally these can
fail. These properties have been reviewed in two papers by Hanahan and
Weinberg (2000, 2011) and are outlined below.
Self sufficiency in growth signals
Normal cells require extracellular growth signals to make them actively pro-
liferate. Without these signals the cells remain quiescent. This homeostatic
mechanism ensures the proper behaviour of the various cell types within a tis-
sue. Various mutations have been identified in cancerous cells which enables
them to evade this control. These include the cell abnormally synthesising
growth factors to which it itself responds or altering the cellular circuitry such
that the response to growth signals is activated even without the presence of
the growth signals. This allows the cells to be in a continuous proliferative
state.
Insensitivity to antigrowth signals
Anti-growth factors also exist, with the reverse function of growth factors,
that is, they signal cell quiescence. Different types of anti-growth factors can
induce temporary or permanent quiescent states. Cells avoid these signals by
downregulating or displaying dysfunctional cell surface receptors or altering
the cellular circuitry such that no response to anti-growth signals is made.
This allows cells to ignore growth-inhibiting signals from surrounding cells.
Apoptosis evasion
Apoptosis is programmed cell death, an essential process by which cells ‘dis-
mantle’ themselves in precisely choreographed steps and their components
are taken up by surrounding cells. Various events can signal apoptosis in-
cluding DNA damage and hypoxia, as well as controls to maintain tissues in
the correct configuration. The p53 tumour suppressor is heavily involved in
the apoptotic pathway and its inactivation is seen in over half of human can-
cers (Harris, 1996). This evasion allows the cells to persist even in situations
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where they would normally be signalled to destroy themselves (reviewed by
Fulda, 2010).
Limitless replicative potential
Even with the three capabilities listed above cells cannot replicate forever.
Cells have a finite replicative potential, after which they enter senescence.
Circumventing this allows cells to replicate for a further period until they
enter crisis, which is characterised by cell death. This limit is imposed by
telomeres, short sections of which are lost with every cell cycle (reviewed by
Stewart and Weinberg, 2002). This progressive erosion means that the whole
telomere will eventually be lost, causing end-to-end chromosomal fusions and
the death of the cell. Unlimited replicative potential can be acquired by
modifying telomeres in a way that means they never become lost. Nearly all
cancer cells show such telomere maintenance (Shay and Bacchetti, 1997).
Sustained angiogenesis
Angiogenesis is the production of new blood vessels. In order for a tumour to
grow it must have the ability to create new blood vessels to carry oxygen and
nutrients to all cells within it. Initially the cells do not have this ability. Var-
ious mechanisms are acquired in order to stimulate angiogenesis, including
the production of angiogenesis-initiating signals (reviewed by Kerbel, 2000).
Tissue invasion and metastasis
Once cancerous cells become free of the normal growth constraints and be-
come immortal, they may become limited in the space available for them to
physically grow into. Overcoming this involves producing cells that can move
away from the original tumour and form new tumours elsewhere (metastasis)
and developing the ability to grow into and through surrounding tissues (in-
vasion), traits not associated with normal cells. The majority — as much as
90% — of human cancer deaths are due to metastases (reviewed by Chaffer
and Weinberg, 2011). These traits are acquired by modifying proteins in-
volved in tethering cells to their surroundings, which have various regulatory
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functions, and upregulating extracellular proteases, which can degrade and
disrupt surrounding cells.
Reprogramming energy metabolism
In order for cancer cells to proliferate at the faster rate allowed by the above
modifications, they must also change the way they produce energy. Most can-
cer cells limit their metabolism to glycolysis, even in the presence of oxygen,
creating a state referred to as “aerobic glycolysis” (reviewed by Hsu and Saba-
tini, 2008). This process produces less energy than conventional metabolism
and so is commonly accompanied by upregulation of glucose transporters.
The reason for this is unclear but may allow glycolysis intermediates to be
diverted into other biosynthetic pathways, including nucleosides and amino
acids, aiding the production of new cells.
Evading immune detection
The immune system is highly effective at removing malignant cells. It is
thought that the majority of cancerous cells are detected and eliminated by
the immune system and therefore that cancerous cells that survive this pro-
cess do so by somehow evading the immune system (recent evidence discussed
by Bindea et al., 2010). There is some evidence to show that the immune
system plays an important role in cancer removal in mice.
1.3 Measuring DNA damage
In order to investigate DNA damage and its subsequent repair, methods of
measuring the amount of DNA damage present in a cell or cells are required.
Repair is estimated by measuring damage at time points after exposure to a
particular damaging agent. Any decrease in the level of damage over time can
be indicative of repair having taken place. Repair assays can be divided into
two broad categories: high and low resolution. This refers to the ability to
resolve the sites at which damage occurs. Low resolution techniques provide
a very limited, if any, way of determining where in the genome damage
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occurs. Many of the assays allow total damage to be measured, that is,
they show damage throughout entire genomes, but the sites at which the
damage is located within the genome cannot be determined. Conversely,
high resolution techniques allow the locations of damage to be determined to
within a number of base pairs. Typically, these techniques allow only a small
section of a genome to be investigated at a time, and so do not enable genome
wide damage to be investigated. The following sections outline the techniques
that have been used to measure DNA damage, with specific reference to their
use in measuring CPD incidence where appropriate.
1.3.1 Low resolution techniques
Early investigations of DNA damage were low resolution and whole genome.
The first used radioactive labels to indirectly measure the presence of dam-
age. For example, an alkaline sucrose gradient method developed by Mc-
Grath and Williams (1966), used to separate long strands of (radioactively
labelled) genomic DNA by length, thus producing a distribution of fragments
by molecular weight, has been used to measure the repair of such things as
Escherichia coli DNA exposed to x-ray radiation (McGrath and Williams,
1966) and lymphoma cells treated with alkylating agents (Peterson et al.,
1973). Here the presence of damage is indicated by the amounts of differing
length DNA fragments. Radioactive labelling can also be used to investigate
the removal of CPDs in E. coli (Setlow and Carrier, 1964), for example, by
damaging cells containing labelled thymine and monitoring its replacement,
as it is repaired, with unlabelled thymine.
The first assay to demonstrate NER in mammalian cells in culture used a
radiolabelled DNA precursor (Rasmussen and Painter, 1964). Only during S
phase would this normally be expected to be incorporated into the genome.
Dipping slides containing cells into a photographic emulsion for autoradiog-
raphy highlights areas of radiolabelling by the accumulation of silver grains
in the nucleus. Cells in S phase show this labelling, while those in other
phases do not. Following UV irradiation all cells show labelling, indicative
of DNA synthesis as a result of NER.
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Pulsed field gel electrophoresis (PFGE) can be used to monitor double
strand breaks (first used by Contopoulou et al., 1987). This technique allows
individual chromosomes to be resolved as individual bands on the gel, allow-
ing their repair to be monitored separately. This technique has an increased
resolution from whole genome to whole chromosome, but is still considered
low resolution as the sites of damage cannot be resolved. The FAR (fraction
of activity released) assay (Rydberg et al., 1994) provides another measure
of double strand breaks using PFGE, by measuring the amount of DNA that
enters the gel from a plug containing a cell sample.
A very simple gel based assay allows for double stranded breaks to be
visualised by separation by electrophoresis. The more breaks present the
more short fragments present, which travel further on the gel creating a
‘smear.’ With no or few breaks only long fragments are present which do not
travel very far on the gel and so no, or only a small, smear is created.
The alkaline unwinding assay can be used to monitor single strand breaks
in DNA (first used by Elkind and Chang-Liu, 1972). Here chemical condi-
tions are made such that the DNA helix can unwind from sites of single
strand breakages, causing the two strands to separate. The amount of single
stranded DNA present is then indicative of the number of breaks present.
This technique can also be used to monitor NER (Erixon and Ahnstro¨m,
1979), by measuring the short fragments of excised DNA. During the NER
process short fragments of DNA containing damage are excised, following
the introduction of nicks either side of the damage. Monitoring these short,
single stranded fragments shows the amount of NER activity. An alternative
method, alkaline filter elution (developed by Kohn and Grimek-Ewig, 1973),
is based on the same principle, but without the centrifugation required by
the previous two assays. Instead filters are used to separate the DNA frag-
ments in a more reproducible manner. This technique has also been used to
monitor NER (Fornace et al., 1976).
Cadet et al. (1983) discuss some other methods of analysing NER (avail-
able at the time) which either indirectly measure repair, such as a method
which separates DNA containing radioactive nucleotides removed through
repair in isopycnic gradients (Pettijohn and Hanawalt (1964) cited in Cadet
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et al., 1983), or directly analysing sites of damage with endonucleases that
cut at damage sites, such as with alkaline elution (Fornace Jr (1982) cited
in Cadet et al., 1983). They address the problem that these techniques do
not allow identification of the types of lesions present by applying HPLC
(high performance liquid chromatography) to the detection of damage which
is able to detect the different dimers produced at the four dipyrimidine sites
(TT, TC, CT and CC) following UV radiation.
The comet assay, first described in 1990 (Olive et al., 1990), is a popular
method still used today and has been reviewed extensively (see, for example,
Collins, 2004). It is a single cell assay which uses an electrophoretic gel to
separate damaged (short) DNA fragments from undamaged (long) genomic
DNA. As well as detecting single and double strand breaks, other damages
such as cross links and base damage can be detected (Speit and Hartmann,
2006). The shape of the resulting DNA resembles a comet, with the undam-
aged DNA in the body and the damaged DNA forming the tail, the length
and shape of which can be used to describe the damage. Software is avail-
able to automate this process (discussed, along with the rest of the protocol,
in Olive and Bana´th, 2006). More recent adaptations of the technology use
microwell arrays, where a single comet can be produced in each of 24 or 96
wells (Wood et al., 2010). This is amenable to high throughput screening,
enhancing the generation of results. The comet assay can be used to mon-
itor NER (Myllyperkio¨ et al., 2000, for example) by measuring the single
stranded excised DNA fragments.
An alternative to the comet assay for some types of DNA damage is the
halo assay (Sestili et al., 2006). Whereas the comet assay uses an electric field
to ‘pull’ DNA out of cells, the halo assay relies on the diffusion of fragments
out of the cell. Like the comet assay, it is named after the shape produced
as the damaged DNA migrates out of the cell, which surrounds each cell in
a ring as it is not attracted in any one direction. This assay can also be
adapted to high throughput screening (Qiao et al., 2011).
The TUNEL assay (terminal deoxynucleotidyl transferase-mediated dUTP-
biotin nick end labelling, developed by Gavrieli et al., 1992) can be used to
visualise DNA breaks with a microscope by the attachment of a fluorescent
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molecule to the free ends.
Various formats of mass spectrometry (MS), such as gas chromatography
(GC, first used by Dizdaroglu, 1984, to investigate radiation induced damage)
and HPLC-electrospray (first used by Wolf and Vouros, 1994, to investigate
deoxynucleoside adducts) have been used to detect particular types of DNA
damage. It has been used to detect CPDs (for example, by Douki et al.,
2000, to analyse the formation of different thymine dimers). Although very
sensitive and specific, MS assays can be limited in the amount of material that
can be tested and the damages that can be detected. Cost and availability
can be prohibitive in widespread use.
Electrochemical methods, which use biosensors, have been used to de-
tect radiation- (Wang et al., 1997) and chemical-induced (Zhou and Rusling,
2001) DNA damage. These methods are specific, and therefore limited, to
the damage they are developed to detect. A different sensor would be re-
quired to analyse each different type of damage, which limits their widespread
application.
Immunological assays use antibodies against antigens of interest, in this
case DNA damages, to examine the presence of the damage. Immuno-slot
blots are a common sensitive and specific assay. They are a simple alternative
to the western, northern and Southern blots, omitting the separation stage
of these techniques. An antibody against the damage of interest is used to
identify its presence in a sample, which is simply transferred or ‘dotted’ onto
a membrane. The lack of a separation stage means products of different sizes
cannot be distinguished, which does not represent a problem if the aim of the
assay is to determine the total amount of damage present. The technique has
been applied to investigating UV damage (for example, Perdiz et al., 2000,
analysed the formation of the different types of UV-induced lesions).
Other types of immunological assay, including the RIA (radio immunoas-
say) and ELISA (enzyme linked immunosorbent assay) can also be used
quantify total damage amounts. The multi-well format of ELISAs makes
them useful for high throughput analyses. A RIA, for example, was used
to show that 6-4 photoproducts are removed from DNA faster than CPDS
(Mitchell et al., 1985).
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1.3.2 High resolution techniques
More recent DNA damage measurement techniques have allowed analyses
focussed on particular genome regions to be carried out. The PCR reaction
can be used to quantify damage amounts, by taking advantage of the fact
that the polymerase cannot replicate across sites of damage. This was first
demonstrated by Moore and Strauss (1979) and first used as a quantitative
PCR assay to detect CPDs by Govan III et al. (1990). Using primers to a
particular region of interest allows the presence of damage in the region to be
determined. The reduction in reaction yield compared to undamaged DNA is
indicative of the amount of damage present in the region. Although not able
to identify the locations of damage events, this type of assay allows damage
in specific regions to be investigated and is therefore higher resolution than
the previously discussed assays.
Another assay uses enzymes that cut at sites of damage, with true high
resolution results. With respect to CPDs, a CPD specific nuclease can be
used to cut at CPD sites. A method developed by Teng et al. (1997) uses
phage T4 endonuclease to cut at damage sites and probes specific to two ends
of a region of interest to separate the two DNA strands of the region from the
rest of the genomic DNA. The lengths of the separated fragments thus vary in
length, depending on whether and where they are cut by the endonuclease.
Undamaged fragments will be full length, whereas the lengths of shorter
fragments represent the position of the closest cut damage site to the probe.
These different lengths of fragment can be radiolabelled and resolved on a
gel. A sequence ladder run on the same gel allows precise identification of the
sequence at which damage has been detected. Running several samples from
different time points allows repair to be visualised, as the number of short
fragments decreases. The separation of the two strands allows repair rates
of these to be analysed separately, which allows, for example, the different
repair rates of TC-NER and GG-NER to be visualised, with the strand being
analysed containing a gene (or section thereof) being actively transcribed,
and its complement strand, which is not transcribed.
A novel use of microarray technology developed in our laboratory (Teng
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et al., 2011) allows high resolution, genome wide measurements of DNA
damage. This overcomes the problem of the above techniques, which are
limited to short (several hundreds of base pairs) regions of a genome due
to the limiting size of the gels. In the same way that ChIP-chip can be
used to identify the binding locations of proteins with an antibody raised
against them, an antibody against damage, CPDs in this case, is used to
immunoprecipitate DNA containing damage. Applying this material to an
appropriate microarray covering a whole genome, or section thereof, allows
the relative amount of damage in a given region to be determined. This is
discussed in more detail in Chapter 6.
1.4 CPDs and NER: a paradigm
UV radiation is used in our laboratory as a way of generating DNA damage,
namely CPDs, which is measured over time to investigate its repair by NER.
This section outlines this paradigm.
1.4.1 Ultra violet radiation
UV radiation is a well studied, relevant DNA damaging agent, as many
organisms, including humans, are exposed to it on a regular basis in solar
radiation, and have been for millennia. The UV spectrum is divided into
three segments based on wavelength: UV-A (320–400 nm); UV-B (295–320
nm); and UV-C (100–295 nm). The ozone layer absorbs UV at wavelengths
up to around 300 nm, meaning little UV-C radiation reaches the Earth’s
surface. The UV absorption peak of DNA is 260 nm, so the most DNA-
damaging wavelengths are filtered out by the atmosphere.
In the laboratory, UV lamps provide a convenient and readily available
method of inducing DNA damage in cells in order to investigate repair. This
is often done with wavelengths in the UV-C region of the spectrum which,
although not strictly environmentally relevant, induces the same damages as
UV-A and UV-B, but at a higher efficiency. All UV-induced damage referred
to in this thesis was produced with 254 nm radiation at a rate of 100 J/m2.
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This produces, on average, 1 damage event per 1,000 bp (Courcelle et al.,
2006).
1.4.1.1 Cyclobutane pyrimidine dimers
The absorption of UV radiation by DNA causes alterations to its structure,
called photoproducts. These include pyrimidine-pyrimidone (6-4) adducts
((6,4)PPs), spore photoproducts, purine-containing lesions, pyrimidine hy-
drates, thymine glycol and CPDs. These are the most frequently formed
photoproducts and are used in our laboratory to investigate damage and
repair.
CPDs are formed by covalent linkages between adjacent pyrimidines,
forming a 4-membered ring structure resulting from saturation of the pyrim-
idine 5,6 double bonds (Figure 1.5). The two pyrimidines are unable to form
correct pairing with their complementary bases. This lesion causes a distor-
tion in the shape of the DNA helix of approximately 30° (Park et al., 2002,
Figure 1.6). This distortion inhibits DNA replication and transcription and
thus is lethal to cells if left unrepaired. It is this distortion, specifically the
resulting reduced base stacking, that is thought to be recognised by repair
enzymes (Yang, 2007).
CPDs form between two adjacent pyrimidines on the same DNA strand,
but the frequency of formation between different dipyrimidine combinations
varies. The ratio of formation of dimers at TT:TC:CT:CC sites in plasmid
DNA with UV-C radiation is 68:16:13:3 (Mitchell et al., 1992).
1.4.2 Saccharomyces cerevisiae as a model organism
A model organism is an organism used in place of humans to investigate
and gain insights into human diseases. Several such organisms are used in
biomedical research. The budding yeast Saccharomyces cerevisiae has been
used as a model organism for many years due to it being easy to grow and
manipulate in the laboratory, particularly with respect to genetic analyses.
The yeast genome is approximately 13 Mbp, 270 times smaller than the
human genome, and codes for around 6,000 genes. With respect to NER,
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Figure 1.5: The cyclobutane pyrimidine dimer: Molecular structure of two
adjacent thymine nucleotides (left) and a cyclobutane pyrimidine dimer
(right) formed from saturation of the pyrimidine 5,6 double bonds.
Figure 1.6: Kinked DNA molecule: Side (left) and top (right) view of the
kink induced in the DNA molecule by the presence of a CPD (Park et al.,
2002). Damaged DNA (red) bends approximately 30° relative to undamaged
DNA (green).
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the great majority of the proteins identified in yeast cells have homologous
partners in human cells.
1.4.3 Nucleotide excision repair
NER is the pathway by which CPDs and a variety of other DNA lesions are
removed. The speed of removal varies with different types of lesion. (6-4)PPs,
for example, which distort the DNA to a greater extent than CPDS, are
repaired 5–10 times faster than CPDs (Friedberg et al., 2006). The position
of incisions relative to the lesion and the length of the excised fragment
also varies slightly depending on the type of lesion being repaired (Friedberg
et al., 2006). GG-NER occurs throughout a genome, with no specificity for
any particular region(s). It is complemented by TC-NER which occurs only
within genes that are being actively transcribed, when the polymerase stalls
at the site of a lesion. The repair process in the two pathways is identical;
they differ only in this initial recognition step.
The whole NER process has been elucidated for prokaryotic cells (re-
viewed by Truglio et al., 2006), which requires only three proteins: UvrA,
UvraB and UvrC. UvrA and UvrB are involved in damage detection and
verification. UvrB and UvrC perform the damage removal. A trimer of two
UvrA and a UvrB molecules detects DNA damage via the UvrA dimer. The
trimer then binds the damage via UvrB, whereupon the UvrA dimer leaves
the complex. A UvrC molecule then forms a dimer with the UvrB molecule
bound to the damage and performs the incisions at both the 5′ and 3′ sides.
UvrD (DNA helicase II) then removes the incised fragment, allowing DNA
polymerase I to remove the bound UvrB molecule and fill the gap. Finally
DNA ligase seals the newly synthesised DNA ends. NER in eukaryotic cells
follows the same sequence of events but requires upwards of 30 different pro-
teins, reflecting the more complex environment of the eukaryotic cell in which
they have to function.
The actual repair of lesions by eukaryotic NER on naked DNA is also
reasonably well understood, and an in vitro system of purified yeast proteins
able to fully repair damage on naked DNA has been available for a number
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of years (Prakash and Prakash, 2000). The repair process itself, which occurs
once the GG-NER and TC-NER pathways converge, is briefly described in
Section 1.4.3.2. It is how the lesion is recognised and accessed in the complex
context of chromatin in the GG-NER pathway that is the current focus of
research in this area, which is outlined in the following section.
1.4.3.1 Lesion recognition
In TC-NER, RNA polymerase II (RNAPII) stalls at sites of lesions on the
strand of DNA being transcribed (Donahue et al., 1994). Genes being tran-
scribed by RNA polymerase I and III are not subject to TC-NER (Tornaletti
and Hanawalt, 1999, and references therein). Several other obstacles can
cause the temporary stalling of RNAPII, such as secondary DNA structures,
which is overcome by transcription elongation factor SII (TFIIS), but this
factor still does not allow transcription across a CPD (Friedberg et al., 2006,
and references therein). It is this permanent stalling that directs the rest
of the NER machinery to the site, initiating TC-NER, although the exact
mechanism of this remains unclear in both yeast and humans (Reed, 2011).
In human cells, three other proteins are required for TC-NER: CSA, CSB,
and XAB2 (Nakatsu et al., 2000). In yeast, Rad26, the homologue of human
CSB, and Rpb9, a subunit of RNAPII, are required for TC-NER (van Gool
et al., 1994; Li and Smerdon, 2002). Rad28, the closest homologue of human
CSA, is not required for strand specific repair (Bhatia et al., 1996).
Lesions in all regions of the genome, including those on strands being
actively transcribed, are repaired via the GG-NER pathway. In yeast this
requires the Rad16, Rad7 and Abf1 proteins (Verhage et al., 1994; Reed et al.,
1999) although the mechanism of recognition has yet to be elucidated. These
proteins form a complex and are required to generate superhelical torsion in
DNA, which is required for NER (Yu et al., 2004). This requires Abf1’s
ability to bind to specific binding sites throughout the genome (Yu et al.,
2009). A Rad7/Rad16 complex specifically binds UV damaged DNA in an
ATP dependent manner (Guzder et al., 1997). Rad7 and Rad16 mutants
show reduced, but not eliminated, repair following UV irradiation (Miller
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et al., 1982; Prakash, 1977), because repair by TC-NER can still take place
in their absence.
Rad16 is a member of the SWI/SNF (switch/ sucrose non-fermentable)
superfamily of proteins (Bang et al., 1992). This family of proteins have the
ability to remodel chromatin through their DNA translocase activity (see,
for example, Wilson and Roberts, 2011). Rad16’s DNA translocase activity
allows the complex to create superhelicity in DNA, which is required for the
excision of the damage-containing fragment (Yu et al., 2004), but it does not
have the ability to slide nucleosomes (Yu et al., 2009), which is a property of
some other SWI/SNF proteins. This is suggested not to permit unregulated
gene transcription upon repair of repressed regions of the genome (Yu et al.,
2009).
UV irradiation leads to histone H3 hyperacetylation (H3Ac) and chro-
matin remodelling in yeast (Yu et al., 2005). (Histone acetylation has long
been known to be required for efficient repair, first shown in human cells, for
example, Smerdon et al. (1982); Ramanathan and Smerdon (1989)). This hy-
peracetylation requires Rad16 and Rad7 (Teng et al., 2007; Yu et al., 2011).
Regions of hyperacetylation induced in the absence of Rad16 and Rad7 ex-
hibit Rad7- and Rad16-independent repair (Teng et al., 2007), showing that
histone hyperacetylation is an important first step in the repair process.
Rad7 and Rad16 control the H3Ac level by controlling the accessibility
to chromatin of the histone acetyl transferase (HAT) Gcn5 (Yu et al., 2011).
Gcn5 has the ability to acetylate N-terminal lysines on histones H2B and H3
(Grant et al., 1997) and is involved in transcriptional regulation (reviewed
in Lee and Young, 2000). The ATPase and RING domains of Rad16 play an
important role in this (Yu et al., 2011). Mutations introduced into each do-
main individually result in intermediate UV survival, while a double mutant
is as sensitive as a Rad16 deletion. The two single mutants do not display
very different phenotypes to the wild type with respect to UV-induced H3Ac
change and Gcn5 occupancy. Conversely, the H3Ac and Gcn5 occupancy in-
creases seen in the wild type are abolished in the double mutant. In keeping
with these results, repair of CPDs in the two single mutants is of an inter-
mediate level, while in the double mutant it is reduced to the level seen in
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the Rad16 delete strain.
Investigation of the Abf1 member of this protein complex is the main
biological avenue of investigation in this thesis. It is hypothesised to function
to sequester the GG-NER complex at points throughout the genome, ready
for repair to take place where necessary (Reed et al., 1999; Yu et al., 2009).
Abf1 is described in more detail in Section 1.4.4.
No human homologues of Rad7, Rad16 or Abf1 have been identified, but
the human proteins DDB1 and DDB2 share several functional similarities to
yeast’s Rad7 and Rad16 (Reed, 2011).
1.4.3.2 Lesion repair
The repair of lesions by NER can be broadly split into five steps: damage
recognition, incision either side of the damage site, excision of the resulting
damage containing fragment, the filling of the resulting gap and ligation of the
newly synthesised strand. The first step requires the assembly of a number
of proteins at the damage site, termed the pre-incision complex (PIC). An
essential component of this is Rad14, which binds specifically to UV-damaged
DNA (Guzder et al., 1993). The human homologue, XPA, also preferentially
binds UV-damaged DNA (Jones and Wood, 1993). Although not required
for the initial damage recognition, this protein is essential for repair, with
Rad14 delete yeast and human XP-A patients having no functional NER
(Guzder et al., 1993; Tanaka et al., 1990).
A second essential component of the PIC is Replication protein A (RPA),
a 3-subunit complex able to bind ssDNA, composed of RFA1, RFA2 and
RFA3. Human RPA contains the proteins RPA1, RPA2 and RPA3. This
complex is involved in processes which have ssDNA intermediates, such as
replication and transcription, as well as playing an essential role in NER
(Huang et al., 1998; Coverley et al., 1991), in which it has a role in positioning
the nucleases which perform the incisions (De Laat et al., 1998). It has a
preference for binding DNA damaged by a variety of agents (Friedberg et al.,
2006, and references therein).
TFIIH is the final essential component of the PIC. It is a complex made
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up of nine proteins in two units and has dual roles in transcription initiation
and DNA repair (Takagi et al., 2003). Several of the proteins are essential
for efficient NER but only as part of the complex (Feaver et al., 2000).
Rad4 and Rad23 (human XPC and HR23B) form a complex which binds
damaged DNA with a much higher preference than undamaged DNA in vitro
(Guzder et al., 1998; Masutani et al., 1994). Rad23 contains a ubiquitin-
like domain at its amino terminus (Watkins et al., 1993) which allows it to
interact with the 26S proteasome (Schauber et al., 1998). Mutations in the
proteasome can reduce cell survival following UV irradiation but blocking its
protein degradation activity does not affect NER in vitro or in vivo, showing
independent functions of the proteasome in the two processes (Russell et al.,
1999).
Following the assembly of the PIC, the DNA section containing the dam-
age fragment can be cut. The two incisions are made by two different proteins
or protein complexes, one each for the 5′ and 3′ sides of the lesion. The Rad1-
Rad10 (human XPF-ERCC1) complex cuts at the 5′ side (Bardwell et al.,
1994; Park et al., 1995) and Rad2 (human XPG) at the 3′ side (Harrington
and Lieber, 1994; O’Donovan et al., 1994).
Rad1 and Rad10 are DNA binding proteins with a preference for ssDNA
but not damaged DNA (Sung et al., 1993, 1992). The complex binds to
Rad14 suggesting that this is the means by which it is directed to sites of
damage (Guzder et al., 1996).
The Rad2 protein forms a complex with TFIIH (Habraken et al., 1996).
It has ssDNA endonuclease activity but no specificity for damaged DNA
(Habraken et al., 1993). TFIIH is required to recruit XPG to the PIC (Zotter
et al., 2006).
1.4.4 The Abf1 protein
The autonomously replicating sequence (ARS) binding factor 1 (Abf1) pro-
tein is an abundant, multifunctional S. cerevisiae protein which binds at
many locations throughout the genome. It was first characterised in the late
1980s as a protein with a regulatory role of the silencing of the HML and
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HMR mating type loci, by binding to specific sequences at the E and I ele-
ments (Shore et al., 1987; Buchman et al., 1988). It has since been shown to
have a number of additional roles and as such has been classed as a general
regulatory factor (GRF) (Chasman et al., 1990). GRFs are characterised as
being abundant, essential and multifunctional, acting as obligate synergisers
with many binding sites throughout the genome (Fourel et al., 2002).
Abf1 is essential for the viability of yeast cells (Rhode et al., 1989) and
is often associated with the binding of the Rap1 protein, another GRF (see
Yarragudi et al., 2007, for example). It has roles in DNA replication, pos-
itive and negative regulation of transcription, chromatin silencing and re-
modelling, NER, genome partitioning and telomere maintenance (Buchman
et al., 1988; Fourel et al., 2002; Lascaris et al., 2000; Loo et al., 1995; Miyake
et al., 2002; Reed et al., 1999; Rhode et al., 1992).
Abf1’s role in replication is context dependent. Early investigations
showed that plasmids with Abf1 binding sites at their replication origins
showed reduced stability when these binding sites were mutated, showing
Abf1 stimulates the efficiency of replication but is not essential for it (Walker
et al., 1989, 1990). Cells expressing the temperature sensitive DNA binding
mutant abf1-1 also showed reduced stability of such plasmids at the restric-
tive temperature (Rhode et al., 1992). The Abf1 binding site of ARS1 can
be functionally replaced by the binding sites of the GRFs Rap1 and Gal4
(Marahrens and Stillman, 1992). Furthermore, adding an Abf1 binding site
to certain ARSs without one can reduce replication efficiency (Kohzaki et al.,
1999). The precise nature of the role played by Abf1 in these different con-
texts has not yet been elucidated.
Abf1 alone is a weak transcription factor, and strong transcriptional acti-
vation is only achieved in conjunction with other transcription factors (Buch-
man and Kornberg, 1990). It also plays a negative role in transcription in
some cases, with the removal of an Abf1 binding site increasing the level of
transcription of some genes (Einerhand et al., 1995, for example).
Abf1 has been shown to be important for maintaining chromatin structure
at many locations in the genome, where mutation of a binding site causes
a loss in the positioning of nucleosomes (Lascaris et al., 2000). It is also
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associated with nucleosome depleted regions (Badis et al., 2008), which may
function to allow other transcription factors to bind to their intended sites.
It also has been shown to be important in maintaining barriers between
different chromatin states (Fourel et al., 2002).
A multitude of Abf1 binding sites have been identified since its first char-
acterisation and it is now recognised as having a function at hundreds of
promoters and other sites throughout the yeast genome (Ganapathi et al.,
2011). It has been shown to bind at the well characterised consensus DNA
binding motif 5′-RTCRYNNNNNACG-3′, which is present at numerous sites
throughout the yeast genome including promoter elements, mating-type si-
lencers and ARSs (Rhode et al., 1992). Initially this consensus sequence came
from investigations of selected binding sites of interest (Buchman et al., 1988;
Rhode et al., 1992; Della Seta et al., 1990). Following this, many more indi-
vidual sites of interest were identified as Abf1 binding sites with techniques
such as electrophoretic mobility shift assays (EMSAs). Latterly, global tech-
niques such as transcription microarrays (Yarragudi et al., 2007) and ChIP-
chip (Lee et al., 2002; Harbison et al., 2004; Schlecht et al., 2008) have been
used to identify Abf1 binding sites throughout the yeast genome in vivo.
Lee et al. (2002) and Harbison et al. (2004) analysed the binding sites of
106 and 203 DNA binding proteins respectively, by the use of Myc epitope
tagging. These identified 462 and 458 Abf1 binding sites respectively, but
the analyses were limited to a subset of intergenic regions only. Schlecht
et al. (2008) analysed binding during fermentation, sporulation and respira-
tion, using an antibody for Abf1, identifying 1,689 potential binding sites,
of which 1,169 occurred in all three conditions. Additionally, a SELEX ap-
proach (Beinoravicˇiu¯te˙-Kellner et al., 2005) and protein binding microarrays
(PBMs) (Mukherjee et al., 2004) have been used to identify Abf1 binding
sites in vitro.
These genome wide investigations consistently identified the consensus
sequence at Abf1 binding sites, but there were many instances where Abf1
binding was observed without this sequence, and no other consensus sequence
could be identified. Suggestions for why this may be include Abf1 having a
non-specific DNA binding affinity (Schlecht et al., 2008) and overlapping
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binding sequences precluding the identification of a single motif (Ganapathi
et al., 2011). The positive element distal (PED) region in the promoter
region of the Spt15 gene binds strongly to Abf1 but does not contain the
consensus motif (Schroeder and Weil, 1998). Instead it contains the sequence
RTARYNNNNNACG, with an adenine replacing the cytosine at the third
position. This suggests that Abf1 has the ability to bind to sequences similar
to, but not exactly matching, the consensus motif.
Structurally, Abf1 comprises two main components: a C-terminal acti-
vation domain and an N-terminal DNA binding domain. The C-terminal
domain is not required for DNA binding alone, but its loss confers loss of
full functionality (Rhode et al., 1992; Cho et al., 1995; Li et al., 1998). It
consists of two regions: C-terminal sequence 1 (CS1) is required for proper
nuclear localisation of Abf1 and may be involved in negative transcriptional
regulation; CS2 is required for activating DNA replication, chromatin remod-
elling and transcriptional activation (Miyake et al., 2002; Loch et al., 2004).
The N-terminal domain contains a bipartite DNA binding domain consist-
ing of a zinc finger motif (Rhode et al., 1989) and a novel DNA binding
domain (Cho et al., 1995). Mutations in both DNA binding domains result
in reduced or eliminated DNA binding (Cho et al., 1995). A temperature
sensitive binding mutant with a point mutation in the zinc finger binding
domain, abf1-1, exhibits normal functionality at the permissive temperature
but looses its binding ability at the semi-permissive temperature (Rhode
et al., 1992). This mutant has been used to investigate various functions
of Abf1 including transcriptional regulation (Miyake et al., 2004) and NER
(Reed et al., 1999).
1.4.4.1 Role in NER
Abf1 was initially implicated in NER when it was observed to copurify with
the Rad7 and Rad16 proteins (Reed et al., 1999). Reducing the cellular level
of the Abf1 protein, via the addition of a temperature-dependent degrada-
tion signal, resulted in a severe NER deficiency at the restrictive temperature
compared to the permissive temperature. Additionally, the temperature sen-
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sitive DNA binding mutant abf1-1 was shown to be deficient at the removal
of photoproducts from damaged DNA at the restrictive but not the semiper-
missive temperature.
This Rad/Rad16/Abf1 complex was subsequently shown to generate su-
perhelical torsion in DNA, via the Rad16 protein, which is required for NER
(Yu et al., 2004). This superhelical torsion is required for the excision of the
damage-containing fragment of DNA, following the introduction of the two
incisions either side of the damage. The binding of Abf1 to DNA is required
for efficient NER in a region adjacent to the binding site (Yu et al., 2009).
The mutation of an Abf1 binding site in the HMLα promoter caused a region
of reduced repair efficiency over a region of ∼400 bp in one direction from the
Abf1 binding site. Reversing the direction of the non-mutated Abf1 bind-
ing site creates the same domain of reduced repair, showing the orientation
of the binding of Abf1 to the site significantly affects its function in NER.
It has been hypothesised that Abf1 functions to position the Rad7/Rad16
complex to chromatin in the absence of damage, which can then facilitate
histone acetylation by allowing access to the HAT (Yu et al., 2011, shown in
Figure 1.7).
The Rad7 and Rad16 proteins are required for the UV-induced histone
H3 acetylation required for efficient repair, by controlling the occupancy of
the histone acetyl transferase Gcn5 on chromatin (Yu et al., 2011). It may
be that Abf1 provides a means of positioning the Rad7 and Rad16 proteins
throughout the chromatin, which enables the promotion of super helical tor-
sion, histone acetylation and subsequent repair upon the detection of damage.
This may be achieved locally to the Abf1 binding site, or by the Rad7/Rad16
complex translocating a longer distance along the DNA. The previously iden-
tified directionality of the complex may determine the direction in which the
superhelical torsion or acetylation is initiated.
An investigation by Dr. Matthew Leadbitter showed that Abf1 preferen-
tially binds at promoters, with the majority of inter-genic regions showing
some level of binding (Leadbitter, 2011). The binding of the Rad16 protein
was also investigated by ChIP-chip and this was shown to colocalise with
Abf1 at many sites, which associated with UV-induced H3Ac at the sites.
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Figure 1.7: Abf1 and GG-NER: Hypothesised model for UV-induced chro-
matin remodelling, taken from Yu et al. (2011). The Abf1/Rad7/Rad16
complex is present on the DNA in the absence of damage (top panel) but
access by the HAT is inhibited. Following UV irradiation (bottom panel) the
DNA translocase (1) and E3 ligase (2) activities of Rad16 promote accessi-
bility by the HAT (3) and acetylation (4), leading to a more open chromatin
structure (5). Transcription remains inhibited during the process (6) while
allowing repair of damage (7).
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Several Abf1 binding sites showed reduced levels of binding following UV
irradiation and preliminary data from this study suggest that there may be
UV induced changes in the DNA binding kinetics of Abf1.
1.5 This study
This study can be divided into two overlapping parts. The first is mainly
bioinformatic, in which ChIP-chip data from various investigations have been
used to develop bioinformatic tools which can be applied to analyse other
ChIP-chip datasets. This includes normalisation and peak detection algo-
rithms. The second is mainly biological, in which Abf1 binding ChIP-chip
datasets have been analysed to increase understanding of the protein’s bind-
ing behaviour. The two overlap in the development of a method to predict
damage profiles throughout genomes and the development of bioinformatic
tools to display and interogate ChIP-chip data, which have been applied to a
selection of real ChIP-chip datasets to produce biologically significant results.
The first three results chapters present a collection of R scripts of tools
for the analyses of ChIP-chip data using novel normalisation and enrichment
detection algorithms. The aim when developing these tools was to allow the
processing of ChIP-chip data from its raw state, through quality assessment,
to its loading into R, where normalisation and enrichment detection can be
applied and graphical outputs showing features of interest produced. The
objective of the novel normalisation procedure is to process data from mul-
tiple ChIP-chip datasets so as to allow relative comparisons between them.
The objective of the novel enrichment detection procedure is to identify ei-
ther regions of enrichment or peaks indicative of binding sites across datasets
in a way that does not require the application of a multiple testing correc-
tion, by dynamically adjusting the threshold of detection based on the probe
density of the region being analysed. The tools were developed with the
objective that the data should be easily accessible and well described such
that separate, possibly more advanced, analyses can be carried out by users
if required. Thus all code is shown, annotated and described and a separate
condensed, instruction document is provided for users.
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Chapter 6 presents a method of predicting the output of a DIP-chip assay
measuring UV induced CPDs in the yeast genome, based on the genome se-
quence and known frequencies of occurrence of the different possible dipyrim-
idine combinations. The objective of this work was to determine the capa-
bility of the DIP-chip assay to detect these CPDs, which was shown to be
the case. A comparison of the two datasets was undertaken with the aim of
determining whether or not there were any genome regions with higher or
lower damage levels than those predicted based on the sequence alone. Here
the null hypothesis tested was that there would be no significant differences
between the two, which is shown to be the case.
Chapter 7 presents an application of the bioinformatic tools, using them
to analyse Abf1 protein binding. The objective of this work was both to
show the practical applications of the bioinformatic tools with real ChIP-
chip datasets, analyse the binding sites in their own right and compare the
binding sites identified with those of previously published genome wide in-
vestigations. Sequences at the binding sites were analysed which showed
that many Abf1 binding sites do not contain the previously identified con-
sensus binding motif and no further consensus sequences could be identified.
A much larger number of binding sites were identified in this investigation
than had been previously, the locations of which were analysed under the
null hypothesis of no significant overlaps with previously identified genome
wide binding locations, which is shown not to be the case.
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Technical Overview
ChIP-chip, and modified versions thereof, is the main technology used to
produce the results analysed in this thesis. This chapter describes the ‘wet’
laboratory processes leading up to the generation of the data, the ‘dry’ labo-
ratory processing of which is described in later chapters. Only the dry labo-
ratory analyses of the data have been carried out in this thesis. The following
sections describe the techniques, employed by colleagues in the laboratory,
used to generate the data for these analyses. Much of this work has been
carried out by Evans (2011) and Leadbitter (2011). Some of the information
presented in this chapter is adapted from, and further information can be
found in, these works.
2.1 Microarrays
The microarray is the component of the ChIP-chip technology that allows
the generation of genome-wide data (described in Section 1.1). All microar-
ray data produced in our laboratory analysed in this investigation are from
microarrays manufactured by Agilent Technologies Inc. These microarrays
contain probes of average length 60 nt, ‘printed’ onto the slide surface, one
base at a time, to build up each sequence, (Agilent Technologies Inc., 2003).
The yeast slides used (product number G4493A) contain 4 microarrays each
(Figure 2.1), each of which contains 45,219 features. Of these, 41,775 con-
tain probes against the yeast genome. The remainder are various technical
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Figure 2.1: Agilent 4 x 44k microarray format: Layout and dimensions of
Agilent 4 x 44k microarrays (Agilent Technologies Inc., 2007), of which the
G4493A is used here.
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probes, including positive and negative controls and special patterns to allow
correct alignment to the grid by the Feature Extraction software, described
in Section 2.6. This means four sets of results are generated from each slide
of this type.
2.2 Chromatin immunoprecipitation
The first stage of the procedure, ChIP, is a useful tool in its own right for
identifying sites in chromatin, genome wide, to which proteins of interest
are bound. The following description is adapted from that in Alberts et al.
(2002) with specific details taken from Evans (2011). The standard DNA
purification procedures include a protein digestion stage and so are not suit-
able for immunoprecipitation of proteins in chromatin, as this would mean
no proteins would be available for antibodies to bind. Therefore a chromatin
purification procedure is employed. Proteins are covalently cross-linked to
DNA in living cells by treatment with formaldehyde. Following this, glycine
is added to stop the crosslinking. Cells are then collected and washed over
three centrifugation steps before being lysed using glass beads and vortexing.
The cell lysate is separated from the glass beads and any non-crosslinked solu-
able proteins with a further three centrifugation/wash steps. The remaining
pellet of chromatin is resuspended and subject to sonication with a Bioruptor
for 6 cycles of 20 sec on/40 sec off. This produces high frequency sound waves
which shear the chromatin into fragments of average length 600 nt. After two
further centrifugation/wash steps the fragmented chromatin supernatant is
snap frozen with liquid nitrogen and stored at -80◦C.
Antibodies raised against a protein of interest can be used to separate
fragments of DNA bound to that protein from the purified chromatin. Al-
ternatively, proteins may be separated by means of an exogenous epitope
tag, to which antibodies are available, fused to the protein. These antibodies
bind to the epitope on the protein, facilitating the immunoprecipitation pro-
cess. This also captures the DNA fragment to which the protein is covalently
bound. An antibody titration experiment is first carried out to determine
the optimal amount of antibody to use. The antibodies are incubated with,
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and allowed to bind to, magnetic Dynabeads. These are then collected with
a magnet, washed, resuspended and added to the sonicated chromatin. The
bead-DNA-protein mix is then separated from the rest of the genomic DNA
by the use of a magnet, and washed several times. Collected DNA is eluted
off of the beads.
An input sample is also prepared, which does not undergo this immuno-
precipitation procedure and therefore contains all fragmented genomic DNA.
Two DNA samples are applied to the Agilent microarrays, comprising the
immunoprecipitated material, henceforth referred to as the IP sample, and
purified total genomic DNA taken before the immunoprecipitation process,
referred to as the input sample. All samples are incubated with RNase and
purified with a Quiagen PCR purification kit.
Used as a stand-alone technique, at this point DNA primers of a region
of interest can be used to determine whether or not the protein of interest
is bound at that region, by PCR amplification. If the region is bound to the
protein, the immunoprecipitated material will contain DNA fragments to
which the primers will anneal and it will therefore be amplified by PCR, the
product of which can be detected by a variety of methods. If the protein is
not bound, no amplification will take place. Quantitative-PCR (Q-PCR) can
be employed to determine quantitative protein binding levels at the selected
genomic region.
2.3 Amplification
Combining ChIP with microarrays in ChIP-chip removes the need to carry
out individual assays for each region of interest, as multiple locations are
represented on the microarray. These locations may cover a whole genome
or represent specific genomic regions of interest. The detection of DNA is
achieved through the measurement of fluorescence from fluorescently labelled
hybridised DNA. The amount of DNA generated by ChIP is not sufficient
to apply directly to a microarray and so it is amplified by ligation mediated
(LM) PCR. T4 DNA polymerase (an endonuclease) is used to blunt end the
DNA fragments which then undergo a phenol/chloroform extraction, cold
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ethanol precipitation, centrifugation and resuspension in purified water. This
is then incubated with a ligation mixture, which ligates a section of linker
DNA to the blunt-ended fragments. These linkers are used to amplify the
DNA by PCR, using a single set of primers to the linker sequences. Two sets
of PCR reactions are carried out to ensure a sufficient quantity of DNA.
2.4 Fluorescent labelling and hybridisation
The Agilent microarrays used to generate the data in this investigation are
two colour. This means two DNA samples are represented on each microar-
ray, here the IP and input samples, each distinguished by labelling with a
different coloured fluorescent dye. This is in contrast to other platforms,
such as Affymetrix, which are one colour systems where each microarray
represents a single sample. The input sample acts as an internal control
on the microarray, removing the effects of differential hybridisation, due to
factors such as sequence variations, at different points in the genome. This
is achieved by calculating the log2 IP:input sample signal ratio as the final
data. This enables genuine regions of binding to be identified (where the IP
sample is present at a larger amount than the input sample) over regions
where other factors cause high levels of binding to the microarray (where the
IP and input samples are present at the same, albeit large, amounts). This is
demonstrated in real ChIP-chip data with Abf1 binding IP and input signals
over a section of chromosome 1 in Figure 2.2.
The two DNA samples are differentially labelled with the dyes Cy3 and
Cy5. Cy3 produces a green fluorescence (555/565 nm excitation/emission
respectively) and Cy5 a red fluorescence (650/670 nm excitation/emission
respectively). Dye bias arises when one fluor produces a higher signal in-
tensity than the other. Several microarrays produced in our lab have been
analysed for dye bias, including the Abf1 binding data presented in Chap-
ter 7 (Leadbitter, 2011), where it was shown that this did not have an effect
on the data, and so there was no need to apply any correction for this effect
on the datasets analysed here. The labelling reaction is achieved via an am-
plification step which incorporates nucleotides labelled with the dye, along
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with unlabelled nucleotides, into a newly synthesised DNA fragment. Two
pools of labelled DNA are thus created, which are applied to the microar-
ray together and allowed to hybridise. A cover slip containing rubber gaskets
prevents the samples leaking and keeps those applied to each microarray sep-
arate. This process takes place overnight in a rotating oven at 65◦C, which
allows the pool of labelled DNA fragments to cover the whole microarray and
bind to any corresponding probes. The slides are then washed to remove any
unbound material. The concentration of DNA applied to the microarrays is
the same level for all experiments, regardless of the initial IP and input sam-
ple concentrations, so as to ensure optimal performance of the microarray in
the following stages.
2.5 Microarray processing
Following hybridisation, the microarrays are scanned using an Agilent mi-
croarray scanner (model G2505B) to produce a TIFF image, from which the
signal intensities can be extracted. The scanner uses two lasers at 532 and
633 nm. These scan across the slide surface, exciting the fluors of the la-
belled DNA as they do so. Fluorescence is detected and an image produced
at a resolution of 5 microns. The brighter the fluorescence of a feature the
more DNA is bound to it. There is not however a linear relationship between
fluorescence and DNA amount (Schena, 2003) so when analysing results one
can only infer relative, rather than absolute, DNA amounts.
2.6 Feature extraction
The TIFF image produced by the microarray scanner is loaded into Agilent’s
Feature Extraction software (Agilent Technologies Inc., 2010b, current ver-
sion 10.10.1.1). This aligns a grid to the image, determining the positions of
all features, and analyses the red and green colouration of each. This con-
verts the fluorescence intensities into numerical values. The software contains
information about the genomic region each feature represents which is linked
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together with the intensity values. This is written to a tab delimited text file
containing over 40 columns of data, including information such as scanner
settings and a range of diagnostics. The layout of this file is represented in
Figure 2.3.
All analyses presented in this thesis use background subtracted data.
This is data from which the intensity values surrounding the features are
subtracted from the intensity values of the features themselves. This ensures
that the intensity values analysed are due to the specific hybridisation of
labelled DNA to the probes and not the general fluorescence of the slide.
2.7 Data analysis
All data were loaded into R (current version 2.14.2) for processing and anal-
ysis. A PC with a 3.20 GHz Intel i7 processor and 24 GB of RAM, running
64 bit Microsoft Windows 7, was used for the extraction and analysis of data
and the creation and testing of all R scripts. These R scripts were then used
in our laboratory on several different computers running various versions of
Microsoft Windows and Mac OS X.
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Figure 2.2: The importance of IP and input samples: A short section of
chromosome 1 showing Abf1 binding IP (red) and input (green) sample data.
There are peaks in the IP data at ∼12,500 and ∼25,000, which are matched
by the input data, in contrast to the peaks at ∼30,000, ∼33,000, and ∼35,000.
This shows that only the last three are likely to be representative of binding.
Without the input sample the first two may also be incorrectly considered to
be binding sites.
Line Contents 
1 Data type 
2 Data name Parameters → 152 columns 
3 Data values 
4 [Blank line] 
5 Data type 
6 Data name Statistics → 147 columns 
7 Data values 
8 [Blank line] 
9 Data type 
10 Data name Features → 112 columns 
      ↓ 
  p rows 11 Data Values 
Figure 2.3: Feature extraction file format: The contents and layout of the
tab delimited text file produced by Agilent’s Feature Extraction software are
represented. Parameters and statistics run for three lines each. Features run
for p rows, where p is the number of probes on the microarray. For each
column the data type, its name and a value are provided.
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Chapter 3
Creation of a collection of R
scripts to process and
interrogate ChIP-chip data
3.1 Introduction
The primary objective of the work presented in this thesis was to analyse
ChIP-chip datasets produced in our laboratory. To achieve this, the major
issues in current ChIP-chip data analysis methodologies have been investi-
gated and new tools developed to fill some of the existing gaps. Two of the
main aspects of this work, the development of novel normalisation and peak
detection methods, are presented in the following two chapters. This chapter
details how these and several other aspects have been brought together into
a collection of R scripts for use by researchers wishing to analyse their own
data, both in our laboratory and beyond.
To date the only R package dedicated to the analysis of ChIP-chip data
is RINGO (Toedling et al., 2007). This package contains several facilities for
analysing ChIP-chip data, including data import, quality assessment, nor-
malisation, visualisation and enrichment detection, developed for the anal-
ysis of Nimblegen data. It uses aspects of other Bioconductor packages for
some of these functions, such as loading data in the limma package’s RGList
format (Smyth, 2005). The normalisation consists of applying a choice of
existing normalisation procedures to the data, from the packages VSN (Huber
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et al., 2002) and limma and the Tukey-biweight scaling. The package there-
fore is only suitable for analysing technical replicates of a single experimental
condition, for the reasons outlined in Section 1.1.3.2 and Chapter 4.
ChIPMonk, a Java application (Andrews, 2007), contains a similar set of
tools to RINGO, and at the time of publication was limited to only being
able to analyse Nimblegen data. The methods are basic and as with RINGO
do not facilitate the simultaneous analysis of different types of data.
Tilescope (Zhang et al., 2007) also provides similar tools, such as normali-
sation and peak detection, as web server, with data uploaded as tab-delimited
text files. The publication does not list Agilent data as a format that can be
uploaded and at the time of writing the website was unavailable for testing.
A short report by Toedling and Huber (2008) outlines more methods for
the analysis of ChIP-chip data in R, none of which allow the comparative
analysis of datasets from different experimental conditions. Here several
different methods and packages are used to load data, assess its quality, load
genome annotations, process, plot and analyse the data, showing that no
single package is capable of performing all of these tasks. Although this
may not pose a problem for someone adept at data analysis and familiar
with the R interface, the aim of the functions created here was to enable
researchers with little or no bioinformatic experience to quickly use the tools
described in the coming chapters to extract meaningful results from their
data, while maintaining scope for more detailed analyses should these be
required. The objective of the work presented in this chapter was therefore
to produce a collection of annotated, documented, integrated tools, using
the R programming language, able to process ChIP-chip data from its raw
state through to the generation of meaningful biological results, in such a
way that basic analyses can be conducted easily and efficiently, while the
scope for more advanced analyses is maintained.
3.2 The scripts
All of the analyses presented in this thesis have been carried out in R (R
Development Core Team, 2011) using Bioconductor (Gentleman et al., 2004).
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A collection of functions and classes was created to perform these analyses.
This section describes these different functions and shows the corresponding
scripts. Scripts are described with reference to specific line numbers denoted
by an ‘L’ in brackets. All scripts are also available in the “R scripts” folder of
the electronic appendix (see Page 367). A condensed version of this chapter,
in the form of a user guide, has been produced (“instructions.pdf” file in
the electronic appendix; see Page 367). This is available alongside the full
set of scripts and is intended to provide users with instructions for running
the functions and interpreting the outputs, along with overviews of the more
complex functions.
Figure 3.1 shows a diagram of all of the different components created
here and how they relate to each other. All objects are shown, indicating the
functions used to create them and the functions which act upon them. All
functions are shown, indicating which objects they act upon or in which other
functions they are used. External Bioconductor packages are also shown,
indicating the function in which they are used.
Functions and objects, and their associated descriptions, have been split
into the following eight broad categories, which form the basis of this and
subsequent chapters.
• How data is loaded into and organised within R (Section 3.2.1).
• Data quality assessment (Section 3.2.2).
• Accessing data-containing objects (Section 3.2.3).
• Manipulated data-containing objects (Section 3.2.4).
• Textual display of data and results (Section 3.2.5).
• Graphical display of data and results (Section 3.2.6).
• Data normalisation (Chapter 4).
• Enrichment detection (Chapter 5).
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arrayData 
genomeData 
splitCoords 
Raw Data 
File 
Genome 
Database 
limma 
consecutive 
biomaRt 
Tab 
Delimited 
File 
show 
[ (extraction)* 
dim* 
overlap 
profilePlot* 
rainbowPlot* 
+, -, ×, ÷ * 
dim* 
cbind* 
rowMeans* 
getProbeInfo* 
density* 
summary* 
plot* 
show 
[ (extraction)* 
arrayDataValidity 
writeArrayData* 
peakList 
preprocessCore 
rmRegion 
rmNAs 
shiftByMode 
quantileNormalise 
Creates 
Uses 
Acts on Function 
Object (R) Object (other) 
R package 
KEY 
R Output 
Graphic 
Text 
checkData* 
loadArray* 
plot 
normalisation* 
mirror 
dim* 
[ (extraction)* 
show 
Text 
Graphic 
True/False 
Graphic 
maths 
peakDetection* 
venn* 
stNormScale 
QQ-plots* 
positionsPlot* 
getSequences* 
BSgenome 
Biostrings 
loadAnnotation* 
hist* 
Figure 3.1: Overview of the functions presented: Diagram showing the vari-
ous functions and objects and how they relate to each other. R objects and
functions are those newly written or created for this work. Other objects are
files or databases outside of R. R packages are those already available on Bio-
conductor. Coloured arrows indicate functions that create or act on objects
and use other functions. For clarity coloured boxes highlight some functions
an arrow relates to. The direction of the arrows shows the relationship be-
tween two items. For example, the loadArray function “uses” splitCoords,
“acts on” raw data and tab delimited files and “creates” arrayData objects.
Asterisks denote functions intended to be called by users while the rest are
called within other functions.
78
SECTION 3.2 CHAPTER 3
3.2.1 Loading data
The production and format of raw microarray data are described in Chap-
ter 2. This section details the methods used to load this data into R and the
format this takes. It also describes the loading of other other data relevant
to the analyses.
3.2.1.1 Utilising limma
The limma package was developed to analyse transcription array datasets
(Smyth, 2005). This has a function, read.maimages, to read microarray
data files into R in the form of an RGList object. These contain the following
components.
R Red signal intensity values.
G Green signal intensity values.
Row Probe microarray row number.
Col Probe microarray column number.
ProbeUID Unique probe ID.
ProbeName Probe name.
GeneName Corresponding gene name.
SystematicName Genome position details.
Description Probe position relative to gene.
Originally, the limma package was used here to load data into R as
RGLists, and the functions were written to act on the data in this format. Be-
cause limma is intended for transcription microarray data analysis its RGList
does not include readily accessible data on probes’ genomic positions. This
data therefore had to be extracted from the “Systematic Name” column of
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the Agilent Feature Extraction file, split into its component parts (chromo-
some number and start and end coordinates) and added to the RGList as
new columns.
These modified RGLists were used as the basis of early analyses and
all new functions were written to extract relevant data from them. This
initially proved satisfactory but became limiting when more advanced scripts
were being written. The structure of the RGLists — dataframes contained
within a list — meant that some analyses, especially those requiring repeated
looping, were slow. It is generally the case with the analysis of transcription
microarrays that the data is processed relatively quickly, in a small number of
steps, to produce a final set of results consisting of information on the genes
determined to be differentially expressed. There is then generally no further
use for the original microarray data and so it can be disregarded. Depending
on the type of data generated and the analyses being undertaken, this is
not necessarily the case with ChIP-chip data, as all features can be equally
informative in a number of different applications. It is therefore useful to
have all data in a format that can be quickly and easily processed in multiple
ways, which the RGList format is not best suited to. To overcome this a new
data format was created, containing similar information to the RGList but in
a format better suited to ChIP-chip data and the analyses to be performed
on it. This new class was named arrayData and replaced the RGList for
ChIP-chip data storage in R. All existing functions were adapted, and all
new functions written, to work with this new format. The following sections
detail this arrayData format and its creation upon loading data into R.
3.2.1.2 The arrayData class
The minimum information required to perform analyses on ChIP-chip data
is each probe’s fluorescence intensity values and the genomic position it rep-
resents. This information allows the fluorescence values to be linked to the
relevant sections of the genome. A unique reference is also an important com-
ponent, which allows each probe to be identified individually. The arrayData
class was written to contain all of this data, along with any other data speci-
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fied by the user and information relevant to the processing of the data. This
section describes the format of an arrayData object; how data is loaded into
this object is detailed in the next section. Each arrayData object takes the
format of a list containing the following five components.
coordinates A three-column matrix containing the chromosome number,
start position and end position of each probe as a separate row.
annotations A matrix consisting of at least one column, but can have any
number containing user specified information. The first column must
contain a unique identifier for each probe.
ratios A matrix containing one column of log2 red:green ratios for each
dataset. Column names show the file name from which the data were
taken and are edited by some functions to show processes that they
have undergone.
grid name A character vector containing only the name of the microarray
grid the data have come from. This is used to ensure data of different
types are not accidentally mixed.
status A list containing information on the normalisation procedures car-
ried out on each dataset. This starts out as “raw” when data is initially
loaded and is updated by the various normalisation functions to show
the processing that has taken place. It is checked by other functions to
ensure that datasets have been processed in the ways that they require.
3.2.1.3 Creating new arrayData objects
The loadArray function (Script 3.1) is the most crucial, as it is the only
one able to take data from an external source, load it into R and convert
it to the required format for an arrayData object. It would be possible to
do this manually, but via a number of stages and so would take longer and
require more work. The function can load data from two file types: the text
file created by the Agilent Feature Extraction software, which is of a specific
format, or a tab-delimited file, which can be created containing data from
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any source. The feature extraction file is of a fixed format (Section 2.6 and
Figure 2.3) and the majority of the data are not needed for analyses. There-
fore, in order to allow efficient processing of the data, the function scans the
file for the required regions and only these are loaded into R. This data is
represented in four ‘Features’ columns of the file: one contains probe chro-
mosome numbers, start coordinates and end coordinates as a single string,
one each contain the red and green intensity values and one contains unique
IDs in the form of probe names.
Tab-delimited files must contain all the same essential data in a certain
format for the function to create a correct arrayData object from it. The
layout is outlined in Figure 3.2. The first line (“Data types”) details the
type of data in the column and may be one of “coords”, “anno” or “ratios”.
The second line (“Data names”) contains the column names. Coordinates
must contain “probeChr”, ‘probeStart” and “probeEnd”. Annotations must
contain “probeID” and any other optional columns. Ratios must contain
data names. All values follow for p rows, where p is the number of probes.
A grid name and statuses may also be provided. In this case the first line
(“Extra data names”) contains “grid name” and the data names. The second
(“Extra data values”) contains the grid name and each status. The rest of
the file then starts on line three. The function looks for the text “grid name”
in the first position; if this is not present it assumes the probe data starts on
the first line. The order of the status file names are compared to the order of
the data file names and the correct status assigned to each set of data. The
function has the following arguments:
fileName Names of .txt or .tab files to load (no default).
essentialColumns A list of the names of the columns in the Feature Ex-
traction text file containing essential information. Red and green in-
tensity values are taken from the “rBGSubSignal” and “gBGSubSig-
nal” columns respectively, coordinates from “SystematicName”, probe
names from “ProbeName” and control types from “ControlType” by
default and do not need to be modified under normal circumstances.
otherColumns A list of other columns specified by the user (no default).
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Line Contents 
1 Extra data names 
2 Extra data values 
3 (1) Data types 
4 (2) Data names 
5 (3) Data values  
         ↓ 
     p rows 
Figure 3.2: Tab-delimited file format: Representation of the contents of the
tab-delimited text file for loading into R by the loadArray function. The first
two lines (grey) are optional and specify the grid name and normalisation sta-
tuses. Lines 3–5 (1–3 if the optional data is not included) show data types (co-
ordinates/annotations/ratios), data names (chrNum/chrStart/. . . etc) and
the corresponding data values. These run for a minimum of five columns
but can contain multiple annotation and ratio columns. Values run for p
rows, where p is the number of probes.
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processCoords The name of the function required to split the coordinates
into their component parts (default “splitCoords”; Script 3.2).
spikes Specifies whether or not spike in probes are present on the microarray,
the processing of which is different to genomic probes (default FALSE).
Script 3.1: loadArray: loads data from Agilent Feature Extraction files or
tab delimited files with correct column headings into a new arrayData object
1 ## loadArray function ##
2 ## arguments: fileName (file(s) to load), essentialColumns (list of
essential columns to load from FE file), otherColumns (list of other
columns to load from FE file), processCoords (function to process
systematicName data), spikes (whether the dataset contains spikes)
3 loadArray <-function(fileName , essentialColumns=list(red="rBGSubSignal",
green="gBGSubSignal", coords="SystematicName", probe="ProbeName"),
otherColumns=list(), processCoords=splitCoords ,spikes=FALSE) { #define
function
4 if (length(essentialColumns$red) == 0 | length(essentialColumns$green) ==
0 | length(essentialColumns$coords) == 0 | length(essentialColumns$
probe) == 0) stop("Essential columns missing", call.=F) #check all
essential columns (red , green , coords , probe) are defined
5 if (missing(fileName)) { #if file names are not provided
6 fileName.txt <-list.files(pattern=".txt$") #get all .txt files in working
directory
7 fileName.tab <-list.files(pattern=".tab$") #get all .tab files in working
directory
8 }else{ #file names are provided
9 ext <-character(length = length(fileName)) #initialise vector to store
file types
10 fileName.txt <-fileName.tab <-character () #initialise vectors to store
file names
11 for (n in 1: length(fileName)) { #loop through file names
12 if (substring(fileName[n],nchar(fileName[n]) -3,nchar(fileName[n])) ==
".txt") ext[n]<-"A" #search for .txt files
13 if (substring(fileName[n],nchar(fileName[n]) -3,nchar(fileName[n])) ==
".tab") ext[n]<-"D" #search for .tab files
14 } #exit loop
15 fileName.txt <-fileName[ext == "A"] #get all .txt file names provided
16 fileName.tab <-fileName[ext == "D"] #get all .tab file names provided
17 }
18 if (length(fileName.txt) > 0 & length(fileName.tab) > 0) stop("Mixtures of
file types cannot be loaded together", call.=F) #stop with message if
files of both types are present
19 if (length(fileName.txt)== 0 & length(fileName.tab) == 0) stop("No files
to load", call.=F) #stop with message if no files are present
20 if (length(fileName.txt) > 0) { #if .txt files are provided/present
21 fileName <-fileName.txt #store them
22 txt <-TRUE #set txt to TRUE
23 }else{ #.tab files are provided/present
24 fileName <-fileName.tab #store them
25 txt <-FALSE #set txt to FALSE ie tab is true
26 }
27 for (n in 1: length(fileName)) { #loop through files
28 if (txt) { #a .txt file is to be loaded
29 message (paste("Loading:",fileName[n])) #print the name of the file
being loaded
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30 columnNames <-scan(fileName[n],skip=1,nlines=1,what="",quiet=T) #get
column names from row 2 of the file
31 totalColumns <-length(columnNames) #get total numer of columns of file
32 columnRead <-rep("NULL",totalColumns) #set all columns to NULL (so they
are not read)
33 columnRead[columnNames == "Grid_Name"]<-NA #set grid name column to NA
(in order to be read)
34 grid_name <-as.character(as.matrix(read.table(fileName[n],colClasses=
columnRead ,skip=2,fill=T,sep="\t",nrows =1))) #load the grid name
35 grid_name <-strsplit(grid_name ,"_")[[1]][1] #split the grid name and
store the first part
36 if (length(grid_name) == 0) warning("No grid name found", call.=F) #
warn if no grid name is found
37 columnNames <-scan(fileName[n],skip=9,nlines=1,what="",quiet=T) #get
column names from row 10 of the file
38 if (length(grep(essentialColumns$red ,columnNames)) != 1 | length(grep(
essentialColumns$green ,columnNames)) != 1 | length(grep(
essentialColumns$coords ,columnNames)) != 1 | length(grep(
essentialColumns$probe ,columnNames)) != 1) stop("Essential columns
not present", call.=F) #stop with message if not all essential
columns present in file
39 totalColumns <-length(columnNames) #get total numer of columns of data
40 columnRead <-rep("NULL",totalColumns) #set all columns to NULL (so they
are not read)
41 columnsF <-which(columnNames %in% c(essentialColumns ,otherColumns)) #
get columns specified
42 columnRead[columnsF]<-NA #set listed columns with NA (to be read)
43 arrayFile <-as.matrix(read.table(fileName[n],colClasses=columnRead ,skip
=9,header=T,fill=T,sep="\t",quote="")) #read data into R
44 if (spikes) {
45 spikeData <-arrayFile[grep(">",arrayFile[,which(colnames(arrayFile)
== "SystematicName")]) ,]
46 }
47 arrayFile <-arrayFile[grep("chr",arrayFile[,which(colnames(arrayFile)
== "SystematicName")]) ,] #get data representing non -control probes
48 coords <-processCoords(arrayFile[,which(colnames(arrayFile) ==
essentialColumns$coords)]) #split coordinates with defined
function
49 chromosomes <-sort(unique(coords [,1])) #get ordered , unique chromosome
numbers
50 startWarn <-as.numeric(options("warn")); on.exit(options(warn=startWarn
)) #get current warning state and maintain on exit
51 options(warn=-1);chromosomes.numeric <-as.numeric(chromosomes);options(
warn=startWarn) #make chromosomes numeric (without warnings for
non -numeric values)
52 chromosomesNonNumeric <-which(is.na(chromosomes.numeric)) #identify non
-numeric chromosomes
53 if (length(chromosomesNonNumeric) > 0) { #if there are non -numeric
chromosomes
54 for (cnn in 1: length(chromosomesNonNumeric)) { #loop through non -
numeric chromosomes
55 coords[coords [,1] == chromosomes[chromosomesNonNumeric[cnn]],1] <-(
max(chromosomes.numeric ,na.rm=T)+cnn) #assign non -numeric
entries with the next available numeric value
56 }
57 }
58 coords <-matrix(as.numeric(coords),ncol =3) #convert coordinates to
matrix
59 options(warn=-1);ratios <-matrix(log2(as.numeric(arrayFile[,colnames(
arrayFile) == essentialColumns$red])/as.numeric(arrayFile[,
colnames(arrayFile) == essentialColumns$green])),ncol =1);options(
warn=startWarn) #calculate log2 ratios from red and green values (
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without warnings for negative values)
60 annotations <-matrix(arrayFile[,colnames(arrayFile) == essentialColumns
$probe]) #get essential annotations
61 otherAnnotations <-matrix(arrayFile[,colnames(arrayFile) ==
otherColumns ]) #get other (user define) annotations
62 if (length(otherAnnotations) > 0) annotations <-cbind(annotations ,
otherAnnotations) #join annotations if more than one set are
loaded
63 annoNames <-c("probeID",otherColumns) #set column names for annotation
matrix
64 status <-as.list("raw") #set status of data to "raw"
65 ratioNames <-fileName[n] #set column names for ratio matrix
66 }else{ #tab delimited file is to be loaded
67 message (paste("Loading:",fileName[n])) #print the name of the file
being loaded
68 columnNames <-scan(fileName[n],skip=0,nlines=1,what="",quiet=T) #get
column names from row 1
69 if (columnNames [1] == "grid_name") { #extra data is provided
70 values <-scan(fileName[n],skip=1,nlines=1,what="",quiet=T) #get
values from row 2
71 grid_name <-values [1] #get grid name (first position)
72 statusFileNames <-as.matrix(columnNames [2: length(columnNames)][!is.na
(columnNames [2: length(columnNames)])]) #get file names for
statuses
73 statuses <-as.matrix(values [2: length(values)][!is.na(values [2: length(
values)])]) #get statuses
74 columnTypes <-scan(fileName[n],skip=2,nlines=1,what="",quiet=T) #get
column types from row 3
75 columnNames <-scan(fileName[n],skip=3,nlines=1,what="",quiet=T) #get
column names from row 4
76 arrayFile <-as.matrix(read.table(fileName[n],header=F,sep="\t",quote=
"",skip =4)) #load remainder of tab delimited file
77 dataFileNames <-as.matrix(columnNames[columnTypes =="ratios"]) #get
data file names
78 status <-as.list(statuses[apply(dataFileNames ,1,function(x){which(
statusFileNames == x)})]) #reorder statuses
79 }else{ #no extra data is provided
80 columnTypes <-scan(fileName[n],skip=0,nlines=1,what="",quiet=T) #get
all row 1 column names
81 columnNames <-scan(fileName[n],skip=1,nlines=1,what="",quiet=T) #get
all row 1 column names
82 arrayFile <-as.matrix(read.table(fileName ,header=F,sep="\t",quote="",
skip =2)) #load tab delimited file
83 grid_name <-"unspecified" #set grid name to "unspecified"
84 status <-as.list(rep("raw",length(which(columnTypes =="ratios")))) #
set status to "raw"
85 }
86 coordTypes <-which(columnTypes =="coords") #get columns containing
coordinates
87 coordColumns <-c(coordTypes[which(columnNames[coordTypes] == "probeChr"
)],coordTypes[which(columnNames[coordTypes] == "probeStart")],
coordTypes[which(columnNames[coordTypes] == "probeEnd")]) #get
coordinate columns with specified column names
88 if (length(coordColumns) != 3) stop("Incorrect column names present",
call.=F) #stop with message if the wrong number of coordinate
columns are provided
89 annoTypes <-which(columnTypes =="anno") #get columns containing
annotations
90 annoColumns <-c(annoTypes[which(columnNames[annoTypes] == "probeID")],
annoTypes[!columnNames[annoTypes] == "probeID"]) #get annotation
columns with specified and unspecified (user defined) names
91 if (length(annoColumns) < 1) stop("Incorrect column names present",
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call.=F) #stop with message if no annotation columns are provided
92 ratioColumns <-which(columnTypes =="ratios") #get columns containing
ratios
93 coords <-matrix(as.numeric(arrayFile[,coordColumns ]),ncol =3)#get
coordinates as numeric
94 ratios <-matrix(as.numeric(arrayFile[,ratioColumns ]),ncol=length(
ratioColumns)) #get ratios as numeric
95 annotations <-matrix(nrow=nrow(coords),arrayFile[,annoColumns ]) #get
annotations
96 annoNames <-c("probeID",columnNames[annoTypes ][!columnNames[annoTypes]
== "probeID"]) #get column names for annotation matrix
97 ratioNames <-columnNames[columnTypes =="ratios"] #get ratio names for
ratio matrix
98 }
99 if (length(which(duplicated(annotations [,1]))) > 0) stop("Non -unique IDs
present", call.=F) #check all IDs are unique; stop message if not
100 arrayFile <-new("arrayData",list(coordinates=coords ,annotations=
annotations ,ratios=ratios ,grid_name=grid_name ,status=status)) #
create new arrayData object with loaded data
101 arrayFile <-arrayFile[order(arrayFile$coordinates [,1], arrayFile$
coordinates [,2]) ,] #order data by coordinates
102 colnames(arrayFile$coordinates)<-c("probeChr","probeStart","probeEnd") #
set coordinates matrix column names
103 colnames(arrayFile$annotations)<-annoNames #set annotations matrix
column names
104 colnames(arrayFile$ratios)<-ratioNames #set ratios matrix column names
105 if (n > 1) { #if loading beyond the first file
106 allArrayFiles <-cbind(allArrayFiles ,arrayFile) #cbind arrayData objects
107 }else{ #loading the first file
108 allArrayFiles <-arrayFile #store arrayData object
109 }
110 }
111 return(allArrayFiles) #return data
112 }
The function first checks that a column name is provided for each of the
items in the “essentialColumns” list and is stopped with the warning message
“Essential columns missing” if not (L4).
The file names to load are determined from the “fileName” argument
or R working directory (L5–26). If file names are not provided the working
directory is scanned for all files with ‘.tab’ and ‘.txt’ extensions (L6–7). All
file names, either user specified or from the working directory, are examined
for .txt and .tab extensions (L9–16). If both are present the function stops
with the error message “Mixtures of file types cannot be loaded together”
(L18). This prevents files of different formats being loaded together. If
neither are present the function stops with the error message “No files to
load” (L19). If only .txt files are provided the “txt” object is set to TRUE,
or if only .tab files are provided it is set to FALSE (L20–26). This is used to
determine the processing of the data as it is loaded.
87
CHAPTER 3 SECTION 3.2
A loop is initiated to load each file individually (L27). For ‘.txt’ files the
processing is based on the Agilent Feature Extraction file format (L28–67).
The name of each file is printed as it is loaded (L29). The second line of
the file, containing the parameter names, is scanned and the column con-
taining the text “Grid Name” specified to load (L30–33). The corresponding
position in the third line, containing the grid name, is loaded (L34). This
contains extra text separated by a ‘ ’, which is removed (L35). If no grid
name is found the warning message “No grid name found” is displayed (L36).
The tenth line of the file containing the feature names is red (L37). If the
column names from the “essentialColumns” argument are not all present the
function stops with the warning “Essential columns not present” (L38), oth-
erwise the corresponding features values are set to load from the eleventh line
(L39–43). Spike probe data are separated (L44–46) and control probe values
removed (L47). The function specified in the “processCoords” argument is
used to split the coordinates into their component parts (L48). Non-numeric
chromosome numbers are converted to the next available number and the
coordinates stored in a new matrix (L48–58). Ratio values are calculated as
the log2 ratio of red:green values and stored in a new matrix (L59). Warning
messages are disabled while there is the potential for non-numeric values to
be treated as numeric, during the processing of chromosome numbers and
ratios. Annotations — essential and user specified — are stored in a new
matrix and the column names saved (L60–63). The status is set to “raw”
(L64) and the ratios column names saved (L65).
For .tab files (L67–98) the processing is based on the file format shown in
Figure 3.2. The name of each file is printed as it is loaded (L67). The first
line is read (L68) and if the text of the first position is “grid name” (L69)
the first two lines are known to contain extra data. These values are loaded
(L70) and the grid name, statuses and status file names saved (L71–73). The
data types, names and values are read from lines 3, 4 and 5 onwards (L74–
76). Statuses are reordered according to the order of the data file names
(L77–78). If no extra data is provided the values are read from the first line
(L80–82). The grid name is stored as ‘unspecified” (L83) and the statuses
as “raw” (L84). Coordinate columns are sought (L86–87) and the function
88
SECTION 3.2 CHAPTER 3
stopped with an error message if these are not all present (L88). The same
is done for annotation data (L89–91). Coordinates, annotations and ratios
are stored as new matrices and column names saved (L92–97).
Following the loading and processing of data, annotations are checked for
unique entries (L99). A new arrayFile is created with the data (L100),
ordered by coordinate values (L101), and column names are set (L102–104).
If the arrayData object is not the first to be loaded it is joined with the others
with the cbind method, otherwise it is left on its own (L105–109). The final
arrayData object is returned when all files have been loaded (L111).
The splitCoords function
The splitCoords function (Script 3.2) runs within the loadArray func-
tion to process the probe coordinate data in the Agilent Feature Extrac-
tion file. This is in one column of the file, named “SystematicName”, and
contains genomic probe data in the format “chr” [chromosome num-
ber] [colon] [start coordinate] [hyphen] [end coordinate], for exam-
ple, chr1:100-160 for a probe on chromosome 1 that runs from position
100 to 160. Probe names are listed for non-genomic probes, such as con-
trols. The loadArray function passes all SystematicNames that begin with
“chr” to this function, which splits them into their component parts, that
is, a chromosome number and start and end coordinate. These are put into
a three-column matrix and returned to the loadArray function. This pro-
cessing allows each probe to be associated with a genomic location in the
arrayData object. The function has one argument:
x A character vector containing the coordinates to be split (no default).
Script 3.2: splitCoords: script to split the “systematicName” column of
the Agilent Feature Extraction file into its component parts, namely the
chromosome number and probe start and end coordinates.
1 ## splitCoords function ##
2 ## arguments: x (SystematicName column data to split)
3 splitCoords <-function(x) { #define function
4 split1A <-strsplit(x,"-") #split by "-"
5 doubles <-as.numeric(summary(split1A)[,1]) == 2 #identify doubles ie those
split into two
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6 split1 <-matrix(unlist(split1A[doubles ]),ncol=2,byrow=T) #get doubles
7 split2 <-matrix(unlist(strsplit(split1[,1],":")),ncol=2,byrow=T) #split
first half by ":"
8 split3 <-matrix(unlist(strsplit(split2[,1],"chr")),ncol=2,byrow=T)[,2] #
remove "chr" text from first half
9 coords <-matrix(ncol=3,nrow=length(x)) #initialise matrix to store
coordinates
10 coords[doubles]<-matrix(cbind(split3 ,split2[,2],split1 [,2]),ncol=3,byrow=F
) #recombine coordinates
11 return(coords) #return data
12 }
The function first breaks strings at the “-” location (L4) and the positions
of those split into two are stored (L5). The first component of the strings
split in two is split at the “:” location (L6–7) and the “chr” text removed
from the beginning (L8). All coordinates are recombined in a new matrix
and returned to the loadArray function (L9–11).
Validating arrayData
The arrayDataValidity function (Script 3.3) performs a series of checks
on arrayData objects to ensure that they are in the correct format, as de-
scribed in Section 3.2.1.2 and below, and is specified as the validity function
when setting the arrayData class. Validity functions are run automatically
in R every time a new object is created, to ensure that the object being
specified matches the expected format. Functions in this package that mod-
ify arrayData objects return new objects, and so this checking is performed
every time they are run. Its main purpose therefore is to check that the mod-
ification of the object has been carried out correctly. Users do not have any
need to directly modify the contents of an arrayData object, but if they do
so in such a way that they change the format of the object, this will create an
error when another function attempts to modify it. The arrayDataValidity
function can be called directly by a user if required, but there is no need for
this to be done as a matter of routine. Other functions that use, but do
not modify, arrayData objects do not perform this validity checking. The
following details are checked:
• The object contains five slots (for coordinates, annotations, ratios, grid
name and status).
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• The first three slots contain matrices.
• The last slot contains a list.
• The names of the objects in the slots are correct (“coordinates”, “an-
notations”, “ratios”, “grid name” and “status” respectively).
• The number of columns of the matrices are correct (3, 1+ and 1+).
• The number of statuses equals the number of datasets.
• The coordinates and ratios are numeric.
• The first column of annotations contains only unique values.
• The three matrices have the same number of rows.
• A single grid name is present.
The function has the following argument:
object The arrayData object to be validated (no default).
Script 3.3: arrayDataValidity: script to check presented arrayData objects
are in the correct format. Called by functions about to use an arrayData
object. Returns TRUE if the format is correct, in which case the function
carries on using the object, or an error message if not.
1 ## arrayDataValidity function ##
2 ## arguments: object (an arrayData object)
3 arrayDataValidity <-function(object) { #define function
4 if (length(object) == 5) { #length of arrayData is equal to 5
5 if (is.matrix(object [[1]]) & is.matrix(object [[2]]) & is.matrix(object
[[3]]) & is.character(object [[4]]) & is.list(object [[5]])) { #first
three slots contain matrices , fourth contains a chacacter vector and
fifth contains a list
6 if (names(object)[1] == "coordinates" & names(object)[2] == "
annotations" & names(object)[3] == "ratios" & names(object)[4] ==
"grid_name" & names(object)[5] == "status") { #slots contain items
of the correct names
7 if (ncol(object [[1]]) == 3 & ncol(object [[2]]) >= 1 & ncol(object
[[3]]) >= 1 & length(object [[4]]) == 1 & length(object [[5]]) ==
ncol(object [[3]])) { #slots contain items of the correct
dimensions
8 if (nrow(object [[1]]) > 0) if (is.numeric(object [[1]][1 ,1]) & is.
numeric(object [[3]][1 ,1])) { #coordinates and ratios are
numeric
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9 if(nrow(object [[1]]) > 0) if (length(which(duplicated(object
[[2]][ ,1]))) == 0) { #no probe names are duplicated
10 if (nrow(object [[1]]) == nrow(object [[2]]) & nrow(object [[1]])
== nrow(object [[3]])) { #all matrices are of the same
number of rows
11 if (nchar(object [[4]]) >= 1) { #a grid name is present
12 TRUE #all criteria have been met; return TRUE
13 } else print("Grid name is absent") #a grid name is not
present; print message
14 } else print("Unequal matrix lengths") #matrices are of
differing numbers of rows; print message
15 } else print("Non -unique IDs present in annotations") #some
probe names are duplicated; print message
16 } else paste("Non -numeric entries found which should be numeric")
#non -numeric coordinates/ratios found; print message
17 } else print("Items of incorrect length") #slots contain items of
incorrect dimensions; print message
18 } else print("Slot names incorrect") #slots contain items of incorrect
names; print message
19 } else print("Slots contain incorrect objects") #slots do not contain
the expected objects; print message
20 }else print("Incorrect number of slots") #length of arrayData is not equal
to 5; print message
21 }
22
23 ## Define arrayData class ##
24 setClass("arrayData",representation("list"),validity=arrayDataValidity) #set
class with validity
The function checks the components in a specific order, each check relying
on the last to be correct. That the length of the object is 5 is checked first
(L4) allowing the formats (L5), names (L6) and dimensions (L7) of these 5
components to be checked. Coordinates and ratios are checked to be numeric
(L8) and probe IDs are checked to be unique (L9). Components are checked
to contain the same number of probes (L10). The grid name is checked to
contain one entry (L11). If all of these checks are passed the function returns
TRUE (L12), otherwise an error message corresponding to the failed check is
returned (L13–20). This function is set as the validity check of the arrayData
class (L24).
3.2.1.4 Writing arrayData to external files
There may be occasions where a user wishes to use data from an arrayData
object in a different program, or for some other reason save their data outside
of R. The function writeArrayData allows this by writing the data to a tab-
delimited text file. The format of the text file is that shown in Figure 3.2,
and as such the files written with this function can be loaded back into R
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as an arrayData object with the loadArray function. The function has the
following arguments:
object The arrayData object to be written to the file (no default).
fileName The name of the file to create (no default). The ‘.tab’ extension
is added if not present so the file will be correctly recognised by the
loadArray function.
Script 3.4: writeArrayData: script to write an arrayData object to a tab-
delimited text file. All information in the object is written in a format that
can be read back in as an arrayData object by the loadArray function
1 ## writeArrayData function ##
2 ## arguments: object (an arrayData object), fileName (the name of the file
to be created)
3 writeArrayData <-function(object ,fileName) { #define function
4 validObject(object ,test=T) #check arrayData object is correct
5 data <-matrix(ncol =3+ ncol(object$annotations)+ncol(object),nrow=nrow(object
)) #initialise matrix to store data
6 data [,1:3] <-matrix(object$coordinates ,ncol =3) #put coordinates in first 3
columns
7 data [ ,4:(3+ ncol(object$annotations))]<-matrix(object$annotations ,ncol=ncol
(object$annotations)) #put annotations in next columns
8 data [,(4+ ncol(object$annotations)):(3+ ncol(object$annotations)+ncol(object
))]<-matrix(object$ratios ,ncol=ncol(object)) #put ratios in last
columns
9 top <-matrix(ncol=ncol(data),nrow =2) #initialise matrix to store extra info
10 top[,1]<-c("grid_name",object$grid_name) #store grid name
11 for (n in 1:ncol(object)) top[,(n+1)]<-c(colnames(object$ratios)[n],paste(
object$status [[n]],collapse=",")) #store each data name
12 data <-rbind(top ,c(rep("coords",ncol(object$coordinates)),rep("anno",ncol(
object$annotations)),rep("ratios",ncol(object$ratios))),c(colnames(
object$coordinates),colnames(object$annotations),colnames(object$
ratios)),data) #combine all together into final format
13 if(missing(fileName)) fileName <-deparse(substitute(object))
14 if(substr(fileName ,nchar(fileName) -3,nchar(fileName)) != ".tab") substr(
fileName ,nchar(fileName)-3,nchar(fileName))<-".tab" #change file
extension to ".tab" if not already
15 write.table(data ,fileName ,quote=F,sep="\t",row.names=F,col.names=F) #write
to tab delimited file
16 message(paste("arrayData object \"",deparse(substitute(object)),"\"
written to ",fileName ,sep="")) #print message
17 }
The function first confirms the validity of the arrayData object (L4), to
ensure that all the data is in the required format to write to the file. A new
matrix is created and the coordinate, annotation and ratio data added to it
(L5–8). Another matrix is created for the extra data and the grid name, file
names and statuses added to it (L9–11). Both matrices are combined (L12).
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If no file name is provided it is set to be the object name (L13) and a ‘.tab’
extension added to the end if required (L14). The object is then written
(L15) and a confirmatory message displayed (L16).
3.2.1.5 The genomeAnnotation class
In addition to loading microarray data, the biomaRt (Durinck et al., 2005)
package has been used to load complementary genome annotation data. This
is used to determine the positions of probes relative to ORFs, which is used
in several plotting functions and to assign location-specific information to
probes. This information is loaded into a genomeAnnotation object which
is of a similar format to the arrayData object, in that it is a list structure
containing several matrices, in the following format.
coordinates A three column matrix containing the chromosome number,
start position and end position of each ORF.
annotations A three column matrix containing the name, chromosome name
and strand of each ORF. The chromosome number is always numeric,
and is based on the chromosome name in the database. If this is nu-
meric both will be the same, otherwise the next available number is
assigned. These values are stored in the “coordinates” matrix while
the original names are stored in the “annotations” matrix.
dataset The name of the biomaRt dataset used to load the data.
The biomaRt package links to databases of genome annotations for sev-
eral organisms, including S. serevisiae and humans. The loadAnnotation
function (Script 3.6) was written to extract information from these. The
function contains the following arguments:
mart A character vector specifying the database to use (default “ensembl”,
which should not need to be changed.)
dataset A character vector specifying the name of the dataset to be accessed
(default “scerevisiae gene ensembl”).
attributes A vector containing the names of the attributes in the database
to be loaded (defaults “external gene id” (gene name), “chromosome name”
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(chromosome name or number), “start position” (ORF start coordi-
nate), “end position” (ORF end coordinate), and “strand” (ORF strand),
which should be consistent between different datasets and therefore
should not need to be changed).
chromosomes A vector containing the names of the chromosomes to be
loaded (default Roman numerals from 1 to 16 for S. serevisiae; for
humans they should be listed as the numbers 1 to 22 plus “X” and
“Y”).
Script 3.5: loadAnnotation: script to load genome annotation data using
the biomaRt package. Gene names, coordinates and strands along with the
dataset name are stored as the newly defined genomeAnnotation class.
1 ## loadAnnotation function ##
2 ## arguments: mart (biomaRt mart to use), dataset (biomaRt dataset to use),
attributes (data to load from database), chromosomes (the organisms
chromosoms names as they appear in the database)
3 loadAnnotation <-function(mart="ensembl",dataset="scerevisiae_gene_ensembl",
attributes=c("external_gene_id","chromosome_name","start_position","end_
position","strand"),chromosomes=as.roman (1:16)) { #define function
4 require(biomaRt) #load biomaRt package if not already done so
5 annotation <-as.matrix(getBM(mart=useMart(mart , dataset = dataset),
attributes=attributes)) #download data (gene name , chromosome name ,
gene start , gene end , strand) from mart/dataset
6 chromosomes <-as.character(chromosomes) #set chromosomes as characters
7 annotation <-annotation[which(as.character(annotation [,2]) %in% chromosomes
),] #get data matching defined chromosomes
8 annotation <-cbind(annotation ,matrix(ncol=1,nrow=nrow(annotation))) #add
new column to data
9 for (n in 1: length(chromosomes)) { #loop through chromosomes
10 annotation[which(annotation [,2] == chromosomes[n]) ,6]<-n #set numerical
value for each chromosome
11 }
12 coords <-matrix(as.numeric(annotation[,c(6,3,4)]),ncol =3) #get coordinates
13 annotations <-matrix(annotation[,c(1,2,5)],ncol =3) #get annotations
14 anno <-new("genomeAnnotation",list(coordinates=coords ,annotations=
annotations ,dataset=dataset)) #put data in new genomeAnnotation object
15 anno <-anno[order(anno$coordinates [,1],anno$coordinates [,2])] #order
genomeAnnotation object
16 return(anno) #return genomeAnnotation object
17 }
The function first ensures the biomaRt package is loaded (L4) and uses it to
load the specified annotations (L5). Provided chromosomes are converted to
characters (L6) and used to get the required data from the loaded annotations
(L7). A new column is added to this data (L8) and used to store numeric
chromosome values based on the order they are provided (L9–11). Data
95
CHAPTER 3 SECTION 3.2
is split into coordinates (L12) and annotations (L13) and added to a new
genomeAnnotation object (L14). This is ordered by coordinate values (L15)
and returned to the user (L16). Messages are generated by biomaRt if errors
occur.
Manipulation of genomeAnnotation objects
The genomeAnnotation objects are not intended to be called directly by users
or modified by functions other than loadArray and so has few methods for its
manipulation (Script 3.6). The “dim” method has been defined to show the
number of ORFs present, and square brackets to extract details for particular
positions. To prevent the object being displayed in full and filling up the R
console the show method has been defined to give a message showing the
number of ORFs in the object and the dataset from which they came.
Script 3.6: genomeAnnotation: scripts to process genomeAnnotation ob-
jects. The class is first defined. The show method displays a single line
of information, the dim method returns the dimensions of the coordinates
matrix and the extraction method allows particular genes to be extracted.
1 ## define genomeAnnotation class ##
2 setClass("genomeAnnotation",representation("list"))
3
4 ## genomeAnnotation show function ##
5 ## arguments: object (a genomeAnnotation object)
6 setMethod("show", "genomeAnnotation", function(object) { #define function
7 message(paste("genomeAnnotation object of length",nrow(object),"from",
object$dataset)) #print message
8 }
9 )
10 ## genomeAnnotation extract function ##
11 ## arguments: object (a genomeAnnotation object), i (rows)
12 setMethod("[", "genomeAnnotation", function(x,i ,...) { #define function
13 if (nargs() != 2) stop("One subscript required", call. = FALSE) #check
only one subscript (for rows)
14 return(new("genomeAnnotation",list(coordinates=matrix(x[[1]][i,],ncol=ncol
(x[[1]])),annotations=matrix(x[[2]][i,],ncol=ncol(x[[2]])),dataset=x$
dataset))) #return new genomeAnnotation object
15 }
16 )
17 ## genomeAnnotation dim function
18 ## arguments: x (a enomeAnnotation object)
19 setMethod("dim", "genomeAnnotation", function(x) { #define function
20 return(dim(x[[1]]))
21 }
22 )
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The “show” method (L6) prints the length of the object (the number of
ORFs it contains) and the name of the dataset it was downloaded from (the
organism name) (L7). The extraction method (L12) accepts one argument
(L13) and returns all information relating to the specified positions (L14).
The “dim” method (L19) prints the number of genes in the object.
3.2.2 Quality assessment
It is prudent to assess the quality of data produced by a microarray before any
analyses are undertaken, as there are several stages at which problems can
be introduced into the ChIP-chip procedure which can render the final data
unreliable. The checkData function (Script 3.7) loads Agilent Feature Ex-
traction files and produces a set of graphics which can aid in this assessment.
This helps any faults or irregularities in the data or on the microarray to be
identified and a decision made as to whether or not to go on to load the data
for analysis. The limma imageplot function is used to create pseudo-images
of the arrays. This is achieved by loading the coordinates of the physical lo-
cations of the probes on the array and representing the corresponding probe
intensities at those positions in the image. One image is created for each
of the two channels. These allow artifacts on the microarray surface, such
as scratches, or regions of poor hybridisation to be visualised. At this point
a user may decide to reject a dataset from further analyses if there is an
obvious defect on the microarray which will likely make some, if not all, of
the data unreliable.
The intensity values of the two channels are shown as box plots, which
allows a visual estimation of the range of values, which can be compared
between different datasets to identify any with unusual features. Additional
box plots can be displayed for microarrays containing custom spike in probes
(see Section 4.4.1), allowing the signal intensities of the spike probes to be
compared to the rest of the probes. This can be useful to see whether or not
the spike in values are in the correct range, which would be expected to be
similar to the range of the genomic probe values if spike ins are included, or
lower than the genomic values if they are not. Density plots of the genomic
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probes are also created, which can show unusual patterns in the distribu-
tions, such as skewness or unevenness, which may suggest that the data are
unreliable. A density plot of the red:green log2 ratios is also created, showing
the pattern of the final results.
A scatter plot of the red and green values allows the relationship between
the two channels to be visualised. The function smoothScatter is used
to create this plot, which displays more dense areas of points with darker
colours. This allows the data to be better visualised than a standard scatter
plot. The function has the following arguments:
fileName A character vector specifying the names of the files to load (no
default).
essentialColumns A list of the names of the columns in the Feature Ex-
traction text file containing essential information. Red and green inten-
sity values are taken from the “rBGSubSignal” and “gBGSubSignal”
columns respectively, probe row and column positions from “Row” and
“Col” respectively and coordinates from “SystematicName” by default
and do not need to be modified under normal circumstances.
spikes A logical value specifying whether or not spike probes are included
on the microarrays (default FALSE).
spikeStart A character vector specifying text used to identify spike probes
(default “>”).
Script 3.7: checkData: script to load Agilent Feature Extraction text files
and create a series of graphics in order to assess the quality of the microarray
and the data it has produced.
1 ## checkData function ##
2 ## arguments: fileName (name of Agilent FE file), essentialColumns (required
columns from the feature extraction file), spikes (whether or not the
array contains spikes , spikeStart (character defining spike probes)
3 checkData <-function(fileName , essentialColumns=list(red="rBGSubSignal",
green="gBGSubSignal", row="Row", col="Col", coords="SystematicName"),
spikes=F,spikeStart=">") { #define the function
4 if (length(essentialColumns$red) == 0 | length(essentialColumns$green) ==
0 | length(essentialColumns$row) == 0 | length(essentialColumns$col)
== 0 | length(essentialColumns$coords) == 0) stop("Essential columns
missing", call.=F) #check all essential columns are defined
5 require(limma) #ensure limma package is loaded
6 if (missing(fileName)) fileName <-list.files(pattern=".txt$") #search for
all .txt file if no filename is provided
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7 for (n in 1: length(fileName)) { #loop through files
8 message(paste("Loading:",fileName[n])) #print the name of the file being
loaded
9 columnNames <-scan(fileName[n],skip=9,nlines=1,what="",quiet=T) #get
column names from row 10 of the file
10 if (length(grep(essentialColumns$red ,columnNames)) != 1 | length(grep(
essentialColumns$green ,columnNames)) != 1 | length(grep(
essentialColumns$row ,columnNames)) != 1 | length(grep(
essentialColumns$col ,columnNames)) != 1 | length(grep(
essentialColumns$coords ,columnNames)) != 1) stop("Essential columns
not present", call.=F) #stop with message if not all essential
columns present in file
11 totalColumns <-length(columnNames) #get total numer of columns of data
12 columnRead <-rep("NULL",totalColumns) #set all columns to NULL (so they
are not read)
13 columnRead[which(columnNames %in% essentialColumns)]<-NA #set listed
columns with NA (in order to be read)
14 arrayFile <-as.matrix(read.table(fileName[n],colClasses=columnRead ,skip
=9,header=T,fill=T,sep="\t",quote="")) #read data into R
15 red <-as.numeric(arrayFile[,which(colnames(arrayFile) == essentialColumns
$red)]) #get red channel values
16 green <-as.numeric(arrayFile[,which(colnames(arrayFile) ==
essentialColumns$green)]) #get green channel values
17 rows <-as.numeric(arrayFile[,which(colnames(arrayFile) ==
essentialColumns$row)]) #get row coordinates
18 cols <-as.numeric(arrayFile[,which(colnames(arrayFile) ==
essentialColumns$col)]) #get column coordinates
19 maxR <-max(rows) #get maximum row value
20 maxC <-max(cols) #get maximum column value
21 full <-paste(sort(rep(1:maxR ,maxC)),rep(1:maxC ,maxR),sep="-") #get all (
full) potential positions
22 actual <-paste(rows ,cols ,sep="-") #get actual array positions
23 same <-full %in% actual #get full positions actually present
24 redNew <-greenNew <-numeric () #initialise vectors
25 redNew[same]<-red #get red values in position
26 greenNew[same]<-green #get green values in position
27 red <-redNew #redefine red
28 green <-greenNew #redefine green
29 par(bty="n") #don ’t plot boxes around plots
30 layout(matrix(c(1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 3, 3, 3, 3, 2, 2, 2,
2, 4, 4, 4, 4, 5, 5, 5, 5, 6, 6, 6, 6, 7, 7, 7, 7, 8, 8, 8, 8),
byrow=T,ncol =8),height=c(2,5,5,10,10)) #define layout
31 if(spikes) layout(matrix(c(1, 1, 1, 1, 1, 1, 1, 1, 2, 2, 2, 2, 3, 3, 3,
3, 2, 2, 2, 2, 4, 4, 4, 4, 5, 5, 6, 6, 7, 7, 7, 7, 8, 8, 8, 8, 9, 9,
9, 9),byrow=T,ncol =8),height=c(2,5,5,10,10)) #define layout with
spikes
32 par(mar=c(0,0,3,0)) #set margins
33 plot(0,1,type="n",bty="n",xaxt="n",yaxt="n",main=fileName[n],xlab="",
ylab="") #print file name
34 plot(0,1,type="n",bty="n",xaxt="n",yaxt="n",main="",xlab="",ylab="",xlim
=c(0,1),ylim=c(0,6)) #initialise plot to print text:
35 text(0,1,"Cy3 (Green):",pos =4)
36 text(0,2,"Cy5 (Red):",pos=4)
37 text(0,3,"Organism & Strain:",pos=4)
38 text(0,4,"Date:",pos=4)
39 text(0,5,"Name:",pos=4)
40 text(0,6,"Description:",pos =4)
41 imageplot(c(red ,rep(0,((max(cols)*max(rows))-length(red)))),list(ngrid.r
=1,ngrid.c=1,nspot.r=max(rows),nspot.c=max(cols)),low = "white",
high = "red", zlim = c(0, mean(red ,na.rm=T) + 3*mad(red ,na.rm=T)),
legend=F,mar=c(0.1 ,3 ,0.1 ,3),xlab="",ylab="") #create red pseudoimage
using limma ’s imageplot
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42 imageplot(c(green ,rep(0,((max(cols)*max(rows))-length(red)))),list(ngrid
.r=1,ngrid.c=1,nspot.r=max(rows),nspot.c=max(cols)),low = "white",
high = "green", zlim = c(0, mean(green ,na.rm=T) + 3*mad(green ,na.rm
=T)),legend=F,mar=c(0.1 ,3 ,0.1 ,3),xlab="",ylab="") #create green
pseudoimage using limma ’s imageplot
43 if(spikes) { #if spikes are present
44 spikeData <-arrayFile[grep(spikeStart ,arrayFile[,which(colnames(
arrayFile) == essentialColumns$coords)]) ,] #get spike data
45 }
46 arrayFile <-arrayFile[grep("chr",arrayFile[,which(colnames(arrayFile) ==
essentialColumns$coords)]) ,] #get only probes with chromosomal
coordinates
47 red <-as.numeric(arrayFile[,which(colnames(arrayFile) == essentialColumns
$red)]) #get red channel values
48 green <-as.numeric(arrayFile[,which(colnames(arrayFile) ==
essentialColumns$green)]) #get green channel values
49 startWarn <-as.numeric(options("warn")); on.exit(options(warn=startWarn))
#maintain warning state on exit
50 options(warn=-1); ratios <-log2(red/green) #calculate log2 ratios without
warnings
51 red <-log2(red) #log2 red values
52 green <-log2(green) #log2 green values
53 rS<-gS<-NA #set red and green spike values to NA
54 if(spikes) { #if spikes are present
55 rS<-log2(as.numeric(spikeData[,which(colnames(spikeData) == "
rBGSubSignal")])) #get red spike values
56 gS<-log2(as.numeric(spikeData[,which(colnames(spikeData) == "
rBGSubSignal")]) ) #get green spike values
57 }
58 options(warn=startWarn) #reset warning state
59 par(mar=c(5, 4, 1.5, 1)) #set margins
60 boxplot(list(red ,green),col=c(2,3),names=c("Red","Green"),main="Signal
Intensities",ylab="Log2 Signal",ylim=c(range(c(red ,green),na.rm=T)))
#plot signal intensities as boxplot
61 if(spikes) boxplot(list(rS,gS),col=c(2,3),names=c("Red","Green"),main="
Spikes",ylab="Log2 Signal",ylim=c(range(c(red ,green),na.rm=T))) #
plot signal intensities as boxplot
62 par(xaxt="s") #set x-axis type
63 smoothScatter(green ,red ,main="Red v Green",xlab="Log2 Green Signal",ylab
="Log2 Red Signal",pch =20) #red v green plot
64 abline(0,1,col="blue") #add line y=x
65 r<-density(red ,na.rm=T) #calcualte red density
66 g<-density(green ,na.rm=T) #calculate green density
67 plot(r,col="red",lwd=2,xlab="Log2 Signal",main="Signal Intensities",xlim
=range(c(r$x,g$x)),ylim=range(c(r$y,g$y))) #plot red density
68 lines(g,col="green",lwd=2) #add green density
69 plot(density(ratios ,na.rm=T),lwd=2,main="Red/Green Ratios",xlab="Log2
Ratio") #plot log2 ratio densities
70 }
71 }
The function first checks that the names of the required columns have been
specified (L4) and loads the limma package if required (L5). File names with
the ‘.txt’ extension are taken from the working directory if not provided in the
“fileName” argument (L6). A loop is initiated to load each file individually
(L7). The name of each file is is printed as it is loaded (L8). The tenth
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line of the file is scanned for the required column names (L9) and an error
message displayed if they are not all present (L10). The data values from
the specified columns are then read from the eleventh line of the file onwards
(L11–14).
Red, green, row and column values are extracted (L15–18). Row and
column numbers are used to determine the probe positions within the grid
(L19–23) and these positions used to reassign the red and green values to
correspond to their correct positions (L24–28). The plotting parameters and
layouts are defined (L29–32) and a series of text labels printed in the first
plot region (L33–40). Pseudo-images of the red and green values are created
(L41–42). Spike data are extracted if required (L43–45) and genomic probes
stored (L46). Red and green values are again extracted (L47–48) and used
to calculated log2 red and green values as well as their ratios, with warning
messages disabled (L49–58). Parameters are adjusted (L59) for box plot
plotting (L60–61) and again (L62) for scatter plotting (L63–64). Red and
green intensity value densities are plotted (L65–67) followed by their log2
ratios (L69).
An example of the output of this function is shown in Figure 3.3, created
from an Abf1 binding dataset (see Chapter 7). The pseudo-images do not
show any obvious abnormalities on the microarray surface. The box plots
show the bulk of the intensity values are in the expected range and the
density curves show smooth distributions, indicating that both the red and
green channels have produced good quality results. The scatter plot shows a
good relationship between the two channels, with some probes higher in the
red (IP sample) channel than the green (input sample), as expected. This
is also shown in the density plot, with the tail on the right hand side as a
result of the enriched regions.
The application of a statistical test could also be used to determine the
similarity or otherwise of replicate datasets. A test such as Spearman’s
rank correlation coefficient may be used to test the relationship between
two datasets in a non-parametric manner, allowing comparisons to be made
between all replicate datasets. This would allow the objective identification
of any datasets that do not follow the same properties of their replicates at
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a defined P-value cutoff (under the hypothesis that the rho value is equal to
zero; after the application of a multiple testing correction where appropri-
ate). This can then be used in conjunction with the quality control graphics
to determine whether or not to use datasets for further analyses.
3.2.3 Accessing data
Extracting specific probe data from an arrayData object is important both
for users and functions working with them. In R this is achieved with a square
bracket notation to define the required part(s) of an object. This notation
is specific to the object type being used, and each has a method associated
with it which defines how data is extracted from it. A method has been
defined for the arrayData object to allow probe data to be extracted from it
(Script 3.8). With regard to 2-dimensional objects, row and column numbers
are specified. For example, matrixName[2,3] returns data from the third
column of the second row of the named matrix. This same format is used to
access probe data from an arrayData object, with row numbers relating to
probes and column numbers relating to datasets. In addition, probe names
may be specified as the rows argument, in which case the relevant rows are
determined from the unique probe names in the annotations matrix. A new
arrayData object is created with ratio data from the specified probe(s) and
dataset(s), coordinate and annotation data for the probe(s), status data for
the dataset(s) and the grid name for the object. This method can also be
used to split arrayData objects into multiple different objects. This may be
required if, for example, multiple datasets that represent different conditions
have been loaded at the same time. These may be subject to different down-
stream processing and so it is useful to store them, and therefore process
them, separately. The dollar ($) notation can be used to directly access any
of the components of an arrayData object, for which no specific methods
need be defined.
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Figure 3.3: Output of the checkData function: The name of the file is printed
at the top of the page with space for details of the microarray to be written.
Pseudo images (top right) can show artifacts on the slide surface. Box plots
and density curves of red and green signal intensities show the distributions
of the values. A scatter plot shows the relationship between the two channels
and a density curve shows the distribution of the log2 ratio values.
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Script 3.8: arrayData extraction: extracts data from the given positions into
a new arrayData object.
1 ## [ (extract) function ##
2 ## arguments: x (an arrayData object), i (required row number(s)), j (
required column number(s))
3 setMethod("[", "arrayData", function(x,i,j) { #define function
4 if (nargs() != 3) stop("Two values required", call. = FALSE) #ensure
correct dimensions are specified
5 if (missing(i)) i<-1:nrow(x$ratios) #if no colums specified get all
6 if (missing(j)) j<-1:ncol(x$ratios) #if no rows specified get all
7 if (is.character(i)) { #if IDs are provided
8 for (n in 1: length(i)) { #loop through IDs
9 probe <-which(x$annotations [,1] == i[n]) #search for ID
10 if (length(probe) > 0) { #if ID is found
11 i[n]<-probe #get row number
12 }else{ #ID is not found
13 i[n]<-0 #don ’t get a row
14 }
15 }
16 i<-as.numeric(i) #ensure numeric
17 }
18 newArrayData <-new("arrayData",list(coordinates=matrix(x$coordinates[i,],
ncol=ncol(x$coordinates),dimnames=list(NULL ,colnames(x$coordinates))),
annotations=matrix(x$annotations[i,],ncol=ncol(x$annotations),dimnames
=list(NULL ,colnames(x$annotations))),ratios=matrix(x$ratios[i,j],ncol=
ifelse(j[1]>0, length(j),(ncol(x)-length(j))),dimnames=list(NULL ,
colnames(x$ratios)[j])),grid_name=x$grid_name ,status=x$status[j])) #
create new arrayData object from extrated data
19 return(newArrayData) #return desired data
20 }
21 )
The function checks the number of arguments is correct (L4) and assigns
full row and column ranges if they are not provided (L5–6). If characters
are specified for rows the first “annotations” column is used to identify the
corresponding row number (L7–17). A new (arrayData) object is created
containing the specified probes and datasets (L18) and returned (L19).
3.2.4 Manipulation of arrayData objects
Mathematical manipulation of the ratio values of arrayData objects forms a
crucial part of their processing, most importantly here as part of the normal-
isation procedure. Users may also need to perform these operations directly,
either to create further data to analyse, such as calculating the differences be-
tween two datasets, or to temporarily adjust data, such as to display different
datasets on a similar scale on the same graph. The standard mathematical
operator methods (+, -, * and /) have been defined to apply the operations
to the ratio values of arrayData objects (Script 3.9). Processing common to
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all procedures is carried out by the maths function. Two arguments must be
specified, the first of which must be an arrayData object. The second can
be another arrayData object, or a single number. A single number is used to
create a new arrayData object, the ratio values of which are filled with that
number. Probes common to both are maintained and any others removed,
with a warning message. If different numbers of datasets are provided the
extras are removed with a warning message. These processed objects are
returned to the individual functions, which perform the mathematical oper-
ations on the ratio values of these objects. The results of the calculations are
returned as the ratios of a new arrayData object.
Script 3.9: Mathematical operators: Scripts to manipulate arrayData objects
by the standard mathematical operators +, -, * and /. The maths function
performs processing common to all operations. The individual methods apply
the operator and return a new arrayData object.
1 ## mathematical operator functions
2 ## arguments: e1 (first arrayData object), e2 (second arrayData object or
single number)
3 ## processing common to all operations:
4 maths <-function(e1,e2) { #define function
5 if(length(e2) == 1 & is.numeric(e2)) { #if a single number is provided in
e2
6 number <-e2 #store the number
7 e2<-e1 #set e2 as arrayData object from e1
8 e2$ratios <-matrix(ncol=ncol(e2),nrow=nrow(e2),number) #fill ratios with
number
9 colnames(e2$ratios)<-rep(number ,ncol(e2)) #set column names
10 }
11 if (ncol(e1) != ncol(e2)) {
12 if (ncol(e1) > ncol(e2) ) e1<-e1[,1:ncol(e2)] else e2<-e2[,1:ncol(e1)]
13 warning("Differing numbers of datasets: extras removed", call.=F)
14 }
15 matchingProbes1 <-which(e1$annotations [,1] %in% e2$annotations [,1]) #find
matching probes in e1
16 matchingProbes2 <-which(e2$annotations [,1] %in% e1$annotations[
matchingProbes1 ,1]) #find matching probes in e2
17 object <-e1[matchingProbes1 ,] #get arrayData containing matching probes
18 if(length(matchingProbes1) != nrow(e1) | length(matchingProbes2) != nrow(
e2)) warning("Differing arrayData lengths: non -matching probes removed
", call. = FALSE) #warn if not all probes match
19 e2<-e2[matchingProbes2 ,]
20 object$status <-as.list(rep("Processed",ncol(object))) #set status of
datasets to "processed"
21 return(list(e2=e2 ,object=object)) #return all arrayData objects
22 }
23 ##Add datasets
24 setMethod ("+","arrayData", function(e1,e2) { #define function
25 processed <-maths(e1 ,e2) #get processed arrayData objects
26 e1<-processed$object #get new object
27 e2<-processed$e2 #get new e2
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28 e1$ratios <-e1$ratios+e2$ratios #add ratios
29 colnames(e1$ratios)<-paste(colnames(e1$ratios),"+",colnames(e2$ratios),sep
="") #adjust column names
30 return(new("arrayData",e1)) #return arrayData object
31 }
32 )
33 ##Subtract datasets
34 setMethod ("-","arrayData", function(e1,e2) { #define function
35 processed <-maths(e1 ,e2) #get processed arrayData objects
36 e1<-processed$object #get new object
37 e2<-processed$e2 #get new e2
38 e1$ratios <-e1$ratios -e2$ratios #subtract ratios
39 colnames(e1$ratios)<-paste(colnames(e1$ratios),"-",colnames(e2$ratios),sep
="") #adjust column names
40 return(new("arrayData",e1)) #return arrayData object
41 }
42 )
43 ##Multiply datasets
44 setMethod ("*","arrayData", function(e1,e2) { #define function
45 processed <-maths(e1 ,e2) #get processed arrayData objects
46 e1<-processed$object #get new object
47 e2<-processed$e2 #get new e2
48 e1$ratios <-e1$ratios*e2$ratios #multiply ratios
49 colnames(e1$ratios)<-paste(colnames(e1$ratios),"*",colnames(e2$ratios),sep
="") #adjust column names
50 return(new("arrayData",e1)) #return arrayData object
51 }
52 )
53 ##Divide datasets
54 setMethod ("/","arrayData", function(e1,e2) { #define function
55 processed <-maths(e1 ,e2) #get processed arrayData objects
56 e1<-processed$object #get new object
57 e2<-processed$e2 #get new e2
58 e1$ratios <-e1$ratios/e2$ratios #divide ratios
59 colnames(e1$ratios)<-paste(colnames(e1$ratios),"/",colnames(e2$ratios),sep
="") #adjust column names
60 return(new("arrayData",e1)) #return arrayData object
61 }
62 )
The maths function examines the second argument to see if it is a num-
ber (L5). In this case a new arrayData object is created and a single set
of ratio values filled with this number (L6–10). If two arrayData objects
containing different numbers of datasets are provided the longer is reduced
to the length of the shorter and a warning message displayed (L11–14). If
two arrayData objects containing different numbers of probes are provided,
those common to both are maintained and a warning message displayed if
required (L15–19). The status of the first object is changed (L20) and both
adjusted objects returned to the original function (L21). These adjusted
datasets are processed, the dataset names updated, and the results returned
as a new arrayData object for the addition (L24–32), subtraction (L34–42),
106
SECTION 3.2 CHAPTER 3
multiplication (L44–52) and division (L54–62) functions.
rowMeans
The rowMeans method has been defined to calculate average ratio values from
multiple datasets. This can be used to reduce replicate datasets to a single
averaged dataset.
Script 3.10: arrayData rowMeans: Script to calculate ratio row means using
the rowMeans method. A new arrayData object is returned containing a
single set of averaged ratios.
1 ## rowMeans function ##
2 ## arguments: x (an arrayData object)
3 setMethod("rowMeans", "arrayData", function(x) { #define the function
4 averaged <-x[,1] #initialise new object to store means
5 averaged$ratios <-as.matrix(ncol=1,rowMeans(x$ratios)) #calculate ratio row
means
6 colnames(averaged$ratios)<-paste("rowMeans of: ",paste(colnames(x$ratios),
collapse=","),sep="") #set new data name
7 averaged$status <-x$status [1] #set status of first object
8 return(new("arrayData",averaged)) #return mean data
9 }
10 )
A new arrayData object is created with a single dataset to store the averaged
values (L4). The rowMeans function is applied to the “ratios” matrix and
the results stored (L5). The dataset name is set to show all its component
datasets (L6), the status modified (L7) and the resulting object returned
(L8).
cbind
Many of the functions written here accept only one arrayData object for
processing. There may be instances where multiple arrayData objects are
present, either because they have been loaded separately or processed to
create separate results, which a user requires to pass together to another
function. The cbind method allows multiple columns of data to be combined
together. The method has been defined for arrayData objects (Script 3.11),
which joins multiple columns of ratio values together. This allows multiple
sets of ratios to be joined and associated with a single set of coordinate and
107
CHAPTER 3 SECTION 3.2
annotation data. The function will only join objects with the same grid
name, preventing different data formats coming together in the same object.
If differing numbers of probes are provided for the same grid name, only those
appearing in all datasets are maintained and a warning message is displayed.
A new arrayData object containing the combined ratios is returned.
Script 3.11: arrayData cbind: Script to combine data from multiple array-
Data objects using the cbind method. The ratio values are combined for
probes common to all datasets and a new arrayData object returned.
1 ## cbind function ##
2 ## arguments: ... (any number of arrayData objects)
3 cbind.arrayData <-function (..., deparse.level) {
4 objects <-list (...) #get arrayData objects
5 gridName <-objects [[1]]$grid_name #get first grid name
6 cbinded <-objects [[1]] #initialise new arrayData object to store results
7 warn <-FALSE #set warn to FALSE
8 if (length(objects) > 1) { #if there are more than 1 arrayData objects
9 for (n in 2: length(objects)) { #loop through arrayData objects
10 if(cbinded$grid_name != objects [[n]]$grid_name) warning("Differing
grid names", call.=F) #stop if grid names are different
11 matchingProbes1 <-which(cbinded$annotations [,1] %in% objects [[n]]$
annotations [,1]) #find matching probes
12 matchingProbes2 <-which(objects [[n]]$annotations [,1] %in% cbinded$
annotations[matchingProbes1 ,1]) #find matching probes
13 if(length(matchingProbes1) != nrow(cbinded) | length(matchingProbes2)
!= nrow(objects [[n]])) warn <-TRUE #set warn to TRUE if differing
numbers of probes
14 cbinded <-cbinded[matchingProbes1 ,] #get matching probes
15 cbinded$ratios <-as.matrix(cbind(cbinded$ratios ,objects [[n]][
matchingProbes2 ,]$ratios)) #join ratios with identical IDs
16 cbinded$status <-c(cbinded$status ,objects [[n]]$status) #join statuses
17 }
18 }
19 if(warn) warning("Differing arrayData lengths: non -matching probes removed
", call. = FALSE) #warning message if probes have been removed
20 return(new("arrayData",cbinded)) #return data
21 }
The function first stores all separate arrayData objects in a list (L4), gets
the grid name from the first object (L5) and initialises a new object to store
the results (L6). The warning state is set to FALSE (L7). A loop is initiated
starting at the second object if more than one is provided (L8–9). Grid names
are compared to the first object and the function stopped with a message if
they do not match (L10). Probes common to both objects are maintained
and the warning state set to TRUE if any are removed (L11–14). The ratio
values and statuses are then combined (L15–16). A warning is printed if the
warning state is TRUE (L19) and the processed object returned (L20).
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3.2.5 Displaying data
The arrayData object format provides a method of storing ChIP-chip data,
but is not well suited to displaying this in a meaningful way. Therefore the
dim, show and summary methods have been defined for this object, to enable
useful information to be quickly accessed without any processing required by
the user (Script 3.12). The dim method returns dimensions of an object, that
is, numbers of rows and columns. Dimensions of an arrayData object are
taken from the ratios matrix. Therefore an object containing 5 datasets of
1,000 probes will be deemed to have 1,000 rows and 5 columns.
Script 3.12: Displaying arrayData objects: 1. Script to calculate the di-
mensions of an arrayData object, taken from the ratios slot. Therefore the
number of rows is the number of probes and the number of columns is the
number of datasets. 2. Script to print details of an arrayData object to the R
console using the show method. Displays data names, normalisation statuses
and the number of probes. 3. Script to print a summary of an arrayData
object to the R console using the summary method. Displays grid name,
probe and dataset counts, annotation names, file names and probe statistics.
1 ## arrayData dim function ##
2 ## arguments: x (an arrayData object)
3 setMethod("dim", "arrayData", function(x) { #define function
4 return(dim(x$ratios)) #dimensions relate to ratios
5 }
6 )
7 ## arrayData show function ##
8 ## arguments: object (an arrayData object)
9 setMethod("show", "arrayData", function(object) { #define function
10 message("An arrayData object containing:") #print message
11 for (n in 1: length(colnames(object$ratios))) { #loop through datasets
12 message(paste("\t",colnames(object$ratios)[n])) #print data name
13 message(c("\t\tNormalisation procedures: ",paste(object$status [[n]],
collapse="->"))) #print data status
14 }
15 message("Number of probes:") #print message
16 message(paste("\t",nrow(object))) #print the number of probes
17 }
18 )
19 ## arrayData summary function ##
20 ## arguments: object (an arrayData object)
21 setMethod("summary", "arrayData", function(object) { #define the method
22 message("Summary of arrayData object") #print message
23 arraySummary <-data.frame (1) #initialise data frame
24 arraySummary [1,1] <-object [[4]] #get grid name
25 arraySummary [2,1] <-nrow(object) #get number of probes
26 arraySummary [3,1] <-ncol(object) #get number of datasets
27 rownames(arraySummary)<-c("Grid","Probes","Datasets") #name rows
28 colnames(arraySummary)<-"" #blank column names
29 annos <-matrix(colnames(object$annotations),nrow =1) #get annotations
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30 rownames(annos)<-"" #blank row names
31 colnames(annos)<-1: length(colnames(object$annotations)) #name columns
32 chrSummary <-matrix(ncol=7,nrow=length(unique(object [[1]][ ,1]))) #
initialise matrix
33 colnames(chrSummary)<-c("Chromosome","Number of probes","Lowest coordinate
","Highest coordinate","Lowest ratio","Highest ratio","NA values") #
name columns
34 chrSummary [,1]<-sort(( unique(object [[1]][ ,1]))) #get chromosomes
35 rownames(chrSummary)<-chrSummary [,1] #name rows
36 files <-matrix(colnames(object$ratios),nrow =1) #get data names
37 rownames(files)<-"" #blank row names
38 colnames(files)<-1: length(colnames(object$ratios)) #name columns
39 for (n in 1: length(chrSummary [,1])) { #loop through chromosomes
40 data <-which(object [[1]][ ,1] == chrSummary[n,1]) #get chromosome data
41 chrSummary[n,2] <-length(data) #number of probes
42 chrSummary[n,3] <-min(object [[1]][ data ,2]) #min coordinate
43 chrSummary[n,4] <-max(object [[1]][ data ,3]) #max coordinate
44 chrSummary[n,5] <-min(object [[3]][ data ,],na.rm=T) #min ratio
45 chrSummary[n,6] <-max(object [[3]][ data ,],na.rm=T) #max ratio
46 chrSummary[n,7] <-length(which(is.na(object [[3]][ data ,]))) #NA count
47 }
48 summaryList <-list(Summary=arraySummary ,Annotations=annos ,Files=files ,
Chromosomes=chrSummary [,-1]) #create list
49 return(summaryList) #return summary data
50 }
51 )
The dim method returns the dimensions of the ratio component of an arrayData
object (L4). The show method (L9) prints a series of messages showing the
names of datasets (L12), the normaliation procedures applied (L13) and the
number of probes (L16). The summary method (L21) compiles a series of
information. A data frame is created (L23) containing the grid name (L24),
number of probes (L25) and number of datasets (L26). A matrix is created
(L29) to store the names of the annotation columns (L31). A second matrix
is created (L32–38) to store chromosomes. Statistics for each chromosome
are calculated (L39-47), all information combined in a list (L48) and returned
to the user (L49).
The show method is used to print an object to the R console (an example
is shown in Figure 3.4). Unspecified, the whole object would be printed,
which is not useful for the large arrayData objects. Therefore the show
method was adapted to print a series of useful information about the object.
For each dataset the name and normalisation status is shown along with the
total number of probes in the dataset. All of the data within the object can
still be accessed by a user if required, using the dollar ($) notation.
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Figure 3.4: Output of arrayData show method: Exemplified with Abf1 bind-
ing datasets (see Chapter 7). The names of the datafiles, their normalisation
states and the total number of probes in the dataset are shown.
111
CHAPTER 3 SECTION 3.2
The summary method provides a summary of the data in an object (an
example is shown in Figure 3.5). This returns more information than the
show command. Four sets of information are gathered into a list. By default
this is printed to the R console, but can be manipulated to access the data
within it. The first slot contains a summary of the object, showing the grid
name and the number of probes and datasets. The second shows the names of
the annotations, which will show if any additional columns are present. The
third shows the names of all of the data files in the object. The last shows
statistics on the probe coordinates and ratios, showing, for each chromosome,
a count of the number of probes, the coordinate range, the ratio range and
the number of NA values present.
3.2.6 Plotting data
As well as displaying data on the R console, several functions have been
written to plot arrayData object ratios in various ways. This allows patterns
or other aspects of data to be visualised and identified, which may not be
possible from viewing the data alone.
3.2.6.1 Genome plots
Genome plots allow arrayData object ratios to be plotted against their re-
spective genomic positions (Script 3.13). This creates a graph with genome
position on the x axis and ratio values on the y axis. This plots either data
over a specified range or the whole dataset, which automatically creates a
new PDF file to store the plots.
Plots are produced as several sub-plots across rows on a page. The num-
ber of rows per page and the length of the region in each of these can be set
by the user. The default shows the first chromosome over four rows. Multiple
sets of arrayData ratios can be plotted on the same page as individual sub-
plots, allowing data from different regions or different datasets to be plotted
together. The function has the following arguments:
object An arrayData object to be plotted (no default). Each dataset is
plotted as a separate line.
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Figure 3.5: Output of arrayData summary method: Exemplified with Abf1
binding datasets (see Chapter 7). The first part (Summary) show the grid
name, number of probes and number of datasets. The second part (Anno-
tations) show the names of annotation data. The third part (Files) shows
the names of the datasets. The fourth part (Chromosomes) shows probe and
log2 ratio information for each chromosome.
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annotationData A genomeAnnotation object used to plot annotations along
the genome (no default).
chr A numeric vector specifying the chromosome number of data to plot
when the whole genome is not being plotted (default 1).
from A numeric vector specifying the position to start plotting when the
whole genome is not being plotted (defaults to the minimum value of
the chromosome, rounded down to the nearest thousand).
to A numeric vector specifying the position to stop plotting when the whole
genome is not being plotted (defaults to the maximum value of the
specified chromosome, rounded upwards to the nearest thousand).
rows A numeric vector specifying the number of sub-plots to create on each
page (default 4).
size A numeric vector specifying the length of the region to plot in each sub-
plot (default 100,000; changes to the total plot region (“to” coordinate
minus “from” coordinate) divided by the number of rows to plot when
the whole genome is not being plotted).
ylab A character vector specifying the y-axis label (default “log2 binding”).
wholeGenome A logical value indicating whether or not to plot the whole
genome (default FALSE).
fileName Character vector specifying the name of the PDF file to create
when “wholeGenome” is set to TRUE (default “plot.pdf”).
paper Character vector specifying the page size of the PDF file to create
when “wholeGenome” is set to TRUE (default “a4”).
width Numeric vector specifying the plot width of the PDF file to create
when “wholeGenome” is set to TRUE (default 7).
height Numeric vector specifying the plot height of the PDF file to create
when “wholeGenome” is set to TRUE (default 15).
constantMinMax A logical value indicating whether or not to maintain
the same y-axis limits on all subplots (default TRUE).
ylim A numeric vector specifying the limits of the y-axis (defaults to the
overall range of the data if “constantMinMax” is TRUE, otherwise is
calculated from the values of each subplot).
geneColour A character or numeric vector specifying the colour to fill boxes
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representing ORFs, passed to the genomeAnnotation plot function (de-
fault “yellow”).
geneBorder A character or numeric vector specifying the colour of the bor-
der of boxes representing ORFs, passed to the genomeAnnotation plot
function (default “orange”).
cols Character or numeric vector specifying the colours to plot each line for
each dataset (defaults to standard R colours).
alpha A numeric vector specifying the alpha (transparency) value for each
line (no default).
highlightProbes A matrix containing the names of probes to highlight,
passed to the genomeAnnotation plot function (no default).
highlightRegions A matrix containing coordinates of regions to highlight,
passed to the genomeAnnotation plot function (no default).
geneNames A logical value indicating whether to print gene names on the
plots, passed to the genomeAnnotation plot function (default TRUE).
muti A 5 column matrix specifying the details for plotting multiple datasets
or regions on different rows of the same graph (no default). Con-
tains chromosome numbers, start and end coordinates and arrayData
dataset number ranges. All datasets to be plotted are specified as the
“object” argument and the matrix specifies the data for each plot.
geneNameCutoff A numeric vector specifying the length of a gene name
over which the name is printed in a smaller font size (default 1).
lab.adjust A numeric vector to adjust the position of plot labels when using
“multi” (no default).
type A character vector specifying the plot type to create (default “l”).
Script 3.13: plot arrayData: script to plot arrayData object ratios values
against their coordinates. Each set of ratios is displayed as a separate line.
1 ## plot (arrayData) function ##
2 ## arguments: object (an arrayData object), annotationData (a genomeData
object), chr (chromosome to plot), from (coordinate to plot from), to (
coordinate to plot to), size (length of each plot region), rows (number
of rows per page), ylab (y acis label), wholeGenome (TRUE/FALSE),
constantMinMax (TRUE/FALSE), ylim (y axis limits), geneColour (colour of
gene boxes), geneBorder (colour of gene box borders), cols (colours of
lines), geneValues (values to plot), fileName (name of PDF file), paper
(PDF paper size), width (PDF plot width), height (PDF plot height),
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alpha (colour transparency), highlightProbes (probes to highlight),
highlightRegions (coordinates of regions to highlight), geneNames (names
of genes to highlight), multi (matrix specifying multiple data to plot)
, geneNameCutoff (small font limit), lab.adjust , type (type of plot)
3 plot.arrayData <-function(object ,annotationData ,chr=1,from=0,to=240000 , size
=60000 , rows=4,ylab="log2 Binding",wholeGenome=F,constantMinMax=T,ylim ,
geneColour="yellow",geneBorder="grey",cols ,geneValues ,filename="plot.pdf
",paper="a4r",width=15, height=7,alpha ,highlightProbes ,highlightRegions ,
geneNames=TRUE ,multi ,geneNameCutoff =1,lab.adjust =10,type="l" ,...) { #
define function
4 on.exit(layout (1)) #reset plot layout on exit
5 if(!missing(multi)) { #multi is provided
6 if(!is.matrix(multi)) stop("multi must be a matrix",call.=F) #check
format
7 rows <-nrow(multi) #set row value as number in multi
8 wholeGenome <-FALSE #set not to plot whole genome
9 }else{
10 if(!missing(from) & !missing(to)) if (from > to) stop("\’from\’ must be
greater than \’to\’") #check provided coordinates
11 }
12 maxYValue <-minYValue <-F #set FALSE max and min Y values
13 if(missing(alpha)) alpha <-255 #define alpha value
14 if (missing(cols)) { #no colours provided
15 cols <-1:nrow(object) #define colours
16 }
17 if (!missing(geneValues)) { #gene values provided
18 if (constantMinMax) { #constant min/max values required
19 geneValues <-rbind(c(NA,max(as.numeric(geneValues [,2]),na.rm=T)),
geneValues) #find maximum gene value
20 geneValues [2: nrow(geneValues) ,2]<-(as.numeric(geneValues [2: nrow(
geneValues) ,2])/max(as.numeric(geneValues [2: nrow(geneValues) ,2]),
na.rm=T))*geneValues [1,2] #scale gene values to log2 ratios
21 }
22 }
23 if(!missing(highlightRegions)) highlightRegions <-matrix(ncol=3,as.numeric(
highlightRegions)) #format highlightRegions
24 if(wholeGenome) { #the whole genome is to be plotted
25 plot.all <-object #get all data
26 on.exit(dev.off()) #shut down graphics when function exits
27 pdf(filename ,paper=paper ,width=width ,height=height) #create PDF to store
whole geneome plot
28 }else{ #the whole genome is not to be plotted
29 op<-par(no.readonly = TRUE) #get current par
30 on.exit(par(op)) #reset par on exit
31 if(!missing(multi)) { #multi is provided
32 plot.all <-object #get all data
33 }else{ #multi is not provided
34 if(missing(from)) {
35 from <-floor(object$coordinates[object$coordinates [,1] == chr ,2][1]/
1000)*1000 #calculate lower plot boundary
36 to<-ceiling(object$coordinates[object$coordinates [,1] == chr ,3][
length(which(object$coordinates [,1] == chr))]/1000)*1000 #
calculate upper plot boundary
37 }
38 if(missing(size)) size <-ceiling (((to-from)/rows)/1000)*1000 #calculate
size
39 region <-which(object$coordinates [,1] == chr & object$coordinates [,2]
>= from & object$coordinates [,3] <= to) #find data to plot
40 if(length(region) == 0) stop("No data to plot", call.=F) #stop if no
data in range
41 r1<-min(region) #get lowest data point
42 r2<-max(region) #get highest data point
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43 if(r1 > 1) if(object$coordinates[r1 ,1] == object$coordinates [(r1 -1)
,1]) r1<-(r1 -1) #reduce lowest data point if same chromosome
44 if(r2 < nrow(object)) if(object$coordinates[r2 ,1] == object$
coordinates [(r2+1) ,1]) r2<-(r2+1) #increase highest data point if
same chromosome
45 plot.all <-object[r1:r2 ,] #get data to plot
46 }
47 if(nrow(plot.all) == 0) stop("No data to plot", call.=F) #stop if no
data in range
48 }
49 plan <-matrix(ncol=3,nrow =0) #create matrix to store plot details
50 allChrs <-unique(plot.all$coordinates [,1]) #get unique chromosomes
51 if (length(allChrs) == 0) allChrs <-chr #get chromosome number
52 for (currentChr in allChrs) { #loop through chomosomes
53 min.value <-max.value <-1
54 if (wholeGenome) { #the whole genome is to be plotted
55 from <-0 #set start point
56 to<-max(plot.all$coordinates[which(plot.all$coordinates [,1] ==
currentChr) ,3]) #set end point
57 }
58 if(!missing(multi)) { #multi provided
59 plan <-multi #get plan from multi
60 }else{ #multi not provided
61 plan.froms <-seq(from ,to,size) #get all from points for plot
62 plan.froms <-plan.froms[!plan.froms==to] #remove from = to point
63 plan.tos <-plan.froms+size #get all to points for plot
64 plan.chrs <-rep(currentChr ,length(plan.froms)) #get chromosome numbers
65 plan.chr <-cbind(plan.chrs ,plan.froms ,plan.tos) #join all together
66 plan <-rbind(plan ,plan.chr) #add to plan
67 }
68 }
69 if (constantMinMax) { #constant min/max required
70 minYValue <-min(plot.all$ratios ,na.rm=T) #get min ratio
71 maxYValue <-max(plot.all$ratios ,na.rm=T) #get max ratio
72 }
73 if (!missing(ylim)) { #ylim is defined
74 minYValue <-ylim [1] #set min value
75 maxYValue <-ylim [2] #set max value
76 }
77 mat <-matrix(ncol=3,nrow=rows) #initialise matrix for layout
78 column <-1 #set column to 1
79 for (m in c(1,2,1)) { #loop to create layout
80 mat[,column]<-seq(m,by=2,length.out=rows) #get layout values
81 column <-column +1 #increase column by 1
82 }
83 mat <-matrix(t(mat),ncol=1,byrow=F) #transpose mat
84 layout(mat ,height=c(rep(c(0 ,0.75 ,0.25),rows))) #define layout
85 for (p in 1:nrow(plan)) { #loop through rows of plan
86 if(!missing(multi)) { #multi provided
87 size <-multi[p,3]-multi[p,2] #calculate size based on multi
88 }
89 whichData <-which(plot.all$coordinates [,1] == plan[p,1] & plot.all$
coordinates [,2] >= plan[p,2] & plot.all$coordinates [,3] <= plan[p
,3]) #get data
90 if (!missing(annotationData)) currentAnnotationData <-annotationData[
which(annotationData$coordinates [,1] == plan[p,1] & annotationData$
coordinates [,3] >= plan[p,2] & annotationData$coordinates [,2] <=
plan[p,3])] else currentAnnotationData <-new("genomeAnnotation",list(
coordinates=matrix(nrow=0,ncol =1),annotations="",dataset="")) #get
annotation data for region or set as empty
91 if(length(whichData) <= 1) { #no/one probes in region
92 less <-plot.all[plot.all$coordinates [,1] == plan[p,1] & plot.all$
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coordinates [,3] <= plan[p,3],] #find probes below plot region
93 greater <-plot.all[plot.all$coordinates [,1] == plan[p,1] & plot.all$
coordinates [,2] >= plan[p,2],] #find probes above plot region
94 if (nrow(less) == 0) less <-plot.all[1,] #set lowest point if not found
95 if (nrow(greater) == 0) greater <-plot.all[nrow(plot.all) ,] #set
highest point if not found
96 whichData <-c(which(plot.all$annotations [,1] == less$annotations[which.
min(plan[p,2] - less$coordinates [,3]) ,1]),which(plot.all$
annotations [,1] == greater$annotations[which.min(greater$
coordinates [,2] - plan[p,3]) ,1])) #define which data
97 }
98 min.value <-min(whichData) #get min probe
99 max.value <-max(whichData) #get max probe
100 if (min.value > 1) { #first probe is above 1
101 if (plot.all$coordinates[min.value -1,1] == plot.all$coordinates[min.
value ,1]) { #previous probe on same chromosome
102 min.value <-min.value -1 #include previous value
103 }
104 }
105 if (max.value < nrow(plot.all)) { #last probe is before the end probe
106 if (plot.all$coordinates[max.value +1,1] == plot.all$coordinates[max.
value ,1]) { #next probe on same chromosome
107 max.value <-max.value+1 #include next probe
108 }
109 }
110 if(!missing(multi)) { #multi is provided
111 plot.current <-plot.all[plot.all$coordinates [,1] == multi[p,1] & plot
.all$coordinates [,2] >= multi[p,2] & plot.all$coordinates [,3] <=
multi[p,3],multi[p,4]: multi[p,5]] #get data to plot based on
multi
112 }else{ #multi is not provided
113 plot.current <-plot.all[min.value:max.value ,] #arrayData taken from
plan
114 }
115 if(length(whichData) > 0) probePositions <-rowMeans(matrix(ncol=2,plot.
current$coordinates [ ,2:3])) #get probe middles
116 if (!missing(highlightProbes)) { #probes are to be highlighted
117 highlightProbes.current <-which(highlightProbes %in% plot.current$
annotations [,1]) #find probes to be highlighted
118 if(length(highlightProbes.current) > 0 ) { #probes are to be
highlighted in the current plot
119 highlightProbes.current <-rowMeans(matrix(plot.current[
highlightProbes[highlightProbes.current],]$coordinates [,2:3],
ncol =2)) #get positions of probes to highlight
120 }else{ #probes are not to be highlighted in the current plot
121 highlightProbes.current <-NULL #set as NULL
122 }
123 }else{ #no probes to be highlighted
124 highlightProbes.current <-NULL #set as NULL
125 }
126 if (!missing(highlightRegions)) { #ranges to be highlighted
127 highlightRegions.current <-matrix(highlightRegions[which(
highlightRegions [,1] == plan[p,1] & highlightRegions [,2] >= plan
[p,2] & highlightRegions [,3] <= plan[p,3]) ,],ncol =3) #get ranges
to be highlighted
128 }else{ #no ranges to be highlighted
129 highlightRegions.current <-NULL #set as NULL
130 }
131 if (!constantMinMax) { #not constant min/max values
132 minYValue <-min(plot.current$ratios ,na.rm=T) #get min ratio value
133 maxYValue <-max(plot.current$ratios ,na.rm=T) #get max ratio value
134 }else{ #constant min/max values
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135 minYValue <-min(plot.all$ratios ,na.rm=T) #get min ratio value
136 maxYValue <-max(plot.all$ratios ,na.rm=T) #get max ratio value
137 }
138 if (!missing(ylim)) { #ylim is defined
139 minYValue <-ylim [1] #set min value
140 maxYValue <-ylim [2] #set max value
141 }
142 par(mar=c(1,5,1,2),bty="n") #set plot for annotation
143 plot(currentAnnotationData ,plan[p,1],plan[p,2],plan[p,3], probePositions ,
geneColour ,geneBorder ,constantMinMax ,geneValues ,highlightProbes.
current ,highlightRegions.current ,geneNames ,geneNameCutoff=
geneNameCutoff) #plot annotation data
144 par(mar=c(1,5,2,2),bty="n",mgp=c(1.75 ,1 ,0)) #set plot for ratios
145 plot(1,1,type="n",xlim=c(plan[p,2],plan[p,3]),ylim=c(minYValue ,maxYValue
),xaxs="i",yaxs="i",xlab="",ylab=ylab ,xaxt="n",yaxt="n") #initialise
plot
146 abline(h=0,lty=2,col="lightgrey") #add zero line
147 for (a in 1:ncol(plot.current)) { #loop through datasets
148 startWarn <-as.numeric(options("warn")); on.exit(options(warn=startWarn
)) #get current warning state and maintain on exit
149 options(warn=-1) #don ’t warn about NA values
150 if (!is.na(cols[a]) & !is.null(plot.current)) { #data is to be plotted
151 if (length(whichData) > 1) { #there is data to plot in the range
152 points(approx(rowMeans(matrix(plot.current$coordinates [,2:3],ncol
=2)),plot.current$ratios[,a],xout=rowMeans(matrix(plot.current
$coordinates [,2:3],ncol =2))),col=rgb(matrix(ncol=3,col2rgb(
cols[a])),max=255, alpha=alpha),type=type ,...) #plot data
153 }else{ #there is no data to plot in the range
154 points(sum(matrix(plot.current$coordinates [,2:3], ncol =2))/2,plot.
current$ratios[,a],col=rgb(matrix(ncol=3,col2rgb(cols[a])),max
=255, alpha=alpha),pch=19,cex =0.5) #plot extended probes
155 }
156 }
157 options(warn =0) #reset warnings
158 }
159 if(!missing(multi)) { #multi is provided
160 mtext(LETTERS[p],side=3,at=plan[p,2]-( size/lab.adjust),las =1.75 ,cex
=1.5) #print letters if multiple plots
161 }
162 axis(2,tcl=-0.3,padj =0.8) #format axis
163 axis(3,tcl=-0.3,padj=1,line =0.5) #format axis
164 }
165 }
The function first ensures the plot is reset when it exits (L4). Then checks
are performed and a series of parameters set and configured, based on the
arguments provided, in order to correctly plot the data (L5–23). If the whole
genome is not to be plotted the specified subset is extracted, extending the
data by one upwards and downwards if on the same chromosome (L43–44),
otherwise all data is kept and a PDF initiated (L24–48). A “plan” is created,
detailing the data to plot on each row of the display (L49–68). y-axis limits
are set (L69–76) and the plot layout defined (L77–84). A loop for each row
of the plan is initiated (L85). The plot size is created dynamically with
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“multi” (L86–88). Data for the current region is identified (L89) along with
the annotation data, if required (L90). If no or one probes are present in the
range to be plotted (L91), this is redefined to include the previous and next
probes (L92–97).
The data range is then found (L98–99). Data extending out from the
plot region are specified (L100–109) which allows the plots to extend to
the edges of their regions. The data to be plotted is extracted (L110–114)
and probe positions calculated (L115). Probes (L116–125) and ranges to be
highlighted (L126–130) are identified. Plot y-axis limits are defined (L131–
141). Plot margins are defined (L142) and the genomeAnnotation data plot
is created (L143), showing ORF information where provided. Plot margins
are defined (L144) and the arrayData plot is initialised (L145–146). Data
for each dataset is plotted in a loop (L147–158) with warnings for NA values
disabled. Letters are printed at the edge of “multi” plots (L159–161). Finally,
axes are added to the plots (L162–163).
A genomeAnnotation object can also be specified, which adds extra in-
formation to the plots. This is carried out by the genomeAnnotation plot
method (Script 3.14). This plots a line representing the genome, showing all
ORFs over the given region as boxes indicating the direction of transcription.
Gene names, taken from the gene name column of the genomeAnnotation
annotations matrix, can optionally be displayed over each ORF. Addition-
ally, this function indicates the position of each probe in the genome with a
grey dot. Particular probes can be highlighted, with the addition of a red
cross. Regions can also be highlighted, with the addition of a coloured box
covering the region of the genome. The function has the following arguments,
all of which are specified by the arrayData plot function and so none have
defaults.
object The genomeAnnotation object to be plotted.
chr A numeric vector specifying the current chromosome number.
from A numeric vector specifying the current start coordinate.
to A numeric vector specifying the current end coordinate.
arrayProbes A numeric vector specifying the positions of probes to plot.
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geneColour A character or numeric vector specifying the colour to fill boxes
representing ORFs.
geneBorder A character or numeric vector specifying the colour of the bor-
der of boxes representing ORFs.
constantMinMax A logical value indicating whether or not to maintain
the same y-axis limits on all subplots.
highlightProbes A matrix containing the names of probes to highlight on
the plots.
highlightRanges A matrix containing coordinates of regions to highlight
on the plots.
geneNames A logical value indicating whether or not to print gene names
on the plots.
geneNameCutoff A numeric vector specifying the length of a gene name
over which the name not printed.
Script 3.14: plot genomeAnnotation: script to plot genomeAnnotation object
annotations within the arrayData plot function. ORFs and probe positions
are plotted.
1 ## plot (genomeAnnotation) function ##
2 ## arguments: object (a genomeAnnotation object), chr (chromosome number),
from (from coordinate), to (to coordinate), arrayProbes (probe positions
), geneColour (colour of gene boxes), geneBorder (colour of gene box
borders), constantMinMax (whether or not constantMinMax), geneValues (
values to plot gene bars), highlightProbes (probes to highlight),
highlightRanges (ranges to highlight), geneNames (names of genes),
geneNameCutoff (gene name length cutoff)
3 plot.genomeAnnotation <-function(object ,chr ,from ,to,arrayProbes ,geneColour="
yellow",geneBorder="orange",constantMinMax ,geneValues ,highlightProbes ,
highlightRanges ,geneNames=TRUE ,geneNameCutoff =0) { #define function
4 plot(1,1,type="n",xlim=c(from ,to),ylim=c(-1,8),xlab="",ylab="",xaxt="n",
yaxt="n",xaxs="i") #initialise plot
5 grid(nx=NULL ,ny=0,lty=2) #add grid
6 if(nrow(object) > 0) { #if genomeAnnotation is provided
7 square <-((to -from)/100) #calculate size of arrow section
8 y<-c(0.53 ,0.28 ,0.03 ,0.03 ,0.53) #set y values for polygons
9 textCentre <-0.2 #set the centre point for gene names
10 genes.U.labels <-genes.L.labels <-matrix(ncol=4,nrow =0) #initialise
matrices to store labels for upper and lower strands
11 genes.U<-object[which(object [[2]][ ,3] == " 1")] #get upper strand genes
in range
12 genes.L<-object[which(object [[2]][ ,3] == "-1")] #get lower strand genes
in range
13 if (nrow(genes.U) > 0) { #if genes are present on the upper strand
14 genes.U.labels <-matrix(ncol=3,nrow=nrow(genes.U)) #initialise matrix to
store labels
15 for (n in 1:nrow(genes.U)) { #loop through genes
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16 left <-genes.U[[1]][n,2] #get left hand (start) value
17 right <-genes.U[[1]][n,3]- square #get box end value
18 point <-genes.U[[1]][n,3] #get right hand (end) value
19 if (right <left) {right <-left} #set box end as start if it goes
beyond the start
20 x<-c(right ,point ,right ,left ,left) #set x values for polygon
21 polygon(x,y,col=geneColour ,bor=geneBorder) #plot the current gene
22 genes.U.labels[n,1] <-(left+point)/2 #get the middle of the gene
23 genes.U.labels[n,2] <-0.6 #set the font size
24 if (nchar(genes.U[[2]][n,1]) > 6) genes.U.labels[n,2] <-0.4 #reduce
the font size for long gene names
25 if(point - left > geneNameCutoff) genes.U.labels[n,3] <-genes.U[[2]][
n,1] #set the gene name
26 }
27 }
28 if (nrow(genes.L) > 0) { #if genes are present on the lower strand
29 genes.L.labels <-matrix(ncol=3,nrow=nrow(genes.L)) #initialise matrix
to store labels
30 for (n in 1:nrow(genes.L)) { #loop through genes
31 right <-genes.L[[1]][n,3] #get right hand (start) value
32 left <-genes.L[[1]][n,2]+ square #get box end value
33 point <-genes.L[[1]][n,2] #get left hand (end) value
34 if (right <left) {left <-right} #set box end as start if it goes
beyond the start
35 x<-c(left ,point ,left ,right ,right) #set x values for polygon
36 polygon(x,-y,col=geneColour ,bor=geneBorder) #plot the current gene
37 genes.L.labels[n,1] <-(right+point)/2 #get the middle of the gene
38 genes.L.labels[n,2] <-0.6 #set the font size
39 if (nchar(genes.L[[2]][n,1]) > 6) genes.L.labels[n,2] <-0.4 #reduce
the font size for long gene names
40 if(right - point > geneNameCutoff) genes.L.labels[n,3] <-genes.L
[[2]][n,1] #set the gene name
41 }
42 }
43 if(geneNames) { #show gene names
44 if (nrow(genes.L.labels) > 0) { #if there are genes on the lower
strand to be labelled
45 text(as.numeric(genes.L.labels [,1]) ,-0.2,labels=genes.L.labels[,3],
cex=as.numeric(genes.L.labels [,2]),srt=-30,pos=4,offset =0) #add
the gene name text
46 }
47 if (nrow(genes.U.labels) > 0) { #if there are genes in the upper
strand to be labelled
48 text(as.numeric(genes.U.labels [,1]) ,0.2,labels=genes.U.labels[,3],
cex=as.numeric(genes.U.labels [,2]),srt=-30,pos=2,offset =0) #add
the gene name text
49 }
50 }
51 if (!missing(geneValues)) { #geneValues are provided
52 labels <-at<-pretty (0:as.numeric(geneValues [1 ,2])) #define labels
53 axis(4,tcl=-0.3,padj=-0.8, labels=labels ,at=labels*(8/as.numeric(
geneValues [1,2]))) #add axis
54 mtext("Gene Value", side=4, line=2,cex =0.7) #label axis
55 currentGeneValues <-matrix(geneValues[which(geneValues [,1] %in% object
[[2]][ ,1]) ,],ncol =2) #get gene values
56 if (!constantMinMax) { #not constant min max
57 currentGeneValues <-rbind(c(NA,max(as.numeric(currentGeneValues [,2]),
na.rm=T)),currentGeneValues) #get values
58 currentGeneValues [2: nrow(currentGeneValues) ,2]<-(as.numeric(
currentGeneValues [2: nrow(currentGeneValues) ,2])/max(as.numeric(
currentGeneValues [2: nrow(currentGeneValues) ,2]),na.rm=T))*8
59 currentGeneValues <-currentGeneValues [2: nrow(currentGeneValues),]
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60 }
61 if(length(currentGeneValues != 0)) { #some values are present
62 for (g in 1:nrow(currentGeneValues)) { #loop through values
63 rect(object [[1]][ which(object [[2]][ ,1] == currentGeneValues[g,1])
,2],0,object [[1]][ which(object [[2]][ ,1] == currentGeneValues[g
,1]) ,3],as.numeric(currentGeneValues[g,2]),col=rgb
(0.3 ,0.3 ,0.3 , alpha =0.5) ,bor=NA) #add rectangles
64 }
65 }
66 }
67 }
68 if (!is.null(highlightRanges)) rect(highlightRanges [,2],rep(-0.25,nrow(
highlightRanges)),highlightRanges [,3],rep(0.25 , nrow(highlightRanges)),
bor=0,col=rgb (255 ,192 ,203 , max=255, alpha =200)) #highlight ranges
69 abline(h=0,col="grey") #add a horizintal grey line at h=0
70 if (!missing(arrayProbes)) points(arrayProbes ,rep(0,length(arrayProbes)),
pch=19,col="darkgrey",cex =0.5) #add a dot at each probe position
71 if (!is.null(highlightProbes)) points(highlightProbes ,rep(0,length(
highlightProbes)),pch=4,col="red") #add a dot at each highlighted
probe position
72 mtext(paste("Chr.",chr),side=2,las=1,line =1.75,at=0,cex =0.7) #label the
chromosome number
73 }
The arrayData plot function determines the genomeAnnotation data for
the region being plotted and passes it to this function. A plot of the correct
size is first initialised (L4) and a grid added (L5). If genome annotation
data is provided (L6) Parameters for the ORF polygons are determined (L7–
9) and matrices to store their labels created (L10). ORFs on the upper
and lower strands are separated (L11–12). For ORFs on the upper strand
(L13) the labels are extracted (L14). A loop is initialised for each (L15)
where the polygon parameters are determined (L16–20), the polygon plotted
(L21), and the gene name text parameters determined (L22–25). The same
procedure is repeated for ORFs on the lower strand (L28–42). Gene names
are added if required (L43–50). Gene values are used to add bar plots if
required (L51–66). Ranges to be highlighted are drawn (L68), a central
line added (L49) and probes drawn (L70) and highlighted (L71) if required.
Finally the chromosome name is printed (L72).
Figure 3.6 shows an example of the output of the two plot functions,
showing data plotted along a short section of chromosome 1 with examples
of the additional information that can be plotted. The arrayData plot
function creates the plot of the the data specified in the arrayData object
along with the two sets of axises. The genomeAnnotation plot creates the
representations of ORF and probe positions, highlights specified probes and
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regions
The functions are used to generate more plots shown in the following
chapters.
3.2.6.2 Histograms, density and Q-Q plots
Histograms are graphical representations of the distribution of continuous
data. They consist of a series of bars, the areas of which represent the
frequencies of data points falling into a set of discrete bins. They are useful
for visualising the distribution of a set of data and can be used to estimate an
underlying probability density function. The existing R histogram method
was adapted to produce histograms from arrayData ratios (Script 3.15),
using the following argument:
x An arrayData object to create the histogram from (no default). Multiple
histograms are not easy to distinguish on the same graph and so only
values from the first dataset are used.
Script 3.15: arrayData histogram: script to plot a histogram of ratios from
an arrayData object.
1 ## hist (arrayDat) function ##
2 ## arguments: x (an arrayData object)
3 setMethod("hist", "arrayData", function(x,...) { #define function
4 hist(x$ratios [,1],...)
5 }
6 )
The function plots a standard histogram from the first column of the arrayData
ratios (L4).
An example histogram is shown in Figure 3.7, created from a normalised
Abf1 binding dataset, showing the skew of the data as a result of the protein
binding.
An alternative to the histogram is the kernel density plot. This uses
kernel density estimation to estimate the probability density function of a
set of data. Various kernels can be used to create this estimation. Rather
than binning data and displaying bars, as in a histogram, kernel density
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Figure 3.6: Output of arrayData plot method: Exemplified with three Abf1
binding datasets (see Chapter 7) plotted over a short section of chromosome
1. The genome coordinates are plotted along the top of the graph and the
dataset units on the left. Genome annotations are shown at the bottom
with the chromosome number printed to the left hand side. Each of the
three datasets is shown as a separate line, in this case using the default
different colours. Genes are represented with yellow shapes, with the arrow
representing the direction of transcription. Gene names are printed, those
with longer names in a smaller font size. Probe positions are represented
with grey circles and some have been highlighted, shown with red crosses. A
region has also been highlighted, shown with a pink box.
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estimation produces a curve representing the distribution of the data. This
is described further in Section 4.2.4.2.
The existing R density and plot methods were adapted to produce density
plots from arrayData ratios (Script 3.16). The density function produces the
kernel density estimate as a density class, and the plot method for this class
produces a graph showing the curve. The function plots each dataset in the
provided arrayData object as a separate line on the same graph. All kernel
density estimates are first calculated, in order to determine the x and y-axis
ranges for all data. This plot is then initialised, and each line plotted. By
default each line is given a different colour, which can be manually overridden.
The function also has the option to mirror values about zero to display a
representation of the estimated background region (see Section 4.2.4.2). The
density of all negative values, along with the positive equivalents, is added
to the plot as a red dashed line. This shows a mirror image of the section of
the density plot below zero. To this is added a standard normal curve, with
a mean of zero and standard deviation of one, as a blue dotted line. This
provides a method of visually comparing the background estimation to the
normal distribution. In this case only the first arrayData object dataset is
plotted. The function has the following arguments:
x An arrayData object to create the density plots from (no default).
cols Character or numeric vector specifying the colours to plot each line for
each dataset (defaults to standard R colours).
mirror Logical vector indicating whether or not to display mirrored esti-
mated background values and the standard normal distribution for the
first dataset (default FALSE).
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Script 3.16: arrayData density plot: script to plot a density plot of ratios from
an arrayData object. Each set of ratios is plotted as a separate line and the
axes are scaled accordingly. The densities of negative data mirrored about
zero and the standard normal distribution can also be plotted to visualise
the estimated background population.
1 ## density function ##
2 ## arguments: x (an arrayData object), cols (colours to plot lines), mirror
(whether or not to show mirror information)
3 setMethod("density", "arrayData", function(x,cols ,mirror=F,xlim ,ylim ,...) {
#define function
4 if (missing(cols)) cols <-1:ncol(x) #define colours if missing
5 if (mirror) cols <-rep(1,ncol(x)) #redefine colours if mirroring
6 xs<-ys<-list() #initialise lists to store values
7 for (n in 1:ncol(x)) { #loop through datasets
8 d<-density(x$ratios[,n],na.rm=T) #get kernel densities
9 xs<-c(xs,list(d$x)) #get x values
10 ys<-c(ys,list(d$y)) #get y values
11 }
12 if(missing(xlim)) xlim <-range(xs)
13 if(missing(ylim)) ylim <-range(ys)
14 plot(1,1,type="n",xlim=xlim ,ylim=ylim ,...) #initialise plot
15 for (n in 1:ncol(x)) { #loop through datasets
16 points(xs[[n]],ys[[n]],type="l",col=cols[n],...) #add points
17 if (mirror) { #data is to be mirrored
18 points(c(xs[[n]][xs[[n]]<=0],abs(xs[[n]][xs[[n]] <=0][ length(which(xs[[
n]] <=0)):1])),c(ys[[n]][xs[[n]]<=0],ys[[n]][xs[[n]] <=0][ length(
which(xs[[n]] <=0)):1]),type="l",lty=2,col="red" ,...) #add mirrored
points
19 norm <-dnorm(c(xs[[n]][xs[[n]]<=0],abs(xs[[n]][xs[[n]] <=0][ length(which
(xs[[n]] <=0)):1]))) #get normal distribution
20 norm <-norm * max(ys[[n]][xs[[n]] <=0])/max(norm) #scale norm
21 points(c(xs[[n]][xs[[n]]<=0],abs(xs[[n]][xs[[n]] <=0][ length(which(xs[[
n]] <=0)):1])),norm ,col="blue",type="l",lty =3) #plot normal curve
22 }
23 }
24 }
25 )
The function first defines the plot colours if not specified (L4) or the data
is to be mirrored (L5). Lists are created to store the x and y density values
(L6) and a loop through datasets initialised (L7) where the kernel densities
are calculated (L8–10). Axis limits are set if required (L12–13). A plot is
initialised with limits based on the density values (L14). A second loop of
datasets is initialised (L15) and the density lines plotted (L16). If data are
to be mirrored the mirror and standard normal representation line are added
(L17–22).
An example density curve is shown in Figure 3.7, created from a nor-
malised Abf1 binding dataset, showing the skew of the data as a result of the
protein binding.
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Quantile-quantile (Q-Q) plots are a means of graphically comparing two
distributions. Quantiles of the two distributions are calculated and displayed
as points, each representing one quantile from the first distribution (on the
y axis) and the same quantile in the second distribution (on the x axis). A
QQ-line can be added to the plot to represent equal distributions. If the
points fall on this line the two distributions are equal. The R qqnorm and
qqplot methods were adapted to display arrayData object ratio quantiles
against normal distribution quantiles or another set of arrayData ratios
respectively (Script 3.17). The qqline method was adapted to show the
line representing identical distributions. This plots only the first dataset in
the provided arrayData object(s).
The same mirror option as the density function is also included in the
qqnorm and qqline functions, providing another method of comparing the
estimated background distribution to the normal distribution.
The functions have the following arguments:
y An arrayData object specifying the first set of values to create the Q-Q
norm, Q-Q plot or Q-Q line from (no default).
mirror Logical vector indicating whether or not to display mirrored esti-
mated background value Q-Q norm or Q-Q line (default FALSE).
x An arrayData object specifying the second set of values to create the Q-Q
plot or Q-Q line from (no default; optional for Q-Q line, if left blank
uses standard normal values).
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Script 3.17: arrayData Q-Q plot: scripts to create Q-Q plots with arrayData
objects. Q-Q norm plots ratios against a normal distribution, Q-Q plot plots
two sets of ratios against each other and Q-Q line adds a Q-Q line to the plot.
The quantiles of negative data mirrored about zero can also be plotted with
Q-Q norm and Q-Q line to visualise the estimated background population.
1 ## qqnorm function ##
2 ## arguments: y (an arrayData object), mirror (whether or not to show mirror
information)
3 setMethod("qqnorm", "arrayData", function(y,mirror=F ,...) { #define function
4 if (!mirror) { #plot all data
5 qqnorm(y$ratios [,1],...) #create QQ plot
6 }else{ #plot mirrored data
7 qqnorm(c(y$ratios[y$ratios [,1]<0,1],abs(y$ratios[y$ratios [,1]<0,1]))
,...) #create mirrored data QQ plot
8 }
9 }
10 )
11 ## qqplot function ##
12 ## Arguments: x, y (both arrayData objects)
13 setMethod("qqplot", "arrayData", function(x,y,...) { #define function
14 qqplot(x$ratios[,1],y$ratios [,1],...) #create QQ plot
15 }
16 )
17 ## qqline function ##
18 ## Arguments: y (an arrayData object), mirror (whether or not to show mirror
information)
19 setMethod("qqline", "arrayData", function(y,x,mirror=F,...) { #define
function
20 if (missing(x)) { #single dataset
21 if (!mirror) { #plot all data
22 qqline(y$ratios [,1],...) #add QQ line
23 }else{ #plot mirrored data
24 qqline(c(y$ratios[y$ratios [,1]<0,1],abs(y$ratios[y$ratios [,1]<0,1]))
,...) #add mirrored data QQ line
25 }
26 }else{ #two datasets
27 qqline(x$ratios[,1],y$ratios [,1],...) #add QQ line
28 }
29 }
30 )
The qqnorm method (L3) plots either a Q-Q plot of the whole first column of
arrayData ratios (L5) or only those values less than zero (L7), if “mirror” is
TRUE, against normal quantiles. The qqplot method (L13) plots a Q-Q plot
of the first columns of two arrayData objects (L14). The qqline method
(L19) adds a Q-Q line with a single arrayData object (L20) against normal
quantiles using the first set of ratios (L22) or only those less than zero (L24)
if “mirror” is TRUE, or using two arrayData objects (L27).
An example normal Q-Q plot is shown in Figure 3.7, created from a
normalised Abf1 binding dataset, showing the data do not follow a normal
distribution. A mirrored Q-Q plot is also shown, with a mirrored Q-Q line
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in red, showing these data do approximate a normal distribution.
3.2.6.3 Profile plots
“Profile plot” is the name given to a type of plot which overlays several
sections of ChIP-chip data on the same graph, which gives an overview of a
particular feature. The format is similar to that of the arrayData genome
plots, except that rather than continuing the plotted data as a single line
over a long distance, the data are split into defined sections and multiple lines
representing these are ‘piled up’ on top of each other over a short distance. A
trend line can be added to these to show any overall pattern in the data. The
profilePlot function (Script 3.18) allows three types of plot to be created,
plotting data over genic, intergenic and peak regions. The genic plot shows
ORFs with sections of their upstream (promoter) and downstream regions,
aligned so all run left-to-right across the plot. The intergenic plot shows the
inverse of the genic, that is, whole intergenic regions with sections of the
flanking ORFs at either side. The peak plots are centred on probes found
by the peakDetection function (Chapter 5) and show the regions flanking
these. Gene data is taken from a genomeData object and peak data from a
peakList object, created by the peakDetection function.
Plotting a single dataset has the option to plot all individual lines of data
and/or the trend line. Only trend lines are plotted when more than one
dataset is provided. Trend lines are calculated from a number of averaged
points, the number of which can be specified. The ends of trend lines can
sometimes become distorted if there are few data points from which to cal-
culate the average. These ends can be clipped, by specifying a cutoff based
on the fraction of data present at each point to be averaged. Standard er-
rors of the trend lines can be shown as coloured shapes. The standard error
increases with standard deviation and as fewer points are used to calculate
it, and so thicker shapes may indicate less reliable regions.
The data to be plotted can be specified in various ways, such as providing
names or size ranges of genes to plot. ORF start/end boundaries are always
aligned at the same points in genic and intergenic plots, as indicated by the
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Figure 3.7: Output of arrayData statistical graphics: Examples of a his-
togram, density curve, normal Q-Q plot and a mirrored Q-Q plot showing a
mirrored Q-Q line using one set of normalised Abf1 binding data.
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label on the y-axis. This can be achieved by either scaling or splitting the
data. Scaling can be done relative to the largest or smallest region being
plotted, maintaining the shortest line and scaling all longer lines down to
fit, or maintaining the longest line and scaling all shorter lines up to fit.
Scaling all lines down to the shortest ensures that no regions go beyond the
boundaries of the plot region. However, it can be useful to plot data in
this way in certain circumstances. Splitting allows data to be split at the
centres of ORFs. Each of the two resulting lines is aligned at the respective
boundary. In this way all lines are shown at the same scale. The function
has the following arguments:
object An arrayData object to be plotted (no default). Each dataset can
be plotted as a separate trend line or the first dataset is used to plot
all individual lines.
plotType A character vector specifying the type of plot to create; either
“genic”, “intergenic” or “peaks” (default “genic”).
annotation A genomeAnnotation object, used to specify ORF positions
when creating genic or intergenic plots (no default).
peakList A peakList object, used to specify peak positions when creating
peak plots.
showAllLines A logical vector indicating whether or not to plot all indi-
vidual lines from a single dataset (default TRUE; when more than one
dataset is provided is set to FALSE).
allLines.col A character vector specifying the colour of the (non-trend line)
lines (default rgb(0,0,0,alpha=0.5)).
showTrendLine A logical vector indicating whether or not to plot trend
lines from all provided datasets (default TRUE; when more than one
dataset is provided is reset to TRUE).
col A character or numeric vector specifying the trend line colour (defaults
to standard R colours).
lty A character or numeric vector specifying the trend line type (default 1
(solid line)).
lwd A numeric vector specifying the trend line width (default 1).
averagePoints A numeric vector specifying the number of points at which
132
SECTION 3.2 CHAPTER 3
to calculate the trend line averages (default 50).
tidy A numeric vector specifying the minimum fraction of data points to be
present to plot a trend line point (default 0).
showSEs A logical vector indicating whether or not to show standard errors
as coloured shapes around trend lines (default FALSE).
range A numeric vector specifying the size range of genes or intergenic re-
gions to include in plots (defaults 1000 and “Inf”).
geneList A character vector specifying genes (from the genomeAnnotation
object) to include in genic and intergenic plots (no default). Overrides
the “range” argument.
extend A numeric vector specifying the size of the regions to plot extending
from the gene/intergene ends or the probes at the centres of peaks
(default 1000).
keepSmallest A logical vector specifying whether to scale data relative to
the smallest or largest gene being plotted (default TRUE).
split A logical vector specifying whether to split or scale data (default
FALSE).
ylim A numeric vector specifying the y-axis limits (defaults to the data
range).
ylab A character vector specifying the y-axis label (default “Binding Value”).
main A character vector specifying the plot title (defaults to the graph type
created and the number of lines plotted or used to calculate the trend
line).
labels A character vector specifying the labels for the x-axis (defaults vary
depending on the plot type).
add A logical vector specifying whether to add the plotted lines to an exist-
ing plot or create a new plot (default FALSE).
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Script 3.18: profilePlot: script to display profiles of arrayData object data
showing genic or intergenic regions, defined by an annotationData object
properties or list of genes, or peak regions, defined with a list of probes.
1 ## profilePlot function ##
2 ## arguments: object (an arrayData object), plotType (type of plot to create
), annotation(a genomeAnnotation object), peakList (a list of probes),
geneList (a list of genes), range (range of gene sizes to plot), extend
(value to extend), showAllLines (whether to show all lines),
showTrendLine (whether to show trend lines), showSEs (whether to show
standard errors), averagePoints (number of trend line points), tidy (
tidy value), ylim (y axis limits), ylab (y axis label), main (title),
keepSmallest (whether to scale to the smallest gene), alLines.col (
colour of all lines), col (colour of trend line), lty (trend line type),
lwd (trend line width), add (whether to add to an existing plot),
labels (x axis labels), split (whether to split the data)
3 profilePlot <-function(object , plotType="genic", annotation , peakList ,
geneList , range=c(1000 ,Inf), extend =1000 , showAllLines=TRUE ,
showTrendLine=TRUE , showSEs=FALSE , averagePoints =50, tidy=0, ylim , ylab ,
main ,keepSmallest=TRUE ,allLines.col=rgb(0,0,0,alpha =0.5),col=2,lty ,lwd
,add=FALSE ,labels ,split=F) { #define function
4 if(missing(plotType)) plotType <-"genic" #plot genes if region not
specified
5 if (ncol(object) > 1) { #more than one dataset to plot
6 showAllLines <-FALSE #do not show all lines
7 showTrendLine <-TRUE #do show trend line
8 }
9 if(missing(ylab)) ylab <-"Height" #specify ylab if missing
10 if(missing(col)) col <-2:(1+ ncol(object)) #specify colours if missing
11 if(missing(lty)) lty <-rep(1,ncol(object)) #specify trend line types if
missing
12 if(missing(lwd)) lwd <-rep(2,ncol(object)) #specify trend line widths if
missing
13 if(length(col) != ncol(object)) col <-2:(1+ ncol(object)) #specify colours
if wrong number
14 if(length(lty) != ncol(object)) lty <-rep(1,ncol(object)) #specify trend
line types if wrong number
15 if(length(lwd) != ncol(object)) lwd <-rep(2,ncol(object)) #specify trend
line widths if wrong number
16 if (showSEs) lty <-lty <-rep(2,ncol(object)) #set line type if showing SEs
17 if (showSEs) tidy <-0 #set tidy value if showing SEs
18 p<-0 #set probe count to zero
19 objectChr <-object [0,] #get empty arrayData object
20 probesList <-list() #initialse list to store probes
21 allRegions <-matrix(ncol=4,nrow =0) #initialise matrix to store coordinates
22 orientations <-regionSizes <-numeric () #initialse vectors to store
orientations and gene sizes
23 for (chr in unique(annotation$coordinates [,1])) { #loop through
chromosomes
24 p<-p+nrow(objectChr) #increase probe count
25 annotationChr <-annotation[annotation$coordinates [,1] == chr] #get
current annotation
26 objectChr <-object[object$coordinates [,1] == chr ,] #get current arrayData
27 if (nrow(objectChr) == 0) next() #skip chr if no data
28 coordinates <-objectChr$coordinates #get coordinates
29 chrMax <-max(coordinates[nrow(objectChr) ,3], annotationChr$coordinates[
nrow(annotationChr) ,3]) #get max chr value
30 if (plotType == "genic") { #genic plot
31 if(missing(labels)) labels <-c(paste("-",extend ,sep=""),"Promoter","ORF
start","Inside","ORF end","Downstream",paste("+",extend ,sep=""))
#set labels if missing
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32 regions <-cbind(c(1, annotationChr$coordinates [1:( nrow(annotationChr) -1)
,3]),annotationChr$coordinates [,2:3],c(annotationChr$coordinates
[2: nrow(annotationChr) ,2],chrMax)) #get regions
33 }else if (plotType == "intergenic") { #intergenic plot
34 if(missing(labels)) labels <-c(paste("-",extend ,sep=""),"ORF","ORF
boundary","Intergenic","ORF boundary","ORF",paste("+",extend ,sep="
")) #set labels if missing
35 regions <-cbind(c(1, annotationChr$coordinates [,2]),c(1, annotationChr$
coordinates [,3]),c(annotationChr$coordinates [,2],chrMax),c(
annotationChr$coordinates [,3],chrMax)) #get regions
36 }else if (plotType == "peak") { #peaks plot
37 if(missing(labels)) labels <-c(paste("-",extend ,sep=""),"Peak Centres",
paste("+",extend ,sep="")) #set labels if missing
38 get <-which(objectChr$annotations [,1] %in% peakList) #peak probes
39 centres <-rowMeans(matrix(ncol=2, coordinates[get ,2:3])) #peak centres
40 regions <-cbind(c(1,centres [1:( length(centres) -1)]),centres ,centres ,c(
centres [2: length(centres)],chrMax)) #get regions
41 }else{ #another plotType provided
42 stop("Incorrect plotType", call.=F) #stop with error message
43 }
44 regions [,1]<-ifelse (( regions[,2]-regions [,1]) > (2*extend),regions[,2]-
extend ,( regions [,1]+ regions [,2])/2) #modify regions downwards
45 regions [,4]<-ifelse (( regions[,4]-regions [,3]) > (2*extend),regions [,3]+
extend ,( regions [,3]+ regions [,4])/2) #modify regions upwards
46 if (plotType != "peak") { #genic/intergenic plot
47 regionSize <-apply(regions [,2:3],1,diff ,na.rm=T) #calculate region
sizes
48 if(missing(geneList)) keep <-(regionSize >= range [1] & regionSize <=
range [2]) else keep <-which(annotationChr$annotations [,1] %in%
geneList) #find required regions
49 if(length(keep) == 0) next() #move onto next chr if no probes
extracted
50 regions <-matrix(ncol=4,regions[keep ,]) #get regions to keep
51 regionSize <-regionSize[keep] #get region sizes to keep
52 }
53 if (plotType =="genic") orientation <-as.numeric(annotationChr$annotations
[keep ,3]) else orientation <-rep(1,nrow(regions)) #get/set
orientation values
54 probesListChr <-vector("list", nrow(regions)) #initialise list to store
probes
55 if (nrow(regions) > 0) { #regions are found
56 for (n in 1:nrow(regions)) { #loop through regions
57 probesListChr [[n]]<-which(rowMeans(matrix(ncol=2, coordinates [ ,2:3]))
>= regions[n,1] & rowMeans(matrix(ncol=2, coordinates [ ,2:3])) <=
regions[n,4])+p #get probe numbers
58 }
59 }
60 probesList <-c(probesList ,probesListChr) #save probes together
61 allRegions <-rbind(allRegions ,regions) #save regions together
62 orientations <-c(orientations ,orientation) #save orientations together
63 if (plotType != "peak") regionSizes <-c(regionSizes ,regionSize) else
regionSizes <-c(0,1)#save region sizes together
64 }
65 if(!missing(geneList)) range <-range(regionSizes) #redefne range if a
genelist is provided
66 if(split) keepSmallest <-F #if spitting data set keepsmallest to TRUE
67 if(range [2] == Inf) range [2] <-max(regionSizes) #set max range value
68 if(range [1] == -Inf) range [1] <-min(regionSizes) #set min range value
69 if(missing(main)) main <-paste("Profile plot of ",plotType ," regions\n(n =
",length(probesList),")",sep="") #set main if missing
70 In<-ifelse(keepSmallest ,range[1], range [2]) #set inside length
71 if (!add) { #create new plot
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72 if(showAllLines) { #showing all lines
73 if (plotType != "peak") { #genic/intergenic plot
74 if(missing(ylim)) ylim <-range(object[unique(unlist(probesList)),]$
ratios ,na.rm=T) #define ylim if missing
75 plot(1,1,type="n",bty="n",xaxt="n",xlab="",ylab=ylab ,xlim=c(-extend ,
In+extend),ylim=ylim ,main=main) #initialise plot
76 axis(1,c(-extend ,In+extend),c("",""),lwd.ticks=0,line =0) #add axis
77 axis(1,c(-extend ,0,In ,In+extend),c(labels [1], labels [3], labels [5],
labels [7]),line=0,tck =0.02) #add axis
78 axis(1,c(-(extend/2) ,(In/2),In+( extend/2)),c(labels [2], labels [4],
labels [6]),tick=F,line=-1) #add axis
79 }else{ #peaks plot
80 if(missing(ylim)) ylim <-range(object[unique(unlist(probesList)),]$
ratios ,na.rm=T) #define ylim if missing
81 plot(1,1,type="n",bty="n",xaxt="n",xlab="",ylab=ylab ,xlim=c(-extend ,
extend),ylim=ylim ,main=main) #initialise plot
82 axis(1,c(-extend ,extend),c("",""),lwd.ticks=0,line =0) #add axis
83 axis(1,c(-extend ,0,extend),labels ,line =0) #add axis
84 }
85 }
86 }
87 if (keepSmallest) scale <-range [1]/regionSizes else scale <-range [2]/
regionSizes #calculate scales
88 if (plotType =="peak") scale <-rep(1,length(probesList)) #remove scales if
peaks
89 if (plotType != "peak") trendLinePoints <-seq(-extend ,In+extend ,length.out=
averagePoints) else trendLinePoints <-seq(-extend ,extend ,length.out=
averagePoints)#define points at which to calculate trend line
90 coordinates <-object$coordinates #get coordinates
91 approxLines <-approxLinesSEs <-matrix(ncol=averagePoints ,nrow=ncol(object))
#initialse matrix to store approx values
92 for (r in 1:ncol(object)) { #loop through datasets
93 ratios <-object$ratios[,r] #get ratios
94 approxLine <-matrix(ncol=averagePoints ,nrow=length(probesList)) #
initialse matrix to store approx values
95 for (n in 1: length(probesList)) { #loop through probes list
96 if (length(probesList [[n]]) > 0) { #if probes are present
97 y<-ratios[probesList [[n]]] #get y-axis values
98 x<-rowMeans(matrix(ncol=2, coordinates[probesList [[n]] ,2:3])) #get x-
axis values
99 if (!split) { #data not to be split
100 if (orientations[n] == 1) { #watson strand
101 x<-(x-allRegions[n,2])*scale[n] #shift and scale x-axis values
102 }else{ #crick strand
103 x<-((( max(x)-x)+min(x))-(max(x)-allRegions[n,3]+ min(x)))*scale[n]
#flip , shift and scale x-axis values
104 }
105 }else{ #data to be split
106 halfway <-(allRegions[n,2]+ allRegions[n,3])/2 #get gene halfway
values
107 if (orientations[n] == 1) { #watson strand
108 y<-c(y[x <= halfway],NA ,y[x > halfway ]) #add NA to middle of y
values
109 x<-c(x[x <= halfway]-allRegions[n,2],NA ,(x[x > halfway]-allRegions
[n,3])+In) #split x values
110 }else{ #crick strand
111 y<-c(y[x >= halfway],NA ,y[x < halfway ]) #add NA to middle of y
values
112 x<-c(((max(x)-x[x >= halfway ])+min(x)) -((max(x)-allRegions[n,3])+
min(x)),NA ,(( max(x)-x[x < halfway ])+min(x)) -((max(x)-
allRegions[n,2])+min(x))+In) #split x values
113 }
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114 }
115 if (showAllLines) points(x,y,type="l",col=allLines.col) #plot all
lines
116 if (showTrendLine) if (length(which(!is.na(y))) > 1) approxLine[n,]<-
approx(x,y,xout=trendLinePoints)$y #calculate approx line
117 }
118 }
119 counts <-100*apply(approxLine ,2,function(x) {return(length(which(!is.na(x
))))})/nrow(approxLine) #get counts
120 approxLines[r,]<-colMeans(approxLine ,na.rm=T) #calculate trend line
121 approxLinesSEs[r,]<-apply(approxLine ,2,sd ,na.rm=T)/sqrt(apply(approxLine
,2,function(x) {return(length(which(!is.na(x))))})) #calculate
standard error
122 approxLines[r,counts < tidy]<-NA #’tidy ’ data
123 }
124 if (!add) { #create a new plot
125 if (!showAllLines) { #not showing all lines
126 if (plotType != "peak") { #genic/intergenic plot
127 if(missing(ylim)) { #no y limits provided
128 if (showSEs) ylim <-range(c(approxLines+approxLinesSEs ,approxLines -
approxLinesSEs),na.rm=T) else ylim <-range(approxLines ,na.rm=T)
#get ylim
129 }
130 plot(1,1,type="n",bty="n",xaxt="n",xlab="",ylab=ylab ,xlim=c(-extend ,
In+extend),ylim=ylim ,main=main) #initialise plot
131 axis(1,c(-extend ,In+extend),c("",""),lwd.ticks=0,line =0) #add axis
132 axis(1,c(-extend ,0,In ,In+extend),c(labels [1], labels [3], labels [5],
labels [7]),line=0,tck =0.02) #add axis
133 axis(1,c(-(extend/2) ,(In/2),In+( extend/2)),c(labels [2], labels [4],
labels [6]),tick=F,line=-1) #add axis
134 }else{ #peaks plot
135 if(missing(ylim)) { #y limits not provided
136 if (showSEs) ylim <-range(c(approxLines+approxLinesSEs ,approxLines -
approxLinesSEs),na.rm=T) else ylim <-range(approxLines ,na.rm=T)
#get ylim
137 }
138 plot(1,1,type="n",bty="n",xaxt="n",xlab="",ylab=ylab ,xlim=c(-extend ,
extend),ylim=ylim ,main=main) #initialise plot
139 axis(1,c(-extend ,extend),c("",""),lwd.ticks=0,line =0) #add axis
140 axis(1,c(-extend ,0,extend),labels ,line =0) #add axis
141 }
142 }
143 }
144 if (showTrendLine) { #trend line to be plotted
145 for (r in 1:ncol(object)) { #loop through datasets
146 points(trendLinePoints ,approxLines[r,],col=col[r],lty=lty[r],lwd=lwd[r
],type="l") #add trendline
147 if (showSEs) { #standard errors to be shown
148 SDinclude <-!is.na(approxLines[r,]) & !is.na(approxLinesSEs[r,]) #
remove NA values
149 polygon(c(trendLinePoints[SDinclude],trendLinePoints[SDinclude ][
length(trendLinePoints[SDinclude ]):1]),c(( approxLines[r,
SDinclude ]+ approxLinesSEs[r,SDinclude ]) ,(approxLines[r,SDinclude
][ length(trendLinePoints[SDinclude ]):1]- approxLinesSEs[r,
SDinclude ][ length(trendLinePoints[SDinclude ]):1])),col=rgb(
matrix(ncol=3,col2rgb(col[r])),max=255, alpha =100),lty=0) #add SE
polygon
150 }
151 }
152 }
153 }
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The function sets the plot type to “genic” if not provided (L4) and adjusts
the lines to plot depending on the number of datasets provided (L5–8). The
y axis label is set if not provided (L9). Colours and line types are set if
those provided are not suitable (L10–15). Adjustments are made if standard
errors are to be shown (L16–17). A count, arrayData object, list, matrix
and vector are initialised to store data (L18–22) and a loop through chromo-
somes initiated (L23). The count is increased by the number of probes on the
previous chromosome (L24) and arrayData and annotationData from the
current chromosome extracted (L25-26). The loop moves to the next chro-
mosome if no data is found for the current chromosome (L27). Coordinate
data are extracted (L28) and the maximum chromosome coordinate deter-
mined (L29). Labels and regions to plot are determined for genic, intergenic
or peak plots (L30–41). The function stops with a message if one of these
types is not specified (L42). Plot regions are extended in both directions
based on the “extend” value and adjacent plot region positions (L44-45).
For genic and intergenic plots, regions are extracted based on region sizes or
the “geneList” (L47–51). ORF orientations are stored (L53). Probes for each
region are stored in a list (L54–59). Probes, regions, orientations and sizes
for all chromosomes are stored together (L60–63). Parameters for plots are
defined based on the identified probes (L65–70). If a new plot is required, and
all lines are to be shown, this is created based on the extracted probe values
and required plot type (L71–86). A scale factor is determined (L87-88) and
the points at which to define the trend line defined (L89). Coordinates are
extracted (L90) and matrices initiated to store trend line and SE values for
each dataset (L91). A loop through datasets is initiated (L92). Ratio values
are extracted (L93) and a matrix initiated to store the values from which
to calculate the trend line and SEs (L94). A loop in initiated through each
region with probes to be plotted (L95–96) and the line’s x and y values deter-
mined (L97–98). These are shifted, scaled, flipped and/or split as determined
by the region’s scale factor, orientation and the plot type (L99–114). This
line is plotted if required (L115) and the trend line points calculated (L116).
Counts are calculated for the “tidy” argument (L119), the trend line and
SEs calculated from all regions (L120–121) and the “tidy” argument applied
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(L122). A new plot is created if all lines are not being shown, based on the
trend line and SE values and plot type, and the trend lines/SEs calculated
(L124–143). The trend lines/SEs are then added to the current plot, which
either contain all other lines or just trend lines (L144–152). The process is
largely vectorised for efficiency.
Examples of the types of plots this function can create are shown in Fig-
ure 3.8. The genic plot (top panel) is demonstrated with normalised Abf1
binding data over ORFs of defined size with regions of defined size upstream
and downstream of the ORFs. All data lines are shown in grey, taken from
each of the ORFs and overlayed and scaled to align the start and end posi-
tions together. The trend line, shown in red, is calculated from these data.
The intergenic plot (middle panel) is demonstrated with a single trend line
showing standard errors as a coloured shape around the line. The peak plot
is demonstrated with peaks from the peakDetection function (Chapter 5),
showing three trend lines from three replicate datasets.
3.2.6.4 Rainbow plots
The normalisation procedure presented here (Chapter 4) allows for compar-
isons to be made between datasets. The “rainbowPlot” function, so named
because of the multi-coloured lines it produces, allows these changed to be vi-
sualised at a subset of probes. The values for each probe across the datasets
are plotted as a single line, which shows the variations between datasets.
Data are ordered by the first set of ratios and colours defined by the rainbow
function. This produces the relevant number of different colours. The order
of plotting is calculated from the total differences in probes values between
datasets. In this way the largest differences are plotted last, making them
more visible on the plot. The clarity of the plot can be further increased by
plotting only data where the total difference between values is over a defined
amount. The function has the following arguments:
object An arrayData object containing more than one dataset to be plotted
(no default).
probes A character vector specifying the probes to display data for (no
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Figure 3.8: Output of profilePlot function: Examples of the three types
of plot that can be created by the profilePlot function using a normalised
Abf1 binding dataset. The genic plot (top panel) shows lines for the data
across 3,608 ORFs meeting the default criteria (grey), along with a trend line
(red). The intergenic plot (middle panel) shows the trend line, with standard
errors shown, created from 641 intergenic regions meeting the default criteria.
The peak plot (bottom panel) shows the data with three trend lines over 3,932
detected peaks, extending the plot region to ±2000 bp.
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default).
dataNames A character vector specifying the names of data to show on the
graph (default numeric).
cutoff a numeric vector specifying the difference cutoff (default 0).
ylab A character vector specifying the y-axis label (default “Binding Value
(log2)”).
Script 3.19: rainbowPlot: script to display the relationship between the same
probes of different arrayData objects. Coloured lines show changes in values
between datasets.
1 ## rainbowPlot function ##
2 ## arguments: object (an arrayData object), probes(a list of probes),
datanames (for data labels), cutoff (differences value cutoff), ylab (y
axis label)
3 rainbowPlot <-function(object ,probes ,dataNames ,cutoff=0,ylab="Binding Value (
log2)" ,...) { #define function
4 if(ncol(object) < 2) stop("Too few datasets to plot",call.=F) #stop with
error if not enough data
5 data <-object[probes ,]$ratios #get data for relevant peaks
6 data <-data[order(data [,1]) ,] #sort data by values of first column
7 plot(1,1,type="n",xlim=c(0.8, ncol(data)+0.2),ylim=range(data),bty="n",xaxt
="n",xlab="",ylab=ylab ,...) #initlaise plot
8 if(missing(dataNames)) dataNames <-1:ncol(object) #set names if missing
9 axis (1,1: ncol(data),dataNames ,tick=F,line=-1) #draw axis
10 diffs <-apply(abs(diff(data)) ,1,sum) #calculate total differences
11 data <-data[diffs > cutoff ,] #get data above defined differences cutoff
12 plotOrder <-order(diffs[diffs > cutoff ]) #set plot order by differences
13 col <-rainbow(nrow(data),start=0,end =0.9) #set colours
14 for(n in plotOrder) { #loop through data
15 points (1: ncol(data),data[n,],type="l",col=col[n]) #add data line
16 }
17 grid(nx=0,ny=NULL) #add grid
18 }
The function first checks enough datasets are provided and stops with a
message if not (L4). The ratios to be plotted are then extracted (L5) and
ordered (L6). A new plot is created based on the ratio values and number of
datasets (L7). Data names are specified if required (L8) and the x-axis drawn
(L9). Total differences across all datasets for each probe are calculated (L10)
and those above the “cutoff” extracted (L11). The plot order is determined
by the difference values, from smallest to largest (L12). Rainbow colours are
calculated (L13) and each set of lines added in the correct order with the
relevant colour (L14–16). Finally horizontal lines of a grid are added (L17).
A rainbow plot has been used to analyse Abf1 binding data in Figure 7.10.
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3.2.7 Annotating data
Each probe in an arrayData object is associated with its genomic location,
but this does not give any context to that location, specifically how it re-
lates to ORFs. It is useful to be able to determine this information as it
adds another layer of depth to analyses that can be performed. The func-
tion getProbeInfo (Script 3.20) was written to perform this task. For each
probe, the nearest ORF is found, based on the data of a genomeAnnotation
object, and its name and the probe’s distance to its start coordinate stored.
Whether or not the probe is in that ORF is determined, and a labelling
process initiated accordingly. Probes in ORFs are labelled as “Inside”. In-
tergenic probes are labelled depending on their distance from their nearest
ORF, the orientation of that ORF and the “distance” value. This specifies
a cutoff value used when annotating probes in intergenic regions, with dis-
tances over this cutoff being labelled “Intergenic”, rather than “Promoter” or
“Downstream”. The adjacent ORF is also examined and a “Divergent” label
applied if the ORF is in the opposite orientation to the closest ORF. This
may result in a divergent promoter region, where two ORFs point away from
each other, or a divergent downstream region, where two ORFs point towards
each other (Figure 3.9). The process is largely vectorised for efficiency. The
function has the following arguments:
object An arrayData object specifying the probe(s) to be processed (no
default).
annotation A genomeAnnotation object from which to take annotation
information (no default).
distance A numerical vector specifying the distance cutoff (default Inf).
append A logical vector specifying whether or not to append the resulting
data to the arrayData object as extra annotation columns, or return
it as a new matrix (default FALSE).
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Script 3.20: getProbeInfo: script to associate probes with their nearest ORFs
and provide information on their positions relative to these.
1 ## getProbeInfo function ##
2 ## arguments: object (an arrayData object), annotation (a genomeAnnotation
object), distance (distance to consider promoter/downstream), append (
whether to add the results to the arrayData object)
3 getProbeInfo <-function(object ,annotation ,distance=Inf ,append=FALSE) { #
define function
4 results <-matrix(ncol=4,nrow=nrow(object)) #initialise matrix to store
results
5 colnames(results)<-c("ClosestGene","Distance","Association","Divergent") #
set result column names
6 x<-1 #start count at 1
7 for (chr in unique(object$coordinates [,1])) { #loop through chromosomes
8 annoChr <-annotation[annotation$coordinates [,1] == chr] #get annotation
for current chromosome
9 objectChr <-object[object$coordinates [,1] == chr ,] #get arrayData for
current chromosome
10 if (nrow(annoChr) == 0) { #if no annotation for current chromosome
11 results[x:(x+nrow(objectChr) -1) ,]<-NA #store NA values
12 x<-x+nrow(objectChr) #increase count
13 }else{ #annotation present for current chromosome
14 result <-matrix(ncol=4,nrow=nrow(objectChr))
15 afterGene <-inGene <-matrix(ncol=1,nrow=nrow(objectChr))
16 mids <-rowMeans(matrix(ncol=2,objectChr$coordinates [ ,2:3])) #get mid
points
17 for (n in 1:nrow(objectChr)) { #loop through probes
18 A<-annoChr$coordinates [,3] >= mids[n] #find genes greater than mid
19 B<-annoChr$coordinates [,2] <= mids[n] #find genes less than mid
20 ingene <-which(A+B > 1) #find if probe is in a gene
21 if (length(ingene) > 0) { #probe is in a gene
22 if (length(ingene) > 1) ingene <-ingene[which.max(apply(annoChr$
coordinates[ingene ,2:3],1, diff))] #get longest gene if more
than one
23 inGene[n]<-ingene #set ORFs probes are in
24 }else{ #probe is not in a gene
25 afterGene[n]<-which(c(A,1)+c(1,B) > 1) -1 #find ORFs probes are
after
26 }
27 }
28 present <-which(!is.na(inGene)) #probes in a gene
29 result[present ,]<-cbind(annoChr$annotations[inGene[present ],1],ifelse(
as.numeric(annoChr$annotations[inGene[present ],3]) == 1,mids[
present]-annoChr$coordinates[inGene[present ],2],annoChr$
coordinates[inGene[present ],3]-mids[present ]),rep("Inside",length(
present)),rep(FALSE ,length(present))) #get info for probes in
genes
30 mids <-mids[!is.na(afterGene)] #get mids for intergenic probes
31 afterGene <-afterGene[!is.na(afterGene)] #get non -na aftergenes
32 intergenic <-matrix(ncol=7,nrow=length(afterGene)) #create matrix to
store data
33 intergenic [,4]<-mids #insert mids
34 intergenic [,1]<-afterGene #insert LHS positions
35 intergenic [( intergenic [,1] == 0) ,1]<-NA #remove 0 values
36 intergenic [,5]<-afterGene +1 #insert RHS positions
37 intergenic [( intergenic [,5] > nrow(annoChr)) ,5]<-NA #remove values too
large
38 intergenic [,2]<-ifelse(as.numeric(annoChr$annotations[intergenic
[,1],3]) == 1,1,0) #define if lhs gene is watson
39 intergenic [,3]<-mids -annoChr$coordinates[intergenic [,1],3] #calculate
distances
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40 intergenic [,6]<-ifelse(as.numeric(annoChr$annotations[intergenic
[,5],3]) == 1,1,0) #define if rhs gene is watson
41 intergenic [,7]<-annoChr$coordinates[intergenic [,5],2]-mids #calculate
distances
42 present <-which(is.na(inGene)) #intergenic positions
43 closer <-intergenic [,3] < intergenic [,7] #LHS closer than RHS
44 result[present ,1] <-ifelse(closer ,annoChr$annotations[intergenic
[,1],1], annoChr$annotations[intergenic [,5],1]) #get closest gene
names
45 result[present ,2] <-ifelse(closer ,intergenic [,3], intergenic [,7]) #get
closest gene ditances
46 result[present ,3] <-ifelse(closer ,ifelse(intergenic [,2] == 1,"
Downstream","Promoter"),ifelse(intergenic [,6] == 1,"Promoter","
Downstream")) #define promoter/downstream
47 result[present ,4] <-intergenic [,2] != intergenic [,6] #define divergent
48 present <-which(is.na(inGene))[is.na(intergenic [,1])] #probes before
first gene
49 result[present ,]<-cbind(annoChr$annotations[intergenic[is.na(
intergenic [,1]) ,5],1], intergenic[is.na(intergenic [,1]) ,7],ifelse(
intergenic[is.na(intergenic [,1]) ,6] == 1,"Promoter","Downstream"),
rep(FALSE ,length(present))) #info for probes before first gene
50 present <-which(is.na(inGene))[is.na(intergenic [,7])] #probes after
last gene
51 result[present ,]<-cbind(annoChr$annotations[intergenic[is.na(
intergenic [,7]) ,1],1], intergenic[is.na(intergenic [,7]) ,3],ifelse(
intergenic[is.na(intergenic [,7]) ,2] == 1,"Downstream","Inside"),
rep(FALSE ,length(present))) #info for probes after last gene
52 results[x:(x+nrow(objectChr) -1) ,]<-result #store all results
53 x<-x+nrow(objectChr) #increase count
54 }
55 }
56 results[as.numeric(results [,2]) > distance & results [,3] != "Inside" ,3]<-"
Intergenic" #set intergenic by distance value
57 if(append) { #data is to be appended to arrayData
58 object$annotations <-cbind(object$annotations ,results) #add results to
annotations
59 return(new("arrayData",object)) #return arrayData
60 }else{ #data is not to be appended
61 return(results) #return matrix
62 }
63 }
The function creates a matrix to store the results (L4–5), creates a count (L6)
and initiates a loop through chromosome numbers (L7). The arrayData
and genomeAnnotation for each chromosome are extracted (L8–9). If no
annotation is available for the current chromosome, NA values are set for all
probes on that chromosome and the count incremented (L10–12). Otherwise
three matrices are created (L14–15), the probe mid-points calculated (L16)
and a loop through probes initialised (L17). ORF end points above, and
start points below, the mid-points are identified (L18–19). These are used to
determine whether the probe is in an ORF (L20). If it is (L21), the longest
gene is taken in the case of overlapping genes (L22) and the values stored
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Figure 3.9: ORF position examples: the labels that may be assigned to
probes in different positions relative to their nearest ORF. Yellow boxes
represent ORFs with the arrow indicating the direction of transcription.
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(L23). Otherwise the preceding gene is identified (L25). For probes in ORFs
(L28) the results are compiled (L29). For intergenic probes the mid-points
(L30) and numbers are extracted (L31). Details of ORFs to the left- and
right-hand-sides are gathered (L32–41). These are used to determine the
association details for internal (L42–47) and external ORFs (L48–51). The
results are stored (L52) and the count increased (L53). Intergenic probes
are identified, based on the “distance” value (L56). If the results are to be
appended to the arrayData object this is carried out and the new object
returned (L57–59), otherwise the matrix of results is returned (L61).
3.2.7.1 Positions plot
The positions of peak positions relative to ORFs can be important to know,
especially for proteins that bind throughout a genome. The getProbeInfo
function can be used to find this information for each probe at the top of a
potential binding region (PBR). The positionsPlot function (Script 3.21)
uses this information to create three graphics. The function has the following
arguments:
peakList The peakList object to be plotted (no default).
probeInfo The matrix of results of the getProbeInfo function for the
peakList being plotted (no default).
Script 3.21: positionsPlot: script to display positional information from a
peakList object.
1 ## positionsPlot function ##
2 ## arguments: probeInfo (result of getProbeInfo), peakList (a peakList
object)
3 positionsPlot <-function(probeInfo ,peakList) {
4 op<-par(no.readonly = TRUE); on.exit(par(op)) #reset current par on exit
5 Pr<-In<-Do<-0 #initialise vectors to store max values
6 if(length(which(probeInfo [,3] == "Promoter")) > 0) Pr<-max(as.numeric(
probeInfo[probeInfo [,3] == "Promoter" ,2]),na.rm=T) #max promoter value
7 if(length(which(probeInfo [,3] == "Inside")) > 0) In<-max(as.numeric(
probeInfo[probeInfo [,3] == "Inside" ,2]),na.rm=T) #max inside value
8 if(length(which(probeInfo [,3] == "Downstream")) > 0) Do<-max(as.numeric(
probeInfo[probeInfo [,3] == "Downstream" ,2]),na.rm=T) #max downstream
value
9 if(Pr < In/2) Pr<-In/2 #scale promoter if required
10 if(Do < In/2) Do<-In/2 #scale downstream if required
11 layout(matrix(c(1,2,3) ,3,1),heights=c(0.3 ,0.7 ,0.3)) #set layout
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12 par(mar=c(0,4,2,2)) #set par
13 plot(density(c(Pr -as.numeric(probeInfo[probeInfo [,3]=="Promoter" ,2]),Pr+as
.numeric(probeInfo[probeInfo [,3]=="Inside" ,2]),Pr+In+as.numeric(
probeInfo[probeInfo [ ,3]=="Downstream" ,2])),na.rm=T),main="",bty="n",
xaxt="n",yaxt="n",xlab="",ylab="Density",mar=c(1,2,2,2),xlim=c(0,Pr+In
+Do),lwd=2) #plot density
14 abline(v=c(Pr ,Pr+In),col = "lightgray", lty = "dotted") #add vertical
lines
15 axis(2,labels=F,lwd.tick =0) #add axis
16 par(mar=c(2,4,0,2)) #set par
17 plot(1,1,type="n",bty="n",xaxt="n",xlab="Genome Position",ylab="Peak
Height",xlim=c(0,Pr+In+Do),ylim=range(c(0,peakList$stats [,2]))) #
initialise plot
18 axis(1,c(0,Pr+In+Do),c("",""),lwd.ticks=0,line =0) #add axis
19 axis(1,c(0,Pr,Pr+In,Pr+In+Do),c(-Pr ,0,In ,paste("+",Do ,sep="")),line =0) #
add axis
20 axis(1,c(Pr/2,Pr+(In/2),Pr+In+(Do/2)),c("Promoter","Inside","Downstream"),
tick=F,line=-1) #add axis
21 par(pch=16,cex=0.6,col=rgb(0,0,0,alpha =0.5)) #set par
22 points(Pr-as.numeric(probeInfo[probeInfo [,3]=="Promoter" ,2]),as.numeric(
peakList$stats[probeInfo [ ,3]=="Promoter" ,2])) #plot promoter points
23 points(Pr+as.numeric(probeInfo[probeInfo [,3]=="Inside" ,2]),as.numeric(
peakList$stats[probeInfo [ ,3]=="Inside" ,2])) #plot inside points
24 points(Pr+In+as.numeric(probeInfo[probeInfo [,3]=="Downstream" ,2]),as.
numeric(peakList$stats[probeInfo [ ,3]=="Downstream" ,2])) #plot
downstream points
25 abline(v=c(Pr ,Pr+In),col = "lightgray", lty = "dotted") #add verital lines
26 grid(nx=0,ny=NULL) #add grid
27 par(mar=c(4,8,2,8),las =1) #set par
28 barplot(matrix(c(100*(length(which(probeInfo [,3]=="Downstream" & probeInfo
[,4]=="FALSE"))/nrow(peakList)) ,100*(length(which(probeInfo [,3]=="
Downstream" & probeInfo [,4]=="TRUE"))/nrow(peakList)) ,100*(length(
which(probeInfo [ ,3]=="Inside"))/nrow(peakList)) ,0,100*(length(which(
probeInfo [,3]=="Promoter" & probeInfo [,4]=="FALSE"))/nrow(peakList))
,100*(length(which(probeInfo [,3]=="Promoter" & probeInfo [,4]=="TRUE"))
/nrow(peakList))),ncol=3,byrow=F),horiz=T,beside=FALSE ,xlab="
Percentage",names.arg=c("Downstream","Inside","Promoter")) #plot
barplot
29 }
The function gets the current par settings to be reset when exiting (L4)
and creates vectors for the storage of x-axis values (L5). The maximum
promoter, inside and downstream values are extracted (L6–8) and scaled if
required (L9–10). These define the values along the x-axis and the positions
of the promoter/inside and inside/downstream boundaries. The plot layout
and parameters are set (L11–12) and the density plot created (L13). Lines
indicating the boundaries (L14) and a y-axis (L15) are added. The plot
margins are adjusted (L16) and a plot initialised for the probes (L17). The
x-axis showing the ORF positions is added (L18–20) and the point parame-
ters set (L21). Points are plotted for the promoter (L22), inside (L23) and
downstream (L24) regions. Lines indicating the boundaries (L25) and log2
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Figure 3.10: Output of positionsPlot function: Example of the graph-
ics created, using results from peak detection performed on Abf1 binding
datasets. The middle panel shows probe positions plotted against their
heights with the top panel showing a density plot of this data. The bottom
panel shows the percentage of probes in different categories, with intergenic
regions shown in lighter grey.
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ratios (L26) are added. The margins for the final plot are set (L27) and the
bar plot created (L28).
An example of the positionsPlot output is shown in Figure 3.10. The
centre of the graphic shows a plot of peak heights relative to their nearest
ORF. A promoter, inside and downstream region are displayed along the
x-axis, with log2 ratios on the y-axis. The range of the x-axis is determined
by the largest value in the probe information. Each probe is shown with
a dot, relating its genome position to its height. Above this is a density
plot, representing the numbers of probes along the promoter/ORF/down-
stream region. Overlapping dots, in regions with lots of probes, obscure each
other and therefore prevent an accurate estimation of the relative numbers
of probes. The density plot overcomes this by indicating the numbers of
probes at a given location, allowing the region(s) with the most probes to
be identified. The bottom of the graphic shows the percentage of probes in
promoter, inside and downstream regions as a bar graph, indicating those
from divergent regions with lighter shades of grey.
3.2.7.2 Venn diagrams
Venn diagrams are a method of representing similarity between different
groups of items, with item counts displayed in shapes created by overlap-
ping circles. The function venn (Script 3.22) has been written to create
Venn diagrams to show similarity between two or three peakList objects.
The function provides two methods for displaying this data. The first creates
a standard Venn diagram, where the numbers represent counts of identical
probes between different lists. The second employs the overlap function
(Script 3.23), which identifies PBRs from different peakList objects which
overlap, potentially representing the same binding site but which may have
different probes at their peaks and therefore would not be identified by the
standard Venn diagram format. The function has the following arguments:
peakList1 The first peakList object (no default).
peakList2 The second peakList object (no default).
peakList3 The third peakList object (optional; no default).
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overlap A logical vector specifying whether or not to employ the overlap
function (default FALSE).
arrayData An arrayData object containing probe coordinates (required by
the overlap function; no default).
windowSize A numeric vector specifying the window size to use when cal-
culating overlaps (no default).
cex A numeric vector defining the size of the plotted circles (default 40).
Script 3.22: venn: script to create a Venn diagram showing the relationship
between the contents of two or three peakList objects.
1 ## venn function ##
2 ## arguments: peakList1 (first peakList), peakList2 (second peakList),
peakList3 (third optional peakList), overlap (whether to use overlap),
arrayData (an arrayData object for overlap), windowSize (window size
value for overlap), cex (cirle size adjustment).
3 venn <-function(peakList1 ,peakList2 ,peakList3 ,overlap=F,arrayData ,windowSize ,
cex =40) { #define function
4 if (peakList1$grid_name != peakList2$grid_name) stop("peakList grid names
do not match",call.=F)
5 if(!overlap) { #no overlap required
6 a<-matrix(peakList1$IDs[,1]) #get first probe IDs
7 b<-matrix(peakList2$IDs[,1]) #get second probe IDs
8 ab<-matrix(intersect(a,b)) #a b intersect
9 if(!missing(peakList3)) { #a third list is povided
10 if (peakList1$grid_name != peakList3$grid_name) stop("peakList grid
names do not match",call.=F) #stop if grid names don ’t match
11 c<-matrix(peakList3$IDs[,1]) #get third probe IDs
12 bc<-matrix(intersect(b,c)) #b c intersect
13 ac<-matrix(intersect(a,c)) #a c intersect
14 abbc <-matrix(intersect(ab,bc)) #ab bc intersect
15 abac <-matrix(intersect(ab,ac)) #ab ac intersect
16 bcac <-matrix(intersect(bc,ac)) #bc ac intersect
17 }
18 }else{ #overlap required
19 if (arrayData$grid_name != peakList1$grid_name) stop("arrayData and
peakList grid names do not match",call.=F) #grid names don ’t match
20 a<-peakList1 #get first peak list
21 b<-peakList2 #get second peak list
22 ab<-overlap(a,b,arrayData ,windowSize) #a b overlap
23 if(!missing(peakList3)) { #a third list is provided
24 if (peakList1$grid_name != peakList3$grid_name) stop("peakList grid
names do not match",call.=F) #stop if grid names don ’t match
25 c<-peakList3 #get thrid peak list
26 bc<-overlap(b,c,arrayData ,windowSize) #b c overlap
27 ac<-overlap(a,c,arrayData ,windowSize) #a c overlap
28 abbc <-overlap(ab ,bc,arrayData ,windowSize) #ab bc overlap
29 abac <-overlap(ab ,ac,arrayData ,windowSize) #ab ac overlap
30 bcac <-overlap(bc ,ac,arrayData ,windowSize) #bc ac overlap
31 }
32 }
33 par(bty="n",xaxt="n",yaxt="n") #set par
34 plot(c(1 ,1.835),c(1,1),cex=cex ,xlim=c(0,3),ylim=c(-1,2),xlab="",ylab="",
pch=16,col=c(rgb(1,0,0,0.3),rgb(0,1,0,0.3))) #initialise plot
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35 if(!missing(peakList3)) { #third list is present
36 points (1.42 ,0.19 , cex=cex ,pch=16,col=rgb(0,0,1,0.3)) #third circle
37 text (0.62 ,1.22 , nrow(a)-nrow(ab)-nrow(ac)+nrow(abac)) #show numbers
38 text (2.2 ,1.22 , nrow(b)-nrow(ab)-nrow(bc)+nrow(abac)) #show numbers
39 text (1.42 ,-0.26 , nrow(c)-nrow(ac)-nrow(bc)+nrow(abac)) #show numbers
40 text (1.42 ,1.45 , nrow(ab)-nrow(abac)) #show numbers
41 text (2,0.35, nrow(bc)-nrow(abac)) #show numbers
42 text (0.84 ,0.35 , nrow(ac)-nrow(abac)) #show numbers
43 text (1.42 ,0.72 , nrow(abac)) #show numbers
44 }else{
45 text (0.62,1, nrow(a)-nrow(ab)) #show numbers
46 text(2.2,1,nrow(b)-nrow(ab)) #show numbers
47 text (1.42,1, nrow(ab)) #show numbers
48 }
49 }
The function first checks that the grid names of the first and second peakList
objects match (L4). If the overlap function is not to be used (L5) the
peakList IDs are extracted (L6-7) and those identical identified (L8). If a
third peakList is provided (L9) its grid name is checked (L10) and its IDs
extracted (L11). Identical IDs are identified between all possible combina-
tions (L12–16). Where the overlap function is to be used (L18) the grid
name of the arrayData object is checked against that of the first peakList
(L19). The overlap function is applied to the first two peakLists (L20-
22). If a third peakList is provided (L23) its grid name is checked (L24)
and overlap applied to all possible combinations (L25–30). The parameters
of the plot are set (L33) and a plot created containing the first two circles
(L34). If a third peakList is provided (L35) a third circle is drawn (L36) and
all calculated counts printed at the relevant positions (L37–43). Otherwise
calculated counts for the first two peakLists are printed (L44–47) at the
relevant positions.
The overlap function determines overlapping PBRs using coordinates
from a provided arrayData object and the defined window size value. Probes
in one dataset which occur within the window size distance away from adja-
cent probes in the second dataset are deemed to be overlapping. In this way
PBRs containing at their peaks adjacent probes within the window size dis-
tance of each other, called as peaks in different peakLists, will be deemed to
be overlapping and therefore created by the same binding site, whereas those
separated by one or more probes are considered to be created by separate
binding sites. The function is vectorised making it efficient at comparing
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between lists of hundreds or thousands of PBRs. It is called by the venn
function, providing the two peakList objects to be analysed (“peakList1”
and ““peakList2””), the arrayData object (“arrayData”) and the window
size (“windowSize”).
Script 3.23: overlap: script to determine overlapping PBRs from peakList
objects.
1 ## overlap function ##
2 ## arguments: peakList1 , peakList2 , arrayData , windowSize
3 overlap <-function(peakList1 ,peakList2 ,arrayData ,windowSize) {
4 probes <-arrayData$annotations [,1] #get probe names
5 positions <-rowMeans(arrayData$coordinates [ ,2:3]) #get probe mid points
6 chrs <-arrayData$coordinates [,1] #get coordinates
7 match1 <-which(peakList1$IDs[,1] %in% peakList2$IDs[,1]) #get matching
positions
8 arrayDataPositions <-which(probes %in% peakList2$IDs[,1]) #probes in
peakList2
9 arrayDataPositions.d<-arrayDataPositions[arrayDataPositions > 1] #probes
to look down
10 arrayDataPositions.u<-arrayDataPositions[arrayDataPositions < nrow(
arrayData)] #probes to look up
11 match2 <-which(peakList1$IDs[,1] %in% probes[ifelse(chrs[arrayDataPositions
.d] == chrs[arrayDataPositions.d-1] & (positions[arrayDataPositions.d]
- positions[arrayDataPositions.d-1]) < windowSize ,arrayDataPositions.
d-1, arrayDataPositions.d)]) #overlap down
12 match3 <-which(peakList1$IDs[,1] %in% probes[ifelse(chrs[arrayDataPositions
.u] == chrs[arrayDataPositions.u+1] & (positions[arrayDataPositions.u]
- positions[arrayDataPositions.u+1]) < windowSize ,arrayDataPositions.
u+1, arrayDataPositions.u)]) #overlap up
13 return(peakList1[unique(c(match1 ,match2 ,match3))]) #return overlapping
probes
14 }
The function extracts probe names (L4), mid-points (L5) and chromosome
numbers (L6) from the arrayData object. Matching probes from both of the
peakList objects are identified (L7). arrayData positions of probes in the
second peakList are identified (L8). Those suitable for looking downwards
and upwards from, that is, those not at the start or end of the genome,
are identified (L9–10). Probe names of “peakList1” are compared to probe
names downstream of each “peakList2” probe name, within the window size
and on the same chromosome (L11). This is repeated for upstream probes
(L12). A peakList containing these identified PBRs is returned (L13). The
coordinate component of this peakList will vary depending on the order
the two peakLists are provided to the function, and so these are not useful
for downstream analyses, but the numbers of peaks returned and the IDs
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component will always be the same, making it suitable for use by the venn
function and use in further overlap analyses.
3.2.7.3 Extracting sequence information
In addition to displaying information about detected peaks, analysis of the
DNA sequences of PBRs can reveal important information about binding
sites. Identification of a binding motif is one potential use of these se-
quences. The function getSequences was written to extract these sequences
from peakList PBRs using the BSgenome package (Pages, 2012b). This
package downloads entire genome sequences and, among its features, allows
portions of these to be extracted. The getSequences function uses this fea-
ture to extract sequences based on the coordinates of the PBRs stored in the
peakList. The resulting sequences can be analysed in R, with packages such
as Biostrings (H et al.), or written as FASTA files to be loaded into and
processed in other programs. The function has the following arguments:
peakList The peakList object to get sequences for (no default).
genome A (previously downloaded) BSgenome genome from which to get
sequences (no default).
unmask A logical vector specifying whether to apply the unmasked function
to masked sequences (default FALSE).
Script 3.24: getSequences: script to get sequence information from PBRs of
a peakList using the BSgenome package.
1 ## getSequences function ##
2 ## arguments: peakList (a peakListObject), genome (a previously downloaded
genome), unmask (whether to unmask the genome)
3 getSequences <-function(peakList ,genome ,unmask=FALSE) { #define function
4 require(BSgenome) #load package
5 results <-matrix(ncol=1,nrow=nrow(peakList)) #initialse matrix to store
results
6 x<-1 #set x = 1
7 for (chr in unique(peakList$coordinates [,1])) { #loop through chromosomes
8 if(unmask) genomeChr <-unmasked(genome [[chr]]) else genomeChr <-genome [[
chr]] #get chromosome sequence
9 peakListChr <-peakList[peakList$coordinates [,1] == chr] #get chromosome
peak list
10 coordinates <-round(peakListChr$coordinates [,2:3],0)
11 coordinates[coordinates < 1]<-1 #correct coordinates less than 1
12 coordinates[coordinates > length(genomeChr)]<-length(genomeChr) #correct
coordinates greater than the chromosome length
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13 if (nrow(peakListChr) > 0) { #if a peak is on the chromosome
14 for (n in 1:nrow(peakListChr)) { #loop through peaks
15 results[x]<-as.character(genomeChr[coordinates[n,1]: coordinates[n
,2]]) #get sequence in PBR
16 x<-x+1 #increment x
17 }
18 }
19 }
20 rownames(results)<-peakList$IDs[,1]
21 return(results) #return sequences
22 }
23
24 #source ("http://bioconductor.org/biocLite.R")
25 #biocLite (" BSgenome.Scerevisiae.UCSC.sacCer3 ")
26 #require(BSgenome.Scerevisiae.UCSC.sacCer3)
27 #yeastGenome <-get(" Scerevisiae ","package:BSgenome.Scerevisiae.UCSC.sacCer3 ")
The function first loads the BSgenome package if required (L4), creates a
matrix to store the extracted sequences (L5) and starts a count (L6). A
loop through chromosomes is initiated (L7) and the chromosome sequence
set (L8). PBR coordinates for the current chromosome are extracted (L9–10)
and adjusted if they go beyond the chromosome sequence (L11–12). Where
peaks are present on the chromosome (L13) a loop for peaks is initiated
(L14), the sequence over each PBR stored (L15) and the count incremented
(L16). Probes IDs from the peakList are added as row names (L20) and the
sequences returned (L21). An example of loading the yeast genome sequence
for use in the function is shown (L24–27).
3.3 Discussion
These tools provide methods for easily processing ChIP-chip data of any
format in R. A new format for the storage of this data is created in the form of
the arrayData object, which all other functions presented use. Importantly,
the novel normalisation and enrichment detection procedures, presented in
the following two chapters, also work with data in this format. All functions
presented are therefore compatible with each other, with the results of one
able to be used by another.
Previously, the analysis of ChIP-chip data was generally limited to simply
determining the locations of the presence of the factor under investigation,
such as protein binding sites or the locations of epigenetic modifications (such
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as the investigation of Abf1 binding under different conditions by Schlecht
et al., 2008). Such analyses require a method of determining sites of enrich-
ment (discussed in Chapter 5), the results of which reduce the data to a list
of locations. The format of the complete data is not therefore very impor-
tant, because it would only be used in this single process. Available tools
for additional analyses are limited and disparate, meaning a simple workflow
from raw data to the type of results generated here did not exist (software
packages include those developed by Toedling et al., 2007; Andrews, 2007;
Zhang et al., 2007; Toedling and Huber, 2008). This was a particular prob-
lem for biological researchers with limited or no bioinformatic experience,
for whom analysing ChIP-chip data using these separate tools could prove
difficult. The tools presented here have been created with these people in
mind, so as to provide fast and simple ways of generating results from raw
data and plotting these graphically where relevant. The instruction docu-
ment (“instructions.pdf” in the electronic appendix; see Page 367) shows
these processes. This does not however limit the tools, as the power of the
R software allows people with the ability to use it to more advanced levels
to perform their own, customised analyses on the data in addition to those
presented here. The data can also be written to a text file during any stage
of its processing, which can be used in other programs if required. This data
may then be read back into R, if required, for further analysis or to plot the
results of this external processing.
The work here has opened up a new level of analysis of ChIP-chip data,
outlined further in the following chapters, expanding the potential of the tech-
nology and along with it the results that can be gleaned from a dataset. The
tools presented here allows this to be achieved through the new arrayData
format, which has been created to contain all of the relevant data in an easily
accessible format. Previously, most microarray data were loaded into R in a
format designed for gene expression analysis, such as the RGList object from
limma (for example, Toedling et al., 2007). While these may have been ade-
quate for basic ChIP-chip analyses, they do not have the flexibility required
to manipulate ChIP-chip data in the ways described here. The arrayData
format is simple and fully described, allowing users to access specific data
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where required, which may be used by other R functions or to create graphics
for which specific functions have not been written.
Not all of the tools presented in this chapter are completely unique, nor
are they intended to replace their existing counterparts. The plotting of
data along the genome, for example, can be achieved through a number of
other programs, such as the UCSC genome browser (Kent et al., 2002). The
other graphical functions are relatively simple and similar plots have been
created previously, although the programs used to do this have not been
published (see, for example, Pokholok et al., 2005). The functions presented
here are instead intended to bring all of the tools relevant to the ChIP-chip
analysis and processing together, within a single program, using a common
data format. This simplifies the analysis process, with data being able to
be loaded in its raw state, normalised, enrichment detection performed and
a series of graphics created in a matter of minutes. More complex analyses,
such as within the context of genome data in the genomeAnnotation object or
sequence data extracted from a downloaded genome, can then be performed
repeatedly to ask varying questions of the data. Other Bioconductor packages
can also be used to analyse the results, depending on the investigation.
A number of the functions presented in this chapter produce graphical
outputs of some sort. While these can be used as a way of demonstrating
a final result, they are primarily intended to facilitate the discovery of re-
sults, extending the hypothesis generating status of ChIP-chip by indicating
patterns or features in data that may warrant further investigation. These
patterns may not be identifiable in the data as a whole, but become appar-
ent through these methods of plotting. Mathematical processing of the data,
such as calculating the differences between the values of one dataset and an-
other, can also be plotted using these functions, expanding the potential for
the generation of new hypotheses. These can then be confirmed and demon-
strated by other methods, such as the use of other technologies or applying
statistical tests to subsets of the data.
As previously stated, it can be extremely difficult, if not impossible, to
corroborate the entire results of a ChIP-chip dataset. Confirming results for
a representative subset of data with a different technology is as close as it
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may be possible to get. The tools presented here can facilitate this in two
ways. Firstly, they can be used to determine appropriate points in the data
to test with other technologies. For example, in the enrichment detection
chapter (Chapter 5) a selection of data points are validated with Q-PCR.
To choose these points, the arrayData plot function was used to plot all of
the datasets. From this a selection of probes representing different aspects
of the data, such as different binding values, were chosen. Primers designed
around these probe locations were then used to perform Q-PCRs to validate
the results. Secondly, they can be used to display likely genuine results on
the basis of this subset of tested results. For example, if a subset of detected
peaks from a dataset are shown by another technology to be genuine binding
sites, it is reasonable to assume that all peaks represent genuine binding sites.
These peaks can then be analysed or plotted together, in various ways, to
expand the confirmed results to results that span the whole genome.
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Development of a novel
normalisation method
4.1 Introduction
Normalisation, in the context of microarray data, is the processing of different
datasets so as to reduce technical variations between them. Normalisation of
replicate datasets of the same condition (intra-dataset normalisation) aims
to reduce technical variations within these while maintaining the underlying
biological signal. Normalisation of datasets of different conditions (inter-
dataset normalisation) aims to perform the same function as intra-dataset
normalisation whilst maintaining any biologically important differences be-
tween the biological signals from the different conditions. Several normalisa-
tion methods have been developed to achieve these two objectives for gene ex-
pression microarrays, which allows comparisons to be made between mRNA
levels from different experimental conditions. No such procedure exists for
the inter-dataset normalisation of ChIP-chip data, meaning the levels from
from different experimental conditions cannot be reliably compared with each
other. The importance of normalisation to enable comparisons is summarised
by Gentleman (2005):
“Observed intensities need to be adjusted to give accurate mea-
surements of specific hybridisation. Without proper normalisa-
tion, it is impossible to compare measurements from different ar-
ray hybridisations due to many obscuring sources of variation.”
158
SECTION 4.1 CHAPTER 4
Most ChIP-chip investigations to date have been into a single condition,
or comparisons between different conditions have been very limited. In these
investigations datasets are treated in isolation and the properties of the fac-
tor under investigation are determined independently of any other factor.
Therefore the results of the investigations are generally lists of chromosomal
locations at which the factor under investigation is present, as determined
by a suitable enrichment detection method. This restricts the analysis of
the results, as each different experimental condition can only be compared in
a binary fashion, such as the Abf1 binding analysis carried out by Schlecht
et al. (2008). That is to say, only the presence or absence of the factor un-
der investigation at the same site in the datasets can be compared, not the
relative binding amounts between the datasets. This means that when com-
paring a given location between different experimental conditions the gain or
loss of the factor at the site can be identified, if it is detected in one dataset
and not the other, but a change in the level of binding between the two, if
present in both, cannot be determined, because there is no suitable method
of normalising them to allow these comparisons to be made. Comparisons
of binding levels can be made between different locations within the same
dataset, but these cannot be reliably compared to other datasets.
This inability to reliably compare relative binding levels between different
ChIP-chip datasets severely limits the potential of the technology and has
been highlighted previously (Cesaroni et al., 2008, for example). Much more
information than the simple presence or absence of a binding site is present in
datasets, but this information cannot be utilised without a suitable normali-
sation procedure. To address this problem, a novel normalisation method has
been developed here which allows any number of ChIP-chip datasets from
the same experiment to be normalised together to allow comparisons to be
made between them, in a manner similar to existing approaches for transcrip-
tion array datasets. This chapter describes this procedure, which is based on
the quantile normalisation procedure (Bolstad et al., 2003). This chapter is
written with specific reference to the Agilent yeast G4493A microarray, but
is equally applicable to data from any ChIP-chip microarray, and has also
been used with data from other platforms.
159
CHAPTER 4 SECTION 4.2
4.2 Algorithm
The normalisation process has been written as several different functions,
described in this section, which work with certain assumptions of the data
being analysed.
4.2.1 Expectations of the data
This normalisation process, and the peak detection process described in the
next chapter, is based on certain assumptions about the data being analysed,
in order to determine which probes have values representing enrichment and
which have values representing background noise. These assumptions are
that the data are split into two subpopulations and that the estimated back-
ground region of the data forms a normal distribution distinct from the dis-
tribution of the enriched region. This is the ‘perfect’ scenario, but in many
cases data may not exactly conform to these assumptions. In these situations
the normalisation and peak detection may not perform well, or may not be
able to be applied at all. Figure 4.1 shows representations of some different
possible ChIP-chip data distributions. The skewed distribution (A) is the
most commonly described ChIP-chip distribution, which has the majority of
the data points in the background sub-population, with a small proportion of
enriched values which create a tail on the right hand side of the distribution
of the background population. This is most often seen with protein binding
datasets, where a relatively small proportion of probes is enriched. The Abf1
binding datasets presented in Chapter 7 provide examples of these types of
distributions (Figure 7.2). Bimodal distributions may be created when the
enriched sub-population is larger, where this enriched sub-population may
have a lower (B) or higher density (C) than the background sub-population.
This is often seen with datasets measuring epigenetic modifications that oc-
cur throughout a genome. The histone acetylation datasets presented later
in this chapter provide examples of this type of distribution (Figure 4.8).
The background sub-population cannot be distinguished from the enriched
sub-population if all, or the vast majority, of the data points represent the en-
riched sub-population (D). The CPD datasets presented in Chapter 6 provide
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Figure 4.1: Examples of data distributions: ChIP-chip data may form skewed
(A), bimodal (B and C) and symmetrical (D) distributions as a result of
varying proportions of probes falling into the background and enriched sub-
populations.
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examples of this type of distribution (Figure 6.1). In this case the normal-
isation procedure described in this chapter cannot be applied. A potential
alternative is outlined in Section 4.4.
4.2.2 Overview
The normalisation procedure is performed on data in an arrayData object
in the following stages:
1. Remove irrelevant probe values.
2. Remove absent probe values.
3. Quantile normalise replicate datasets.
4. Shift all datasets’ pseudo-modal points to zero (the pseudo-modal shift).
5. Scale all datasets’ estimated background regions to the standard normal
distribution (the background scaling).
Each is written in a separate function, meaning procedures are always carried
out in the correct order and can be omitted if required. All are called by the
normalise function (Script 4.1), which has the following arguments:
object The arrayData object to be normalised (no default).
batches A list specifying replicate datasets to be normalised together (no
default). All datasets are treated as replicates if not specified.
reorder A logical vector specifying whether or not to reorder data according
to the order in the “batches” argument, which ensures replicate datasets
are together (default TRUE).
rmRegions A logical vector specifying whether or not to call the function
to remove irrelevant probe values (default TRUE).
regions A three-column matrix specifying regions from which to remove
probe values (no default).
rmNAValues A logical vector specifying whether or not to call the function
to remove absent probe values (default TRUE).
quantile A logical vector specifying whether or not to call the function to
perform the quantile normalisation procedure (default TRUE).
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shift A logical vector specifying whether or not to call the function to per-
form the pseudo-modal shift (default TRUE).
customShift A numerical vector specifying the centres of the estimated
background regions if these are not the pseudo-modes (no default).
scale A logical vector specifying whether or not to call the function to per-
form the background scaling (default TRUE).
rowMeans A logical vector specifying whether or not to perform normali-
sation on averaged datasets (default FALSE).
Script 4.1: normalise: script containing the normalisation functions.
1 ## normalise function ##
2 ## arguments: object (an arrayData object), batches (list of groups of
datasets to process together), regions (regions to be deleted: passed to
rmRegions function), customShift (custom shift values: passed to
shiftByMode function), rmRegions (apply the rmRegions function),
rmNAValues (apply the rmNAValues function), quantile (apply the
quantileNormalise function), shift (apply the shiftByMode function),
scale (apply the stNormScale function), reorder (reorder resulting
datasets to match the order of batches)
3 normalise <-function(object ,batches ,regions ,customShift ,rmRegions=T,
rmNAValues=T,quantile=T,rowMeans=F,shift=T,scale=T,reorder=T) { #define
the function
4 if (missing(batches)) batches <-list (1: ncol(object)) #if no batches are
provided define 1 batch
5 if (missing(customShift)) customShift <-rep(NA ,length(batches)) #if no
custom shifts provided define no custom shifts
6 if (!is.list(batches)) stop("Batches must be a list", call.=F) #check
batches is a list , stop with message if not
7 if(rmRegions & missing(regions)) warning("\"regions\" missing: unable to
rmRegions", call.=F) #warning message if no regions are provided for
the rmRegions function
8 if (rmRegions & !missing(regions)) object <-rmRegions(object ,regions) #if
regions are to be removed run the rmRegions function
9 if (rmNAValues) object <-rmNAs(object) #if NA values are to be removed run
the rmNAs function
10 count <-0 #set count to 1
11 object.n<-object #create arrayData object to store normalised data
12 for (o in 1: length(batches)) { #loop through batches
13 temp <-object[,batches [[o]]] #get data in current batch
14 if(quantile) temp <-quantileNormalise(temp) #if quantile normalisation is
to be performed run the quantileNormalise function
15 if(rowMeans) temp <-rowMean(temp)
16 if (shift) temp <-shiftByMode(temp ,custom=customShift [[o]]) #if a pseudo -
modal shift is to be performed run the shiftByMode function
17 if (scale) temp <-stNormScale(temp) #if a background scale is to be
performed run the stNormScale function
18 object.n$status[batches [[o]]] <-temp$status #get updated statuses
19 object.n$ratios[,batches [[o]]] <-temp$ratios #store normalised data
20 }
21 if(reorder) object.n<-object.n[,unlist(batches)] #reorder datasets
22 return(new("arrayData",object.n)) #return normalised data
23 }
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The function adds all datasets to the same batch (L4) and sets all custom
shift values to NA (L5) if they are not user defined. If “batches” is not a
list the function stops with a message (L6). If rmRegions is set to run but
no “regions” argument is provided, rmRegions is set not to run and a warn-
ing message printed (L7). If set to run, rmRegions (L8) and rmNAValues
(L9) are performed on all datasets. A count is defined (L10) and a new
arrayData object created (L11) before a loop through the batches is initi-
ated (L12). The data for the current batch is extracted (L13) and provided
to quantileNormalise (L14). Data are averaged at this point if required
(L15). shiftByMode (L16), with the corresponding “customShift” values)
and stNormScale (L17) are run when required. Data are reordered if re-
quired (L21) and finally returned (L22).
4.2.3 Preprocessing
Before the data can be normalised it must be prepared for the process. Pre-
processing is a generic term given to the small changes made to datasets to
prepare them for the main processing to take place. The phrase ‘garbage in,
garbage out’ is commonly used in computing as a way of highlighting the fact
that a computer will only return correct results if correct data is first input.
This initial pre-processing step is required to ensure that only the correct
data is passed on to the next processing stage and therefore that the results
produced in the subsequent analyses are correct. There are three stages to
the preprocessing of the G4493A microarray datasets, all of which remove
irrelevant data points so as to ‘tidy’ the datasets.
4.2.3.1 Removing irrelevant probe values
The first stage is to remove all probes corresponding to irrelevant data. On
the G4493A microarray these are probes for the mitochondrial genome and
a selection of genes deleted in the yeast strain BY4742. This is performed
by the rmRegions function (Script 4.2) which has the following arguments:
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object The arrayData object to be processed (no default).
deleteRegions The three-column matrix supplied by the “regions” argu-
ment of the normalise function, containing the chromosome number
and coordinates of the region(s) to be removed.
Script 4.2: rmRegions: script to remove specified regions from an arrayData
object.
1 ## rmRegions function ##
2 ##arguments: object (an arrayData object), deleteRegions (a matrix of
coordinates of regions to remove)
3 rmRegions <-function(object ,deleteRegions) { #define function
4 remove <-numeric () #initialse vector to store probes to remove
5 for (n in 1:nrow(deleteRegions)) { #loop through coordinates of regions to
be removed
6 remove <-c(remove ,which(object$coordinates [,1] == deleteRegions[n,1] &
object$coordinates [,2] <= max(deleteRegions[n ,2:3]) & object$
coordinates [,3] >= min(deleteRegions[n ,2:3]))) #get positions of
probes to be deleted
7 }
8 for (n in 1:ncol(object)) { #loop through datasets
9 object$status [[n]]<-c(object$status [[n]],"rmRegions") #add ’rmRegions ’
to arrayData status
10 object$status [[n]]<-object$status [[n]][!object$status [[n]] == "raw"] #
remove ’raw ’ from status
11 }
12 if (length(remove) > 0) { #if some probes are to be deleted
13 return(new("arrayData",object[-remove ,])) #remove the probes
14 }else{ #no probes are to be deleted
15 return(new("arrayData",object)) #return the original object
16 }
17 }
18
19 regions <-matrix(ncol=3,nrow =5) #regions to delete on the yeast 4x44k array:
20 regions [1,]<-c(2 ,473920 ,469742)
21 regions [2,]<-c(14 ,721947 ,722609)
22 regions [3,]<-c(3 ,91324 ,92418)
23 regions [4,]<-c(5 ,116167 ,116970)
24 regions [5,]<-c(17,0,Inf)
The function creates a vector to store the probe numbers to be removed (L4)
and initialises a loop for each defined region to be deleted (L5), where all
probes falling in the region are identified (L6). The status is updated for
each dataset (L8–11) and, where probes are identified to be removed, they
are taken from the returned dataset (L12–16). The matrix used to remove
regions from the yeast microarray is shown (L19–24).
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Removing probe values for the mitochondrial genome
The G4493A microarray contains 295 probes for the yeast mitochondrial
genome. These probes do not hybridise to mitochondrial DNA as well as
the genomic probes do to genomic DNA, shown with box plots of the IP
sample (red) and input sample (green) genomic and mitochondrial probes
from microarrays measuring CPDs (Figure 4.2, see Chapter 6 for further
information on the data). The average binding levels of the mitochondrial
probes are several orders of magnitude less than the genomic probes. There
is also a greater range of data values: the average standard deviation values
of the 0 hr genomic, 0 hr mitochondrial, 2 hr genomic and 2 hr mitochondrial
log2 ratios are 0.2, 1.5, 0.1 and 3.4 respectively. There is also more variation
in the range of standard deviation values for the mitochondrial probes than
the genomic. This suggests greater variability in the binding of mitochondrial
DNA to their probes than genomic DNA, making the values unreliable.
The reason for this inconsistency is not known, but is most likely due
to the GC content of the mitochondrial genome which is, at an average of
17.2%, much lower than the genomic DNA, at an average of 37.9% (Fig-
ure 4.3). This low GC content has two important implications in the context
of the microarray assays. Firstly, it can affect the two PCR amplification
steps carried out during the DNA preparation stage, as well as the labelling
reaction, which is eqivalent to a single PCR cycle. It is known that PCR
efficiency is affected by GC content, due to this causing variations in the
melting temperature of the dsDNA (Marmur and Doty, 1962). It is possi-
ble to modify the PCR reaction to better suit this low GC content DNA
(Kramer and Coen, 2001, for example), but at the expense of the genomic
DNA and so full amplification of all DNA together is not possible. Secondly,
the low GC content of the probes and complementary DNA sequences means
that they will not hybridise as efficiently to the microarrays. The bonding
between G and C nucleotides is via three hydrogen bonds whereas there are
two between A and T nucleotides. The bond between A and T is therefore
weaker than that between G and C. The abundance of A and T nucleotides
means that the binding of mitochondrial DNA to the corresponding probes
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Figure 4.3: Probe GC contents: Box plots showing the range of GC content
(%) of yeast genomic and mitochondrial probes. The mitochondrial probes
show lower values than the genomic probes, reflecting the overall content.
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will not be as strong as the genomic DNA, potentially resulting in a smaller
amount of bound DNA, which will give a lower fluorescence signal, which is
known to be the case with oligonucleotide micorarrays (Heller, 2002).
The high AT content — as a result of the low GC content — means there
exists a greater potential for the formation of CPDs, as there will be a high
number of TT dinucleotide sequences. This in turn should mean that the
immunoprecipitated binding values from the mitochondria should be higher
than the rest of the genome. In addition, there are multiple mitochondria
per cell, meaning there are many more copies of mitochondrial than genomic
DNA. This increased copy number should give higher signals to the mito-
chondrial probes than the rest of the genome. This is not the case, shown in
Figure 4.2, which further suggests the mitochondrial probes do not provide
an accurate representation of UV damage in these datasets.
This idea was confirmed by predicting the binding levels from the genome
sequence, as has been done for genomic DNA (Chapter 6). This showed a
good correlation between predicted and actual values with a Spearman’s
rank correlation coefficient of 0.77, indicating the microarray results are a
genuine representation of what is occurring in the cell. The same procedure
applied to the mitochondrial genome sequence shows no correlation between
the predicted and actual values with a Spearman’s rank correlation coefficient
of -0.01. Taking only the coding regions of the genome, which have a higher
GC content than the non-coding regions, does not improve the correlation,
with a Spearman’s rank correlation coefficient of 0.03.
Taken together these results suggest that the probes for the mitochondrial
genome do not provide reliable data for the datasets produced here and
therefore these probe values have been removed from all datasets analysed.
Removing probe values for deleted genes
The G4493A microarrays contain probes covering the whole yeast genome.
However, many laboratory strains have some genes deleted, the correspond-
ing probes for which need to be removed from analyses. The BY4742 yeast
strain most commonly used in our laboratory has four deleted genes: Lys2;
168
SECTION 4.2 CHAPTER 4
His3; Leu2; and Ura3, together covering 6,741 bp. There are 26 probes on
the G4493A microarray complementary to sites within these regions.
4.2.3.2 Removing absent values
The data analysed from the microarrays is calculated as the logarithm (base
2) of the red:green signal intensity ratios. This conversion to logarithmic
space can create absent values if either the red or green signal is negative, as
the logarithm of a negative number is not possible. This can arise after the
background subtraction has taken place, if the background intensity is greater
than the probe intensity. All data for probes across a set of datasets where
at least one has such a missing value are removed, so that all probes have a
full complement of replicates. Any statistics applied to the arrays later on
can therefore be interpreted at the same level. This should not remove more
than a small number of probes from the datasets and so will not adversely
affect the remaining analyses. The removal of many probes may suggest a
problem with one or more datasets which would require further investigation
before proceeding with the rest of the normalisation procedure. The rmNAs
script (Script 4.3) performs this function, which has the following argument:
object The arrayData object to be processed (no default).
Script 4.3: rmNAs: script to remove absent values across arrayData datasets.
1 ## rmNAs function ##
2 ## arguments: object (an arrayData object)
3 rmNAs <-function(object) {#define function
4 NAs <-numeric () #initialise vector to store probes
5 for (n in 1:ncol(object)) { #loop through datasets
6 NAs <-c(NAs ,which(is.na(object$ratios[,n]))) #get probes with NA values
7 }
8 NAs <-unique(NAs) #get unique probes
9 if(length(NAs) > 0) object$ratios[NAs ,]<-NA #replace all NA probe values
with NAs
10 message(paste(length(NAs),"NA probes")) #print the number of probes
removed
11 for (n in 1:ncol(object)) { #loop through datasets
12 object$status [[n]]<-c(object$status [[n]],"rmNAs") #add ’rmNAs ’ to
arrayData status
13 object$status [[n]]<-object$status [[n]][!object$status [[n]] == "raw"] #
remove raw from status
14 }
15 return(new("arrayData",object)) #return data
16 }
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The function creates a vector to store probes identified as containing NA
values (L4) and loops through each dataset to find these probes (L5–7).
Identified probes have all ratio values set as NA (L9) and a message is printed
showing the number of these probes found (L10). The status of all datasets
is updated (L11–14) and the new object returned (L15).
4.2.4 Full processing
The full normalisation procedure begins once the pre-processing has been
completed. Pre-processing is applied to all datasets irrespective of their
nature (inter-dataset normalisation). For the reasons discussed previously
the full normalisation procedure cannot be applied in this way and so the
following functions are applied to groups of replicate datasets separately, as
defined by the “batches” argument of the normalise function (intra-dataset
normalisation).
4.2.4.1 Quantile normalisation
Quantile normalisation is performed by the quantileNormalise function
(Script 4.4), using the preprocessCore package which implements the method
described by Bolstad et al. (2003). Briefly, the quantile normalisation pro-
cedure aims “to make the distribution of probe intensities for each array in
a set of arrays the same” (Bolstad et al., 2003). This means that all nor-
malised datasets are transformed to follow the same distribution, which can
be thought of as the average distribution of all the datasets. The procedure
is demonstrated with some randomly generated example data consisting of 3
replicates and 10 points (Table 4.1, plotted in Figure 4.4.).
Each column of the raw data is sorted from largest to smallest values and
the mean of each of these new rows is calculated (Table 4.2).
The values of each position in the row are replaced with the new mean
value and each column is reordered to its original order in the raw data
(Table 4.3).
This procedure has the effect of bringing the replicate values closer to-
gether, thus reducing the variation between datasets (Figure 4.4A, compare
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Position Replicate 1 Replicate 2 Replicate 3
1 1.66 1.88 3.36
2 1.44 1.01 4.56
3 2.80 2.22 4.25
4 2.21 2.26 5.95
5 3.14 3.83 5.24
6 3.70 3.37 5.97
7 3.12 3.41 4.43
8 2.54 2.82 4.38
9 1.73 2.54 3.45
10 1.92 1.64 3.12
Table 4.1: Quantile normalisation example data: Three replicate sets of ten
randomly generated values, representing values from a microarray containing
ten probes. Plotted in Figure 4.4A and B.
Replicate 1 Replicate 2 Replicate 3 Mean
2 1.44 2 1.01 10 3.12 1.86
1 1.66 10 1.64 1 3.36 2.22
9 1.73 1 1.88 9 3.45 2.35
10 1.92 3 2.22 3 4.25 2.80
4 2.21 4 2.26 8 4.38 2.95
8 2.54 9 2.54 7 4.43 3.17
3 2.80 8 2.82 2 4.56 3.39
7 3.12 6 3.37 5 5.24 3.91
5 3.14 7 3.41 4 5.95 4.17
6 3.70 5 3.83 6 5.97 4.50
Table 4.2: Quantile normalisation example processing: Each replicate sorted
from smallest to largest, with its original position from Table 4.1 shown in
red and the mean for each row shown in bold.
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black and red lines). One of the example datasets was deliberately given
larger values to demonstrate this point. It follows that this procedure also
reduces the standard deviation of replicates that are not initially similar (Fig-
ure 4.4B, compare black and red lines). It also gives each dataset the same
statistical properties, including the same distribution. This has the effect of
giving the replicate datasets the same density profile (Figure 4.4C, compare
black and red lines).
In performing these numerical manipulations the quantile normalisation
procedure removes a large proportion of any variations between replicate
datasets. This is demonstrated by the reduction in the size of the error
bars in Figure 4.4B. The example data generated for this demonstration
consists of 3 replicates, one of which is deliberately different from the others
(Table 4.1 and Figure 4.4A) to demonstrate the ability of the normalisation
procedure to remove this difference. This is representative of real ChIP-chip
data, which are rarely similar before normalisation, hence the need to apply
a normalisation procedure. Figure 4.4B shows that the means of the datasets
are not greatly changed by the procedure.
Figure 4.5 shows Q-Q plots of the raw and quantile normalised data. As
expected, all normalised data follow the same distribution, evidenced by all
their points lying on the line y = x.
Quantile normalisation is applied to each set of replicate datasets (intra-
dataset normalisation) to remove variations between theoretically identical
datasets. Figure 4.4C demonstrates why this procedure cannot be applied
to datasets from different biological conditions. If, for example, the third
example dataset (which is deliberately shown with larger values than the
other two datasets to demonstrate the normalisation procedure) was from a
different experimental condition and as a result had higher values due to a
change in biology, a normalisation method should not seek to remove this,
but maintain these differences between the two. Quantile normalisation does
remove these differences, by creating a new distribution somewhere between
the initial distributions. This not only reduces the larger values but increases
the smaller values, which is detrimental to both sets of results and removes
the biological relevance. This is why groups of replicate datasets are provided
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Figure 4.4: The effect of quantile normalisation on data: A: The example
data from Table 4.1 (black) and the quantile normalised data from Table 4.3
(red). B: Means of the example data from Table 4.1 (black) and the quantile
normalised data from Table 4.3 (red). Error bars represent ±1 standard de-
viation. C: Density profiles of the example data from Table 4.1 (black) and
the quantile normalised data from Table 4.3 (red). The quantile normali-
sation procedure makes all datasets follow the same distribution, hence the
appearance of a single red line.
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Position Replicate 1 Replicate 2 Replicate 3
1 2.22 2.35 2.22
2 1.86 1.86 3.39
3 3.39 2.80 2.80
4 2.95 2.95 4.17
5 4.17 4.50 3.91
6 4.50 3.91 4.50
7 3.91 4.17 3.17
8 3.17 3.39 2.95
9 2.35 3.17 2.35
10 2.80 2.22 1.86
Table 4.3: Quantile normalisation example result: The original data replaced
with the mean values from Table 4.2 and reordered to the original order in
Table 4.1 to create quantile normalised data. Plotted in Figure 4.4A and B.
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Figure 4.5: Example data quantile-quantile plots: A: Raw data do not follow
the same quantiles. B: quantile normalised data follow the same quantiles.
Lines show y = x.
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separately. The function has the following arguments:
object The arrayData object to be processed (no default).
Script 4.4: quantileNormalise: script to apply the preprocessCore
normalise.quantiles function to an arrayData object.
1 ## quantileNormalise function ##
2 ## arguments: object (an arrayData object)
3 quantileNormalise <-function(object) { #define function
4 require(preprocessCore) #load package containing qualtile normalisation
function
5 object$ratios <-normalize.quantiles(object$ratios) #perform quantile
normalisation
6 for (n in 1:ncol(object)) { #loop through datasets
7 object$status [[n]]<-c(object$status [[n]],"quantileNormalise") #add ’
quantileNormalise ’ to status
8 object$status [[n]]<-object$status [[n]][!object$status [[n]] == "raw"] #
remove ’raw ’ from status
9 }
10 return(new("arrayData",object)) #return quantile normalised data
11 }
The function loads the preprocessCore package if not already present (L4)
and performs the quantile normalisation on the arrayData ratio values (L5).
The status of all datasets is updated (L6–9) and the new object returned
(L10).
The intra-replicate quantile normalisation process is followed by a novel
inter-replicate normalisation procedure which normalises them together, whilst
seeking to maintain any biologically relevant differences, allowing relative
comparisons to be made between them.
4.2.4.2 Pseudo-modal shift and background scaling
The extended normalisation procedure aims to mimic the quantile normal-
isation procedure on only a subset of data. The subset used is an estimate
of the background population of probes, that is, probes that do not repre-
sent enriched sections of the genome. This background population should
therefore be a list of zero values, but the inherent variation of noise in the
assay means it approximates a normal distribution. This distribution should
be centred around zero, but variations in the assay mean it may not be. In
an assay performed where no material is enriched, all of the probes would
175
CHAPTER 4 SECTION 4.2
fall within this approximately normal background distribution. If two such
assays were performed and were to be compared, they could be quantile
normalised together to form a third normal distribution, because a priori
knowledge states that they are theoretically identical and therefore quantile
normalisation is applicable. An equivalent procedure would be to shift and
scale one or both distributions such that they follow the same distribution,
that is, have the same mean and standard deviation. If both were exactly
normally distributed they would both exactly follow the new distribution,
as achieved with quantile normalisation. If they both approximate normal
distributions, as they would in real data, they would approximately follow
the same distribution following the shift and scale. Therefore taking two
sets of background values and shifting them to centre on the same point and
scaling them to have the same standard deviation makes them comparable,
in the same way they would be if they were quantile normalised. This is the
basis of the novel normalisation procedure presented here, where the overall
distribution of values is used to estimate the background values, which are
shifted to centre on 0 and scaled to a standard deviation of 1 (creating the
standard normal distribution).
Real ChIP-chip data consist of two sub-populations: enriched and non-
enriched probes. These two sub-populations overlap to create the previ-
ously described skewed distribution, the skew as a result of the enriched
sub-population consisting of larger values than the background. The fact
that most ChIP-chip datasets have this background subpopulation as well as
the enriched subpopulation means that it can be used as a constant between
different datasets. Shifting and scaling each background population to follow
the same distribution makes them comparable, as described above. Shifting
and scaling the enriched population along with them means that these also
become comparable between the different datasets.
As the two subpopulations of data are not distinct, an estimate of the
background subpopulation is made by calculating kernel density estimates of
the data via the density command in R and shifting the data to centre the
highest point on zero (Figure 4.6). This is equivalent to aligning the data
by their modal points, but the nature of the data is such that each value is
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0 
Figure 4.6: Representation of the pseudo-modal shift: Grey lines represent
datasets, with their pseudo-modal points indicated with a dashed red line.
The datasets are shifted, upwards or downwards, so that this point lies on
zero. The black line represents a dataset following the pseudo-modal shift.
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rarely replicated and so this pseudo-mode has to be calculated. This is based
on the assumption that this point represents the centre of the background
subpopulation. This is true if the background subpopulation consists of more
than half of the probes. If more than half are enriched the highest point
of the distribution represents the enriched subpopulation, but the peak of
the background subpopulation can still be estimated if the distribution is
bimodal. If a large proportion of probes are enriched and the peak of the
background subpopulation cannot be estimated then this method cannot be
applied.
A Gaussian smoothing kernel is used to create the density plot from which
the pseudo-mode is predicted. Kernel density estimation is non-parametric,
that is, it does not assume any underlying distribution in the data. This is
important as there can be a lot of variation in the distributions of different
datasets and the distribution of any given dataset is not known. A histogram
is a simple form of non-parametric density estimation, which uses counts of
data in a number of bins of set width throughout the dataset. The smoothing
estimate uses a mathematical formula to create the density, which is com-
posed of a number of kernels, one at each data point. In the case of Gaussian
smoothing, each follows a Gaussian distribution. The overall density is the
total of these kernels. R provides 6 other smoothing methods: epanech-
nikov; rectangular; triangular; biweight; cosine; and optcosine, which use
varying distributions as the kernels. All of these methods provide similar
or identical pseudo-modes to the Gaussian method for the H3Ac and Gcn5p
binding datasets (“Kernel density estimates.pdf” file in electronic appendix;
see Page 367). Where there are variations between the different pseudo-
modes, the Gaussian method always produces the most common result for
these datasets, showing it is the most appropriate method to use. However,
the variations between the different methods are so small that the impact on
the final result would be negligible alongside the other sources of variation.
The shifting of the data is achieved via the shiftByMode function (Script 4.5),
which has the following arguments:
object The arrayData object to be processed.
custom A value from the distribution to be centred over 0, where the
178
SECTION 4.2 CHAPTER 4
pseudo-mode is not the centre of the estimated background popula-
tion.
Script 4.5: shiftByMode: script to shift an arrayData object to centre its
pseudo-modal value on zero.
1 ## shiftByMode function ##
2 ## arguments: object (an arrayData object), custom (a value to shift to zero
if not the psedo -mode)
3 shiftByMode <-function(object ,custom=NA) { #define function
4 if (missing(custom)) custom <-NA #check for custom shift
5 for (m in 1:ncol(object)) { #loop through datasets
6 if (is.na(custom)) { #if no custom value specified
7 shift <-density(object$ratios[,m],na.rm=T)$x[which.max(density(object$
ratios[,m],na.rm=T)$y)] #find pseudo -mode
8 }else{ #custom value specified
9 shift <-custom #get custom shift value
10 }
11 object$ratios[,m]<-object$ratios[,m]-shift #shift dataset by appropriate
amount
12 }
13 for (n in 1:ncol(object)) { #loop through datasets
14 object$status [[n]]<-c(object$status [[n]],"shiftByMode") #add ’
shiftByMode ’ to status
15 object$status [[n]]<-object$status [[n]][!object$status [[n]] == "raw"] #
remove ’raw ’ from status
16 }
17 return(new("arrayData",object)) #return pseudo -modal shifted data
18 }
The function sets the custom shift value to NA if none is provided (L4) and
initiates a loop through the datasets (L5). Where no custom shift is defined
the density function is used to identify the pseudo-mode of the dataset
which defines the value to shift the data by, otherwise the custom value is
used (L6–10). The dataset is then shifted by this amount (L11). The status
of all datasets is updated (L13–16) and the new object returned (L17).
The pseudo-modal shift takes account of additive differences between dif-
ferent datasets. For example, if one dataset has all intensity values a number
of units greater than those of another dataset, the shift would correct this by
bringing both datasets to the same background level such that the differences
in intensity values are removed. It cannot however remove multiplicative
(scale) differences which occur at increasing or decreasing levels throughout
a dataset. Smyth and Speed (2003) point out the need to take account of
these potential scale differences,
“Sometimes there are substantial scale differences between mi-
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croarrays, because of changes in the photomultiplier tube settings
of the scanner or for other reasons. In these circumstances it is
useful to scale-normalize between arrays.”
This is the function of the background scaling part of the normalisation
process, performed by the stNormScale function (Script 4.6). Mirroring
the left had side of the background population (all of the negative values
following the shift to zero) onto the right hand side (Figure 4.7 inset) allows
an estimate of the standard deviation to be calculated. A scale factor is then
calculated as 1 ÷ the standard deviation of this mirrored data. The whole
dataset is multiplied by this factor to scale it to the required distribution
(Figure 4.7). The background subpopulation then approximates the same
(standard normal) distribution for all datasets and comparisons of enriched
values can be made relative to this constant. The function has the following
argument:
object The arrayData object to be processed.
Script 4.6: stNormScale: script to scale the mirrored background distribution
to approximate the standard normal distribution.
1 ## stNormScale function ##
2 ## arguments: object (an arrayData object)
3 stNormScale <-function(object) { #define function
4 for (n in 1:ncol(object)) { #loop through datasets
5 if ("shiftByMode" %in% object$status [[n]]) { #if dataset has been
shifted by its mode
6 ratios <-object$ratios[,n] #get ratios
7 ratios.low <-ratios[which(ratios < 0)] #get ratio values below mode
8 SD<-sd(c(ratios.low ,abs(ratios.low))) #calculate standard deviation of
mirrored data
9 object$ratios[,n]<-object$ratios[,n]*(1/SD) #multiply dataset by factor
to make background standard deviation 1
10 object$status [[n]]<-c(object$status [[n]],"stNormScale") #add ’
stNormScale ’ to status
11 object$status [[n]]<-object$status [[n]][!object$status [[n]] == "raw"] #
remove ’raw ’ from status
12 }else{
13 warning(paste("shiftByMode has not been applied to dataset ",colnames(
object$ratios)[n],": stNormScale not applied"), call.=F) #warning
message if dataset has not been shifted by its mode
14 }
15 }
16 return(new("arrayData",object)) #return background scaled data
17 }
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0 
Figure 4.7: Representation of the background scaling: Grey lines represent
datasets to be scaled, with arrows indicating whether they should be made
larger or smaller. The black line represents the datasets following scaling,
where the estimated background values follow the standard normal distribu-
tion. Inset: the standard normal distribution (red dashed line) approximates
the background values of the shifted and scaled data (black line).
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The function initiates a loop through the datasets (L4) and checks that each
one has had the shiftByMode function applied (L5). If so, the ratio values
are extracted (L6) and those below zero taken (L7) and mirrored to find
the standard deviation (L8). The whole dataset is then multiplied by the
reciprocal of this value (L9). The status of the dataset is updated (L10–
11). If the dataset has not had the shiftByMode function applied a warning
message is printed and the scale is not applied (L12–13). The new object is
returned (L16).
4.3 Application
The full normalisation procedure was applied to two sets of ChIP-chip data:
10 histone H3 acetylation (H3Ac) datasets under two conditions: no UV
treatment (0, 5 replicates) and 60 minutes after UV treatment (60, 5 repli-
cates); and 11 datasets of Gcn5p binding (Gcn5p) under four conditions: no
UV treatment (U, 3 replicates), immediately after UV treatment (0, 3 repli-
cates), 15 minutes after UV treatment (15, 2 replicates) and 60 minutes after
UV treatment (60, 3 replicates). These datasets were generated by Dr. Katie
Evans and Dr. Richard Webster and their full analysis is presented in Evans
(2011). All data files are available in the electronic appendix (see Page 367).
The effect of the normalisation procedure from one stage to the next for
this data is shown as density curves for all datasets (Figures 4.8 and 4.9) and
genome plots with the sets of untreated replicates (Figures 4.10 and 4.12)
and averaged datasets from all different conditions (Figures 4.11 and 4.13).
The density plots show data from each normalisation stage (dashed red lines)
with the data from the previous stage (solid black lines). The genome plots
show profiles of the data at each normalisation stage across a section of
chromosome 5.
The preprocessing of the data has little effect on the overall shape of the
distributions of the data: the red lines, showing the preprocessed data den-
sities, follow the same pattern as the black lines, showing raw data densities
(parts A of Figures 4.8 and 4.9). This is because the majority of the data re-
main unaltered by the process, with only a relatively small number of probes
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Figure 4.8: Density plots of H3Ac data undergoing normalisation: The appli-
cation of preprocessing (A), quantile normalisation (B), pseudo-modal shift-
ing (C) and background scaling (D) of no UV treatment (1) and 60 min after
UV treatment (2) datasets. Black lines show data pre- and dashed red lines
post-application of each step.
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Figure 4.9: Density plots of Gcn5p data undergoing normalisation: The
application of preprocessing (A), quantile normalisation (B), pseudo-modal
shifting (C) and background scaling (D) of no UV treatment (1), 0 min
after UV treatment (2), 15 min after UV treatment (3) and 60 min after
UV treatment (4) datasets. Black lines show data pre- and dashed red lines
post-application of each step. Continued on next page. . .
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Figure 4.9: Continued from previous page.
185
CHAPTER 4 SECTION 4.3
lll l l ll ll l lll l ll l l ll ll l l l llll ll l lll ll ll l l ll l lll l ll llllll llllll lllll ll l ll l l l l l lllll ll l l ll lll l l ll lll l ll l lChr. 5
H
3A
c 
le
ve
l
(lo
g2
)
A
−
1
1
3
10000 15000 20000 25000 30000 35000 40000
lll l l ll ll l lll l ll l l ll ll l l l llll ll l lll ll ll l l ll l lll l ll llllll llllll lllll ll l ll l l l l l lllll ll l l ll lll l l ll lll l ll l lChr. 5
H
3A
c 
le
ve
l
(lo
g2
)
B
0
1
2
3
10000 15000 20000 25000 30000 35000 40000
lll l l ll ll l lll l ll l l ll ll l l l llll ll l lll ll ll l l ll l lll l ll llllll llllll lllll ll l ll l l l l l lllll ll l l ll lll l l ll lll l ll l lChr. 5
H
3A
c 
le
ve
l
(lo
g2
)
C
−
1
1
2
10000 15000 20000 25000 30000 35000 40000
lll l l ll ll l lll l ll l l ll ll l l l llll ll l lll ll ll l l ll l lll l ll llllll llllll lllll ll l ll l l l l l lllll ll l l ll lll l l ll lll l ll l lChr. 5
H
3A
c 
le
ve
l
(lo
g2
)
D
−
2
0
2
4
10000 15000 20000 25000 30000 35000 40000
Figure 4.10: Profiles of replicate H3Ac data undergoing normalisation: Pre-
processed (A), quantile normalised (B), pseudo-modal shifted (C) and back-
ground scaled (D) replicate no UV treatment data over a section of chromo-
some 5. Note the changes of y-axis scales between the different plots.
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Figure 4.11: Profiles of averaged H3Ac data undergoing normalisation: Pre-
processed (A), quantile normalised (B), pseudo-modal shifted (C) and back-
ground scaled (D) averaged no UV treatment (black) and 60 min post-UV
treatment (red) data over a section of chromosome 5. Note the changes of
y-axis scales between the different plots.
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Figure 4.12: Profiles of replicate Gcn5 binding data undergoing normalisa-
tion: Preprocessed (A), quantile normalised (B), pseudo-modal shifted (C)
and background scaled (D) replicate no UV treatment data over a section of
chromosome 5. Note the changes of y-axis scales between the different plots.
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Figure 4.13: Profiles of averaged Gcn5 data undergoing normalisation: Pre-
processed (A), quantile normalised (B), pseudo-modal shifted (C) and back-
ground scaled (D) averaged no UV treatment (black), 0 min post -UV treat-
ment (red), 15 min post-UV treatment (green) and 60 min post UV treatment
(blue) data over a section of chromosome 5. Note the changes of y-axis scales
between the different plots.
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being removed from the datasets. The range of the datasets decreases follow-
ing preprocessing (the limits of the red lines are less than the black) because
the quality of the probes removed is poor, meaning that they generally have
outlying values at the extremes of the distributions.
The quantile normalisation has a slightly larger effect on the data, bring-
ing all of the replicate datasets to the same distribution: all densities overlap
as seen by the single red line on the plots (parts B of Figures 4.8 and 4.9).
This does not however bring them all to the same profile (Figures 4.11 and 4.13),
as the process is independent of genomic position. That is, although the
points at any given point in the distribution are equal, these are not neces-
sarily at identical points on the genome. Therefore while each dataset has,
for example, identical maximum and minimum values, meaning the distri-
butions start and end at the same points, these maxima and minima can
(and do) appear at different probes. The process does however reduce the
variation between the probes of the different datasets, shown by the pro-
files of the quantile normalised datasets being more similar than those of the
raw data. This process does not take any variation between datasets from
different experimental conditions into account.
The pseudo-modal shift can have a small or large effect on the datasets
(parts C of Figures 4.8 and 4.9), depending on the original position of the
pseudo-mode. Datasets with the pseudo-mode already centred at or near zero
are shifted on the horizontal axis a small amount (Figure 4.9 C1, for example,
where the red line is almost on top of the black line), thereby having a small
effect on the dataset. The further the pseudo-mode is from zero, the greater
the effect on the dataset, as a greater shift is required (Figure 4.9 C3, for
example, where the red line is further to the left of the black line). These
can be seen in the genome plots as shifts on the vertical axis. Replicate
datasets are shifted by the same amount (Parts C of Figures 4.10 and 4.12),
maintaining the same profile, while different datasets are shifted by different
amounts (Parts C of Figures 4.11 and 4.13), changing the relative positions
of the datasets.
As with the pseudo-modal shift, the effect of the background scaling is
dependent on the original distribution of the background sub-population,
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with the further the sub-population distribution from the standard normal
distribution the greater the effect on the dataset as a greater scaling is re-
quired. Unlike the pseudo-modal shift, which influences all values equally,
the background scaling has a larger effect on probes with higher values, as it
is multiplicative. Therefore even a small scaling can potentially have a large
effect on a dataset that contains large values in the enriched sub-population.
The density plots (parts D of Figures 4.8 and 4.9) show this scale extends
the limits of the datasets, reducing the density accordingly. This change can
be seen more clearly in the the y-axis scale of the genome plots of replicate
datasets (Parts D of Figures 4.10 and 4.12). As with the pseudo-modal shift,
the scaling is different with each different set of replicate datasets, which
can be seen as further relative changes between the datasets (Parts D of
Figures 4.11 and 4.13).
As previously discussed, the aim of the normalisation procedure is to
make the distributions of estimated background regions of different datasets
the same, so as to enable comparisons to be made between the enriched
regions. This objective was investigated by creating QQ-plots of the different
datasets. Figure 4.14 shows pre-and post-UV treatment H3Ac data after
preprocessing (A), quantile normalisation (B), the pseudo-modal shift (C)
and background scaling (D). The grey box shows values less than zero, that
is, the estimated background region. Alignment of the data points on the
line y = x in this region shows equal background distributions, while data
points lying around this line show similar distributions. The distributions of
the fully normalised data in these background regions are similar (shown in
parts D) having the bulk of their data points lying on or around this line.
As discussed previously, the estimated background regions of the datasets
do not need to follow exactly the same distribution for the normalisation to
be effective, they need only approximate the same distributions. This makes
the enriched regions comparable. Similar QQ-plots are shown for the Gcn5p
datasets at the three time points following UV irradiation plotted against
the untreated, showing results pre- and post-normalisation (Figure 4.15).
These plots also show the approximate alignment of the background regions
following the normalisation procedure.
191
CHAPTER 4 SECTION 4.3
−3 −1 1 2 3 4
−
3
−
1
1
2
3
4
H3Ac pre−UV
H
3A
c 
60
 m
in
 p
os
t−
UV
A
−3 −1 1 2 3 4
−
3
−
1
1
2
3
4
H3Ac pre−UV
H
3A
c 
60
 m
in
 p
os
t−
UV
B
−3 −1 1 2 3 4
−
3
−
1
1
2
3
4
H3Ac pre−UV
H
3A
c 
60
 m
in
 p
os
t−
UV
C
−6 −2 2 4 6
−
6
−
2
2
4
6
H3Ac pre−UV
H
3A
c 
60
 m
in
 p
os
t−
UV
D
Figure 4.14: Q-Q plots of H3Ac data undergoing normalisation: Pre- and
post-UV datasets following preprocessing (A), quantile normalisation (B),
the pseudo-modal shift (C) and background scaling (D). The grey region
shows values less than zero, that is, the estimated background region. The
black line shows y = x, that is, equality between the two datasets. Note that
part D is shown at a different scale.
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Figure 4.15: Q-Q plots of Gcn5p data pre- and post-normalisation: Pre-UV
datasets plotted against the three post-UV datasets(0 min (A), 15 min (B)
and 60 min (C)) before (1) and after (2) normalisation. The grey region
shows values less than zero, that is, the estimated background region. The
black line shows y = x, that is, equality between the two datasets. Note the
changes of scales between the pre- and post-normalisation data plots.
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4.3.1 Validation
A method independent of hybridisation to microarrays was used to validate
the results of the normalisation procedure, namely Q-PCR. The fully nor-
malised datasets were used to choose regions of the genome to test by this
method. Six probes were chosen (details in “Q-PCR probes.pdf” in the elec-
tronic appendix; see Page 367) showing a range of different values in both
the treated and untreated datasets. The chosen regions are shown in Fig-
ure 4.16, with black lines showing averaged untreated and red lines showing
averaged UV treated. Two probes show similar low values both before and
after treatment (A), two show high enrichment before and after treatment (B
and E) and two show low enrichment before treatment and high afterwards
(C and D). PCR primers were designed around these probes and Q-PCR
reactions performed by Dr. Katie Evans.
The values for these probes throughout the normalisation process are
shown as bar charts in Figure 4.17, showing the values from preprocessed (A),
quantile normalised (B), pseudo-modal shifted (C) and background scaled
(D) data. This shows that the values at the end of the procedure are differ-
ent from those at the start, with the whole process required to bring out the
differences between the values from the different conditions. These values are
shown (out of log scale for comparison to the Q-PCR data) in Figure 4.18A
along with the Q-PCR results in Figure 4.18B. Untreated values shown as
dark grey and treated values as light grey. These values are shown together
in Figure 4.18C, with microarray values scaled relative to the untreated Q-
PCR values. Shaded bars show Q-PCR results against the corresponding
unshaded bars of the microarray results. It is clear that there is a strong
relationship between all Q-PCR and microarray data. T-tests performed on
these values show that the microarray values are not significantly different
to the Q-PCR values following the normalisation procedure (raw and FDR
corrected P-values are shown in Table 4.4). This is in contrast to the com-
parison of raw values, the results of which produce smaller P-values, with
one statistically significantly different set of values at the 95% significance
level (raw and FDR corrected P values are shown in Table 4.5). Corre-
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lating the two sets of values (Figure 4.19) shows a similar result: the raw
microarray data (black points) show no correlation with their corresponding
Q-PCR values, with a Spearman’s Rank Correlation Coefficient rho value of
0.314, while the normalised data (red points) show a high correlation, with
a rho value of 0.943. This shows that the normalisation procedure is re-
quired to convert the microarray data to a scale that accurately reflects the
true biological state. Together this shows that the normalisation procedure
works as expected and transforms the data into a format that allows relative
comparisons to be made between different datasets, here untreated and UV
treated H3Ac levels. Similar validation work is currently being performed at
a number of sites from the Gcn5 binding datasets.
4.4 Alternative process
In situations where this normalisation process cannot be applied, such as
where a background population is absent (if a whole genome is enriched),
or indistinct (if there are too few probes in the background to form a clear
subset), artificial DNA may be added to fulfill a similar function.
4.4.1 DNA spikes
Spikes are fragments of genetic material of known, varying concentrations
added to the genetic material being assayed with a microarray, which have
unique corresponding probes on the microarray. There are several examples
of experimental techniques where spiked in DNA have been used. Several
of these investigations have been into gene expression microarray normalisa-
tion techniques, where the addition of DNA of known concentrations allows
various normalisation processes to be compared against a set of constant ref-
erence values. Chua et al. (2006) for example compare five normalisation
methods with spike ins representing 200 differentially expressed (DE) genes.
Similarly, Ryde´n et al. (2006) compare 252 normalisation methods with 8 DE
genes and 12 non-differentially expressed (NDE) genes at varying concentra-
tions, each represented 480 times on the microarray. McCall and Irizarry
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Figure 4.16: Probes chosen for Q-PCR analysis: Six probes showing a range
of H3Ac values were selected from five regions. Probe positions are high-
lighted with red crosses. Black lines show averaged untreated data, red lines
show averaged 60 min post-UV treatment data.
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Figure 4.17: Bar charts of data from probes chosen for Q-PCR: Prepro-
cessed (A), quantile normalised (B), pseudo-modal shifted (C) and back-
ground scaled (D) data for the six probes chosen for Q-PCR. Error bars
show standard errors.
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Figure 4.18: Bar charts of microarray and Q-PCR data: Untreated (dark
grey) and treated (light grey) values from the microarrays (A) and Q-PCRs
(B) for the six tested probes. Microarray values have been taken out of
log scale to enable comparisons with Q-PCR values. Combined data (C)
shows microarray (unshaded) and Q-PCR (shaded) values are very similar
across all values tested. In C the Q-PCR values are scaled so as to bring the
untreated values to the respective microarray untreated value. Error bars
show standard errors.
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Site P-value FDR value
1 0.653 0.813
2 0.769 0.813
3 0.643 0.813
4 0.813 0.813
5 0.510 0.813
6 0.410 0.813
Table 4.4: Normalised microarray and Q-PCR comparison P-values: Raw
and FDR corrected P-values from t-tests comparing normalised microarray
and Q-PCR results for the six tested values.
Site P-value FDR value
1 0.789 0.789
2 0.729 0.789
3 0.276 0.413
4 0.074 0.164
5 0.082 0.164
6 0.005 0.032
Table 4.5: Raw microarray and Q-PCR comparison P-values: Raw and FDR
corrected P-values from t-tests comparing raw microarray and Q-PCR results
for the six tested values.
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Figure 4.19: Microarray and Q-PCR values correlation: Raw (black) and
normalised (red) microarray data plotted against their corresponding Q-PCR
values for the six tested values. Each point shows the number of the tested
site.
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(2008) use spike ins to compare gene expression results from Affymetrix, Ag-
ilent and Illumina microarrays. These methods may have provided useful
information about different normalisation procedures, and demonstrated the
usefulness of spike in DNA, but were not designed to be used alongside real
data as a full normalisation procedure.
Fardin et al. (2007) addressed this problem by suggesting using spiked
in DNA to normalise low density gene transcription microarrays. These are
microarrays containing only a selection of genes of interest to a particular
investigation. As such they do not have the large population of NDE genes
used in global normalisation and so require a different normalisation method.
They used 8 RNA spikes to normalise 178 genes using the composite loess
method. This constructs a curve through the spike in values and normalises
all values based on this curve (Smyth and Speed, 2003).
Johnson et al. (2008) used DNA spikes to test various microarray plat-
forms and normalisation methods with ChIP-chip data. A total of 100 se-
quences at varying concentrations were spiked into reference DNA and sent
to 7 different laboratories for analysis. This shows that spiked in DNA is
detectable and useful in ChIP-chip as well as gene expression microarray
investigations.
To the best of my knowledge, there have been no attempts to normalise
ChIP-chip data using spiked material. We attempted to develop a method to
normalise any ChIP-chip datasets that are not suited to the novel procedure
presented above because they do not have a distinct background region. DNA
damage is one such example, which can occur at sufficiently high a level
throughout a genome that no background region sub-population exists to
be used for normalisation. Therefore the comparison of damage levels at
different time points is not possible without the addition of artificial constants
in the form of spikes.
The Escherichia coli genome was chosen as a source to design spike DNA
probes from. This would reduce the likelihood of significant sequence similar-
ity to the yeast and human genomes used experimentally in our laboratory,
and any other eukaryotic genome that may be analysed the future. The first
∼700,000 nt of the E. coli genome was split into 60 nt sequences (the length
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of the probes on the Agilent microarrays). These ∼12,000 sequences were up-
loaded to Agilent’s eArray program (https://earray.chem.agilent.com/
earray/) and analysed using this software to assign a score to each probe.
Full information on how these scores are calculated is not provided, but
factors such as melting temperature, GC content, hairpin ∆G formation,
sequence complexity and homology to the reference genome are taken into
account (Agilent Technologies Inc., 2010a). The scores range from 0 to 1,
with higher scores representing a greater “likelihood that a probe will pro-
duce a good log ratio response.”
All probes with scores greater than 0.95 (1020 total) were analysed for
sequence similarity to the yeast and human genomes with BLAST searches
(Altschul et al., 1990). The blastn program was used, which accommodates
short sequences, and the “Automatically adjust parameters for short input
sequences” box checked to ensure that accurate results were generated with
the short sequences being tested. The 100 probes with the least similarity to
both genomes were taken and used as the initial set of spikes. The statistics
for these probes are summarised in Table 4.6 and shown in full in “Spike
probe information.pdf” in the electronic appendix (see Page 367).
Statistic Human Yeast
No similarity 73 27
Longest similar stretch 30 31
Overall mean similarity 6.3 15.1
Mean similarity with some match 23.2 20.7
Table 4.6: Spike probes summary: Lengths of continuous sequence matches
between the spike probes and the human and yeast genomes.
These probes were added to two custom microarray designs, one each
for yeast and human. The yeast design is the same as that on the G4493
microarrays, with all probes for the mitochondria removed. The human
design contains 39,517 probes over a 5,000,000 region of chromosome 17,
from positions 10,000,000 to 15,000,000, giving an average resolution of one
probe every 126.5 nt.
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Work to use these spike probes as part of a full normalisation procedure
is ongoing in our laboratory.
4.5 Discussion
The novel normalisation procedure presented here allows for the comparison
of data from different microarray experiments to facilitate the discovery of
biologically relevant results beyond the currently detectable large, wholesale
changes, greatly expanding the use of ChIP-chip datasets. Changes in levels
of protein binding, histone modifications or other biological factors can now
be detected and compared under a variety of experimental conditions, where
previously only the presence or absence of binding could be reliably inferred.
This has been demonstrated with H3Ac data from ten microarrays under two
different experimental conditions, revealing genome wide variations in levels
between the different conditions.
Previously, the primary motivation for creating ChIP-chip datasets was
to determine where in the genome a particular feature of interest is present,
be that a protein, epigenetic modification, or other factor that can be iden-
tified by immunoprecipitation. Once this had been determined, by use of
some enrichment or peak detection algorithm, the dataset becomes largely
redundant, being replaced by a list of locations or regions identified as con-
taining the feature of interest. For example, Schlecht et al. (2008) perform an
analysis of Abf1 binding under three different conditions (fermentation, respi-
ration, and sporulation) in this way, determining sites of changed occupancy
between the three conditions. The data from the probes at these locations
may be analysed further, to examine relative binding levels within the same
dataset, or the list may be left as it is, reducing the data to a simple boolean
representation of the genome, showing whether binding is present (TRUE)
or absent (FALSE) at each probe of the microarray. Comparisons between
different datasets was limited by this treatment of the data, and could only
determine whether or not the presence of the factor of interest appeared,
disappeared or stayed the same at a given location. If it stayed the same, the
relative binding level between the two conditions could not be determined
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because of the lack of a normalisation procedure that could be applied to the
different datasets to allow comparisons to be made between them. The novel
normalisation procedure presented here overcomes this problem, revealing an
extra dimension of analysis of ChIP-chip data by giving new meaning to the
binding values of the datasets.
This is not a new concept in the microarray field, with gene expression
microarrays — the most popular use of microarray technology — allowing
comparisons to be made between the levels of mRNAs present in cells from
different conditions. This is possible due to the normalisation of the different
datasets, of which there are many methods. These methods are not applicable
to ChIP-chip data, and no alternative existed, constraining the application of
the technology. The method presented here removes this constraint, opening
ChIP-chip technology up to a wealth of possible new applications. Rather
than reducing the datasets to lists of positions, more robust comparisons can
be performed to determine relative increases or decreases of binding between
the different datasets, coupled with appropriate statistical tests.
While a useful tool for researchers wishing to compare microarrays from
different conditions, there are a number of inherent caveats which should
be taken into account. The method relies on the previously noted expec-
tation that the background sub-populations of data approximately follow a
normal distribution. If this assumption is not met then the scaling part of
the normalisation method may fail, as it will be unable to create the stan-
dard normal distribution from non-normally distributed data. In practice,
small deviations from the normal distribution will not have a large effect on
the results of the normalisation procedure as it will still enable this portion
of the data to approximate the standard normal distribution. In our labo-
ratory we have not seen any examples of datasets that have a background
sub-population that does not approximate a normal distribution. Situations
where the background sub-population is very different to the normal distri-
bution are likely to represent poor quality across the whole dataset and so it
may not be suitable for inclusion in further analyses.
The method requires a clear maximum in the sub-population of back-
ground data at which to assign the pseudo-mode to centre on zero. If this is
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not present then this shift cannot be applied. It is worth noting that while
in most assays this is usually the maximum of the whole population, and
this is what the algorithm automatically searches for, it is not a requirement
that this is the case. If the enriched portion of the data is larger than the
background, this will have the largest peak in the distribution. However,
provided there is still a discernible peak in the background sub-population
this can be manually identified and specified to the algorithm. This allows
for accurate normalisation even when more than 50% of the probes repre-
sent enrichment. The method cannot be applied when all or the majority of
probes are enriched as no estimate of the background will be possible, such
as the case with CPD damage (see Chapter 6). In this scenario, data from
spike probes may be used in place of the background. This methodology is
currently being developed in our laboratory.
This shifting method may introduce small errors, as it is based on an
estimated pseudo-mode. However, there are many other sources of variation
in microarray experiments which limit the accuracy of results and so any
further small variations will not adversely affect the conclusions that can be
drawn. Any introduced variation should be borne in mind along with the
other sources of variation and taken into account when performing analy-
ses. Microarray data should not be treated as a definitive results, rather a
platform from which to generate hypotheses which can be tested by more
sensitive techniques.
The method has been developed to allow comparisons of differences in a
single factor due to changes in experimental conditions. It cannot reliably
compare between data with other sources of variation as these will introduce
undetectable variations. For example, datasets generated with different anti-
bodies used in the immunoprecipitation stage will potentially have variations
due to differing efficiencies of the antibodies. Therefore when comparing be-
tween them, even after normalisation, it will be impossible to say whether
any changes are due to genuine differences in binding levels or differences in
immunoprecipitation efficiencies.
The nature of the normalisation method means that all assays to be
compared do not have to be normalised at the same time. Because each
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background sub-population is scaled to the standard normal distribution,
which is unvarying, each set of replicates can be normalised independently of
the others and therefore the assays do not all have to be carried out at the
same time. However, in the interests of minimising all sources of variation it
is recommended that as many assays as possible are carried out together.
The computational process is very fast, allowing full normalisation of
multiple datasets in a matter of seconds.
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Development of a novel
enrichment detection method
5.1 Introduction
ChIP-chip is a technique that has been used primarily for investigating the
binding locations of proteins on a genome wide scale (Buck and Lieb, 2004).
This has necessitated the development of computational tools to identify
those binding sites. ChIP-chip data can range from thousands to millions of
individual values and so automated methods of peak detection are essential.
Various methods have been developed to perform this function, which are
shown in Table 5.1. Not all are applicable to the data analysed in this
investigation because some have been designed to work only on data from
different microarray formats. The earlier methods have been shown to be
outperformed by the newer methods, which means only those towards the
bottom of the list are currently relevant. Several of these are no longer
publicly available and so the currently available tools for accurate enrichment
detection of any format of ChIP-chip data are limited, potentially limiting the
processing of data. The objective of the work presented in this chapter was to
develop a new enrichment detection procedure to fill this gap, that could work
with any format of ChIP-chip microarray data and detect peaks or extended
regions of enrichment as required. The method developed is able to utilise
multiple replicate datasets to increase the power of detection of enrichment
over analysing the datasets individually. It does this in such a way that
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the detection threshold is dynamically adjusted throughout the procedure
to maintain the same overall probability level, meaning that the application
of a multiple testing correction is not required on the final results, thereby
removing any biases that this may introduce. The performance is indicated
to be more powerful that the previously published methods, without having
those methods available to test.
5.1.1 Existing methods
The first application of what is now referred to as ChIP-chip used a single
array error model to identify enriched probes (Ren et al., 2000; Roberts
et al., 2000). This early microarray had single probes in regions of interest,
predominantly promoters. The error model gives a significance value to each
probe based on the signal intensities of the two channels, uncertainties due
to background subtraction and other non-uniformities such as hybridisation
efficiency variations, taking into account values from replicate arrays.
MDScan (Liu et al., 2002) attempts to find DNA binding sites by iden-
tifying common sequence motifs in enriched areas. This method analyses
sequences of highly enriched regions and uses these results to find additional
sequences from regions of lower enrichment. It is therefore more applicable
to consensus motif identification than peak finding. The final result is reliant
upon there being a consensus motif present.
Median percentile ranking is suggested as an analysis method by Buck
and Lieb (2004). This is a simple statistical procedure reliant on a number of
repeats for each experiment. The probe values are converted to ranks, scaled
to between 0 and 1 and the medians of these for each probe are analysed. If
all binding values are random the medians will fall into a normal distribution
centered on 0.5 and bounded by 0 and 1. If a sub-population of probes are
consistently enriched their ranks will be consistently high and so their median
values will fall at the top end of the range, creating a bimodal distribution.
The trough of this distribution can then be used as a cutoff to define enriched
probes. The advantage of this method is values are converted to ranks, so
the original values become irrelevant and normalisation is not required. It
208
SECTION 5.1 CHAPTER 5
Name Citation Program
readily
available
Works with
any data
format
SAEM Ren et al. (2000) No Yes
MDScan Liu et al. (2002) No -
Median percentile rank Buck and Lieb (2004) No Yes
Peakfinder Glynn et al. (2004) Yes Yes
No name Cawley et al. (2004) No No
Chipotle Buck et al. (2005) Yes Yes
HMM Li et al. (2005) No -
Chipper Gibbons et al. (2005) Yes Yes
No name Kim et al. (2005) No -
TileMap Ji and Wong (2005) No -
JBD Qi et al. (2006) No -
TAMALPAIS Bieda et al. (2006) Yes No
MAT Johnson et al. (2006) Yes No
Permuta Lucas et al. (2007) No -
MA2C Song et al. (2007) Yes No
Mpeak Zheng et al. (2007) No -
Tilescope Zhang et al. (2007) No -
Poisson approximation Zhang (2008) No Yes
Splitter Johnson et al. (2008) No -
JAMIE Wu and Ji (2010) No -
DECODE Barrett et al. (2011) No -
Wavelet Karpikov et al. (2011) No -
Table 5.1: Peak detection methods: names and publications of ChIP-chip
data analysis programs, whether or not they are currently readily available
for use (as a downloadable program or web server) and whether or not they
are able to process data from any microarray format (where information is
available).
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does however require enough repeats to allow the bimodal distribution to be
perceived, which may be a large number if only a small number of sites are
enriched.
Peakfinder (Glynn et al., 2004) smooths data and identifies peaks from
the resulting first derivative. The data is smoothed to remove spurious peaks
caused by noise but keep peaks caused by genuine enrichment. Peaks are then
identified as regions where the first derivative is zero.
Cawley et al. (2004) present a method based on the Wilcoxon Rank Sum
test, comparing treated and untreated datasets to identify differences, which
are taken to be regions of enrichment. Datasets are quantile normalised
within groups and then all scaled to have a median feature intensity of 1000.
Probes within sliding windows of ± 500 bp are tested against the null hy-
pothesis of equality between the datasets. A p-value cutoff of 10-5 is used to
define enriched regions. This method has the disadvantage that a number of
untreated control datasets have to be produced, at extra time and cost.
ChIPotle (Buck et al., 2005) uses a sliding window (default 1 kb in length
with 0.25 kb steps). At each step the average of all points is calculated
which smooths the data, aiming to remove spurious peaks and retain genuine
peaks. A p-value is calculated from the standard error function for each
window under the null hypothesis that the observed ratios are independent,
identically distributed random variables having a Gaussian distribution with
a mean of zero. These p-values are then corrected by the Bonferroni method.
Li et al. (2005) present a hidden Markov model (HMM) approach as an
alternative to the method used by Cawley et al. (2004). This has two hidden
states: ChIP-enriched and non-enriched. The method analyses probes to
determine which of these two states all probes are in, calculating probabilities
based on an estimate of the total number of binding sites and the total
number of probes.
Chipper (Gibbons et al., 2005) uses variance stabilisation to identify pro-
tein binding sites. Data are transformed using vsn (see Chapter 4) and these
scores used to determine p-values based on the null hypothesis of no binding.
Kim et al. (2005) use a two stage approach to identify binding sites in their
datasets. Firstly, microarrays of ∼14.5 million probes at ∼100 bp resolution
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were used to identify potential binding locations. The resulting data was
smoothed by median filtering with a window size of 3 probes. Enriched areas
were then defined as regions with a minimum of 4 probes separated by a
maximum of 500 bp with values greater than 2.5 standard deviations from
the mean. These regions were used to design a second microarray containing
∼400,000 probes covering ∼10,000 regions at 100 bp resolution. This was
used to more precisely define binding sites. A double regression model is
used to fit neighbouring log ratio signals to asymmetric triangles centred
on candidate binding sites using a sliding window approach. Local residual
minima are defined as peaks. This method requires a minimum separation
of 500 bp between peaks. As well as this inability to find peaks closer than
500 bp, the main drawback to this technique is that two microarrays need to
be used, with a design stage between the two, increasing the time and cost
of any experiments.
TileMap (Ji and Wong, 2005) applies a two stage approach. Firstly a
Bayes model is used to calculate a test statistic for each probe. These
statistics are then used to to infer peaks. Neighbouring probes are anal-
ysed through a moving average or hidden Markov model. This approach
allows multiple datasets to be analysed at the same time by calculating the
test statistics from the multiple probes.
Joint binding deconvolution (JBD; Qi et al., 2006) reconstructs binding
events from ChIP-chip at a higher spacial resolution than the underlying
microarray probe spacing. This is achieved by deconvolving the predicted
probe intensity peak shape from the observed peak shape to infer the genuine
binding event location. This allows pairs of nearby events to be distinguished
as multiple binding locations. This is linked to sequence information to
further refine the predicted binding sites by consensus motif analysis.
TAMALPAIS (Bieda et al., 2006) uses a similar methodology to that
described by Kim et al. (2005). Rather than requiring a single user defined
threshold value for an array, the 95th and 98th percentiles of the ratio values
are used. This ‘normalises’ the threshold values for each array to reflect the
amplitude and distribution of the signal. The run size is determined by the
number of probes having a p-value < 0.0001. This corresponds to 6 and 8
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consecutive points above the 98th and 95th percentiles respectively.
Model based analysis of tiling-arrays for ChIP-chip (MAT; Johnson et al.,
2006) is a method created for the analysis of Affymetrix microarray data,
which takes into account the sequence of each probe to apply a correction,
before estimating
Lucas et al. (2007) present a sliding window approach based on window
size, ratio cutoff and the percentage of probes in the window over the cutoff.
A false positive rate was estimated for each window. Peaks were called in
windows with 40–100% of the probes above the defined cutoff and a false
positive rate ≤ 10% in at least 3 of the 4 datasets. The false positive rate
was estimated by 20 repetitions of randomising the data and estimating the
number of peaks found by chance at each cutoff value.
MA2C (Song et al., 2007) is a normalisation method which takes into ac-
count GC content, also containing a peak detection method based on MAT
(Johnson et al., 2006). A sliding window of defined length is centred on each
probe and a score assigned based on the median, pseudo-median, median pol-
ish or trimmed mean of the probes in the window. The median and trimmed
mean values are calculated from all replicate datasets, where present. P-
values are assigned to the windows and a cutoff based on p-values or FDR is
applied.
Mpeak (Zheng et al., 2007) uses a model based method to recognise peak
shapes in data. It looks for the truncated triangle shape of peaks by fitting
a multiple regression model to a window around a central probe. All local
maxima are first found, defined as the largest value in a 200 bp region. These
are ordered from largest to smallest and, working down this list, the method
fits the model to the window around the probe to find the point with the
smallest residual variance. This is repeated for neighbouring probes with the
lowest value indicating the estimated binding site.
Tilescope (Zhang et al., 2007) is a set of programs to analyse ChIP-chip
data. Three peak detection methods are included, one based on the method of
Cawley et al. (2004), one on HMM (Li et al., 2005) and one developed by the
authors. This identifies local signal peaks in an iterative fashion by finding
points that correspond to peaks and meet a predefined p-value threshold.
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All points within a predefined distance are removed so as to prevent the
detection of secondary peaks from the same feature. This is repeated until
the signal being analysed is below the cutoff threshold.
Zhang (2008) propose a Poisson approximation approach which aims to
accurately approximate the statistical significance of peaks in a manner bet-
ter than calculating significance values and applying multiple testing correc-
tions. This uses Poisson clumping on suitably modified data to calculate
p-values, taking into account multiple datasets.
Splitter (Johnson et al., 2008) is available as a web server which also con-
tains basic normalisation and averaging functions. The algorithm dynam-
ically defines the cutoff values for peak detection. This cutoff is increased
over a defined number of steps and the number of hits before and after the
increment are compared. If this ratio is smaller than a defined ‘break ratio’
all of the hits are reported.
JAMIE (joint analysis of multiple ChIP-chip experiments) (Wu and Ji,
2010) is an algorithm which aims to ‘borrow’ information from related datasets
to improve peak detection. Correlations between datasets are found using a
hierarchical mixture model. A sliding window approach is used to determine
binding sites in each dataset based on a defined threshold. These results are
then compared across the related datasets to improve the determination of
binding sites.
DECODE (Barrett et al., 2011) identifies potential binding regions as
those at least 400 bp in length with a value greater than 1, after setting the
histogram maxima to 1. The signal in these regions is then smoothed and
these values analysed further. The first three derivatives of these values are
used to identify local maxima. These maxima are then analysed to estimate
peaks by two methods; minimising the differences between the transformed
and original enrichment signals and maximising the entropy of the probes.
P-values are then assigned to the peaks and a FDR applied to remove false
results.
Wavelet (Karpikov et al., 2011) applies a wavelet transformation to data,
whose fundamental aim is to separate data based on its scale. The method
therefore attempts to separate binding signals from background noise. The
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transformation is applied to both the red and green signals and the log ratio
of these values is analysed. Thresholding allows peaks of varying sizes to be
detected at the same confidence level and a FDR applied to the final results.
Methods produced by the microarray manufacturers for use on their own
datasets also exist (Johnson et al. (2006) for Affymetrix and Scacheri et al.
(2006) for Nimblegen).
5.1.2 Motivation for creating a new method
The majority of the above methods are either not available for use or cannot
be applied to all types of ChIP-chip data, including that analysed here, as
shown in Table 5.1. All of the most recent methods, shown to outperform ear-
lier methods, cannot be applied to the data analysed here. Most of the other
methods are intended to be applied to single datasets, and those that can be
applied to multiple datasets do not do so to increase the power of detection of
peaks, causing the loss of much valuable data from repeated experiments. In
addition, several methods only seek to find defined peaks, which is of no value
when analysing data such as histone acetylation, which occurs over extended
regions. It is widely agreed that ChIP-chip experiments should be carried out
in replicate to reduce the likelihood of spurious results being deemed genuine
binding sites. Generally, these replicate datasets are analysed separately and
peaks found in several or all of these datasets are reported as genuine peaks.
This methodology means that smaller binding peaks may be missed because
the power of detection in each individual dataset is not great enough to find
them. Combining all datasets increases the power of detection and increases
the chances of these peaks being identified.
A new enrichment detection method has been developed here to overcome
these problems. The method is able to work with data from any microarray
format, being able to work with data loaded from simple tab-delimited text
files (Section 3.2.1.3) as well as the Agilent Feature Extraction file format. It
analyses all replicate datasets simultaneously to achieve an increased power
of detection, thereby allowing more binding sites to be identified. It also
dynamically adjusts the detection cutoff level to maintain a p-value that seeks
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to find no false positive results. This eliminates the need for any multiple
testing correction to be applied to the final results, as all potential false
results are removed at the point of detection. This means that the final
results are more likely to all represent genuine peaks in the data than other
methods, where the multiple testing correction method that is applied may
be over- or under-sensitive. This new method is later shown to outperform
existing methods at detecting enrichment in datasets containing artificially
enriched spike regions.
5.2 Algorithm
The peakDetection function performs the enrichment and peak detection
processes (Script 5.1) using the following arguments:
object An arrayData object to be processed (no default).
annotation A genomeAnnotation object for the current genome to be used
in calculating the chromosome end points (no default).
windowSize A numeric vector specifying the window size to be used in
determining enrichment (default 600).
fdre A numeric vector specifying the false peaks to ‘find’, used in determin-
ing the statistical significance levels (default 0.9).
scale A numeric vector specifying the factor to scale the dataset by, im-
proving the detection of peaks in datasets which do not fully meet the
expectations of the data.
findPeaks A logical vector indicating whether or not to perform peak de-
tection and return a peakList or return regions of enrichment, as a
TRUE or FALSE value for each probe (default TRUE).
shearSize A numeric vector specifying the average chromatin shear size of
the material hybridised to the microarray (default 600).
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Script 5.1: peakDetection: script to perform the enrichment and peak detec-
tion of an arrayData object.
1 ## peakDetection function ##
2 ## arguments: object (an arrayData object), annotation (a genomeAnnotation
object) , windowSize (size of windows to use), fdre (statistical value),
findPeaks (perform peak detection), scale (dataset scale factor),
shearSize (average chromatin shear size)
3 peakDetection <-function(object ,annotation ,windowSize =600, fdre =0.9, findPeaks=
TRUE ,shearSize =600, scale =1) { #define function
4 for (n in 1:ncol(object)) { #loop through datasets
5 if("shiftByMode" %in% object$status [[n]] & "stNormScale" %in% object$
status [[n]] & "rmNAs" %in% object$status [[n]]) { #dataset has been
shifted and scaled
6 }else{ #stNorm and shiftByMode not applied
7 warning(paste(colnames(object$ratios)[n]," has not been fully
normalised",sep=""), call.=F) #warn if correct normalisation has
not been applied
8 }
9 }
10 peaks.keep <-!is.na(object$ratios [,1]) #define non -missing ratios in
dataset 1
11 object.full <-object #copy data
12 object <-object[peaks.keep ,] *scale #remove ratios missing in dataset 1 and
scale all data
13 windows.all <-list() #initialise list to store windows
14 peaks <-rep(F,nrow(object)) #initialise vectors to store peaks
15 peaks.full <-rep(F,nrow(object.full))
16 cutoffs <-matrix(ncol=1,qnorm(1-(fdre/nrow(object))^(1/1:10000))) #
calculate cut off values
17 cutoffs[cutoffs < 0]<-0
18 multFactor <-ncol(object) #define multiplication factor = the number of
datasets
19 previous <-0 #set previous to zero
20 for (chr in unique(object$coordinates [,1])) { #loop through chromosomes
21 chrEnd <-max(c(annotation$coordinates[annotation$coordinates [,1] == chr
,2:3], object$coordinates[object$coordinates [,1] == chr ,2:3]) ,na.rm=T
) #get the maximum chromosome value
22 objectChr <-object[object$coordinates [,1] == chr ,] #get data on current
chromosome
23 coordinates <-ceiling(rowMeans(objectChr$coordinates [ ,2:3])) #get probe
coordinate mid points
24 ratios <-objectChr$ratios #get dataset ratios
25 probes <-objectChr$annotations [,1] #get probe IDs
26 nRows <-nrow(objectChr) #get number of probes
27 for (n in 1:nRows) { #loop through probes
28 gap <-0 #set gap to zero
29 d<-n #set down value (d) to probe number (n)
30 if (coordinates[n] > windowSize) { #if probe coordinate is greater
than the windowsize
31 while (gap < windowSize) { #loop while gap value is less than the
windowsize
32 d<-d-1 #decrease d by 1
33 if (d > 0) gap <-coordinates[n] - coordinates[d] else gap <-
windowSize +1 #calculate the gap between the current and
downward probes if the downward value is greater than zero ,
other wise set gap to greater than the windowsize
34 } #gap greater than windowsize = window found + 1 probe
35 d<-d+1 #add 1 to d to reenter the window
36 if (min(ratios[d:n,],na.rm=T) > cutoffs [(n-d+1)*multFactor ]) peaks[(
d+previous):(n+previous)]<-T #if probe is to be included , if all
ratios in the window are greather than the cutoff , set probes
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in window to TRUE
37 gap <-0 #set gap to zero
38 d<-d+1 #add 1 to d
39 while (gap < windowSize) { #loop while gap value is less than the
windowsize
40 d<-d-1 #decrease d by 1
41 if (d > 0) gap <-(coordinates[n]-1) - coordinates[d] else gap <-
windowSize +1 #calculate the gap between the current - 1 and
downward probes if the downward value is greater than zero ,
other wise set gap to greater than the windowsize
42 } #gap greater than windowsize = window found + 1 probe
43 d<-d+1 #add 1 to d
44 if (d < n) if (min(ratios[d:(n-1) ,],na.rm=T) > cutoffs [((n-1)-d+1)*
multFactor ]) peaks[(d+previous):(n-1+ previous)]<-T #if downward
probe is less than the current probe , if probe is to be included
, if all ratios in the window are greather than the cutoff , set
probes in window to TRUE
45 }
46 if (coordinates[n] < (chrEnd - windowSize)) {#probe coordinate is not
in the last windowsize of the chromosome
47 gap <-0 #set gap to zero
48 u<-n #set up value (u) to probe number (n)
49 while (gap < windowSize) { #loop while gap value is less than the
windowsize
50 u<-u+1 #add 1 to u
51 if(u < nRows) gap <-coordinates[u] - coordinates[n] else gap <-
windowSize +1 #calculate the gap between the current and upward
probes if the upward value is less than the number of probes ,
other wise set gap to greater than the windowsize
52 } #gap greater than windowsize = window found + 1 probe
53 u<-u-1 #subtract 1 from u to reenter the window
54 if (min(ratios[n:u,],na.rm=T) > cutoffs [(u-n+1)*multFactor ]) peaks[(
n+previous):(u+previous)]<-T #if probe is to be included , if all
ratios in the window are greather than the cutoff , set probes
in window to TRUE
55 gap <-0 #set gap to zero
56 u<-u-1 #subtract 1 from u
57 while (gap < windowSize) { #loop while gap value is less than the
windowsize
58 u<-u+1 #add 1 to u
59 if (coordinates[n] > (chrEnd - windowSize)) inc <-F #set probe
include to FALSE if probe coordinate is in the last windowsize
of the chromosome
60 if(u < nRows) gap <-coordinates[u] - (coordinates[n]+1) else gap <-
windowSize +1 #calculate the gap between the current + 1 and
upward probes if the upward value is less than the number of
probes , other wise set gap to greater than the windowsize
61 } #gap greater than windowsize = window found + 1 probe
62 u<-u-1 #subtract 1 from u to reenter the window
63 if (u > n) if (min(ratios [(n+1):u,],na.rm=T) > cutoffs [(u-(n+1)+1)*
multFactor ]) peaks[(n+1+ previous):(u+previous)]<-T #if upward
probe is less than the current probe , if probe is to be included
, if all ratios in the window are greather than the cutoff , set
probes in window to TRUE
64 }
65 } #finished searching all probes
66 previous <-previous+nRows #add number of probes to previous
67 } #finished all chromosomes
68 peaks.full[peaks.keep]<-peaks #store peaks in appropriate locations
69 if(!findPeaks) return(peaks.full) #return enriched regions if required ,
otherwise peak detection:
70 if(length(which(peaks.full)) < 1) { #no enrichment is found
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71 message("No peaks found") #print message
72 return(NULL) #return NULL
73 }#some enrichment is found
74 con <-consecutive(cbind(which(peaks.full),object.full$coordinates[peaks.
full ,1])) #get consecutive enriched probes
75 ratios <-object.full$ratios #get all ratios
76 peaks.found <-peaks.found.to<-peaks.found.from <-scores.found <-numeric () #
initalise vectors to store results
77 for (n in 1:nrow(con)) { #loop through consecutive regions
78 if (con[n,2]-con[n,1] > 0) { #region is longer than a single probe
79 peaks.i<-matrix(ncol=multFactor ,nrow=(con[n,2]-con[n,1]) +1,0) #
initialise matrix
80 ratios.all <-matrix(ncol=multFactor ,ratios[con[n,1]: con[n,2],]) #get
ratios in region
81 for (m in 1: multFactor) { #loop through datasets
82 ratios.current <-ratios.all[,m] #get ratios of dataset
83 ratios.current <-cbind(ratios.current ,c(min(ratios.current),ratios.
current [1:( length(ratios.current) -1)]),c(ratios.current [2: length
(ratios.current)],min(ratios.current))) #align ratios with
previous + next for vectorised maxima searching
84 peaks.i[ratios.current [,2] < ratios.current [,1] & ratios.current [,3]
< ratios.current[,1],m]<-1 #assign maxima 1
85 }
86 ratios.means <-rowMeans(ratios.all) #get mean ratios
87 ratios.means <-cbind(ratios.means ,c(min(ratios.means),ratios.means [1:(
length(ratios.means) -1)]),c(ratios.means [2: length(ratios.means)],
min(ratios.means))) #align means with previous + next for
vectorised maxima searching
88 peaks.a<-ratios.means [,2] < ratios.means[,1] & ratios.means[,3] <
ratios.means[,1] #identify maxima
89 peaks.found <-c(peaks.found ,matrix(con[n,1]: con[n,2])[peaks.a]) #store
found probe positions
90 scores.found <-c(scores.found ,rowMeans(peaks.i)[peaks.a]) #store maxima
scores
91 peaks.i<-consecutive(which(rowMeans(peaks.i) > 0))+con[n,1]-1 #get
consecutive replicates maxima probes
92 for (p in (which(peaks.a)+con[n,1]-1)) { #loop through maxima
93 if (p %in% peaks.i) { #mean maxima in replicate maxima
94 for (r in 1:nrow(peaks.i)) { #loop through maxima
95 if(p %in% peaks.i[r,1]: peaks.i[r,2]) { #find replicate maxima
matching mean maxima
96 peaks.found.from <-c(peaks.found.from ,peaks.i[r,1]) #store
lower boundary
97 peaks.found.to<-c(peaks.found.to,peaks.i[r,2]) #store upper
boundary
98 break() #exit from loop
99 }
100 }
101 }else{ #mean maxima not in replicate maxima
102 closestPeaks <-abs(peaks.i-p) #get replicate peaks
103 near <-unique(peaks.i[closestPeaks == min(closestPeaks)]) #get
replicate peaks closest to average peak
104 near[abs(mean(object.full$coordinates[p ,2:3]) -rowMeans(matrix(ncol
=2,object.full$coordinates[near ,2:3]))) > 200] <-p
105 peaks.found.from <-c(peaks.found.from ,min(c(p,near))) #store from
106 peaks.found.to<-c(peaks.found.to,max(c(p,near))) #store to
107 }
108 }
109 }else{ #region is a singe probe
110 peaks.found <-c(peaks.found ,con[n,1]) #store single probe
111 scores.found <-c(scores.found ,1) #store score as 1
112 peaks.found.from <-c(peaks.found.from ,con[n,1]) #store lower boundary
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113 peaks.found.to<-c(peaks.found.to,con[n,2]) #store upper boundary
114 }
115 }
116 coordinates <-matrix(ncol=3,nrow=length(peaks.found)) #create matrix for
coordinates
117 IDs <-matrix(ncol=2,nrow=length(peaks.found)) #create matrix for IDs
118 stats <-matrix(ncol=2,nrow=length(peaks.found)) #create matrix for stats
119 colnames(coordinates)<-c("PBRchr","PBRstart","PBRend") #set column names
for coordinates
120 colnames(IDs)<-c("ID","Position") #set column names for IDs
121 colnames(stats)<-c("Score","Height") #set column names for stats
122 coordinates [,1]<-object.full$coordinates[peaks.found ,1] #add peak
chromosomes
123 stats[,2]<-rowMeans(object.full[peaks.found ,])$ratios #add peak mean
ratios
124 stats[,1]<-scores.found #add peak scores
125 coords <-matrix(object.full$coordinates[peaks.found.from ,],ncol =3) #store
lower boundary coords in matrix
126 adjustAddValues <-adjustSubValues <-FALSE #initialise adjustors
127 subValues <-peaks.found.from -1 #get lower boundary - 1 probes
128 if(min(subValues) < 1) { #lowest probe is less than 1
129 subValues[subValues < 1]<-1 #set lowest probe to 1
130 adjustSubValues <-T #set subtracted values to be adjusted
131 }
132 coordsDown <-matrix(ncol=3,object.full$coordinates[subValues ,]) #get lower
boundary - 1 probes
133 if(adjustSubValues) coordsDown [1 ,2:3] <-rep(-Inf ,2) #set first coordDown as
-Inf if to be adjusted
134 sameChrDown <-coords [ ,1]== coordsDown [,1] #identify adjacent peaks on the
same chromosome
135 coordinates[which(sameChrDown) ,2]<-ifelse(rowMeans(matrix(ncol=2,coords[
sameChrDown ,2:3])) - rowMeans(matrix(ncol=2, coordsDown[sameChrDown
,2:3])) < 2*shearSize ,( rowMeans(matrix(ncol=2,coords[sameChrDown ,2:3])
) + rowMeans(matrix(ncol=2, coordsDown[sameChrDown ,2:3])))/2,rowMeans(
matrix(ncol=2,coords[sameChrDown ,2:3])) - shearSize) #calculate
downward coordinate boundaries
136 coords <-matrix(object.full$coordinates[peaks.found.to ,],ncol =3) #store
upper boundary coords in matrix
137 addValues <-peaks.found.to+1 #get upper boundary + 1 probes
138 if(max(addValues) > nrow(object)) { #highest probe is greater than the
number of probes
139 addValues[addValues > nrow(object)]<-nrow(object) #set highest probe to
the number of probes
140 adjustAddValues <-T #set added values to be adjusted
141 }
142 coordsUp <-matrix(ncol=3,object.full$coordinates[addValues ,]) #get lower
boundary - 1 probes
143 if(adjustAddValues) coordsUp[nrow(coordsUp) ,2:3] <-rep(Inf ,2) #set last
coordUp as Inf if to be adjusted
144 sameChrUp <-coords [,1]== coordsUp [,1] #identify adjacent peaks on the same
chromosome
145 coordinates[which(sameChrUp) ,3]<-ifelse(rowMeans(matrix(ncol=2,coordsUp[
sameChrUp ,2:3])) - rowMeans(matrix(ncol=2,coords[sameChrUp ,2:3])) < 2*
shearSize ,( rowMeans(matrix(ncol=2,coords[sameChrUp ,2:3])) + rowMeans(
matrix(ncol=2,coordsUp[sameChrUp ,2:3])))/2,rowMeans(matrix(ncol=2,
coords[sameChrUp ,2:3])) + shearSize) #calculate upward coordinate
boundaries
146 coordinates[which(!sameChrDown) ,2]<-ifelse(rowMeans(matrix(ncol=2,coords[!
sameChrDown ,2:3])) > shearSize ,rowMeans(matrix(ncol=2,coords[!
sameChrDown ,2:3])) - shearSize ,0) #calculate downward coordinate
boundaries at starts at starts of chromosomes
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147 coordinates[which(!sameChrUp) ,3]<-rowMeans(matrix(coords[!sameChrUp ,2:3] ,
ncol =2)) + shearSize #calculate downward coordinate boundaries at
starts at ends of chromosomes
148 IDs[,1]<-object.full$annotations[peaks.found ,1] #store probe IDs
149 IDs[,2]<-peaks.found #store probe numbers
150 peakList <-new("peakList",list(coordinates=coordinates ,IDs=IDs ,stats=stats ,
from=colnames(object$ratios),windowSize=windowSize ,fdre=fdre ,grid_name
=object$grid_name))
151 return(peakList) #return detected peaks matrix
152 }
The function first checks that all provided datasets have undergone the
rmNAs, shiftByMode and stNormScale normalisation procedures, which are
required for the enrichment detection to work correctly, and gives a warning
message if any have not (L4–9). Ratios in the first dataset with NA val-
ues (and therefore all datasets following the rmNAs function) are identified
(L10) for exclusion. A copy of the full data is made (L11) and a new scaled
arrayData object created without the NA values for analysis (L12). A list
and two vectors are created to store windows and peaks (L13–15). Cutoff
values are calculated for up to 10,000 probes, far more than would occur in
actual data sets (L16). Cutoff values less than zero are set to zero (L17). The
number of datasets is set as a multiplication factor (L18) and a count started
(L19). A loop through chromosomes is initiated (L120). The maximum
chromosome coordinate is found (L21), the arrayData (L22), coordinates
(L23), ratios (L24) and probe IDs (L25) for the chromosome extracted and
the number of probes on the chromosome stored (L26). A loop through the
chromosome probes is initiated (L27), where the windows will be determined.
The gap size is initiated at zero (L28) and a value defining the probes to in-
clude ‘downwards’ is set as the current probe, that is, no probes downwards
(L29). If the current probe is within the window size of the start of the chro-
mosome the downwards window is not included (L30). While the gap size is
less than the defined window size (L31) the ‘downwards’ value is decreased
by one (L32). If the downwards value remains above zero (that is, on the
chromosome) a new gap value is calculated to the downwards probe, other-
wise the gap value is set to be bigger than the window size (L33). In this way
the next downward probe will be sought if the current downwards probe is
above zero and its gap value is less than the window size. Once the gap size
has increased beyond the window size (L34) the downward probe number is
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increased by one to bring it back to the last probe within the window size
(L35). The minimum ratio value in the window is compared to the window
cutoff value (based on the number of probes in the window) and the probes
set to TRUE, representing enriched, if it is greater (L36). This finds probes
within a window that includes the current probe. The process is repeated,
starting with the last determined downwards probe, this time analysing win-
dows downwards from but not including the current probe (L37–45). The
same search processes are carried out analysing probes upwards of the current
probe (L46–65). The count of probes is increased (L66). When all enriched
probes have been identified (L67) enrichment statuses are combined with
those probes not examined (L68). If enrichment states are required by the
user these are returned here (L69) and the function ends, otherwise the peak
detection part of the function begins. If no enrichment is found (L70) the
function returns NULL with a message (L71–72). If enrichment is found (L73)
the consecutive function is run with the enriched data (L74). Ratio values
are extracted (L75) and vectors created for the peak detection process (L76).
A loop through the consecutive regions is initiated (L77). For regions longer
than one probe (L78) a matrix is created to store maxima and minima (L77)
and the ratios of the region extracted (L78). A loop through the dataset is
initiated (L81) and the ratios of the dataset extracted (L82) along with the
two bordering ratios (L83). Maxima are located and indicated in the matrix
(L84). Means of the ratios of the region are calculated (L86) along with the
two bordering means (L87) and the maxima located (L88). These maxima
are treated as peaks and stored (L89). A score is calculated based on the
individual dataset maxima at those positions (L90). Consecutive replicate
maxima probes are identified (L91). A loop through mean maxima probes
is initiated (L92) and replicate maxima containing them identified (L93). A
loop through these replicate maxima ranges is initialised (L94) and the first
mean maxima in these ranges is identified and the range stored (L95–98).
If the replicate maxima do not contain a mean maxima, the nearest to the
mean peak are stored (L101–106). Single probe regions are stored without
searches (L109–114). Matrices are created to store the results to put into
the peakList (L116–121) and filled with identified peak coordinates (L122),
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ratios (L123), scores (L124) and lower peak boundaries (L125). Vectors defin-
ing adjustments are created (L126). The lower boundaries are reduced by
1 (L127) and any less than 1 (L128) are increased to 1 (L129) and the ad-
justment set to TRUE (L130). Reduced lower boundary coordinates are ex-
tracted (L132) and the first one adjusted to -Inf if required (L133). Matching
chromosome numbers are identified (L134) and lower boundaries calculated
as the smaller of halfway to the previous probe or the window size (L135).
The process is repeated to get upper boundaries (L136–144). Corrections are
made for the starts and ends of chromosomes (L145–147). Probe IDs and
numbers are stored (L148–149) and a new (peakList) containing the results
returned (L150–151).
The peakDetection function requires the consecutive function (Script 5.2)
which identifies consecutive regions of enrichment and reduces the list of
TRUE/FALSE enrichment values to a matrix of numerical values defining
‘from’ and ‘to’ enriched probe regions. The process is vectorised for efficiency.
It has the following argument:
object A list of logical values indicating probe enrichment.
Script 5.2: consecutive: script to condense consecutive numbers into a range.
Used within the peakDetection function to find extended regions of enrich-
ment.
1 ## consecutive function ##
2 ##arguments: object (vector or matrix of values)
3 consecutive <-function(object) { #define function
4 if(is.vector(object)) object <-cbind(object ,rep(1,length(object))) #add
second column if missing
5 con <-matrix(ncol=2,nrow =0) #initialise matrix to store results
6 for (chr in unique(object [,2])) { #loop through chromosomes
7 values <-object[object [,2] == chr ,1] #get current chromosome values
8 diffs <-abs(diff(values)) #calculate consecutive differences
9 diffs <-diffs != 1 #convert differences to TRUE/FALSE
10 con <-rbind(con ,cbind(values[which(c(T,diffs))],values[which(c(diffs ,T))
])) #find and store boundaries
11 }
12 return(con) #return result
13 }
The function adds a second column of ‘1’s if a vector is provided, simulating
all values coming from the same chromosome (L4). A matrix is created to
store results (L5) and a loop of chromosome numbers initialised (L6). Values
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on the current chromosome are extracted (L7) and the differences between
adjacent values calculated (L8). These differences are converted to TRUE
and FALSE values, TRUE representing differences other than 1, that is, non-
consecutive values (L9). Boundaries of consecutive values, representing their
ranges, are stored (L10) and the results returned (L12).
The peakList object created by the peakDetection function contains
coordinates of PBRs, IDs of probes at the top of peaks, statistics of the peaks,
the file names the peak detection was performed on, and the windowSize and
FDRE values used. It has a set of methods associated with it (Script 5.3).
The show method displays the dataset names used to create the list, the
number of peaks found and the windowSize and FDRE values. The summary
method shows the number of peaks found and summaries of the peak scores
and heights. The dim method shows the number of peaks detected.
Script 5.3: peakList: methods to show, calculate the dimensions of, produce
a summary and extract data from a peakList object.
1 ## set peakList class##
2 setClass("peakList",representation("list"))
3
4 ## peakList show method ##
5 setMethod("show", "peakList", function(object) { #define function
6 message("A \"peakList\" object created from:") #print message
7 for(n in 1: length(object$from)) message(paste("\t",object$from[n])) #print
dataset names
8 message("Number of peaks:") #print message
9 message(paste("\t",nrow(object$IDs))) #print number of peaks
10 message("\nwindowSize:") #print message
11 message(paste("\t",object$windowSize)) #print windiowSize value
12 message("fdre:") #print message
13 message(paste("\t",object$fdre)) #print fdre value
14 }
15 )
16
17 ## peakList dim method ##
18 setMethod("dim", "peakList", function(x) { #define function
19 return(dim(as.matrix(ncol=1,x$IDs))) #dimensions relate to IDs
20 }
21 )
22
23 ##peakList summary method ##
24 setMethod("summary", "peakList", function(object) { #define function
25 message("Summary of peakList object") #print message
26 message("Number of peaks:") #print message
27 message(paste("\t",nrow(object$IDs))) #print number of peaks
28 message("Peak score statistics: ") #print message
29 scores <-as.matrix(table(object$stats [,1])) #get scores table
30 rownames(scores)<-round(as.numeric(rownames(scores)) ,2) #rename rows
31 colnames(scores)<-"Count" #rename column
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32 print(scores) #print scores table
33 message("Peak height statistics: ") #print message
34 heights <-as.matrix(summary(object$stats [,2])) #get peak heights summary
35 colnames(heights)<-"Value" #rename column
36 print(heights) #print peak heights summary
37 }
38 )
39
40 ## peakList extract method ##
41 setMethod("[", "peakList", function(x,i,...) { #define function
42 if (nargs() != 2) stop("One subscript required", call. = FALSE) #check
only one subscript (for rows)
43 return(new("peakList",list(coordinates=matrix(x$coordinates[i,],ncol =3),
IDs=matrix(x$IDs[i,],ncol =2),stats=matrix(x$stats[i,],ncol=ncol(x$
stats)),from=x$from ,windowSize=x$windowSize ,fdre=x$fdre ,add=x$add ,grid
_name=x$grid_name))) #return new genomeAnnotation object
44 }
45 )
The peakList class is defined (L2). The show method (L5) prints dataset
names (L6), the number of peaks (L9) and the “windowSize” (L11) and
“FDRE” (L13) values used. The dim method (L18) returns dimensions of
the “IDs” slot (L19), with the number of columns always 1. The summary
method (L24) prints the number of peaks (L27), a matrix containing peak
score counts (L29–32) and a matrix containing a peak height summary (L34–
36). The extract method (L41) checks one argument is provided (L42) and
returns data for the specified peaks (rows) (L43).
5.2.1 Window determination
To examine a dataset for enrichment it must first be divided into a number
of subsets of probes, termed windows. Each window contains one or more
probes, depending on the probe resolution, and represents a genome region
likely to show the effect of enrichment in its vicinity. This is due to there
being multiple probes to which the chromatin fragments from a region can
bind, resulting in all probes covering the region showing enrichment. This is
demonstrated in Figure 5.1. All fragmented, immunoprecipitated chromatin
fragments will contain the binding site, represented by the blue dot, but
fewer fragments will cover regions at greater distances from the binding site.
Therefore the greatest distance from a binding site that can be covered by
a fragment is equal to the fragment length, and so the region of enrichment
is equal to twice the fragment length. A window size equal to this length
224
SECTION 5.2 CHAPTER 5
should therefore be capable of containing only enriched probes when centred
over an enriched region. As the fragmentation process is random, an average
chromatin shear size is used to determine this length. In this way, anomalous
peaks occurring at single probes can often be disregarded as the surrounding
probes in the window will not show enrichment. Probe values in each window
are analysed and called as positive if determined to represent enrichment.
Smaller window sizes encompass few probes and are therefore not very
stringent: it is possible for a spurious high probe to be the only value in a
window and so out of the context of the surrounding low values may be called
as positive. This results in a low specificity. Larger window sizes encompass
many probes and can therefore be too stringent: it is possible for high values
as a result of real enrichment to be masked by the surrounding low values
on either side. This results in a low sensitivity. The optimum window size
will allow regions of genuine enrichment to fill the window while keeping
anomalous high values in the context of their surrounding values. This is
illustrated in Figure 5.2.
The peak detection method presented here employs a sliding window ap-
proach, whereby a window of defined length is ‘slid’ along the data in silico.
At defined points processing of the data in the window is carried out. In
other sliding window methods these points are termed the ‘step size’ and
determine the distance the window is moved between sets of calculations
(Chipotle, Buck et al., 2005, for example). Figure 5.3 shows a representation
of these steps to create different windows, using the smallest possible step
size of one (black lines) and, as is more commonly used in peak detection
methods, an appropriate larger value (red lines). Sliding the window by a
defined length like this has two significant disadvantages. Firstly, as the
arrangement of probes is not uniform, some probe combinations may be by-
passed by the window as it takes a step beyond the particular configuration.
For example, in Figure 5.3 there are 6 possible unique probe combinations
with the step size applied (15 nt), but the sliding window with a step size of
5 does not find all of these. Conversely, the step size may not bring about
a new combination of probes and so the same window is ‘found’ multiple
times, wasting computational resources. Additionally, at regions with no
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Figure 5.1: Representation of the formation of a peak shape: Overlapping
chromatin fragments binding to several probes creating a peak shape in plot-
ted data. Chromatin is shown as a DNA helix for clarity. Fluorescent la-
belling of the input(green) and immunoprecipitated (red) samples is repre-
sented by coloured molecules. An immunoprecipitated protein of interest
(blue circle) can be present on a series of chromatin fragments. Following
random binding to the microarray the probe closest to the protein binding
site will have the most intense red signal because more immunoprecipitated
fragments cover this region, with those further away having reduced red sig-
nals because fewer immunoprecipitated fragments cover the regions. Plotting
the red/green ratios gives a peak shape centring on the protein binding site
with a base approximately equal to twice the sheared chromatin length.
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Figure 5.2: How different window sizes affect enrichment detection: Too
small a window size (red) will allow anomalous high probe values in data
to be detected, by taking them out of the context of their surrounding low-
value probes. Too large a window size (orange) will prevent genuine regions
of enrichment from being detected by extending beyond peaks to include low-
valued probes. The correct window size (green) will overcome these problems,
allowing only genuine peaks to be detected.
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probe coverage the window will continue to search for probes where none
will be found, again wasting resources. The first problem can be eliminated
by setting a small step size but this greatly exacerbates the second. This is
shown in Figure 5.3 where all possible windows and probe combinations are
generated with the step size of one, with the creation of many unnecessary
windows in the process.
To eliminate these problems the windows used by this algorithm do not
follow a defined step size, but are instead calculated to analyse every possible
unique window probe combination. This is equivalent to using a step size of
1, in the sense that all probe combinations will be found and analysed, but
is much more computationally efficient than creating every possible window.
This is achieved by creating windows only in the regions surrounding probes
(Figure 5.4). All windows can be found by taking 4 windows at each probe:
upwards from the probe coordinate; upwards from one above the probe co-
ordinate; downwards from the probe coordinate and downwards from one
below the probe coordinate. This creates two windows containing the probe
and two not. This allows all unique probe combinations for any given win-
dow size to be found without the need to search through the whole genome.
To test this, a script was written to determine every possible probe combi-
nation on the G4493A microarray with a window size of 600 bp by using
a step size of 1 through the whole yeast genome. This brute force method
took approximately 8,500 s to run (on a desktop PC with a 3.20 GHz Intel
i7 processor and 24 GB of RAM) and found 82,465 unique windows. The
script presented here, which finds windows in the way described above in a
vectorised manner, takes less than 4 s, over 2,000 times faster, and finds the
same 82,465 windows. These windows form the basis of the rest of the peak
detection procedure.
For the purposes of peak detection the coordinate of each probe is calcu-
lated as the average of the start and end coordinates, that is, the mid-point
of the probe. This means that during analyses a region is deemed to contain
a probe if it contains this mid-point coordinate. In practice this means that
at least half of a probe must overlap region for it to be considered ‘in’ the
region. There are various ways a probe could be defined as in a region, such
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All possible windows: 
Windows with a defined step size: 
Windows generated by this algorithm: 
Figure 5.3: Examples of sliding windows: Representation of the windows
that could be generated in the search for enriched probes. The thick black
line shows a section of genome with each nucleotide position marked by a
dash. Probe positions are shown with grey crosses. For clarity probes are
shown at a much higher resolution than on the microarrays and a window
size of 10 nucleotides is used, creating 6 unique windows. Probe positions
are highlighted with vertical dashed lines. All possible window combinations
(36 windows) find all unique windows with a lot of redundancy. A sliding
window with a step size of 5 (8 windows) does not find all unique windows.
Shading of windows highlights those with the same combinations of probes.
Figure 5.4: Representation of window determination: For each probe (rep-
resented by a cross) four windows are created: one upwards including the
probe, one upwards adjacent to but not including the probe, one downwards
including the probe and one downwards adjacent to but not including the
probe.
229
CHAPTER 5 SECTION 5.2
as requiring the whole probe or at least a section to be within the region.
In real data the effect of binding to a probe will gradually diminish with
distance from it and so it is impossible to define a definitive cutoff point for
these calculations. The mid-point was chosen as an average of these two ex-
tremes and for computational efficiency as only a single coordinate is needed
to define the probe, not the two coordinates of the extremes.
The speed of the script has been increased by improving the efficiency
of the determination of which probes to include in each window. The most
simple way of achieving this in R is with the which function in the form
which (probeCoordinates >= windowStart & probeCoordinates <=
windowEnd). This performs a search of all probe coordinates and returns
those that match the criteria, in this case those that are in the specified
window. Although this which command is efficient, repeating it four times
for every probe on a microarray to get all windows slows the function down
considerably. This process was therefore replaced with a series of loops which
limit the search process to the region around each probe, rather than the
whole chromosome. The loop starts at the coordinate of the probe being
examined to find the window starting at and including the probe. The gap
between this and the coordinate of the next probe is calculated and compared
to the window size. If it is less, the gap to the next probe is calculated, and so
this loop continues. When the gap is greater than the window size the loop
stops and the binding values from the range of the probe being examined
to the probe preceding that with a gap greater than the window size is
analysed. This is then extended a further step to get the window starting
immediately adjacent to the probe being examined. The same process is
repeated in the opposite direction to get windows upstream and downstream
of the probe being examined. The ratios in each window are analysed to
determine whether or not they represent an enriched region, based on the
cutoff value for the window, as described in the following sections. When all
four windows have been analysed the probe being examined is incremented
and the process repeated. This computational process is shown as a flow
chart in Figure 5.5 and represented graphically in Figure 5.6.
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Figure 5.5: Window determination and enrichment detection process flow
chart: The computational processes of the enrichment detection process,
including the window determination and ratio cutoff analysis.
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Figure 5.6: Representation of window determination and enrichment detec-
tion: The grid on the left represents the values and actions of the algorithm,
displayed in the graphic on the right. ‘d’ is the probe number being tested
downwards from the current probe. ‘u’ is the probe number being tested
upward from the current probe. ‘gap’ shows if the gap between the probes
is greater or less than the window size. ‘Action’ shows the step taken by the
algorithm. The ‘d’ value is initially set to the current probe value (demon-
strated here with probe 5), shown with a green cross. In step 1 the gap is
less than the window size and so the action is to decrease the ‘d’ value. This
is repeated for steps 2 to 4 with the window being tested shown with a green
line. In step 5 the ‘d’ value gives a gap larger than the window size, indicated
by a red line, and so the action is to return to the previous ‘d’ value. The
values of all probes in this range are then analysed (step 6). The ‘d’ value is
then decreased again in step 7, this time to calculate the gap to the point im-
mediately preceding the current probe. The process is repeated, analysing a
new window in step 10. Once both downward windows have been determine,
the process is repeated in the upward direction, starting with a ‘u’ value at
the current probe (step 11).
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5.2.1.1 Cutoff calculation
The algorithm requires a user defined false discovery rate equivalent (FDRE)
value of the number of false peaks to ‘find’. Setting this value at less than
one means that the cutoff values are maintained at a level that, statistically,
no false peaks should be found. The default value for this argument is there-
fore 0.9. In theory, there will be a limit to the genuine peaks that can be
detected in a dataset, due to its properties, including the sizes of the genuine
peaks and the level of noise in the background. The default FDRE value
of 0.9 is intended to find the maximum number of detectable genuine peaks
without detecting any false peaks. Smaller values will result in fewer genuine
peaks being detected, reducing the sensitivity, without affecting the speci-
ficity. Larger values will result in more false peaks being detected, reducing
the specificity, without affecting the sensitivity. This process works in the
reverse manner to traditional multiple testing corrections, where a series of
tests produce a series of probability values to which a multiple testing correc-
tion is applied. The aim of this correction is to remove any significant results
caused by chance alone, maintaining only those that occur due to genuine bi-
ological factors. Different corrections have varying levels of conservation and
so remove varying numbers of results. This means that, even after applying
the correction, some of the remaining results may still be false positives and
some true positives may be removed. Adjusting the cutoff value for each win-
dow removes the need to apply any correction to the final results, meaning
they can be treated with greater confidence.
The defined number of false peaks it is statistically acceptable to find
is adjusted to take into account the total number of probes in the dataset,
such that the overall level stays at the specified level regardless of how many
probes are being analysed. For example, in a dataset of a single probe, that
probe must have a value over -1.281552 to be called a peak at the level of
significance which seeks to find 0.9 false peaks. In a dataset of 44,000 probes,
a single probe in a window containing only that probe must have a value over
4.102284 to meet the same statistical requirements. This larger value reflects
the fact that, statistically, more false peaks will be found in 44,000 probes
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than 1 probe. The higher cutoff counteracts this as fewer probes will be over
the higher value, so all the peaks found from the 44,000 probes should be
statistically genuine.
As the number of probes in a window increases, the cutoff value is reduced
while maintaining the same probability level, because the individual levels
are multiplied together to give the overall probability. In the single-probe
window from 44,000 probes example above, the probability level is 2.045452×
10−5, that is, the probability that the value is from the normal background
population is 2.045452 × 10−5, so it is actually very unlikely to have come
from that population and is more likely to have come from the population of
genuine peaks. If the window contained two probes, the cutoff value would
reduce to 2.610336 which has a probability of 4.522667 × 10−3. 4.522667 ×
10−3 × 4.522667 × 10−3 = 2.045452 × 10−5, that is, the overall probability
level of the cutoff value of the window containing two probes is the same as
the window containing a single probe.
Replicates can also contribute to this. For example, a window containing
3 probes, each of which has 3 replicates is treated as containing a total of
9 probes. The cutoff value for this is 0.52071 which has a probability of
0.3012844. 0.30128449 = 2.045452 × 10−5, that is, the same overall proba-
bility as before. So the more probes in a window (from probe dense regions
or/and replicates) the lower the cutoff value can be to achieve the same
probability level, thus increasing the detection sensitivity. In doing this the
overall probability of finding a false peak is maintained at the level originally
specified and so no correction needs to be applied to the final results. The
results presented later show that this may not be beneficial in all datasets.
Cutoff values are calculated at the beginning of the algorithm so as to
save computational time by not having to perform the calculation for every
window. Cutoff values less than zero are set to zero, so only positive values
can be found as enriched.
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5.2.2 Enrichment detection
Enrichment detection takes place by examining the probe ratios in each win-
dow and recording which windows, if any, contain probes over the cutoff.
It is likely that many probes will appear in more than one window. These
probes need only be in one window with all values over the cutoff to be
recorded as enriched. All probes in the window are required to be over the
cutoff to avoid the detection of spurious high values caused by events other
than enrichment (see Figure 5.7). At sites of genuine enrichment, a region
approximately double the average chromatin shear size will be immunopre-
cipitated and the resulting peak will have a base approximately the same
width (assuming a high probe coverage, otherwise the peak is theoretical).
There will therefore be a region of values higher than background over this
region. However, the smaller values at the two extremes of this region may
be indistinguishable from the background. The window size is therefore set
to the average chromatin shear size so that it can cover the central portion
of the peak and analyse only these larger values, without the influence of the
smaller values. Therefore windows over the centres of genuine peaks should
contain values which are all above the cutoff value and be recorded as en-
riched. It may also be the case that windows covering the regions either side
of the centre of the peak will contain values over the cutoff and so these too
will be recorded as enriched, resulting in the detection of a larger enriched
region. High values due to other factors are likely to affect single probes only,
possibly extending to multiple probes in rare circumstances. It is unlikely
that these will fill a whole window with values over the cutoff and so these
will not be recorded as enriched by this method. It is also very unlikely that
these spurious high values will occur at the same points in multiple datasets
and so combining all data in the same analysis provides another method by
which these regions are not detected as enriched. Figure 5.7 demonstrates
this process over a short section of data, showing four windows detecting four
probes as enriched. The final probe is not detected as enriched, even though
it has a higher value that some of the other detected probes, because there
are fewer probes in the window and so the cutoff is higher.
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Following this stage of the algorithm every probe is assigned a TRUE or
FALSE status representing whether or not it has been detected as enriched. If
only enrichment detection is required by the user these statuses are returned,
indicating all probes which the algorithm has determined to be showing en-
richment. This is useful for conditions which do not exhibit distinct binding
sites and therefore do not contain a series of peaks, such as histone modifi-
cations. These modifications may span regions of hundreds or thousands of
nucleotides and so reducing this information to the location of a single peak
is not biologically informative. Rather, the whole modified region is required
which can then be analysed further by the user, depending on the aims of
their investigation.
Because this method requires all of the values in a window to be above
the cutoff it is only suited to good quality data with consistent replicates.
Only a single probe need be less than the cutoff for the window not to be
found, so a peak present in some datasets but not others will not be found by
this method. This can be overcome by analysing the means of the datasets,
which should create peaks above the cutoff value in area where enrichment is
present in some of the datasets. This will result in a reduced ability to detect
small peaks, as fewer probes will be analysed and so larger cutoff values will
be calculated. However, it is unlikely that any such peaks could be reliably
determined in poor quality data and so this averaging should not reduce the
overall ability to detect regions of enrichment.
For investigations requiring peak detection the next stage of the algorithm
can be invoked.
5.2.3 Peak detection
The peak detection stage of the algorithm is used to identify likely binding
sites of immunoprecipitated molecules that bind at distinct sites, including
proteins. All regions detected as enriched are analysed and a series of binding
region coordinates are produced. The coordinates are based on the probe
coordinates at the peak.
The enriched probes are first broken down into regions, each one repre-
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Figure 5.7: Enrichment detection representation: A short section of example
data showing 9 possible windows. For each window the number of probes,
its lowest value and the calculated cutoff is shown. From these the enriched
windows (those with their lowest values above the window cutoff) are found,
which are highlighted as red.
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senting each run of enriched probes. These may therefore range in length
from one to scores of probes. Each of these regions is analysed in turn for
binding peaks. The algorithm analyses all individual datasets as well as the
means of these datasets when determining peak positions. Peak calling is
based on the average values of the region, where every probe at a peak, that
is, a probe with a value higher than its two adjacent probes, is recorded as
a potential binding probe. This is based on the assumption that a genuine
binding peak will occur in all replicate datasets and also therefore in the
average of the datasets. Spurious, small peaks occurring in a small number
of datasets are unlikely to also occur in the averaged dataset, depending on
the number of replicates, and so these regions will not be detected as peaks.
Following this initial process all individual datasets are analysed at the
detected sites to determine whether or not they also contain peaks at or near
to the same probe. Peaks that occur at the same probe in the averaged
and all individual datasets are given a score of 1, representing the fact that
this is very likely to represent a probe near a genuine binding site. The
process is outlined as a flow chart in Figure 5.8 and represented graphically
in Figure 5.9.
It is possible, due to the resolution of the technology, that a genuine bind-
ing site will manifest as peaks at close, adjacent probes in different datasets.
This fact is taken into account in situations where not all replicate datasets
contain a peak at the same site as the averaged dataset. Here, probes within
the average chromatin shear size of the probe detected from the averaged
dataset are also analysed for peaks. If peaks are present in these regions the
probe detected in the averaged dataset is recored as a peak. The score is
calculated as a fraction of the number of individual datasets also present at
the same site. For example, if two out of three replicates contain a peak at
the same probe the score is 2/3 = 0.6˙.
As well as detecting and scoring peaks, the algorithm calculates a range
over which the genuine binding site is likely to be located based on probe co-
ordinates and the average chromatin shear size, termed the potential binding
region (PBR). For peaks with a score of 1 this is calculated as the smaller
of the average chromatin shear size or half the distance to the previous/next
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Figure 5.8: Peak detection process flow chart: The computational processes
of the peak detection process, which takes the results from the enrichment
detection to find potential binding regions.
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•Consecutive probe maxima in individual 
datasets: 3:3, 8:9, 16:16 and 18:18 
 
•Probe maxima in averaged dataset: 3, 9 
and 17 
 
•Analysing these peaks: 
1. Probe 3, in individual maxima probe 
range 3:3 = PBR range 3:3, score 1 
2. Probe 9, in individual maxima probe 
range 8:9 = PBR range 8:9, score 0.5 
3. Probe 17, not in any individual 
maxima probe ranges, closest to 
maxima at 16 and 18 (both within 
window size) = PBR range 16:18, 
score 0. 
Figure 5.9: Representation of peak determination: The top graphic shows a
genome section with probe positions indicated by crosses. Black and red lines
indicate two datasets with their mean shown in green. The columns of values
represent the computational process of finding peaks or peak regions. The
first ‘Ratios’ column shows the values of the black data line. The next two
show the same values offset by one position in both directions, with the values
in brackets being the resulting gaps filled with the original value. These three
columns are analysed for maxima, occurring where a value in the first column
is larger than the equivalent value in the next two columns. These sites are
indicated with values of 1 in the black ‘Maxima’ column. The red ‘Maxima’
column shows the same results for the red data. Values in the ‘Scores’ column
are calculated as the mean of these values. Peak sites are determined by the
positions of maxima in the averaged data, shown in the green ‘Maxima’
column and highlighted in the ‘Scores’ column. Consecutive probe maxima
in individual and averaged datasets are calculated and each averaged dataset
maximum is analysed in the context of the individual dataset maxima to
determine the potential binding region which is stored with the score, as
shown in the text.
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probe (Figure 5.10). This is based on two assumptions. The first is that
the genuine binding site must lie within one average chromatin shear size
length of the peak probe as beyond this range the probe will not detect the
enrichment. This is relevant in situations where the distance between probes
is greater than the average chromatin shear size and this lack of resolution is
reflected in the large potential binding region. The second assumption is rel-
evant where the distance between probes is less than the average chromatin
shear size and is that the genuine binding site must lie closer to the peak
probe than its adjacent probes. If this were not the case the adjacent probe
would be at the top of the peak.
For peaks with a score less than 1, the same procedure is applied in cal-
culating the likely binding region taking into account all of the probes from
all replicate datasets that are considered to make up the peak (Figure 5.11).
This extends the region, reflecting the fact that the peaks in differing posi-
tions reduce the certainty in determining the likely binding region.
The final result of this peak detection process is a six column matrix con-
taining the chromosome, start and end coordinates of the potential binding
region, the unique probe ID and log2 binding value of the probe at the top
of the peak (taken from the averaged dataset).
5.3 Testing the performance of the algorithm
Testing the performance of enrichment detection algorithms, and comparing
the results of different algorithms, poses a problem. The nature of ChIP-chip
datasets means that many, if not all, of the genuine biological binding sites
are not known. Therefore there is no way of comparing the performance of
one algorithm with another, because it is not possible to know which results
from the two are correct or incorrect. The accuracy of different methods is
therefore difficult to assess. Although a subset of microarray results should
always be validated by other techniques, it is impractical to validate every
single result, both positive and negative, and so it cannot be known with
absolute certainty which results are correct or incorrect.
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Potential 
binding region 
Potential 
binding region 
A B 
Figure 5.10: Calculating the PBR with consistent peaks: Crosses represent
probes, the probe at the peak is highlighted; coloured lines represent in-
dividual datasets. A - Where adjacent probes are closer than the average
chromatin shear size the distance is set as half the distance to the adjacent
probe. B - Where adjacent probes are further than the average chromatin
shear size the distance is limited to the average chromatin shear size.
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A B 
Potential 
binding region 
Potential 
binding region 
Figure 5.11: Calculating the PBR with inconsistent peaks: Crosses represent
probes, the probes at the peaks are highlighted; green and red lines represent
individual datasets. The region is calculated as in Figure 5.10 from the probes
at the two extremes of the range of peaks. A - peaks occurring at adjacent
probes form a potential binding region spanning those probes. B - peaks
occurring at non adjacent probes are identified by a peak in the averaged
data (blue line) and the potential binding region spans several probes.
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5.3.1 Data
Two sets of data have been used here in an attempt to overcome the above
problem and assess the performance of this algorithm compared to other
published algorithms. The first is the creation of artificial datasets, designed
to mimic the expected output of a microarray by simulating binding sites at
known locations. The second is the use of a series of spike datasets produced
by various labs, presented by Johnson et al. (2008), where a number of known
locations have been artificially enriched to varying degrees. These datasets
were created to evaluate variability in ChIP-chip experiments and peak de-
tection algorithms. As locations of genuine enrichment (both simulated and
real) are known for these datasets, the performance of the enrichment de-
tection algorithm can be assessed. Comparing the regions detected by the
algorithm with the genuine regions of enrichment allows the numbers of true
and false positive and negative results to be calculated. These values can be
used to determine the sensitivity and specificity of the algorithm (outlined
later), giving a measure of its accuracy. They are then compared to the re-
sults created by other algorithms analysing the same datasets, to compare
their performances.
5.3.1.1 Creating simulated ChIP-chip data
Simulated ChIP-chip data were created to test the performance of the en-
richment detection process, based on the probe arrangement of the G4493A
microarray. From this layout, 2000 probes were randomly selected to repre-
sent ‘peaks’. The predictProfile function (Chapter 6) was used to generate
a dataset based on these positions, with randomly generated values repre-
senting peak heights. A window size of 600 was used. Properties of the Abf1
datasets (no UV treatment; see Chapter 7 for details) were used to make
the simulated data represent a set of real ChIP-chip data as accurately as
possible. The largest value in these raw datasets is around 6.8, so this was
used as an estimate of the maximum peak height to simulate. Four sets of
height values were generated: small (0.5 to 2.5), medium (2.5 to 4.5), large
(4.5 to 6.5) and a combination of all of these (0.5 to 6.5). Noise, in the form
244
SECTION 5.3 CHAPTER 5
of randomly generated normally distributed values, was added to the data,
to simulate the noise associated with real data. The standard deviation of
the estimated background data from the Abf1 datasets was calculated and a
normal distribution with a mean of zero and standard deviation of this value,
0.31, applied.
For each set of randomly generated peaks, five different sets of random
normally distributed values were applied. This was intended to simulate five
replicate datasets, which all have the peaks present at the same positions but
are subject to different random noise. As the noise is applied to peaks as well
as the background, the heights and shapes of the peaks will be different in
each dataset, depending on the random values applied to them. In addition,
for each dataset 500 randomly generated probes had their values increased
by a randomly generated value between 0 and 3, to simulate small, spurious
peaks which may occur in data. This allowed the performance of the peak
detection to be assessed with single and multiple datasets. Peak positions,
heights and noise were applied blind, so as not to introduce any user bias in
the analyses. The full normalisation procedure was applied to each dataset
before peak detection was applied, to replicate the same procedure real ChIP-
chip data is subject to. Peak detection was set to find peaks, resulting in a
list of probes determined to be closest to the binding region.
5.3.1.2 Using spike datasets
Spike datasets, produced as a means to test the performance of different
microarray platforms and peak detection methods, is presented by John-
son et al. (2008). These microarrays contain probes covering regions se-
lected by the ENCODE consortium, covering 1% of the human genome.
The spikes consist of 100 samples of cloned genomic DNA sequences of av-
erage length 497 bp, added at concentrations ranging from 1.25- to 196-
fold above the background — a commercial human genomic DNA prepara-
tion. Datasets were downloaded from the Gene Expression Omnibus (http:
//www.ncbi.nlm.nih.gov/geo) under accession number GSE10114. In to-
tal, 7 individual Agilent datasets were produced: 3 produced by Myers et al.
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containing undiluted spikes and 4 produced by McCuire et al., 2 containing
undiluted spikes and 2 containing diluted spikes which went through a PCR
amplification procedure prior to their application to the microarray. These
datasets were analysed individually and in various combinations, shown in
Table 5.2 along with the amplification status of each.
The consistency of the datasets was investigated by creating scatter plots
of all replicates, shown in Figure 5.12 along with Spearman’s rank corre-
lation values. These show that there is very little correlation between any
two datasets, with the best correlation value being 0.5. While the bulk of
the data points should not show any correlation, under the assumption that
these are from the background sub-population, there should be a small but
significant subset of probes from the enriched sub-population which do show
a correlation. While this is partially apparent in some comparisons, all plots
also show higher values in one dataset which are not present in the other.
Compared to the Abf1 datasets (see Figure 7.7), which have good correla-
tions between replicates in their enriched sub-population regions, the plots
created here suggest that the spike datasets may not be well suited to the re-
quirements of this algorithm, as outlined in Section 5.2.2. Averaged datasets
were therefore analysed along with combined datasets. As previously dis-
cussed, this can increase the ability of the algorithm to detect the larger
peaks, possibly at the expense of smaller ones.
5.3.2 Optimisation of the algorithm
The algorithm was applied to the simulated and spike datasets with a number
of different settings, to test its performance under different conditions and
determine the optimal values for the different arguments. There are three
user-modifiable arguments that can influence the results of the algorithm:
the window size, FDRE value and scale factor. The algorithm was run with
a range values for each of these, centred around the value expected to give the
optimal results, and extending to values thought likely to give poor results.
This range of results allowed ROC plots to be created and an estimate of the
value producing the best results to be made, be this the expected optimum
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Number Dataset(s) Amplified
1 Myers 1 No
2 Myers 2 No
3 Myers 3 No
4 Myers 1 & 2 No
5 Myers 2 & 3 No
6 Myers 1 & 3 No
7 Myers 1, 2 & 3 No
8 McCuire 1 No
9 McCuire 2 No
10 McCuire 1 & 2 No
11 McCuire 3 Yes
12 McCuire 4 Yes
13 McCuire 3 & 4 Yes
14 Myers 1, 2 & 3 and McCuire 1 & 2 No
Table 5.2: Johnson et al. (2008) spike datasets: Combinations of Agilent
spike datasets presented by Johnson et al. (2008), showing the group that
created the data and the amplification status. Colours are as used in later
plots of the data and indicate single (grey), pairs (black, Myers only), full
(red) and combined (blue) datasets.
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Figure 5.12: Johnson et al. (2008) data correlations: The darker the blue
colour the more points occur in the region. Individual points outside of
the central region are shown with dots. The black line shows y = x. The
Spearman rank correlation value is shown above each plot.
248
SECTION 5.3 CHAPTER 5
or not.
The algorithm was first applied with a range of different window sizes,
centred on the expected optimal values for the two sets of data: 600 for
the simulated and 150 for the spike datasets. As previously outlined (Sec-
tion 5.2.1), windows that are too small or too large are likely to have a
detrimental impact on the ability of the algorithm to resolve sites of genuine
enrichment. The optimal values found from these tests were used to test
the algorithm’s performance with different FDRE values, centred around the
expected optimum of 0.9. As previously outlined, values that are too small
or too large will create unsuitable cutoff values, limiting the ability of the
algorithm to correctly extract values representing genuine enrichment. The
optimal values found from these two runs were finally used to test the effect
of a range of scale values on the algorithm’s performance. If the properties
of the estimated background sub-population vary from those of the assumed
normal distribution, genuine enriched regions may be thought to represent
background regions, or genuine background regions may be thought to repre-
sent enriched regions. The “scale” argument allows the properties of the data
to be modified, by scaling the whole dataset by the given factor, to improve
the ability of the algorithm to correctly identify enriched and background
regions.
The function was applied to the simulated data with the following set-
tings:
object arrayData objects containing normalised simulated dataset in the
combinations outlined in Section 5.3.1.1.
annotation The genomeAnnotation object for the yeast genome.
windowSize A range of values, shown in Table 5.3
FDRE A range of values, shown in Table 5.5.
findPeaks TRUE, in order to identify probes at the tops of peaks.
The function was applied to the spike data with the following settings:
object arrayData objects containing normalised spike dataset in the com-
binations shown in Table 5.2.
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annotation The genomeAnnotation object for the human genome.
windowSize A range of values, shown in Table 5.4.
FDRE A range of values, shown in Table 5.5.
findPeaks FALSE, in order to identify regions of enrichment.
Peak detection was applied to the simulated data, returning a list of
probes deemed to be at the tops of peaks. These were compared to the 2,000
randomly selected probes at the tops of the genuine, simulated peak sites.
Only enrichment detection was applied to the spiked datasets, without peak
detection, because of the nature of the data. A protein immunoprecipitation
procedure creates a triangular region of enrichment, because more DNA is
present from the site of the protein than the surrounding regions (Figure 5.1),
the top of which the peak detection aims to identify. The spike probes are
present at a consistent level across their length, creating rectangular regions
of enrichment (these can be seen in the “Enriched regions (combined).pdf”
file in the electronic appendix; see Page 367). The probes in this region
can be identified by the enrichment detection procedure, but as there is no
actual peak the peak detection procedure will not provide useful additional
information. Probes detected as enriched were compared to probes in the
regions containing spikes.
Receiver operating characteristic (ROC) curves are a method of display-
ing the performance of signal detection methods, used here to display the
performance of the peak detection method. The curves show the relation-
ship between sensitivity — the ability to correctly detect genuine results —
and specificity — the ability to correctly ignore false results. In other words,
sensitivity measures the proportion of true positives identified as positive,
that is, detected, and specificity measures the proportion of true negatives
identified as negative, that is, not detected. Therefore a detection method
with high sensitivity is able to correctly identify a high proportion of true
positives, and a method with high specificity is able to correctly ignore a
high proportion of true negatives. Both of these characteristics are required
in a reliable and informative detection method. A ROC curve shows how
the sensitivity and specificity change as a given parameter of the method is
altered, in this case the window size, FDRE and scale values. Sensitivity is
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shown on the y axis and 1-specificity on the x axis, so that the top left hand
corner of the plot represents the ‘perfect’ scenario: maximum sensitivity and
specificity. The format of a ROC plot, the relationships between sensitivity
and specificity and example curves are shown in Figure 5.13.
The sensitivity and specificity values for a ROC curve are calculated from
the numbers of true positives (detected known positives; TP), false positives
(detected known negatives; FP), true negatives (undetected known nega-
tives; TN) and false negatives (undetected known positives; FN), using the
following Equations 5.1 and 5.2.
sensitivity =
TP
TP + FN
(5.1)
specificity =
TN
FP + TN
(5.2)
Johnson et al. (2008) use a variation on this format to create ROC-like
plots from the results of their peak detections. Because most probes on these
microarrays are are true negatives (over 99%), large numbers of detected
false positives can be masked. This can create apparently good ROC curves
even with large numbers of incorrectly called positive results. Therefore
they calculate results based on the number of spikes; a much smaller value
than the number of true negatives. This methodology was applied to the
simulated data with a variation applied to the spike data, as this did not
have peak detection process applied. For this variation, detected probes were
split into consecutive regions and each of these compared with the genuine
enriched regions. Those overlapping were deemed to be true positives. This
principle is demonstrated in Figure 5.14. This format also reduces misleading
results that can be produced when probes around, but not including, enriched
regions are called as positive, or some, but not all, probes in enriched regions
are called as positive. This can cause probes to be called as FP when they
are immediately adjacent to enriched regions, and probes to be called as FN
when they occur in enriched regions where a number of probes have been
correctly called as TP. These modified sensitivity and specificity values were
calculated using the following Equations 5.3 and 5.4.
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1 - Specificity 
High sensitivity and high 
specificity: 
Many positive results are 
correctly identified with few 
negative results incorrectly 
identified.  Most results 
therefore represent true 
positives and the method  
is reliable. 
Low sensitivity and high 
specificity: 
Few positive results are 
correctly identified with few 
negative results incorrectly 
identified.  Few results are  
therefore generated and most 
true positives are missed, so 
the method is unreliable. 
High sensitivity and low 
specificity: 
Many positive results are 
correctly identified with many 
negative results incorrectly 
identified.  Many results are 
therefore generated with no 
differentiation between true 
and false positives, so the 
method is unreliable. 
Curves around the line y = x 
indicate unreliable detection 
methods. 
Curves passing further from the line 
y = x indicate improving reliability. 
Curves passing close to the top left-
hand corner represent good results. 
0 1 
0 
1 
Figure 5.13: ROC plot properties: Examples of poor (red), intermediate
(orange) and good (green) curves are shown.
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Modified sensitivity =
Number of correct sites found
Total number of sites
(5.3)
Modified specificity =
Number of incorrect sites found
Total number of sites
(5.4)
5.3.2.1 Optimising the window size selection
The window size used by the algorithm can potentially have a large effect
on the results generated. Too large or too small a window can reduce the
sensitivity or specificity of the algorithm, reducing the reliability of the re-
sults (Figure 5.2). Optimal results should be generated when the window
size is large enough to include enough probes to mask the effects of single,
anomalous values and small enough to be entirely filled by regions of genuine
enrichment. The average chromatin shear size was therefore expected to be
the best value to use, as it meets these two criteria and is easily determined
for each assay in the laboratory. The simulated datasets were created with
a simulated chromatin fragment size of 600. A range of window sizes, based
on this expected optimum, were tested (shown in Table 5.4). No information
about the lengths of fragments produced by the sonication procedure for the
spiked datasets is provided in the publication or supplementary information
from Johnson et al. (2008). The average spike in length is around 500, sug-
gesting the optimal window size to be 250. A range of window sizes, centred
on this expected optimum were tested (shown in Table 5.3). All of these were
carried out with the expected optimal FDRE value of 0.9.
The results of these tests are shown in Figure 5.15, with the first column
showing ROC curves and the second ROC-like curves. The first row shows
results from the simulated datasets. Green crosses indicate the results from
the expected optimal value of 600. Single datasets are shown with grey lines,
triplicates with black and all five with blue. The curves for the combined
datasets (black and blue) are an unexpected shape, revealing an unusual
result. They show that while the expected optimal window size produces
the best sensitivity values, the specificity can be improved by reducing the
window size to the smallest value tested (1). This is due to the fact that
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TN TN TN TN TN FN FN FP FP TP TP TP TP TP 
Enriched region Probe called positive Probe called negative 
Single consecutive region 
called positive 
Figure 5.14: Labelling of consecutive enriched regions: Probes are indicated
by crosses, with those called positive shown in red. The real enriched region
is indicated with a pink box. Statuses, under each probe, show how indi-
vidual probes are labelled as for use by Equations 5.1 and 5.2. Converting
results to consecutive regions and comparing these positions to regions of
real enrichment means this single region of consecutive probes is called as
positive for use by Equations 5.3 and 5.4.
Number Window Size
1 1
2 100
3 200
4 300
5 400
6 500
7 600
8 700
9 800
10 900
11 1,000
Table 5.3: Window sizes for testing simulated data: Window sizes used by
the enrichment detection procedure with the simulated datasets to generate
results used to create ROC and ROC-like curves. The expected optimal value
is shown in bold.
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Number Window Size
1 1
2 50
3 100
4 150
5 200
6 250
7 300
8 350
9 400
10 450
11 500
Table 5.4: Window sizes for testing spike data: Window sizes used by the
enrichment detection procedure on the spike datasets to generate results used
to create ROC and ROC-like curves. The expected optimal value is shown
in bold.
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combined datasets are being analysed, which on its own is enough to remove
the effects of any spurious results occurring in single datasets, without the
need for the added sensitivity gained by combining probes in larger windows.
Using smaller window sizes does not improve the sensitivity, meaning all the
peaks that can be detected are detected with the expected optimal window
size, but it does improve the specificity, meaning fewer incorrect peaks are de-
tected. This means that the lower cutoff values — produced when analysing
multiple probes in a window — are detrimental in this situation, allowing
more regions to be incorrectly called as enriched. The curves for the single
datasets (grey) are a more usual shape, with the window size of 600 produc-
ing the best combination of sensitivity and specificity. The curves show that
values around this also produce good combinations of sensitivity and speci-
ficity and so the value does not have to be determined with a high degree of
accuracy in the laboratory. With single datasets, the extra sensitivity gained
by analysing combinations of probes in windows is still beneficial. Therefore
in all further analyses of these datasets a window size of 600 was used for
single datasets and 1 for combined datasets.
The results of the spiked datasets are shown in the next two rows, with
combined datasets in B and averaged datasets in C. Single datasets are shown
with grey lines, triplicates with black, total datasets with red and com-
bined (Myers and McCuire) blue. These also produce some unusually shaped
curves, but the green crosses, highlighting the expected optimal value of 250,
show that this generally produces the best combination of sensitivity and
specificity across all datasets. Unlike the simulated datasets, a window size
of 1 does not improve the results from the combined datasets. This is likely
due to the different format of this data, which lacks true peak shapes, and
the resulting different analysis method, which analyses single probes called
as enriched, rather than probes at the tops of peaks. All further analyses of
these datasets use a window size of 250. Comparing the combined and aver-
aged dataset curves shows mixed results. Generally, better sensitivity values
are produced with averaged data, but better specificity values are produced
with combined data.
These results show that in most cases the best balance of sensitivity
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Figure 5.15: ROC curves from window size variations: Results produced by
varying the window size used by the enrichment detection algorithm. The
left hand column shows ROC curves created using Equations 5.1 and 5.2 and
the right hand column shown ROC-like curves created with Equations 5.3
and 5.4. The first row shows results from the simulated datasets, with green
crosses showing the expected optimal window size of 600. The second and
third rows show results from the combined and averaged spiked datasets
respectively, with green crosses showing the expected optimal value of 250.
Note the differences in axis scales.
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and specificity are at the expected window sizes, with the exception of the
combined simulated datasets. There is scope to vary the value used with-
out adversely affecting the results, depending on the nature of the datasets.
Those with little background variation will produce good results even with
a smaller window size, whereas those with increased levels of background
variation may not. When performing peak detection on the results of the
enrichment, only the probe at the centre of the peak need be found for the
peak to be called. Therefore, changing the window size, resulting in a change
in the probes called as enriched, will only affect the final result if this changes
whether or not the probe at the centre of the peak is called as enriched. The
average chromatin shear size can readily be determined in the laboratory,
and these results show that this value is appropriate to use in the algorithm.
They also show that this value does not need to be determined with a high
level of accuracy, as small deviations from the optimal value do not have a
large effect on the final results.
5.3.2.2 Optimising the FDRE value selection
The FDRE value used by the algorithm determines the cutoffs for each win-
dow and so can influence the performance of detection. Too small a value
will give high cutoff values, enabling the detection only of enriched probes
with large values and reducing the sensitivity. Too large a value will give
low cutoff values, enabling the detection of probes with small values which
may not be due to genuine enrichment, reducing the specificity. Optimal re-
sults should be generated with an FDRE value of around 0.9. The algorithm
was applied, with the window sizes determined in the previous section, using
a range of FDRE values based on this expected optimum value, shown in
Table 5.5.
The results of these tests are shown in Figure 5.16, with the first column
showing ROC curves and the second ROC-like curves. Green crosses indicate
the results from the expected optimal value of 0.9. The first row (A) shows
results from the simulated datasets. These plots confirm that sensitivity and
specificity generally increase as the enrichment detection is performed on
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FDRE Value
1 0.1
2 0.2
3 0.3
4 0.4
5 0.5
6 0.6
7 0.7
8 0.8
9 0.9
10 1.0
11 1.1
12 1.2
Table 5.5: FDRE values for testing simulated data: FDRE values used by
the enrichment detection procedures on the simulated and spike datasets to
generate results used to create ROC and ROC-like curves. The expected
optimal value is shown in bold.
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more datasets, with the grey lines of single datasets being lower and further
to the right than the coloured lines of combined datasets. The results of the
spiked datasets are shown in the next two rows, with combined datasets in B
and averaged datasets in C. Single datasets are shown with grey lines, tripli-
cates with black, total datasets with red and combined (Myers and McCuire)
blue. There is a general trend for improved sensitivity and specificity with
the analysis of more datasets, but this is not as clear cut as the simulated
data. For example, the first plot (B1) shows a grey line, representing a sin-
gle dataset, to have a higher sensitivity than the combined datasets at lower
specificity levels. The curves show that generally the best balance of sensitiv-
ity and specificity for each curve is at the expected, highlighted points. Some
improvement is possible with some curves, but good results are achieved with
all. This shows that under the conditions of normal ChIP-chip assays, where
genuine results are not known, this value would be able to provide reliable
results for a range of datasets, confirming the expectation that this value is
the best to use in the algorithm. Using lower values generates fewer correct
results, with little change in the number of incorrect results, so does not have
any additional benefit. Using higher values generates more incorrect results
with little change in the number of correct results, reducing the usefulness
of those results. Therefore this value of 0.9 was used for all further analyses.
5.3.2.3 Optimising the scale value selection
The results in the previous sections have been generated from datasets as-
sumed to fully meet the expectations for enrichment detection (see Sec-
tion 4.2.1). Although the expected optimal values are generally at the op-
timal points on the curves, some of the sensitivity and specificity values
are poor, showing that there is still scope for improvement in the detection
method. The performance of the algorithm was therefore assessed by varying
the scale values, using the optimal window size and FDRE values.
The results of the peak detection using these values on the simulated
datasets are shown in Figure 5.17. Each row shows the results of datasets
with the small, medium, large and combined peak heights. The results show
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Figure 5.16: ROC curves from FDRE variations: Results produced by vary-
ing the FDRE value used by the enrichment detection algorithm. The
left hand column shows ROC curves created using Equations 5.1 and 5.2
and the right hand column shown ROC-like curves created with Equa-
tions 5.3 and 5.4. The first row shows results from the simulated datasets,
the second and third show results from the combined and averaged spiked
datasets respectively. Green crosses show the expected optimal FDRE value
of 0.9. Note the differences in axis scales.
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the method generally has a good sensitivity and specificity.
The first row (A) shows good results to be generated from the datasets
with small peaks. The optimum result corresponds to around 80% of the total
peaks being found, with 50–100 incorrect peaks. This result shows that the
detection method produces reliable results even with low levels of enrichment,
suggesting it is suitable for use on genuine ChIP-chip data containing only
low levels of enrichment. The second (B) and third (C) rows, showing the
results from the medium and large peaks, give near perfect results, especially
with the combined datasets, with the correct peaks found approaching 100%
with the number of incorrect peaks approaching zero. However, as these lack
any small peaks, they may not be representative of genuine ChIP-chip data.
The fourth row (D), showing results of datasets with a range of combined
peak heights, is likley to most accurately represent genuine ChIP-chip data.
The optimal results here corresponds to around 90–95% of the total peaks
being found, with around 50 incorrect peaks.
The sensitivity and specificity values are markedly improved by analysing
combined datasets compared to analysing datasets individually. The best re-
sults come from the combination of all five datasets, shown with red lines.
Many biological experiments are carried out in triplicate, represented with
black lines, which still give a large improvement in sensitivity and speci-
ficity over the individual datasets, shown with grey lines. The analyses of
individual datasets are reasonably robust, with the ROC-like curves of com-
bined peak height datasets (Figure 5.17D2) showing around 85% of the
total genuine peaks are found, along with around 200 incorrect peaks (a
specificity value of 0.1). This shows the method is reliable even when only
single datasets have been created, although it is clearly preferable to have
multiple datasets to analyse together.
Green crosses mark the results from the datasets with no scaling applied.
These generally occur at the point on the curve closest to the top left hand
corner, indicating the optimal result. Many are on the ‘bend’ of the curves,
that is, the point at which the increase in sensitivity slows down while the
decrease in specificity speeds up. Results before this point tend to show large
increases in sensitivity with small decreases in specificity, meaning the quality
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Figure 5.17: ROC curves from simulated data: Results produced by varying
the scale value used by the enrichment detection algorithm on the simulated
datasets. The left hand column shows ROC curves created using Equa-
tions 5.1 and 5.2 and the right hand column shown ROC-like curves created
with Equations 5.3 and 5.4. The first row show results from small peak
heights, the second medium, the third large and the fourth all combined.
Grey lines show results from individual datasets, black groups of three and
blue all five. Green crosses show the expected optimal scale value of 1, that
is, no scaling. Note the differences in axis scales.
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of the results is increasing. Results beyond this point tend not to show large
increases in sensitivity but do have large decreases in specificity, meaning the
quality of the results is decreasing. The results of the medium and large peak
datasets (B and C) show that some reduction in scale can improve results,
but this is not the case with the small and combined datasets (A and D),
most likely to represent real ChIP-chip data. As these data are known to
have a normally distributed background, no scaling would be expected to be
required and so these results confirm the assumptions of the algorithm.
The results of the peak detection using the scale values on the combined
and averaged spiked datasets are shown in Figures 5.19 and 5.18 respectively.
For each the first row shows results from the unamplified datasets, showing
the Myers (black), McCuire (red) and combined (blue) data, and the second
the amplified (McCuire only) datasets. The left hand column shows ROC
curves and the right hand column shown ROC-like curves. These curves show
that the performance of the algorithm is poor with unscaled datasets, the
results of which are highlighted with green crosses (some crosses are beyond
the scale of the plots and are therefore not visible). This is as a result of
the properties of the background distributions of the datasets not meeting
the assumptions of the algorithm, that is, they do not form normal distri-
butions. This means that the algorithm interprets some probes as enriched
when they are in fact part of the background distribution, resulting in poor
specificity values. Scaling the data down means these regions become cor-
rectly interpreted as background, while the genuine regions of enrichment are
still detected, thus improving the sensitivity and specificity.
Curves created with results from averaged data (Figure 5.18) show a
better performance of the algorithm than the combined individual datasets
(Figure 5.19), evidenced by the fact that they pass closer to the top left hand
corner of the plot regions. The reasons for this are outlined in Section 5.2.1.1,
and stem from the fact that the datasets are not very consistent between
repeats. The point closest to the top left hand corner of the plot regions,
showing the best balance between sensitivity and specificity, was created by
a scale factor of 0.6.
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Figure 5.18: ROC curves from averaged spiked data: Results produced by
varying the scale value used by the enrichment detection algorithm on the
averaged spiked datasets. The left hand column shows ROC curves created
using Equations 5.1 and 5.2 and the right hand column shown ROC-like
curves created with Equations 5.3 and 5.4. The first row show results from
enriched datasets (Myers (black), McCuire (red) and combined (blue)) and
the second non-enriched datasets (McCuire only). Green crosses show the
expected optimal scale value of 1, that is, no scaling.
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Figure 5.19: ROC curves from combined spiked data: Results produced by
varying the scale value used by the enrichment detection algorithm on the
combined spiked datasets. The left hand column shows ROC curves created
using Equations 5.1 and 5.2 and the right hand column shown ROC-like
curves created with Equations 5.3 and 5.4. The first row show results from
enriched datasets (Myers (black), McCuire (red) and combined (blue)) and
the second non-enriched datasets (McCuire only). Green crosses show the
expected optimal scale value of 1, that is, no scaling.
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5.3.2.4 Summary
Plots were created of every region detected as enriched, along with the regions
of genuine enrichment (“Enriched regions (averaged).pdf” and “Enriched re-
gions (combined).pdf” files in the electronic appendix; see Page 367). Of
the non-enriched regions that were detected by the algorithm as enriched, all
appear to be reasonably large peaks containing several probes, so ordinarily
there would be no way of distinguishing between them and genuine peaks
from the data alone. There could be several explanations for the formation
of these peaks. They occur in all datasets and so their formation is unlikely
to be due to chance events in a single experimental run. They may be gen-
uine peaks, that is, caused by genuine enrichment, either because of increased
material over the regions in the commercial human genomic DNA prepara-
tion or the spike in probes used being able to hybridise to other regions of
the genome. Alternatively, they may not be due to genuine increased en-
richment but inconsistencies with the probes on the microarray causing high
signals to be produced from small amounts of bound DNA. There is no way
of distinguishing between these and genuine peaks, and so there is no way
of improving further on the specificity of the algorithm without finding the
reasons for these spurious peaks.
The plots show that the scale value can have a large effect on the results
of the algorithm and so it is important to provide the correct value. Unlike
the expected optimal values for the window size and FDRE parameters, there
is no way to estimate what the scale value should be for a given dataset. The
lowest value of the datasets, used in estimating the background population,
may provide a method of estimating the optimal scale value. The lowest
value of a standard normal distribution is around 4. The lowest value of
the spiked datasets is -7.3. The ratio of these numbers is around 0.6, that
is, the optimal scale value for the datasets. This may be coincidental, or
may represent a way of estimating the scale factor to use in the enrichment
detection. Without more spiked datasets with known enrichments it is not
possible to say with certainty that this provides a method of determining
this value.
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These results show that the expected optimum FDRE value of 0.9 has
proved to produce the best results, meaning there is generally no need for
users to modify this. The optimum window size was at the expected level for
single datasets, but smaller values were shown to produce better results with
combined datasets when detecting peaks. Cutoff values may be applied to
the sensitivity and specificity values of these results, above which all values
may be considered optimal. However, the way the algorithm presented here
works means the theoretical optimal values for the FDRE and window size
are known before hand, and these have been shown in this analysis to provide
optimal results, and so reporting a range of values in this way provides no
additional useful information. The expected optimal values of 0.9 for the
FDRE and the average chromatin shear size (estimated from a gel) for the
window size should be used under normal circumstances. The scale value can
have a large effect on the performance of the algorithm when the data do not
fully meet the expectations of the algorithm. This value is dataset dependent,
specifically relating to the distribution of each dataset, which influences the
estimation of the background region by the algorithm. Therefore the optimal
value will vary for real datasets which do not meet the expectations of the
algorithm, in a manner that cannot currently be predicted. The setting of
the optimum value for this argument therefore needs more investigation.
The fact that the enrichment detection procedure classifies probes as be-
ing from the enriched or background sub-populations means that these can be
compared to the overall and estimated background distributions. How well
the density of the detected background sub-population matches the density
of the estimated background sub-population may provide a way of estimat-
ing the accuracy of the results of the procedure with real ChIP-chip datasets,
for which the correct results are not known a priori. If the densities closely
match then it would be reasonable to assume that the detected enriched
sub-population is accurate and therefore the procedure has performed well.
This may provide a method of ‘fine tuning’ the algorithm to determine the
best parameters to use for each dataset being analysed. An example plot
is shown in Figure 5.20, created from the simulated data, showing how the
densities of the results of the procedure compare to the estimated back-
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ground region. The detected background region (red line) closely follows
the estimated background region (dashed black line). The detected enriched
sub-population (green line) follows the line expected in the enriched region
of the overall dataset density (dashed grey line). There is a discrepancy be-
tween the estimated and detected background sub-populations towards the
high end of the densities, which may be able to be corrected with further
adjustments of the parameters.
5.3.3 Comparison with other methods
As previously stated, the availability of reliable enrichment detection software
for ChIP-chip data is limited. Of the most recent publications that can be
applied to Agilent data, the DECODE and JAMIE software packages are
no longer available, Wavelets is not provided as software and SPLITTER is
available but not functional.
SPLITTER is available as a web server (zlab.bu.edu/yf/anchor/web/
splitter.cgi?step=0), where data to be analysed is uploaded in the form
of tab delimited text files. To compare this algorithm with the one presented
here, the simulated datasets were uploaded for analysis. Default settings
and settings applied by Johnson et al. (2008) were used, but the algorithm
was not able to return any results. A range of additional settings were also
tried, adjusting all available parameters, but no results could be generated.
The Abf1 binding dataset was then uploaded to test the algorithm with
genuine ChIP-chip data, as opposed to the artificial nature of the previous
two datasets, but it was not possible to generate any results from this data
either. All data were uploaded correctly, as verified by histograms shown in
the SPLITTER output. As this algorithm is available only as a web server,
it is difficult to determine the reason for the lack of result generation. The
performance of this algorithm could not therefore be accurately compared.
In addition, the MA2C package was downloaded, which is written to
process only Nimblegen data files. Although the help forum for this program
includes references to converting Agilent data to the required format, the
programs required to achieve this are not publicly available.
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Figure 5.20: Example analysis of peak detection results: The green and
red lines show the density of the detected enriched and background sub-
populations respectively. The dashed grey line shows the overall data density
and the dashed black line the estimated background sub-population.
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Therefore the only way of assessing the performance of this algorithm
relative to those previously published is by the visual comparison of published
ROC and ROC-like curves. ROC-like curves created by Johnson et al. (2008)
for the spiked datasets are shown in Figure 5.21. Here the x-axis value of 0.05
has been used to determine sensitivity values, the Agilent values of which
can be seen to be around 0.5 for the amplified and unamplified datasets.
Comparing these to the equivalent values in Figure 5.18 shows higher values
created from the algorithm presented here, with the combined dataset (blue
curve) reaching a sensitivity value of around 0.8 at this point.
The limited availability and applicability of many of these peak detection
programs highlights the difficulties that users can face when attempting to
analyse their own data. This is why the algorithm created here has been
written in such a way that it can be used on any type of data, provided the
values can be written to a tab delimited text file. The accompanying help
files provide basic instructions on how to run the process from the very start,
as well as more detailed information for more advanced users. It is hoped
that, when published, this will allow a range of people to easily analyse their
data in a way that suits their needs.
5.4 Discussion
Like the normalisation method, the peak detection method presented here
relies on the background sub-population approximately following a normal
distribution. Some other methods of peak detection also rely on this assump-
tion (Buck et al., 2005, for example), which is generally held for ChIP-chip
datasets. Unlike many other methods, it has the advantage of being able to
return estimated binding sites (for example, for protein binding datasets) or
regions of enrichment (for example, for histone modification datasets). This
distinction allows relevant data to be analysed for any given dataset. It also
has the advantage of utilising replicate datasets and overlapping probes to in-
crease the power of detection. Therefore with several repeats of a dataset be-
ing analysed together, smaller binding peaks can detected than by analysing
all the datasets separately and combining the results. Similarly, smaller peaks
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Figure 5.21: ROC-like curves created by Johnson et al. (2008): The combined
results of enrichment detection procedures applied to the three microarray
formats are shown. Adapted from Johnson et al. (2008).
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can be detected in regions with higher probe coverage. Therefore on high
resolution microarrays with multiple repeats it should be possible to detect
the smallest of binding sites.
Users can define several variables, but the defaults for the window size
and FDRE value have been shown here to work well, and so little time need
be spent adjusting these to get the optimal results. The scale value has been
shown to have a large effect on some data and so more time may need to be
spent optimising this. More work needs to be done to determine if there is
any link between a dataset and the optimal scale value, which would provide
an easy way of setting this parameter. The algorithm is incorporated into
the package of functions detailed in Chapter 3 and takes only a matter of
seconds to run, meaning users can easily load data and obtain results from
this algorithm in very little time.
The results of enrichment detection on publicly available spiked datasets
(Johnson et al., 2008) suggest that the algorithm is able to outperform these
published methods. Sensitivity and specificity values were calculated from a
range of window size, FDRE and scale values, the results of which are shown
in ROC and ROC-like curves. Visual comparison of these to published curves
show that this algorithm produces higher sensitivity values at a given speci-
ficity value. The existing algorithms are not available for testing and so this
visual comparison is the only way of gauging their performances relative to
the algorithm presented here. The algorithms themselves would be required
to perform an objective comparison of results and this could be carried out
as a follow up study should they become publicly available in the future.
In addition to this, detection methods that can be applied to any format
of ChIP-chip data are not readily available and so this algorithm is well
placed to fill this gap.
Comparisons of peaks or enriched areas from different arrays can be made
by statistical methods, such as T-tests, or graphical methods, using the tools
provided in Chapter 3. Changes in the shapes of profiles may not be detected
statistically, while being clear to the eye. These may still represent interesting
biological results and so statistics should not be relied upon as the only
definitive result.
273
CHAPTER 5 SECTION 5.4
This new enrichment detection method was created to overcome the limi-
tations of some current algorithms, in the type of data that they can analyse,
the type of detection that they can perform, their ability to analyse multiple
datasets and their current availability for use (outlined in Table 5.1). The
method presented here can analyse data from any platform (by converting
data to the defined tab-delimited file format where necessary), can be set
to find regions of enrichment or peaks (depending on the type of data being
analysed) and is able to utilise multiple replicate datasets to increase the
power of detection over analysing datasets individually.
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Development of a method to
predict sequence specific
damage events
6.1 Introduction
Many DNA damaging agents induce damage at specific nucleotide sequences.
There are many examples in the literature of particular chemicals being
shown to induce damage at particular sequences, such as reactive oxygen
species (Oikawa, 2005), reducing sugars (Morita et al., 1985), lipid perox-
idation products (Ueda et al., 1985) and ozone (Ito et al., 2005). In our
laboratory we investigate primarily UV damage, which occurs with known
frequency at the four possible dipyrimidine sequences. UV radiation, specifi-
cally at or near to 254 nm, is close to the maximum absorption wavelength of
DNA. This can generate many lesions, mainly at adjacent pyrimidine sites.
Two adjacent pyrimidines in the same polynucleotide chain can absorb UV
energy to form a four-membered ring structure, a CPD, resulting from satu-
ration of the C=C double bonds (Figure 1.5). CPDs form solely at adjacent
pyrimidine sites, and as such their position is determined by DNA sequence.
The quantitative ratio of CPD formation after UV irradiation at TT, TC,
CT and CC sites is 68:16:13:3 as determined by measuring these lesions in
plasmid DNA (Mitchell et al., 1992) and DNA from human cells (Tornaletti
et al., 1993).
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When developing assays to measure these damages throughout an entire
genome it is useful to be able to generate a predicted profile of DNA damage
expected immediately after a treatment. This offers an important quality
control function in confirming that the assays are performing as expected.
This gives greater confidence in analysing datasets generated at later time
points, from which repair rates can be calculated.
It also has the potential to enable the identification of ‘hot’ and ‘cold’
spots of damage, by identifying regions of consistently lower or higher damage
than the prediction suggests. The ability to detect and identify these outliers
from the predicted pattern is especially useful for certain types of analysis
(see Section 6.6.1).
6.2 Motivation
The technology developed in our laboratory to measure DNA damage genome
wide (Teng et al., 2011) required a way of testing whether or not the signals
from the microarrays represent genuine UV induced damage or general back-
ground noise (see Section 1.1.3). Damage occurs across the whole genome
and so the data cannot be split into background and enriched subpopula-
tions (shown in Figure 6.1 and described previously in Section 4.2.1): every
probe represents some amount of damage and so the data consists of a single
enriched population. Without this comparison between background and en-
riched subpopulations it is not possible to tell if the data show a signal result-
ing from enrichment following immunoprecipitation of damage or background
noise as a result of non-specific immunoprecipitation and/or hybridisation.
Comparing the microarray data to a predicted profile allows their accu-
racy level to be estimated.
6.3 Methodology
As previously described (see Figure 5.1), a peak is centred on a binding site
with a base width approximately twice the average chromatin shear size.
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Figure 6.1: CPD dataset density plots: CPDs occur throughout the genome
and so the density plots of the two replicates show a distribution of enrich-
ment values without a distribution of background values.
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The height of the peak is determined by the fluorescence signal, which is
determined by the amount of material bound to the probe. Knowing these
properties allows a peak shape to be predicted, given the average chromatin
shear size. The fluorescence signal, or amount of material bound, does not
need to be known in order to predict a peak shape, as the height can be
treated as being in arbitrary units. The value of these units does not affect
the peak shape as all points forming the peak will always have the same
relationship to each other, regardless of their actual values. In the formula
presented here the predicted values range from 0 to 1.
Theoretically, the value at any point of the peak is directly linked to its
distance from the binding site. The point at the centre of the peak will have
the largest predicted value, decreasing linearly as the distance away from the
centre extends to the window size, at which point the predicted binding value
becomes zero. In practice, the peak shape is more likely to form a Gaussian
distribution due to the varying lengths of the sheared chromatin fragments.
These will cause variations in the maximum extent of binding at a given site,
influencing the width of the base of the peak. However, this effect is likely to
be relatively small, with triangular peaks capturing much of the information
of a binding site. Therefore for computational efficiency this peak shape is
used in this prediction method. To calculate a predicted binding value at any
given point one needs to know the location of the actual binding site, the
location of the point at which the prediction is being made (or its distance
from the actual binding site, as whether it is up- or downstream of this does
not affect the binding value) and the window size. The predicted binding
value can then be calculated as the difference between the fragment length
and distance from the actual binding site divided by the fragment length. In
this way if the site being predicted is at the actual binding site the distance
between the two is zero. The calculation is therefore the window size minus
0 (equals the window size) divided by the window size, which equals 1. If the
site being predicted is the distance of the window size away from the actual
binding site, the distance between the two is the window size. The calculation
is therefore the window size minus the window size (equals 0) divided by the
window size, which equals 0. At all other points the predicted value will lie
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between these two extremes. These predicted values at each probe can be
calculated with the following Equation 6.1, with a single binding site. Here
w is the window size and |d| is the positive distance between the binding site
and the point being calculated.
w − |d|
w
(6.1)
This same formula can be used to calculate the binding value from a
damage event, where the term binding site can be replaced by damage site.
In reality there are likely to be multiple damage sites surrounding each probe
on the array, all contributing to their binding values. The equation can
therefore be extended to take all these sites into account, by adding together
their various values, shown in the following Equation 6.2. Here s represents
each of n damage sites, the calculations for all of which are added together.
n∑
s=0
w − |d|s
w
(6.2)
In the event that different damages occur at different frequencies, such
as CPDs, the probability value of any site can be incorporated to reflect the
likelihood of it contributing to the overall value. This reduces the maximum
predictable value from 1 to the probability value of the particular damage.
This is shown in the following Equation 6.3. Here p is the probability value
of binding site s.
n∑
s=0
ps
w − |d|s
w
(6.3)
This equation is applied to the region the size of the window size up-
and downstream of every point in the genome at which a predicted value
is required. It has been published and used to produce a predicted CPD
damage profile for yeast by calculating a value at each of the probes on the
G4493A microarrays (Teng et al., 2011).
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6.4 Algorithm
The equation described here was used as the basis of a script to allow pre-
dictions to be made throughout whole genomes. This was originally written
in Perl, as referred to in Teng et al. (2011), and was subsequently rewritten
in R. The reason for this transition was the ease of access to any genome
sequence in R via the BSgenome (Pages, 2012a) package. The alternative
Perl version required each genome to be manually downloaded in the correct
format and loaded into Perl.
Before running the prediction script, the relevant genome must first be
loaded into R. This is then passed to the predictProfile function along
with coordinates of the points to be predicted, the window size, damage
site sequences and damage site sequence probabilities. The sequence around
each site is taken and the Biostrings (Pages et al., 2009) package used to
determine the locations of all sequences being investigated. The distance
of these sites to the site being scored is calculated and the predicted score
calculated as Equation 6.3. This is repeated for each damage sequence and
all the predicted scores for the site are added together.
6.5 Alternative algorithm
This published method is computationally intensive, having as it does to
perform calculations at every dipyrimidine site in the genome. It became
apparent during investigations of the Kernel density estimate for the nor-
malisation procedure (Chapter 4) that this may also be used to perform
damage predictions. The profile of any ChIP-chip assay can be considered
to be a representation of the density of the number of immunoprecipitation
events along the genome. The density function also has the advantage of
being able to calculate densities from different underlying distributions, po-
tentially enabling a closer match to that in ChIP-chip. Using the triangular
Kernel is essentially identical to the published method, and so this can be
used to make a comparison between the two approaches. Using the Gaussian
Kernel may provide a method of increasing the accuracy of the method, by
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more closely representing the underlying peak distributions, without any loss
of computational efficiency. It was therefore investigated whether this com-
putationally efficient algorithm could be used to replace the existing CPD
prediction algorithm.
The major advantage of using the density function is that looping of
each dipyrimidine site to calculate individual profiles which are then added
together is not necessary. Instead, the function calculates a density from all
dipyrimidine sites on a chromosome at once. The arguments of the function
are modified to increase the resolution of the density to a level similar to
the arrays, as the default values smooth the data too much to be of any use.
Changing these parameters will influence the final prediction as they perform
a similar role to the window size (w) in the equations in Section 6.3.
The locations of each combination of dipyrimidine sites are calculated
with the Biostrings package as previously, which the density function
uses to calculate the density. By default this is done at 512 points, which
is too few across a chromosome consisting of tens or hundreds of thousands
of nucleotides. Therefore one tenth of the number of nucleotides is specified,
which is rounded up to the next power of two in the calculations. There is no
real advantage to using a higher resolution, which is more computationally
expensive for little gain in resolution. The values calculated by the density
function are dependent on the number of points being analysed, which is
different for each dipyrimidine sequence and chromosome. To remove this
discrepancy the results are adjusted to make the maximum density value for
all calculations 1, before being multiplied by the relevant probability value.
The density values are calculated at the specified number of regular intervals
across each chromosome, rather than at probe sites as with the equations
in Section 6.3. The approx function is therefore utilised, which interpolates
the density values at the sites of probes, based on the surrounding density
values.
The results of this procedure provide near identical results to using the
equations in Section 6.3, in a much shorter time. This method is therefore
used in place of that described in Teng et al. (2011). The predictProfile
function (Script 6.1) performs this procedure. In addition to using sequence
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information, the function can create predictions based on coordinates. This
can be useful to predict, for example, the binding profile from the immuno-
precipitation of proteins, where the coordinates of expected binding sites are
known. The function has the following arguments:
arrayData An arrayData object containing the probe positions from which
to create the predicted profile (no default).
seqs A character vector specifying sequences to calculate predictions from
(defaults dipyrimidine sites).
probs A numeric vector specifying probability values for each of the se-
quences provided in “seqs” (defaults for dipyrimidine sites).
genome A previously downloaded BSgenome genome sequence to analyse
(no default).
coordinates A three column matrix containing the chromosome number,
position and probability value for each site to predict (no default).
windowSize A numeric vector specifying the window size to use when cal-
culating predictions from the “coordinates” matrix.
masked A logical vector indicating whether or not the “genome” object is
masked.
In addition, the width argument should be specified as the window size,
which is passed to the density function and used in its calculations.
Script 6.1: predictProfile: script to predict the profile of ChIP-chip data
based on immunoprecipitation events at defined sites or sequences.
1 ## profilePlot function ##
2 ## arguments: object (an arrayData object), seqs (sequences at which to
predict enrichment), probs (probability values to apply to sequences),
genome (a BSgenome sequence), coordinates (coordinates of sites to
predict binding), windowSize (windowsize to predict sites of binding),
masked (whether the genome is masked)
3 predictProfile <-function(object ,seqs=c("TT","AA","TC","GA","CT","AG","CC","
GG"),probs=c(0.68 ,0.68 ,0.16 ,0.16 ,0.13 ,0.13 ,0.03 ,0.03),genome ,coordinates
,windowSize ,masked=T ,...) {
4 require(Biostrings) #load package if required
5 require(BSgenome) #load package if required
6 probeValues <-rep(0,nrow(object)) #set all values to 0
7 if(!missing(seqs)) if(length(seqs) != length(probs)) stops("Different
numbers of sequences and probabilities",call.=F) #check lengths
8 for (chr in unique(object$coordinates [,1])) { #loop through chromosomes
9 current <-object$coordinates [,1] == chr #get current object data
10 probes <-round(rowMeans(object$coordinates[current ,2:3]) ,0) #probe
middles
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11 if(missing(coordinates)) { #coordinates not provided
12 if(masked) currentSequence <-unmasked(genome [[chr]])[min(probes):max(
probes)] else currentSequence <-genome [[chr]][min(probes):max(
probes)] #get chromosome sequence
13 for (s in 1: length(seqs)) { #loop through sequences
14 pos <-as.matrix(matchPattern(seqs[s],currentSequence ,fixed=F))[,1] #
find sequences
15 x<-density(pos ,n=(max(probes)-min(probes))/10 ,...) #kernel densities
16 x$y<-x$y-min(x$y) #scale to max=1
17 x$y<-x$y/max(x$y) #scale to max=1
18 x$x<-x$x+min(probes) #correct for genome position
19 probeValues[current]<-probeValues[current ]+( approx(x$x,x$y,probes)$y
* probs[s]) #interpolate probe values
20 }
21 }else{ #coordinates are provided
22 if(!is.matrix(coordinates)) stop("Coordinates must be matrix",call.=F)
#check coordinates
23 if(ncol(coordinates) != 3) stop("Coordinates must contain three
columns",call.=F) #check coordinates
24 pos <-coordinates[coordinates [,1] == chr ,2] #get current coordinates
25 if(length(pos) > 1) { #if positions to predict
26 x<-density(pos ,n=(max(object$coordinates[current ,3])-min(object$
coordinates[current ,2]))/10 ,...) #calculate kernel density
27 x$y<-x$y-min(x$y) #scale to max=1
28 x$y<-x$y/max(x$y) #scale to max=1
29 x$x<-x$x+min(probes) #correct for genome position
30 probeValues[current]<-probeValues[current ]+( approx(x$x,x$y,probes)$y
) #interpolate probe values
31 probs <-coordinates[coordinates [,1] == chr ,3] #get probabilities
32 for (n in 1: length(pos)) { #loop through positions
33 probeValues[current ][ probes > (pos[n]-windowSize) & probes < (pos[
n]+ windowSize)]<-probeValues[current ][ probes > (pos[n]-
windowSize) & probes < (pos[n]+ windowSize)]*probs[n] #scale
34 }
35 }
36 }
37 }
38 probeValues[is.na(probeValues)]<-0 #set NAs to 0
39 prediction <-object [,1] #create arrayData object
40 prediction$ratios <-matrix(ncol=1, probeValues) #put in predicted values
41 colnames(prediction$ratios)<-"Prediction" #set column name
42 prediction$status <-list("Prediction") #set status
43 return(new("arrayData",prediction)) #return prediction
44 }
The function loads the required packages if not already done so (L4–5) and
assigns a vector to store the predicted probe values (L6). Where provided,
that the sequences have corresponding probability values is checked (L7).
A loop through the chromosomes is initiated (L8) and the corresponding
probe data extracted (L9–10). If coordinate values are not provided (L11)
the sequence for the current chromosome is extracted, unmasking it where
required (L12), and a loop through the provided sequences initiated (L13).
The positions of the occurrences of the sequences are found (L14) and used to
calculate the density values (L15). These density values are scaled to have a
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maximum value of 1 (L16–17) and adjusted to have the correct chromosomal
coordinates (L18). Values at probe positions are calculated, multiplied by the
relevant probability value and added to the probe score (L19). If coordinates
are provided (L21) their format is checked (L22–23) and the positions for the
current chromosome extracted (L24). If positions for the current chromosome
are present (L25) the density is calculated (L26) and adjusted and stored as
for sequences (L27–30). Probability values are extracted (L31) and used to
adjust each of the predicted peaks (L32–33). Any probes containing NA
values are assigned a zero value (L38) and the values stored in an arrayData
object (L39–40). The column names and status are updated (L41–43) and
the results returned (L43).
6.6 Application
The script was used to predict the CPD induction profile of the yeast genome
at the probe locations of the G4493A microarray. As the predicted values
are arbitrary, the predicted data is adjusted to make it comparable to the
microarray data. This is achieved by calculating the equation of the line of
best fit (y = mx + c) through the two datasets and adjusting the predicted
data to make this the line y = x. The values m and c of the equation of the
line of best fit are found from the function lm in R. The c value is subtracted
from the predicted values, which are then divided by the m value. This does
not affect the correlation between the two sets of data and so does not skew
any further analyses of the data.
A short section of chromosome 1 is shown in Figure 6.2 (the whole genome
is shown in “CPD predicted and actual profile.pdf” in the electronic ap-
pendix; see Page 367), showing the profile of the predicted and detected
levels of DNA damage induction are in good agreement. Throughout the
whole genome the Spearman’s correlation coefficient is 0.77 (Figure 6.3), in-
dicating that the data from the whole microarray are a good reflection of the
damage induction throughout the genome. This confirms the efficacy of the
microarrays in detecting genome wide damage events.
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Figure 6.2: CPD damage profile: A section of chromosome 1 showing the
predicted (red) and actual (black) microarray CPD values. Probe positions
are shown with grey circles. ORFs are shown as yellow boxes with the arrow
indicating the direction of transcription.
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Figure 6.3: CPD damage scatter plot: The relationship between the predicted
and actual microarray CPD values for each of the probes on the G4493A
microarray. The darker the blue colour the more points occur in the region.
Individual points outside of the central region are shown with dots. The
black line shows y = x.
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6.6.1 Comparisons
There are several possible reasons the correlation value is not higher than
0.77. One is that there are genuine biological differences between the actual
and predicted values. Another is that the level of inherent variation in the mi-
croarrays is such that even if the true biological values are exactly predicted
by the algorithm, they may not be shown as such on the microarrays. In
this case, taking the average of several normalised datasets will improve the
correlation as some of the variation will be cancelled out. This only provides
a limited solution with the two currently available datasets. Another reason
may be the inverse of this; that the microarray data are accurate but the
prediction is not, due to factors such as variations in the ratio of induction of
DNA damage at the different dipyrimidine sites. These scenarios are not mu-
tually exclusive and so both could be contributing. These ideas were tested
by examining the variation between the actual and predicted values. Work-
ing under the assumption that the prediction is fully accurate throughout
the whole genome and the microarray data vary, these variations will cause
approximately equal numbers of predicted values to be lower and higher than
the true biological values, thereby reducing the observed correlation coeffi-
cient. The same would be true under the assumptions that the microarray
data are fully accurate and the prediction varies, or that both have some level
of variation, as the variations would occur randomly throughout the datasets.
Alternatively, it is possible that there are some regions of the genome which,
for various biological reasons, have higher or lower levels of in vivo damage
induction. These will therefore deviate from the predicted values, reducing
the observed correlation coefficient. In this case the differences are unlikely
to all be random, with some focussed in regions representative of hot or cold
spots of damage.
To identify any such regions, the differences between the predicted and
actual damage values were calculated. If the differences between the two
sets of values are due to random variations as a result of inherent variations
in the microarray technology, random variations in the locations of damage
throughout the genome, and inaccuracies in the prediction method, it is
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reasonable to assume these will follow a normal distribution. Specific regions
of increased or decreased damage are likely to fall outside of this normal
distribution and so can be found by standard outlier detection methodologies.
The differences are shown as a histogram in Figure 6.4. The normal
distribution curve added to this histogram with the mean and standard de-
viation calculated from the differences (0 and 0.7 respectively) shows that
the majority of the difference values approximate the normal distribution.
This suggests that the majority of damage events throughout the genome
occur at the expected rate and are not in areas of specifically increased or
decreased damage.
Plotting the differences as a Q-Q plot shows that some difference values
at the ends of the range deviate from a normal distribution (Figure 6.5). This
suggests that there are probes with variations in the levels of damage beyond
that which would be expected if the variations arose entirely at random. The
plot shows that most of these probes have higher values, representing more
damage, than the prediction.
Outlier detection was used to identify the probes that deviate away from
the expected normal distribution. The “extremevalues” package (van der
Loo, 2010) was used to determine these values, which estimates the under-
lying distribution of the values and uses the properties of this to determine
outliers. A Q-Q plot highlighting these detected outliers (Figure 6.6, pro-
duced using the extremeValues package) shows that the the remainder closely
follow the expected normal distribution. The outlier detection identified 115
probes (0.28% of the total). Visual analysis of the positions of these probes
showed that the majority occur at the beginnings and ends of chromosome
probe regions, where the prediction is consistently low, suggesting that it is
not acurate in these regions (all detected outlying probes are highlighed with
red crosses in the plot of predicted and actual CPD values in “CPD predicted
and actual profile.pdf” in the electronic appendix; see Page 367). It is also
possible that the probe quality is lower in these regions because telomeres
contain repetative sequences, potentially reducing the reliability of some of
the probe values. Other deviating probes tend to occur individually or in
short consecutive regions, which appear to cluster together. Chromosomes
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1 and 6, for example, have several such sites, whereas those betwen have
none. It is possible that the deviation from the prediction at these points is
due to genuine biological changes in the induction of damage at these sites.
However, more testing would be required to gain further evidence for this.
A similar analysis was undertaken with 2 replicate cisplatin induced DNA
damage microarray datasets, produced by James Powell (PhD thesis in pro-
duction). This is a chemotherapeutic drug which produces adducts at a
number of sequence specific sites, of which an antibody against GG adducts
was employed. The prediction was run for GG sites accordingly, which gave
a Spearman’s rank correlation value of 0.55. A total of 57 outlying differ-
ence values were found for these data. As with the CPD data, many out-
lying differences were found at the ends of chromosomes, further suggesting
the prediction and/or the microarrays are unreliable in these regions. The
remainder are isolated sites of small numbers of probes, different to those
identified in the CPD data. Once again, these may be indicative of regions
at which the damage induction rate is different to the rest of the genome, but
more evidence is required. The whole genome plot of predicted and actual
damage, highlighting probes detected as outliers, is provided in “Cisplatin
predicted and actual profile.pdf” in the electronic appendix (see Page 367).
These findings suggest that generally CPD and cisplatin DNA damage in-
duction occurs at a uniform level throughout the genome (taking into account
sequence variations), and that any potential hot or cold spots of damage are
at a level below the detection threshold of the microarrays. Many of the out-
lying differences between the predicted and actual microarray values appear
to be as a result of inconsistencies in the prediction, the microarray probe
values, or a combination of the two. A higher resolution microarray may
enable a more sensitive analysis, as would some additional biological repli-
cate datasets (work which is currently being undertaken in our laboratory).
These data may be combined with a more stringent outlier detection method
to provide a more robust analysis. It may also be possible to use the mi-
croarray data to refine the ratios of damage induction used in the prediction
to improve its accuracy.
Aside from the outlying difference values, which requires more data for
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further investigation, it is evident that the prediction method developed here
is able to generate accurate representations of genome wide DNA damage
induction. It is also clear that this novel use of microarrays is able to de-
tect varying damage induction throughout whole genomes and therefore has
the potential to be able to detect variations in damage levels from a set of
predicted values, which may have important biological implications.
6.6.2 Uses
The primary application for this type of assay is to measure DNA damage
levels and analyse repair rates throughout whole genomes. There are many
additional potential uses for the technology. In pharmacology, analysing
how DNA and chromatin binding drugs localise, interact and perform in
response to damaging agents in the human genome could indicate how they
operate, whether or not they reach their intended targets, or if there is any
non-specific or off-target binding, all in the context of local DNA repair
rates. In pharmacogenomics, analysing drug target sites and the relationship
with repair in individual genomes could show whether or not a given drug
is suitable for a particular person (stratified medicine). In drug discovery,
analysing the effects of novel compounds on repair rates could reveal new
therapeutic agents to be used in the fight against cancer. Analysing where
different proteins bind, or are prevented from binding, and how this affects
DNA repair rates in cancer genomes may provide useful prognostic tools,
cancer biomarkers and the determination of the response to the drug.
Analysing repair rates alone could also help to identify coding and other
important regions of the human genome. Currently the total number of genes
and their respective positions in the genome are not known. Additionally,
there may be important regulatory or other non-coding regions yet to be
identified. Regions of fast repair identified by this technology may be in-
dicative of these regions, either due to TC-NER operating in undiscovered
transcribed regions or as the cell prioritises repair by some other mechanism
in important non-coding regions.
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Figure 6.4: Histogram of predicted and actual differences: The frequencies of
difference values between the predicted and actual CPD microarray values.
The red line shows the normal distribution calculated from the mean and
standard deviation of the difference values.
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Figure 6.5: Q-Q plot of predicted and actual differences: The difference quan-
tiles and theoretical normal distribution quantiles are shown with dots. The
red line represents normally distributed data. The majority of the difference
values follow this line, with a small deviation at the low end and a large
deviation at the high end.
292
SECTION 6.6 CHAPTER 6
l
l
l
l
l
l
ll
lllll
l
ll
lll
l
l
l
l
l
l
l
l
ll
l
l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
ll
l
ll
l l
l l
ll
l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l lll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
−2 0 2
−
5
0
5
10
Theoretical Quantiles
D
iff
e
re
n
ce
 Q
ua
nt
ile
s
Figure 6.6: Q-Q plot of predicted and actual non-outlier differences: The
difference quantiles and theoretical normal distribution quantiles. The black
points represent normally distributed data while the red points show detected
outliers. The black line represents normally distributed data. The majority
of the difference values follow this line showing they approximate a normal
distribution.
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6.7 Discussion
The formula and its application to predict the profile of damage created by
a sequence specific damaging agent presented here has enabled the confir-
mation that microarrays can detect genome wide damage levels. This has
been shown for CPDs (Teng et al., 2011) and is also currently being used
to investigate damage induced by chemotherapeutic platinating agents, with
similar results. This validation of microarray technology for DNA damage
detection is important in the field of DNA damage research as it allows a new
way to analyse damage events at a high resolution throughout a genome.
Comparisons between the predicted CPD levels following UV irradiation
and the actual values from the microarrays allowed an estimation of signif-
icant differences between the two to be determined. This was based on the
assumption that random differences between the two, due to noise in the
microarray data, inaccuracies in the prediction, or a combination of the two,
would follow a normal distribution. Non-random, and therefore potentially
biologically relevant, differences may have indicated regions of damage above
or below the expected level. Outlier detection was used to identify any such
regions, which found only a relatively small number of probes, which were
not linked to biologically significant variations. The same conclusions were
drawn from a similar analysis of cisplatin induced DNA damage data. These
analyses need to be repeated with more replicate datasets to confirm the
findings.
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Genome wide analysis of the
binding site locations of the
Abf1 protein
7.1 Introduction
Abf1 is an essential yeast general regulatory factor (GRF) with multiple roles
in the cell (Buchman et al., 1988; Fourel et al., 2002; Lascaris et al., 2000;
Loo et al., 1995; Miyake et al., 2002; Rhode et al., 1992), including GG-NER
(Reed et al., 1999). Genome wide binding site investigations have been un-
dertaken previously (Lee et al., 2002; Harbison et al., 2004; Schlecht et al.,
2008) which have revealed around 1,500 sites. The microarrays employed in
these investigations were of a lower resolution than the Agilent G4493A mi-
croarrays, and so these have been used here to to conduce a higher resolution
analysis than previously undertaken. Genome wide Abf1 binding ChIP-chip
datasets from before and after UV-irradiation were created and investigated
by Dr. Matthew Leadbitter (Leadbitter, 2011). Those same datasets have
been reanalysed here with a focus on the unirradiated datasets. The in-
vestigation here uses the previously described bioinformatic tools to analyse
Abf1 binding. The objective of this analysis was to demonstrate the tools’
applications to real ChIP-chip data, to analyse these results to identify any
novel information about the genome wide binding properties of Abf1 and to
compare these results to those of previously published investigations.
295
CHAPTER 7 SECTION 7.2
7.2 Methods
7.2.1 Generation of data
All ChIP-chip microarrays analysed in this chapter were created by Dr.
Matthew Leadbitter. This process is detailed in Leadbitter (2011) and out-
lined in Chapter 2. Briefly, an antibody against the Abf1 protein was used in
the immunoprecipitation procedure, which was carried out on yeast BY4742
cells with no UV treatment (U), immediately following UV treatment (0)
and 30 min following UV treatment (30). Three biological replicates were
carried out for each time point, generating nine datasets. The file names of
these are shown in Table 7.1 and the raw data files are provided in the “Abf1
microarray datasets” folder in the electronic appendix (see Page 367).
File name Description
Abf1 U 1.txt No UV treatment replicate 1
Abf1 U 2.txt No UV treatment replicate 2
Abf1 U 3.txt No UV treatment replicate 3
Abf1 0 1.txt 0 minutes after UV treatment replicate 1
Abf1 0 2.txt 0 minutes after UV treatment replicate 2
Abf1 0 3.txt 0 minutes after UV treatment replicate 3
Abf1 30 1.txt 30 minutes after UV treatment replicate 1
Abf1 30 2.txt 30 minutes after UV treatment replicate 2
Abf1 30 3.txt 30 minutes after UV treatment replicate 3
Table 7.1: Abf1 ChIP-chip datasets: dataset file names used in this investi-
gation and available in the accompanying electronic appendix (see Page 367).
7.2.2 Data validation
The checkData function was used to check the quality of the microarray
datasets. The results of this are provided in “check.pdf” in the electronic
appendix (see Page 367) and show that the data are of good quality, with no
suggestions of any reasons not to use any of the datasets. All nine files were
therefore loaded into R and used throughout the remainder of this analysis.
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7.2.3 Data normalisation
All data were normalised using the procedure described in Chapter 4. This
process removes probe values known to be irrelevant, namely from the mito-
chondrial genome and deleted genes, quantile normalises replicate datasets,
shifts the new distributions’ pseudo-modes to zero and scales the distribu-
tions to make the negative part of the distribution approximate the equivalent
part of the normal distribution.
7.2.4 Peak detection
Peak detection was carried out with each set of normalised replicate datasets
using the enrichment detected method described in Chapter 5 to determine
potential sites of Abf1 binding. All datasets for each condition were analysed
together using the optimal settings determined in Chapter 5: a window size of
1 (shown to produce the best peak detection results with multiple datasets),
an FDRE value of 0.9 (the optimal balance of sensitivity and specificity) and
no scaling (unnecessary because the data appear to meet the expectations
of the enrichment detection algorithm). The function was set to find peaks
and therefore the results were returned as three new peakList objects; one
for each of the three experimental conditions investigated.
7.2.5 Hypergeometric distribution
The hypergeometric probability function phyper in R was used to calculate
the significance of overlaps between different groups of genes, based on the
total number of ORFs loaded by the loadAnnotation function, which is
7,071. The four arguments of the function (q, m, n, and k) were provided
as the number of overlapping gene names between this and the published
investigation being compared, the total number of genes in the published
investigation, 7,071 - the total number of genes in the published investigation
(such that m + n = 7,071) and the number of gene names found in this
investigation, respectively. The result was subtracted from 1 to get the p-
value.
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7.2.6 Sequence extraction
The enrichment detection function, when set to detect peaks, provides an
estimate of the PBR — the region likely to contain the genuine binding site
leading to the creation of the peak. These estimates (chromosome numbers
and start and end coordinates) were used to extract sequences for each PBR
with the getSequences function. The UCSC sacCer3 (April 2011) genome
release was used for this, downloaded using tools from the BSgenome package.
7.2.7 Sequence analysis
Extracted sequences were written to files in the FASTA format and analysed
with BioProspector (Liu et al., 2001). All sequences are provided in “Se-
quences at detected PBRs.fasta” in the electronic appendix (see Page 367).
For each FASTA file, the program was run twice, varying the setting to search
for motifs present in all sequences. Running the program under the condi-
tion that the motif does not have to be present in every sequence allows the
strongest motif results to be found, which may or may not be present in all
of the sequences in the file. Running the program under the condition that
the motif must be present in every sequence allows the motif represented
the most in all sequences to be determined, which may be different from
the strongest motif. Searches for a single, continuous sequence were carried
out with a width of 15, 2 positions greater than the length of the current
consensus. Searches carried out for two discrete sequences were carried out
using two widths of 6 and a gap between them ranging from 3 to 7, making
the maximum analysed sequence length 19. All other settings were left as
defaults, each search returning the top 5 motif results.
7.2.8 Motif logo creation
Binding motifs discovered during the sequence analysis were converted to
graphical forms for display using WebLogo version 3.3 (http://weblogo.
threeplusone.com; Crooks et al., 2004), setting the sequence type to ‘DNA’,
base composition to ‘S. cerevisiae’, colour scheme to ‘classic’, and using all
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other default settings. This allows the prevalence of the different bases at
each site to be visualised. Each position shows a stack of bases, displayed in
different colours, the heights of which represent the frequency of occurrence of
each base at each position. The overall height at each position corresponds to
the bit score (y axis), representing the sequence conservation at the position.
Therefore if all bases appear randomly at a site the height of the stack will
be at or close to zero, representing no sequence conservation at the site. If
the same base(s) frequently occur(s) at a site the height of the stack will
increase and the most frequent base(s) will be indicated in the stack in the
proportion in which they are found. This enables more information about
a binding site sequence to be visualised than a consensus sequence alone.
Motifs are assigned a score, as described by Liu et al. (2001), with higher
values representing more robust results.
7.2.9 Ganapathi data
The downloaded microarray data from Ganapathi et al. (2011) is provided in
BAR file format. This is an Affymetrix file format (details available at http:
//www.affymetrix.com/support/developer/powertools/changelog/gcos-
agcc/bar.html) which cannot be read by standard programs. They were
therefore converted to tab-delimited text files using a tool available in the
CisGenome package (Ji et al., 2008). This was downloaded as a ZIP file and
extracted to a known location. The Windows command line editor was used
to navigate to the ‘bin’ folder in this location. From here the affy bar2txt
program was run with each of the BAR files, converting them to text files.
These text files contain three columns: the chromosome number, a single
coordinate for the probe and the probe value. The data from these text files
were used for all analyses.
The microarrays used in this investigation were a much higher resolution
that those used to create the Abf1 binding data analysed here (3,115,004
probes compared to 41,775). In order to make comparisons between the
two, the Affymetrix data was reduced to the locations of the probes one the
Agilent G4493A microarrays. This was achieved with the approx function
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in R, which interpolates values from a dataset at a given set of positions. In
this way values from the Affymetrix data were approximated at the locations
of the Agilent probes, allowing the two datasets to be compared optimally.
As the resolution of the Affymetrix microarray is so much higher than the
Agilent, the majority of these interpolated values should map very closely to
actual probe values.
The two sets of Abf1 binding sites determined in this investigation and
by Ganapathi et al. (2011) are presented as coordinates. These were used
to compare the two sets of results. The Ganapathi et al. (2011) regions are
much shorter than the PBRs determined in this investigation (median length
of 65 compared to 307), as a result of the higher array resolution. Therefore
any two sets of coordinates sharing any overlap were deemed to represent the
same region and therefore the same Abf1 binding site.
7.3 Results
7.3.1 Data validation
The output of the checkData function for the first untreated dataset is shown
in Figure 7.1 and are provided in “check.pdf” in the electronic appendix (see
Page 367). All were visually examined and found to be within reasonable
limits, as described in Section 3.2.2. The pseudo-images of the red and green
channels do not show any signs indicative of artifacts on or damage to the
microarray surface. The final dataset (Abf1 u 3.txt) shows a small area of
reduced hybridisation in both channels in the lower left-hand corner, but not
at a level that gives cause for concern. As both channels look to have the
same pattern of reduced hybridisation the ratio between the two should not
be adversely affected.
The box plots show the bulk of the signal intensity values to be within the
expected range, around a log2 signal intensity of 15, which is consistent with
all microarray datasets produced in our laboratory. There are no large differ-
ences between the red and green intensity values for each dataset, suggesting
the labellings and hybridisations were equally effective in both channels. The
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Figure 7.1: Abf1 checkData output: quality control plots for the first Abf1
dataset, showing the data to be of good quality suitable for further analysis.
All plots are provided in the electronic appendix (see Page 367).
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small number of outlying values, mostly at the lower end of the scale, are
likely due to probes known to be unreliable, such as those for the mitochon-
drial genome, which will be removed as part of the normalisation process.
The scatter plots show consistent one-to-one relationships between the
data from the two channels, with the bulk of the data around the log2 signal
intensity value of 15, as before. This confirms the data from the box plots
and suggests that there is not a large amount of dye bias present between
the two samples. The region extending from the bulk of the data towards
the red signal region of the graph represents binding sites of Abf1, where the
red signal intensities are higher that the green. This area is present in all
datasets and confirms the presence of a large number of binding regions, as
would be expected.
The shapes of the distributions of the signal intensities are smooth, indi-
cating no unusual effects. Once again, the medians are centred around the
expected region of a signal intensity of 15. The input sample (green) distri-
butions are uniform, as is expected for the total genomic DNA, while the IP
sample (red) distributions are skewed to the right, as is expected because a
subset of the genetic material is present in increased amounts.
The distributions of log2 ratios are all similar and of the expected shape,
with no major distortions. The left hand skew is due to the higher sig-
nal intensities of immunoprecipitated material seen in the distribution of
red signal intensities. Many datasets have the median centred around zero,
which is to be expected as this region should represent the background, non-
immunoprecipitated, regions. It does not pose a problem however that some
are not centred around this region, as this is one of the factors corrected for
in the normalisation procedure (see Chapter 4). On the basis of these QC
checks it was decided that all nine datasets were suitable for loading into R
for analysis.
7.3.2 Consequences of normalisation
The effect of the normalisation procedure on the shape of the density plots
of all datasets can be seen by comparing the density distributions of the
302
SECTION 7.3 CHAPTER 7
raw and fully normalised datasets (Figures 7.2 and 7.3), where each set of
replicates is shown as a different colour. The nine raw datasets are not
all aligned together, with several pseudo-modes lying away from zero. The
fully normalised data shows all pseudo-modes align at zero. The replicate
datasets appear as single lines as the quantile normalisation procedure has
caused them to follow the same distributions. The left hand side of the
distributions, below zero, align closely together as a result of their being
scaled to follow the standard normal distribution over this region. As there
is only a small amount of variation between the raw datasets, the main effect
of the procedure has been to increase the binding values as a result of the
background scaling procedure.
Plots along a 30 kb section of chromosome 1 (Figures 7.4 and 7.5) show the
effects on a small section of data in the context of the genome. In this instance
the normalisation procedure has not caused large changes in the data, that is
to say, they were close to the optimal state that the normalisation attempts
to achieve before the process was applied.
The raw data points for each replicate dataset were plotted against their
normalised values to visualise the changes caused by the normalisation (Fig-
ure 7.6 A-C). Values removed by the normalisation procedure are not plotted.
All datasets produced similar, reasonably straight lines in these plots, show-
ing them to follow similar distributions which the normalisation procedure
did not change. They all deviate markedly from the line y = x as a result
of the scaling procedure. These results match with the expected result of
the normalisation, given that the distributions of the raw datasets were very
similar.
Plotting the averages of the three replicates of each dataset (Figure 7.6
D) shows the relationships between the different conditions before and after
normalisation. Again, this shows little difference between the datasets, es-
pecially towards the upper half of the data. The red line (0 min after UV
treatment) deviates from the other two in the lower half of the raw data,
which is corrected for in the normalised data.
Plotting the three untreated datasets against each other (Figure 7.7)
shows that the three replicates are very consistent. The Spearman’s cor-
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Figure 7.2: Raw Abf1 data density plots: The three biological repeats are
shown for each of the no UV treatment (black), immediately following UV
treatment (red) and 30 min following UV treatment (green) Abf1 binding
datasets.
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Figure 7.3: Normalised Abf1 data density plots: The three biological repeats
are shown for each of the no UV treatment (red) and 30 min following UV
treatment (green) Abf1 binding datasets. As quantile normalisation makes
datasets follow the same distribution, the three lines for each dataset overlap
each other and appear as a single line.
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Figure 7.4: Raw Abf1 data profile: A section of chromosome 1 showing each
of the no UV treatment (black), immediately following UV treatment (red)
and 30 min following UV treatment (green) Abf1 binding datasets.
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Figure 7.5: Normalised Abf1 data profile: A section of chromosome 1 showing
each of the no UV treatment (black), immediately following UV treatment
(red) and 30 min following UV treatment (green) Abf1 binding datasets. The
normalisation procedure has reduced the variation in the background regions
(coordinates ∼40,000 to ∼43,000 for example) and altered the order datasets
appear at the top of some of the peaks. The scaling of the datasets has
increased the binding values of the peaks by around 4 times.
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Figure 7.6: Effect of normalisation on averaged Abf1 data: Scatter plots of
the three replicates each (black, red and green points) of no UV treatment
(A), 0 min after UV treatment (B) and 30 min after UV treatment (C)
datasets, and the averages of the no UV treatment (black), 0 min after UV
treatment (red) and 30 min after UV treatment (green) dataset (D) before
and after normalisation. The grey line shows y = x. The relatively straight
lines of data indicate that the normalisation procedure has not had a large
effect on the shape of most of the data, with only a small number of points
deviating from this trend.
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relation values show good reproducibility, suggesting the data are well suited
to the enrichment detection procedure.
7.3.3 Peak detection
Peak detection was carried out for each set of replicates. The numbers of
peaks found for each condition are shown in Table 7.2.
Venn diagrams were created to display the relationships between these
datasets (Figures 7.8 and 7.9) with the venn function, which provides two
methods for creating Venn diagrams from the results of the enrichment de-
tection algorithm (Section 3.2.7.2). Briefly, the first method uses only the
probes determined to be at the tops of the averaged peaks, created by av-
eraging all replicate datasets. The numbers therefore represent the numbers
of probes falling into each of the categories. The second method uses the
PBRs of each peak, which may extend beyond the probe at the centre of the
average peak. The numbers therefore represent regions falling into each of
the categories, where an overlap between two regions, as well as a complete
match, counts as a peak occurring in both datasets. The relative pros and
cons of each method are discussed in Section 3.2.7.2. It is felt that for the
purposes of this investigation the overlapping diagram is more informative as
it is likely that peaks differing by a single probe will be caused by the same
Abf1 binding site and therefore should be counted once.
Both diagrams show that the majority of peaks do not change between
the different conditions. This matches a previous analysis of these datasets
(Leadbitter, 2011) which concluded that there were no significant UV-induced
changes in Abf1 binding sites. The peaks that are not common to all datasets
were determined to be either present in all datasets, but at a level slightly
below the detection threshold in one or more, or present in all datasets but at
adjacent probes so that they appear as separate peaks but are likely caused
by the same binding site. A full analysis and explanation is available in
Leadbitter (2011) and these analyses will not be repeated here. The data
are included to show the consistency of Abf1 binding across nine biological
repeat datasets under three different experimental conditions. This suggests
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Figure 7.7: Abf1 data correlations: The darker the blue colour the more
points occur in the region. Individual points outside of the central region
are shown with dots. The black line shows y = x. The Spearman’s rank
correlation value is shown above each plot.
Condition Number of peaks detected
No UV treatment 4369
0 minutes after UV treatment 4261
30 minutes after UV treatment 3489
Table 7.2: Numbers of Abf1 binding peaks detected
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Figure 7.8: Venn diagram of Abf1 peaks: The relationship between the no
UV treatment (red) 0 min after UV treatment (green) and 30 min after UV
treatment (blue) Abf1 binding datasets based on the probes at the centres
of the peaks as determined by the enrichment detection algorithm.
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Figure 7.9: Venn diagram of overlapping Abf1 peaks: The relationship be-
tween the no UV treatment (red) 0 min after UV treatment (green) and
30 min after UV treatment (blue) Abf1 binding datasets based on overlaps
between potential binding regions determined by the enrichment detection
algorithm.
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that Abf1 binding is targeted to certain points in the genome, the majority
of which do not then vary under these different conditions.
Visualisation of the changes in peak heights, rather than positions, was
achieved with a rainbow plot (Figure 7.10). Here each peak in the untreated
dataset is represented by a line, which tracks the peak height across the
next two time points. The no UV and 0 min after UV treatment data are
very similar, visible by the colour transition being similar in both columns.
Many peaks show a deviation 30 min after UV treatment, both up and down,
visible by the expanded range of binding values in the final column. These
results are confirmed with scatter plots which show that the no UV and 0
min samples are similar (Figure 7.11A), while there is more variation between
these and the 30 min sample (Figures 7.11B and C). The general trend is for
lower values in the 30 min sample.
To confirm that the peak detection process had worked correctly the
profilePlot function was used to create a plot of all 4,369 detected regions
(Figure 7.12A). A second profile plot of 4,369 randomly generated probes was
also created for comparison (Figure 7.12B). Each individual line is shown
in black and it can be seen that the detected regions show a clear peak
shape centred around the probes determined to be at the tops of the peaks.
The trend line, calculated from all lines and shown in red, follows the same
pattern. This shows that the average peak has a height of a log2 binding
value of ∼7 and a width at the base of ∼2000 nt. Beyond this, towards
the extremes of the plot region, all values are centered around zero with no
visible peaks. This shows that these are background, unbound regions. The
plots of randomly generated sites do not show any pattern, with all black
lines falling randomly across the width of the graph. The red trend line is
flat across the width of the graph, showing no pattern is present. Taken
together, these results show that the peak detection process has found only
regions of genuine peaks.
The number of potential binding sites detected in this investigation is
far greater than those identified in previous investigations, which prompted
the analysis of the sequences around the binding sites to determine whether
or not they contained the consensus binding sequence previously identified
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Figure 7.10: Rainbow plot of Abf1 peak changes: Representation of the
changes in the peak heights between the untreated, 0 min after UV and 30
min after UV datasets. Each line represents one peak found in the untreated
dataset and shows how it varies after 0 and 30 min. It can be seen that the 30
min dataset is very similar to the untreated dataset. There is some variation
in the 0 min dataset, with many peak values increasing and decreasing by
reasonably large amounts.
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Figure 7.11: Scatter plots of Abf1 peak changes: The relationships between
the peak heights in the untreated, 0 min after UV and 30 min after UV
datasets. The red line shows y = x. The general trend is for lower values in
the 30 min sample than the no UV or 0 min. The no UV and 0 min samples
are very similar.
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Figure 7.12: Abf1 peaks profile plot: All 4,369 detected peaks (A) and 4,369
random probes (B). All individual lines shown in black; trend line shown in
red. Data are averages of the three replicates. The detected peaks are clearly
visible, centred around the probe determined to be at the top of the peak.
The random probes show no pattern.
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(Rhode et al., 1992).
7.3.4 Genomic binding site locations
The previous analysis of this Abf1 binding data by Leadbitter (2011) showed
that binding peaks occur preferentially in promoter regions of genes. This
analysis was undertaken using the genome location information provided
by Agilent in the results of the feature extraction files, which labels each
probe according to its relation to its nearest ORF(s). This enabled a genome
description of each peak to be extracted and analysed. Statistical analysis
showed a significant over-representation of peaks in promoter regions, which
was corroborated by visual analysis of the plots with respect to gene positions.
The analysis here improves on this with the use of the findGene func-
tion. This determines the genome position of each probe to return results
similar to those listed above, but taken from up to date annotation data and
alongside further positional information. This was used in conjunction with
the positionsPlot function to create Figure 7.13, which shows the positions
of the Abf1 binding sites relative to the start or end of the ORF they are
determined to be located at or near. It can be seen by the large peak in the
density plot around the ORF start position (0) that the majority of peaks
occur at this location, with another significant proportion in downstream
regions. Several peaks also occur inside ORFs, some several thousand nu-
cleotides into the gene. It is possible that many of the genuine binding sites
are in promoter regions but the limited resolution of ChIP-chip means that
those close to the ORF start are recorded as falling withing ORFs. The bar
chart shows ∼75% of the peaks occur in promoters or inside genes. Around
half of the promoter regions are divergent. The remaining ∼25% fall in down-
stream regions. A smaller proportion of these regions (∼25%) are divergent.
It appears from this graph that most of the larger peaks fall in intergenic
regions, and there is a trend for smaller peaks further into genes. There are
still however a number of small peaks around the ORF start and end sites.
The results were filtered to examine the PBRs most likely to contain
genuine Abf1 binding sites. Three strict criteria were used to extract only
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the peaks most likely to be generated by strong Abf1 binding sites: peaks
must be present at the same probe in all three replicate datasets, increasing
the likelihood that the peak is centred around a genuine binding site; the
height of the peak must be greater than 5, meaning it represents a region of
reasonably high Abf1 binding; and the PBR length must be less than 200,
meaning it comes from a region of reasonably high probe coverage where the
data should be more reliable than regions covered by few probes. This left
160 peaks. The positional data of these is shown in Figure 7.14. As before,
most peaks are located around ORF start sites with some at ORF end sites.
The percentage of those inside ORFs has reduced while the percentage in
promoter regions has increased, maintaining the same proportion of divergent
at ∼50%. The percentage in downstream regions has remained approximately
the same. There are still some binding peaks several thousand nucleotides
into ORFs. Nearly all of the tallest peaks occur in intergenic regions and
once again the trend is for smaller peaks further into ORFs.
The method used to generate these results identifies the nearest ORF
to a binding site. Many of the intergenic sites labelled as downstream may
therefore be within promoter regions of other ORFs, the start sites of which
are further away. To remove these potential discrepancies, the plots were
created with only those sites labelled as divergent, for which this problem
does not apply. These are shown in “positionsPlots.pdf” in the electronic ap-
pendix (see Page 367), for total and filtered PBRs respectively, which show
a similar pattern to those in Figures 7.13 and 7.14. This shows that Abf1
binds throughout the genome, including inside ORFs and in non-promoter
intergenic regions, which are likely related to its functions aside from tran-
scriptional regulation.
7.3.5 Comparison with other datasets
Several previous studies have examined Abf1 binding genome wide. These
are summarised in Table 7.3 and described in Section 1.4.4.
The results of this study were compared with these previously published
data. It is immediately apparent that far more PBRs have been identified in
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Figure 7.13: Abf1 binding site locations: All 4,369 Abf1 peak positions rela-
tive to their nearest gene. Top panel shows the density of the peak positions
and percentage of peaks falling into the three categories of promoter, inside
(an ORF) and downstream. The middle panel shows the peak positions plot-
ted against the peak heights. Position 0 indicates the ORF start. Position
13,110 indicates the ORF end; this is the furthest into an ORF a peak is
found. The bottom panel shows the percentage of probes falling into each
category; light shading indicates divergent regions.
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Figure 7.14: Filtered Abf1 binding site locations: The 124 filtered Abf1 peak
positions relative to their nearest gene. Top panel shows the density of the
peak positions and percentage of peaks falling into the three categories of
promoter, inside (an ORF) and downstream. The middle panel shows the
peak positions plotted against the peak heights. Position 0 indicates the
ORF start. Position 6,278 indicates the ORF end; this is the furthest into
an ORF a peak is found. The bottom panel shows the percentage of probes
falling into each category; light shading indicates divergent regions.
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this study than previously. This may be due to limited microarray resolution,
especially so with earlier studies, and/or the application of strict statistical
criteria causing the removal of many genuine binding sites. It is the case
in some studies that results were filtered on the basis of the presence of
the consensus binding sequence, potentially removing genuine binding sites
lacking this. Direct comparisons of the results of the studies is difficult, as
each presents their data in a different format. The earlier studies (Lee et al.,
2002; Harbison et al., 2004; Schlecht et al., 2008) report only a gene name
for each binding site, referring to the analysed promoters found to contain
peaks. Comparisons of gene names can be difficult for many reasons. Genes
can have multiple names (standard and systematic in the case of yeast) and
so the genes being compared must be in the same format. Gene names can
be changed in light of new findings, and so names reported in older studies
may not now be correct. Additionally, genes can be very long, potentially
with multiple binding sites associated with them, and so it may not be clear
to which site a name refers.
These limitations notwithstanding, comparisons were made between the
previous early datasets and the results from this study. The peaks found in
this study were assigned a gene name using the findGene function, based on
their closest ORF, which produced 3,589 unique gene names. Where neces-
sary, gene names were converted to systematic names using the YeastMine
tool on the SGD website (http://yeastmine.yeastgenome.org/yeastmine/
begin.do). These systematic names were then compared between the datasets,
with the resulting overlaps shown in Figure 7.15. Each dataset is represented
in a different oval, and the number of gene names found in each possible over-
lapping category is shown. There is surprisingly little similarity between the
datasets, with only 213 gene names appearing in all four. The overlaps be-
tween this study and those of Lee et al. (2002), Harbison et al. (2004) and
Schlecht et al. (2008) are all 59%. The significance of the overlaps between
the results of this study and the published three were determined by use of
the hypergeometric distribution. This found that all overlaps are significant,
with p values of 2.43 × 10−13 (Schlecht et al., 2008), 4.23 × 10−5 (Harbison
et al., 2004) and 1.14× 10−4 (Lee et al., 2002).
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Study Number of Abf1 binding sites found
Lee et al. (2002) 458
Harbison et al. (2004) 468
Schlecht et al. (2008) 1428
Ganapathi et al. (2011) 1035
Table 7.3: Abf1 binding sites found in previous studies.
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Figure 7.15: Previously published Abf1 comparisons: Diagram showing the
relatedness between 3 previously published Abf1 binding datasets (Lee et al.
(2002), Harbison et al. (2004) and Schlecht et al. (2008)) and this study.
Note areas are not representative of dataset sizes.
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The results of this study were next compared with those of Ganapathi
et al. (2011), which report results as coordinates and provide all microarray
data, allowing a higher resolution comparison to be made. All data were
first compared visually with a scatter plot. Both sets of available data were
plotted against the data from this study: actual microarray values (Figure
7.16A) and calculated p-values (Figure 7.16B). These plots indicate no corre-
lations between either the microarray values or p-values, which is confirmed
with Spearman’s correlation coefficients of 0.05 and -0.04 respectively. In
this investigation Abf1 binding sites were measured indirectly, by analysing
nucleosome positions in the WT and temperature sensitive binding mutant
abf1-1. Significant changes in nucleosome positions between the two were
taken to be as a result of the loss of Abf1 binding and therefore indicative of
Abf1 binding sites. As the datasets are so different they may not be directly
comparable in this way which may explain the lack of any correlation.
The locations determined by the authors to be significant, and therefore
representative of Abf1 binding, were next compared to the PBRs determined
in this investigation. These locations are presented as coordinates, as are
the PBRs, allowing direct comparisons between the two. Of the 1,035 re-
gions provided by Ganapathi et al. (2011) in their list of significant sites, 446
(43%) overlap with probe positions on the Agilent microarray identified as
binding sites here, which is statistically significant by the hyper geometric
distribution with a p-value approaching zero. These points are highlighed
in the scatter plots of Figure 7.16 with large black dots. These are spread
randomly throughout the significant regions of the two datasets, with no
association between the two. Many of the sites have high p-values as de-
termined by Ganapathi et al. (2011) (Figure 7.16B), suggesting that the
mapping of values from the Affymetrix to Agilent datasets carried out here
may not be accurate. However, as with the previous analyses, there is a
statistically significant overlap between the Abf1 binding sites identified in
the two analyses.
It was shown in the investigation by Schlecht et al. (2008) that Abf1
binding sites can vary under different cellular conditions. It is also likely be
the case that they vary between different strains of S. cerevisiae. Some of the
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Figure 7.16: Ganapathi et. al.’s data: Scatter plots showing the relationship
between the data of Ganapathi et al. (2011) (Affymetrix data) and this in-
vestigation (Agilent data). A: values from the microarrays. B: calculated
p-values. Darker blue colours show more dense regions of points; isolated
single points are shown with small black dots. Large black dots show regions
determined to be statistically significant and therefore indicative of Abf1
binding sites.
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discrepancies seen here may therefore be due to variations in the procedures
between the different laboratories performing the investigations. This would
mean that there are many more potential Abf1 binding sites in S. cerevisiae
than have Abf1 bound at any given time.
7.3.6 Sequences at binding sites
An analysis of the yeast genome was undertaken to find the total number
of occurrences of the consensus sequence RTCRYNNNNNACG. A script was
written in R to search the UCSC sacCer3 (April 2011) genome assembly using
tools from the Biostrings package (H et al.). This found 1,785 instances
of the consensus; less than half the number of peaks found. Even taking
into account the fact that some of the PBRs detected in this investigation
may not represent genuine Abf1 binding sites, it is likely that not all of
the Abf1 binding sites can contain the motif. An analysis of these regions
was therefore undertaken to determine if they contain any additional, novel
consensus sequences.
The sequences at PBRs were extracted, using the coordinates from the
peakList, and examined for consensus sequences with BioProspector. The
properties of the PBRs are shown in Table 7.4.
The sequences themselves were first examined for the presence of the
consensus motif. This found 1,034 instances of the motif in 927 of the PBRs,
detailed in Table 7.5. This shows that the majority of the PBRs (79%) do
not contain the consensus motif. Additionally, a large proportion of the total
motifs (42%) do not appear to be associated with an Abf1 binding peak. As
discussed above, it is possible that some or all of these sites have the potential
to be bound by Abf1, but are not under the conditions used here.
Position plots were created from the PBRs with and without the consen-
sus motif, which show a similar pattern to those in Figures 7.13 and 7.14
(shown in “positionsPlots.pdf” in the electronic appendix; see Page 367).
This shows that binding sites relative to ORFs are not associated with the
presence of the consensus motif, or lack thereof.
BioProspector was first run with only the 927 sequences known to contain
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Median length Shortest length Longest length
307 159 9472
Table 7.4: Abf1 PBR lengths: statistical summaries of all detected Abf1
PBRs.
Number of motifs Number of sequences
0 3442
1 832
2 84
3 10
4 1
Table 7.5: Abf1 PBR motif counts: Numbers of detected Abf1 PBRs contain-
ing different numbers of the consensus motif sequence RTCRYNNNNNACG.
324
SECTION 7.3 CHAPTER 7
the consensus sequence, in order to test its performance. The top results of
these runs are shown in Figure 7.17. The top logo shows the best result when
not requiring the algorithm to find a motif in every sequence. The bottom
logo shows the best result when the algorithm is required to find the motif in
every sequence. These show that the program is reliable, since it is able to
discern these known motifs from the remainder of the sequence, with motif
scores of 4.444 and 4.415 respectively. There is little difference between the
appearance of the two logos, showing that in this case the program works
equally well with both settings. The remainder of the results (shown in “All
BioProspector motifs.pdf” the electronic appendix; see Page 367) also all
find the same motif.
The program was then run with all of the 4,369 PBRs to determine if
any motifs are identifiable in these total sequences. The top logos are shown
in Figure 7.18 and have scores of 4.346 and 2.162 respectively. This analysis
did not find the previously identified consensus Abf1 binding site with either
condition. All motifs found in this way contained variants of repeat TA
regions, likely to be caused by TATA boxes present in promoter regions, the
most common region of Abf1 binding. The remainder of the results (shown
in “All BioProspector motifs.pdf” in the electronic appendix; see Page 367)
show similar results, with no indication of any other motif(s) present in the
sequences.
It is possible that other binding motifs may be present in the PBR se-
quences, but the number of additional sequences without them present pre-
vents them being identified by this method. Of the 160 previously filtered
PBRs thought most likely to represent genuine binding sites, 29% contain
the motif (details in Table 7.6). All of these were therefore analysed for the
presence of other motifs. The top sequence logos are shown in Figure 7.19
and have scores of 2.600 and 1.911 respectively. These show the consensus
motif has been identified in this subset of sequences. The remainder of the
results (shown in “All Bioprospector motifs.pdf” in the electronic appendix;
see Page 367) repeatedly find the consensus, with no other motif identified.
This suggested that even at the sites selected here to represent strong Abf1
binding, some other factor(s), independent of sequence, is(are) influencing
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Figure 7.17: Sequence logos from PBRs containing the consensus: Results
where motif is not (top) and is (bottom) required to be present in every
sequence, created from 927 sequences known to contain the consensus Abf1
binding sequence RTCRYNNNNNACG.
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Figure 7.18: Sequence logos from all PBRs: Results where motif is not (top)
and is (bottom) required to be present in every sequence, created from 4,369
sequences from every identified Abf1 PBR.
326
SECTION 7.3 CHAPTER 7
the binding.
Finally, sequences known not to contain the consensus motif were anal-
ysed, to see if any other motif(s) could be identified, without the presence
of the currently known consensus to confound the results. All 3,442 PBRs
were first analysed, and the logos (Figure 7.20 (scores of 4.165 and 2.312)
and “All BioProspector motifs.pdf” in the electronic appendix) show similar
results to those of the total sequences, in that only TATA box-like sequences
appear to have been identified. The procedure was also carried out allowing
a variable gap region between the two motif blocks, to allow any sequences of
variable lengths to be identified, which with respect to the consensus motif
would be in the format XRTCRY[N]3−7ACGXXX, where N represents a non-
conserved base and X a conserved base. (Figure 7.21 and “All BioProspector
motifs.pdf” in the electronic appendix). This method produced the highest
motif scores of all searches (5.063 and 4.439 respectively) but once again
consists of conserved A and T bases, appearing to be relate to the TATA
box.
The same analysis was carried out with the 113 filtered sequences with-
out the consensus motif (Figures 7.22 and 7.23 and “All BioProspector mo-
tifs.pdf” in the electronic appendix). The fixed width sequence logos (scores
of 2.305 and 1.866) show a high proportion of A/T nucleotides, but different
from the previous TATA box-like sequences. There is no indication of a novel
consensus. The sequence logos with variable gap regions (scores of 3.021 and
2.972) show more conservation at several sites, with many positions having
high bit scores. However, these are not as high as the results from the PBRs
containing the known motif, and although individual bases have high scores
there do not appear to be any novel consensus motifs.
It was investigated whether there is a relationship between the number
of motifs in a PBR and the height of the corresponding peak (Figure 7.24A).
The sequences with more motifs tend to come from PBRs with higher peaks,
as shown by the increasing positions of the box plots. However, there are
still a large number of sites with no or few motifs that have high peaks.
Adjusting for the length of the PBR (Figure 7.24B), to take account of the
increasing chance of multiple motifs appearing in longer sequences, reduces
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Number of motifs Number of sequences
0 113
1 43
2 4
Table 7.6: Filtered Abf1 PBR motif counts: Numbers of filtered detected
Abf1 PBRs containing different numbers of the consensus motif sequence
RTCCTYNNNNNACG.
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Figure 7.19: Sequence logos from filtered PBRs: Results where motif is not
(top) and is (bottom) required to be present in every sequence, created from
160 filtered PBRs thought most likely to represent genuine Abf1 binding
sites, showing the consensus Abf1 binding sequence RTCRYNNNNNACG
has been identified.
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Figure 7.20: Sequence logos from PBRs without the consensus: Results where
motif is not (top) and is (bottom) required to be present in every sequence,
created from 3,442 sequences known not to contain the consensus Abf1 bind-
ing sequence RTCRYNNNNNACG.
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Figure 7.21: Sequence logos with variable gap regions from PBRs without
the consensus: Results where motif is not (top) and is (bottom) required
to be present in every sequence, allowing a gap region of 6–10 nt between
blocks, created from 3,442 sequences known not to contain the consensus
Abf1 binding sequence RTCRYNNNNNACG.
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Figure 7.22: Sequence logos from filtered PBRs without the consensus: Re-
sults where motif is not (top) and is (bottom) required to be present in
every sequence, created from 113 filtered sequences known not to contain the
consensus Abf1 binding sequence RTCRYNNNNNACG.
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Figure 7.23: Sequence logos with variable gap regions from filtered PBRs
without the consensus: Results where motif is not (top) and is (bottom)
required to be present in every sequence, allowing a gap region of 6–10 nt
between blocks, created from 113 filtered sequences known not to contain the
consensus Abf1 binding sequence RTCRYNNNNNACG.
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this relationship, but the general trend is still apparent. This shows that the
PBRs containing motifs tend to contain peaks of greater height, but similar
peaks also exist in the absence of the motif.
It is possible that the PBRs calculated by the peak detection script are
too narrow, excluding some motif sites which contribute to Abf1 binding from
the analysed sequence. It was therefore investigated whether or not motif
sites close to, but maybe not within, PBRs have an influence on the peak.
For each peak, the gap between the probe at its centre and the nearest motif
site was calculated. These gap values are plotted against the peak heights in
Figure 7.25. This plot shows that there are a large number of peaks, some
with high binding values, far from a motif site. The 160 peaks determined
by the strict filtering applied earlier are highlighted in red and can be seen
to be scattered throughout the dataset, showing that many of these are also
situated far from a motif site. Taken together these results show that many
Abf1 PBRs do not contain the consensus motif, and this does not seem to
have a detrimental effect on the ability of Abf1 to bind the region.
These results suggest that there are not other sequence motifs causing
the binding of Abf1 in the regions examined. It also suggests that Abf1
binding is not influenced by another protein binding to its own consensus
sequence, as it is likely this would have been identified. Previous studies
have found Abf1 to bind to motifs similar, but not identical, to the consen-
sus. Schroeder and Weil (1998), for example, showed Abf1 to bind to the
sequence RTARYNNNNNACG, with the C changed to an A at the third
position. Analysing the PBRs without the consensus sequence for this mod-
ified sequence found 263 with at least one instance. If Abf1 is able to bind
to other sequences with a single base different from the consensus this will
not be visually detectable in the logos. In this case no true consensus se-
quence would exist, because the sequence would be degenerate, in which
every position could be any base, and so would be represented with an ‘N’.
The consensus provides the basis of this sequence. All possible combinations
of the degenerate sequence with single base changes were searched for, both
genome wide and within PBRs. Based on the fraction of the genome rep-
resented in PBRs, the expected number of these motifs in and out of PBRs
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Figure 7.24: Abf1 peak heights and numbers of motifs: Box plots (A) showing
the heights of peaks with different numbers of motifs present in their PBRs.
The width of the box plot is proportional to the number of peaks present
in the sample. For clarity the final box plot is highlighted with a red circle.
The same data is shown with an adjustment the for the length of the PBR
(B).
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Figure 7.25: Gaps between Abf1 peaks and motifs: Scatter plot showing the
size of gaps between Abf1 peaks and their nearest motif site against peak
heights. Red points indicate 159 peaks identified by a strict filtering as the
most likely to represent genuine binding sites.
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was calculated. This was compared to the observed numbers with the Chi-
squared test. This showed that all sequences, as well as the complete motif,
are statistically significantly overrepresented in PBRs. By way of a com-
parison, random sequences in a similar format to the motif were generated,
searched for and tested in the same way. These did not produce statistically
significant results (data not shown).
7.4 Discussion
These datasets have previously been analysed to investigate the role of Abf1
in GG-NER (Leadbitter, 2011), where it was shown that Abf1 preferentially
binds at promoters, the Rad16 protein colocalises to these sites and Rad16
dependent UV-induced H3Ac occurs at these sites. Preliminary data also
suggest there may be changes in the DNA binding kinetics of Abf1 following
UV irradiation, and a number of sites showed reduced binding levels 30 min
after UV irradiation.
The investigation here used the same data to focus on Abf1 binding with-
out any UV treatment, and has shown that there are many more Abf1 binding
sites in the yeast genome than have previously been identified. Comparisons
of this data with previously published genome wide investigations of Abf1
binding (Lee et al., 2002; Harbison et al., 2004; Schlecht et al., 2008; Ganap-
athi et al., 2011) have shown statistically significant overlaps, albeit through
indirect comparisons, using either gene names, which may relate to different
binding sites over the length of the gene, or by the mapping of an Affymetrix
dataset onto the Agilent dataset created here, which may introduce errors
into the data. There are still numerous sites found uniquely in the differ-
ent investigations, suggesting that Abf1 binding is variable and dynamic,
with thousands of potential binding sites throughout the genome, mainly
in promoter regions but also within genes and in downstream regions, not
all of which are bound by Abf1 in the conditions analysed in the different
investigations.
Previous studies have shown that Abf1 is able to bind at sites other
than those containing the consensus binding motif RTCRYNNNNNACG,
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(Schroeder and Weil, 1998; Ganapathi et al., 2011, for example). Analy-
sis of the sequences at binding sites in this investigation also showed that
many do not contain this motif. In fact, the number of consensus sites
in the whole genome is less than half of the number of peaks identified,
clearly suggesting that Abf1 is able to bind at sites other than those con-
taining this motif. No novel motif could be identified at the sites without
the consensus motif. There may be many possible reasons for this. One
is that a novel motif is present, but the BioProspector software used was
unable to identify it. This is unlikely, as the software was shown to be
able to correctly identify the current consensus sequence. The filtered se-
quences were also run through a second piece of software, MEME (http:
//meme.nbcr.net/meme/cgi-bin/meme.cgi; Bailey et al., 2009), which was
not able to identify any other motif (results shown in “meme.pdf” in the ac-
companying electronic appendix; see Page 367). Another is that there is no
novel motif, and a factor independent of sequence causes Abf1 binding. This
may be related to the TATA box, whereby proteins binding at these sites,
such as transcription factors, facilitate the binding of Abf1. Alternatively,
Abf1 may be able to recognise and directly bind TATA-box like sequences.
However, only ∼20% of yeast promoters have been shown to contain a TATA
box (Basehoar et al., 2004), which would not account for the numbers of
Abf1 binding sites identified here. Finally, Abf1 may be binding to varia-
tions of the consensus sequence, as has been previously shown at a small
number of sites. If Abf1 was able to bind at the consensus with a variation
at any position, this may not show up in the sequence logos as there will
not be any consistency accross the sequences. A statistical analysis of these
sequences in the PBRs suggests that they are overrepresented and therefore
may be having an influence on Abf1 binding. Visual analysis of the actual
sequences detected by BioProspector does not indicate that this is the case
in all PBRs, with many identified sequences varying from the consensus at
multiple positions.
As previously discussed, ChIP-chip is a hypothesis generating technology
whose results need to be confirmed by complementary techniques. Here the
hypothesis is that Abf1 is able to bind to DNA at sites other than those
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containing its known consensus binding motif RTCRYNNNNNACG. In order
to gain evidence for this, binding at a number of these sites needs to be
confirmed by other methods. These other methods would also allow a higher
resolution analysis of the binding region to be determined, giving a better
indication of the DNA sequence bound. There is evidence that some proteins
are able to bind to degenerate binding sites bearing little resemblance to their
consensus sequence (for example, Baumruker et al., 1988) and change their
structural confirmation to fit different variations of their consensus sequence
(for example, Phillips and Luisi, 2000). It may be that Abf1 has a similar
propensity, which may account for its apparent ubiquitous binding profile
and the inability here to identify a novel consensus binding sequence.
In the context of GG-NER, Abf1 is hypothesised to act to locate the
Rad7/Rad16 complex at its binding sites in the absence of damage. The
alternative, previously held view was that the complex only associated with
DNA following the induction of damage. Having the complex bound to DNA
at all times theoretically increases the speed at which the cell can respond to
and repair damage. The complex may translocate from these binding sites
either a short distance, having a distant effect, or a long distance, possibly to
sites of damage, to initiate the repair process. Previous work suggests this is
unidirectional. In this scenario, it is advantageous for Abf1 to be bound reg-
ularly throughout the genome, positioning the GG-NER machinery to act at
any damage site. 20% of the genome is within 400 nt of an Abf1 binding site
identified here which, not taking into account the orientation of the binding
sites, means GG-NER over this proportion of the genome can be influenced
by the previously identified 400 nt window of repair unidirectionally from
an Abf1 binding site. It is possible that the domain of repair is longer than
400 nt at some Abf1 binding sites, increasing the proportion of the genome
accessible to repair by the complex.
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Conclusions and future work
Tools
The bioinformatic tools presented in Chapter 3 provide a way of loading and
analysing data in R. They are intended to provide a complete, integrated
set of tools for these procedures, allowing basic analyses to be undertaken
by people with little previous experience of bioinformatic data analysis or R,
whilst maintaining the scope for more advanced analyses. They have been
tested and used extensively in our laboratory, by people with a range of pre-
vious bioinformatic experience. The tools proved to be useful in generating
results that have been used in publications, PhD theses, both complete and
ongoing, and various other reports, posters and presentations. They have
shown themselves to be simple enough to allow their use, along with the
instructions, without significant additional support, thus achieving both of
their key objectives.
The next step is to create a single R package containing these tools and
present this as a publication, a draft manuscript for which has already been
completed. Combining all the functions into a new package has many ad-
vantages over their current state, which are currently in separate files which
have to be manually loaded into R. A single package can be easily down-
loaded and installed from, for example, Bioconductor, making the functions
more accessible to the wider research community. Having this single entity
makes maintaining and updating the functions easier and ensures that all
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users have all of the most up to date functions at all times. This also allows
new packages to use functions presented here in their processing, if required.
Normalisation
The normalisation method presented in Chapter 4 allows multiple ChIP-chip
datasets from different conditions to be processed so as to allow comparisons
to be made between them. Previously this was not possible and ChIP-chip
investigations tended to either examine a single condition at a time, to de-
termine where a factor of interest is present in a genome, or make limited
comparisons between datasets from different conditions which could only dis-
tinguish the complete loss or gain of the factor at a given location from one
condition to another. Normalising the data in the way described here allows
relative changes in the level of the factor to be examined, opening up a new
dimension of analysis.
Work is ongoing to further validate and refine the procedure with other
quantitative technologies, such as Q-PCR. So far, two sets of data have been
validated in this way, showing the normalisation to be robust. The Gcn5
protein binding dataset is currently undergoing this validation.
The alternative normalisation method, using spiked DNA samples of vary-
ing concentrations, is still under development. Several spike samples have
now been created and these have been applied to several microarrays in or-
der to optimise their concentrations and conditions (work primarily carried
out by Dr. Katie Evans). Following this, samples of a range of optimal con-
centrations will begin to be analysed alongside real ChIP-chip data to develop
a methodology for their use in normalisation.
Enrichment detection
The enrichment detection method presented in Chapter 5 was developed to
fill a gap in the currently available enrichment detection software. There is
no one method that is able to work with ChIP-chip data from any microarray
platform, which the method presented here can do. It can also be used to
detect either regions of enrichment or peaks, depending on the type of data
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being analysed. It is fully integrated with the other functions presented here
and has been optimised for fast performance, allowing for easy generation
and presentation of results.
It has been tested with previously published spike datasets, developed for
testing different aspects of ChIP-chip technology and data analysis. The cal-
culated sensitivity and specificity values from these tests showed the method
to outperform previously published enrichment detection methods tested on
the same datasets. It was also tested with simulated ChIP-chip datasets,
created here for this purpose, which also produced good sensitivity and speci-
ficity values.
Some problems with the available datasets for the testing of enrichment
detection algorithms, such as that presented here, have been highlighted.
There is only one published set of ChIP-chip data created for the purposes
of testing and validating ChIP-chip procedures (Johnson et al., 2008), which
was shown here to be inconsistent between repeats. A simulated dataset
was also created here for testing the algorithm, but this will not necessarily
accurately represent a genuine ChIP-chip dataset. It may be advantageous
therefore to develop new datasets, where all sites of enrichment are known,
possibly using spiked DNA samples, to enable the more accurate testing and
refinement of enrichment detection algorithms.
Damage prediction
The damage prediction method presented in Chapter 6 has been invaluable in
our laboratory for developing and testing a novel use of ChIP-chip technology,
to detect DNA damage. Without the ability to compare microarray results
with the predicted profiles, it would not be possible to determine whether or
not the technology is working correctly, and displaying the results of damage,
or displaying only random noise. The prediction has been used to validate
microarray datasets examining damage created by UV radiation and the
chemotherapeutic drugs cisplatin and oxaliplatin. The R function has been
further optimised since its publication in 2011 and is now able to create these
predictions in seconds, rather than the hours previously required.
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Abf1 binding
The tools presented in this thesis have been used extensively to examine a
range of ChIP-chip datasets generated in our laboratory. They were used
in Chapter 7 to normalise, detect peaks, extract sequence information and
create graphical displays from Abf1 binding datasets. This showed that Abf1
appears to bind at many more sites throughout the genome than have pre-
viously been identified. Many of these sites do not contain the current Abf1
binding consensus sequence RTCRYNNNNNACG.
As explained previously, ChIP-chip is a hypothesis generating technol-
ogy which needs to be validated with other techniques. Some binding sites
containing the consensus have previously been validated using PCR by Dr.
Matthew Leadbitter. Some sites without the consensus also now need to
be tested with a suitable technology, both to confirm the results of the mi-
croarrays and to determine the sequence(s) at which Abf1 is binding. This
will help to answer the questions posed here as to whether there is a novel
Abf1 binding motif or whether some other factor is able to influence Abf1’s
binding, which may have implications in all of the functions of Abf1. The
information can also be incorporated into the current model of the mecha-
nisms of GG-NER. Further tests can be carried out, both genome wide with
the use of ChIP-chip and by other technologies, to determine if and how the
various binding sites influence DNA repair.
The future
Several diverse but related projects in our laboratory are using the bioin-
formatic tools presented here to analyse data. These include clinical and
industrial projects, as well as ongoing basic research. An investigation into
the genome wide profile of damage induced by the platinating chemothera-
peutic agents cisplatin and oxaliplatin, along with cellular responses to these
drugs, is being undertaken to better understand the actions of the drugs, with
a view being able to provide treatment programs tailored to individual pa-
tients based on their responses to these DNA damaging agents. This requires
ways of analysing multiple large datasets, making comparisons between them
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and extracting significant data, which might, for example, predict how a pa-
tient will respond to treatment. The tools described here allow analyses of
this type. An investigation will begin shortly with industrial partners into un-
derstanding how histone deacetylase inhibitors, which affect the epigenome,
lead to genotoxicity. This will also require the tools presented here, to be
able to determine factors such as where the drugs localise, where they then
act, how long they remain bound, what responses they induce and how they
influence DNA repair rates. The previous methods of analysis, enabling only
sites of binding to be identified, would not be sufficiently informative to al-
low these analyses. The basic research being undertaken in our laboratory is
into the mechanisms of the GG-NER pathway. Multiple ChIP-chip datasets
have been produced as part of this research, including histone acetylation,
the chromatin binding of proteins involved in the repair process, and DNA
damage itself. Further investigations will be carried out in this vein, in the
context of newly generated genome wide datasets, to enable a model of the
process to be made at the genome wide level, rather than at the short ge-
nomic regions that have been analysed previously. An analysis of this type
has been published by Leadbitter (2011).
ChIP-seq (chromatin immunoprecipitation followed by next generation
sequencing) is a developing technology which is likely to replace ChIP-chip in
the coming years. ChIP-chip is currently more accessible to most laboratories
as it is cheaper and less labour intensive. Some ChIP-seq data of DNA
damage have been produced in our laboratory. The tools developed here can
and have been adapted to analyse this type of data and can continue to be
updated and modified to do so. There is an increasing focus on integrating
different types of ’omics data produced on different platforms to be able to
analyse them together (Cutts et al., 2012, provide a recent example). This is
something that the tools presented here could be adapted to facilitate, given
that they are already able to load data from any source.
It is anticipated that two publications will be created from the work pre-
sented here, in addition to the already published work from Chapter 6. The
first will present the R scripts as a complete package, which will be made
publicly available for others to use through a platform such as Bioconductor.
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There is currently no other method available for the normalisation of ChIP-
chip datasets from different conditions so as to allow relative comparisons
to be made between them and so it is hoped that the tools presented here
will allow the wider research community to perform this process on their
own data to expand the current uses of ChIP-chip to produce novel results.
The second will present the Abf1 binding data, which has implications in the
variety of fields that Abf1 plays a role, including transcriptional regulation,
genome partitioning, replication and GG-NER. Abf1 is an important general
regulatory factor in the yeast genome and this updated, comprehensive anal-
ysis of genome wide binding sites will be significant for understanding how
this protein functions in the cell.
Over the coming years bioinformatics will become increasingly important
as larger and more detailed biological datasets are generated, which will re-
quire ever evolving computational tools for their analysis (Pepke et al., 2009;
Ji, 2011). The tools presented in this thesis cannot be viewed as an end
point, rather the foundations on which further tools can be based as new
avenues of investigation are revealed. In this way the field of bioinformatics
will increase both in depth, as the focus of investigations becomes ever more
narrow, and breadth, as the number of types of investigation that can be
carried out grows (Park, 2009). It is therefore important that the role of the
bioinformatician is not simply to take over the analysis of data generated by
biologists carrying out wet laboratory work, but to become actively involved
in the design of experiments, having a say over what is investigated and how
this is carried out, and any follow-up studies, in order to maximise the po-
tential of any data generated. As genome wide technologies become more
prevalent and next-generation sequencing becomes more accessible, comput-
ers should be viewed as another weapon in the biologists’ arsenal, as essential
as pipettes or gel rigs, rather than a specialist tool operated by people sep-
arate from those working at the bench. Thus the analysis of large datasets
should become a routine and expected part of everyday experimental biology,
with the distinction between ‘biologist’ and ‘bioinformatician’ becoming less
and less defined.
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